ASSTIS,CI,ASTT,ASST,ASCETY,ASSTY,ASSORGA,CONFSC,ASSSUBCELFRAC,TII,VARI,ASCAT,BFOR,DI,Desc,RELATT,ASSI,SRASI,CHEI,ASTI,CURAB,Ti,SRI
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,7524,,CHEMBL618647,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,N,7525,,CHEMBL618648,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,N,7526,,CHEMBL618649,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,7527,,CHEMBL618650,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,N,7528,,CHEMBL618651,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,N,7529,,CHEMBL876497,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,9866,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,7530,,CHEMBL618652,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,9866,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,N,7531,,CHEMBL618653,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,9866,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,N,7532,,CHEMBL618654,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6351,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,N,7533,,CHEMBL618655,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1465,Compound was tested for solubility in water,N,7534,,CHEMBL618656,10116.0,Intermediate,50597,1
,,,,,P,,0,,,,,BAO_0000100,5182,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),U,7535,,CHEMBL618657,,Intermediate,22229,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17847,Solubility was determined,N,7536,,CHEMBL618658,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15339,solubility in water (ug/mL) at 37 degree C.,N,7537,,CHEMBL618659,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5202,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,N,7538,,CHEMBL618660,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1088,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,N,7539,,CHEMBL618661,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3169,Half life in rats,N,7540,,CHEMBL873807,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5353,Half life in Dawley rat,N,7541,,CHEMBL618662,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2864,Half life period after 3 mg/kg iv administration,N,7542,,CHEMBL618663,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2864,Half life period after 3 mg/kg iv administration in rat,N,7543,,CHEMBL618664,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2864,Half life period after 3 mg/kg iv administration in the rat,N,7544,,CHEMBL618665,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6362,Half life period in female Sprague-Dawley rats,N,7545,,CHEMBL876498,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6249,Half life period in rat,N,7546,,CHEMBL618666,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3169,Half-life in rats was determined,N,7547,,CHEMBL620440,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3169,Half-life in rats with metabolic oxidation,N,7548,,CHEMBL620441,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3169,Half-life in rats,N,7549,,CHEMBL620442,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17260,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,7550,,CHEMBL620443,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17260,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,7551,,CHEMBL620444,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17260,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,7552,,CHEMBL620445,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17260,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,7553,,CHEMBL620446,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2879,Biological half-life measured in plasma of rat,N,7554,,CHEMBL620447,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2879,Biological half-life measured in plasma of rat; 22-25,N,7555,,CHEMBL621129,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2879,Biological half-life measured in plasma of rat; 9-16,N,7556,,CHEMBL621130,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3184,Compound was evaluated for its half life when administered intravenously in rat,N,7557,,CHEMBL873808,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4891,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,N,7558,,CHEMBL876598,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,N,7559,,CHEMBL621131,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5656,Half life (T1/2) after oral administration in rat,N,7560,,CHEMBL621132,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4413,Half life of compound after iv administration of 20 mg/kg dose in rat,N,7561,,CHEMBL621133,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3598,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,7562,,CHEMBL621312,10116.0,Expert,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17267,Half life of compound was determined in rat,N,7563,,CHEMBL621313,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,4727,Half life of compound was determined in rat blood,N,7564,,CHEMBL621314,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17651,Half life at 1 mg/kg was determined in rat,N,7565,,CHEMBL621315,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17651,Half life at 10 mg/kg was determined in rat,N,7566,,CHEMBL621316,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,401,Half life in rats,N,7567,,CHEMBL621317,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4942,Half life in rats in hours,N,7568,,CHEMBL621318,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17735,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,7569,,CHEMBL621319,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6056,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,N,7570,,CHEMBL621377,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5213,Half life was determined,N,7571,,CHEMBL621378,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6616,Half life after i.v. administration,N,7572,,CHEMBL876599,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5937,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,N,7573,,CHEMBL621379,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5819,Half life in rat plasma,N,7574,,CHEMBL621380,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5819,Half life in rat plasma; Not detected,N,7575,,CHEMBL621381,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6803,Half life in rats,N,7576,,CHEMBL618515,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17804,Half life period of compound was determined after peroral administration,N,7577,,CHEMBL618516,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17804,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,N,7578,,CHEMBL618517,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5948,Half life period in rat,N,7579,,CHEMBL618518,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1916,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,7580,,CHEMBL618519,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1916,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,7581,,CHEMBL618698,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1916,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,N,7582,,CHEMBL618862,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4890,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,7583,,CHEMBL618863,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17764,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,N,7584,,CHEMBL618864,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4727,Half life time in rat the dose of 2 mg/kg,N,7585,,CHEMBL618865,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Half-life 24 hr after 10 mg/kg iv administration in rats,N,7586,,CHEMBL618866,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Half-life 24 hr after 2 mg/kg iv administration in rats,N,7587,,CHEMBL618867,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6597,Half-life consistent with the observed metabolic steady state in rats,N,7588,,CHEMBL875828,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17735,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,7589,,CHEMBL618868,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6597,Half-life for oxidative metabolic stability was determined using male human,N,7590,,CHEMBL618869,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17670,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",N,7591,,CHEMBL618870,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1696,Half-life in rat plasma,N,7592,,CHEMBL618871,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1742,Half-life in rat plasma was determined,N,7593,,CHEMBL618872,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17800,Half-life in rats was determined,N,7594,,CHEMBL873816,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,U,7595,,CHEMBL618873,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11954,Area under curve after oral dose of 0.1 mg//kg,U,7596,,CHEMBL621602,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,11954,Area under curve after oral dose of 0.3 mg/kg,U,7597,,CHEMBL621603,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,11954,Area under curve after oral dose of 1 mg/kg,U,7598,,CHEMBL621604,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,11954,Area under curve after oral dose of 10 mg/kg,U,7599,,CHEMBL621605,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,11954,Area under curve after oral dose of 23.4 mg/kg,U,7600,,CHEMBL621606,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,11954,Area under curve after oral dose of 3 mg/kg,U,7601,,CHEMBL621607,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,11954,Area under curve after oral dose of 3.87 mg/kg,U,7602,,CHEMBL621608,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,5237,Area under curve was determined,U,7603,,CHEMBL621609,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,4026,Area under curve at a dose of 10 mg/kg,U,7604,,CHEMBL621610,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5237,Area under curve was determined; ND=No data,N,7605,,CHEMBL621611,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,7606,,CHEMBL621612,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,7607,,CHEMBL622308,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,7608,,CHEMBL622309,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,N,7609,,CHEMBL622310,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,7610,,CHEMBL622311,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,N,7611,,CHEMBL622312,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,7612,,CHEMBL622931,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,N,7613,,CHEMBL622932,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,7614,,CHEMBL622736,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,7615,,CHEMBL622737,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,7616,,CHEMBL622738,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,N,7617,,CHEMBL622739,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,7618,,CHEMBL622740,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,N,7619,,CHEMBL622741,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,7620,,CHEMBL622742,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,N,7621,,CHEMBL622743,10116.0,Intermediate,50597,1
Plasma,,,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,11637,AUC in mice,N,7622,,CHEMBL622744,10090.0,Intermediate,50594,1
,,,,,A,,0,,,,,BAO_0000019,11149,Area under curve was measured from the graph obtained from concentration Vs time,U,7623,,CHEMBL624134,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10016,Area under curve value of compound per hour after oral administration,U,7624,,CHEMBL624135,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17796,Area under curve was determined after oral administration in rats,N,7625,,CHEMBL624136,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17796,Area under curve was determined after oral administration in rats; No data,N,7626,,CHEMBL624137,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17796,Area under curve was determined after oral administration in rats;No data,N,7627,,CHEMBL624320,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12923,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,7628,,CHEMBL624321,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,N,7629,,CHEMBL624322,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Area under curve was determined for the compound after iv dose of 5.06 in rats,N,7630,,CHEMBL624323,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,N,7631,,CHEMBL624324,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,N,7632,,CHEMBL624325,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,N,7633,,CHEMBL624326,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,N,7634,,CHEMBL624327,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,N,7635,,CHEMBL624328,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14169,Area under curve was determined in Dogs after peroral administration,N,7636,,CHEMBL627848,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14169,Area under curve was determined in Rats after peroral administration,N,7637,,CHEMBL627849,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14258,Area under curve was determined in carotid blood of rat when administered intradermally,N,7638,,CHEMBL627850,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14258,Area under curve was determined in portal blood of rat when administered intradermally,N,7639,,CHEMBL627851,10116.0,Intermediate,50597,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,7640,,CHEMBL627852,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,7641,,CHEMBL627853,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,7642,,CHEMBL627854,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,7643,,CHEMBL627855,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),N,7644,,CHEMBL627856,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,7645,,CHEMBL875339,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),N,7646,,CHEMBL627857,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,N,7647,,CHEMBL627858,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,N,7648,,CHEMBL627859,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,N,7649,,CHEMBL627860,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,N,7650,,CHEMBL627019,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,N,7651,,CHEMBL627020,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,N,7652,,CHEMBL627021,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,N,7653,,CHEMBL627022,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,N,7654,,CHEMBL627023,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,N,7655,,CHEMBL627024,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,N,7656,,CHEMBL627025,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,N,7657,,CHEMBL627026,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,N,7658,,CHEMBL627027,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,N,7659,,CHEMBL627028,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,N,7660,,CHEMBL627029,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,N,7661,,CHEMBL627030,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,N,7662,,CHEMBL627031,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,N,7663,,CHEMBL627032,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,N,7664,,CHEMBL627033,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,N,7665,,CHEMBL627034,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,N,7666,,CHEMBL627035,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,N,7667,,CHEMBL627036,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,N,7668,,CHEMBL875340,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,N,7669,,CHEMBL627037,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,N,7670,,CHEMBL627038,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,N,7671,,CHEMBL627039,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,N,7672,,CHEMBL627040,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,N,7673,,CHEMBL624663,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,N,7674,,CHEMBL625963,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,N,7675,,CHEMBL876799,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,N,7676,,CHEMBL626133,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,N,7677,,CHEMBL626134,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6295,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,7678,,CHEMBL626135,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6296,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,7679,,CHEMBL626136,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6296,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,N,7680,,CHEMBL626137,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6295,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,7681,,CHEMBL626138,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6296,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,7682,,CHEMBL626139,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17260,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,7683,,CHEMBL626140,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17260,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,7684,,CHEMBL626141,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17686,C24h in rat p.o. at 20 mg/kg concentration,N,7685,,CHEMBL626142,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,7686,,CHEMBL627930,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,N,7687,,CHEMBL627931,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,N,7688,,CHEMBL627932,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,7689,,CHEMBL627933,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,N,7690,,CHEMBL627934,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,N,7691,,CHEMBL627935,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,7692,,CHEMBL627936,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,N,7693,,CHEMBL627937,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,7694,,CHEMBL627938,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,N,7695,,CHEMBL627939,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,N,7696,,CHEMBL627940,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,7697,,CHEMBL627941,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,7698,,CHEMBL876800,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,N,7699,,CHEMBL627942,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,7700,,CHEMBL627943,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,N,7701,,CHEMBL627944,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,N,7702,,CHEMBL627945,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,N,7703,,CHEMBL628584,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA at 15 min,N,7704,,CHEMBL628585,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,N,7705,,CHEMBL628586,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA at 30 min,N,7706,,CHEMBL628587,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,N,7707,,CHEMBL628588,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,N,7708,,CHEMBL628589,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,N,7709,,CHEMBL625304,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,N,7710,,CHEMBL625305,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,N,7711,,CHEMBL625306,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,N,7712,,CHEMBL625307,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,N,7713,,CHEMBL625308,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,N,7714,,CHEMBL627740,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,N,7715,,CHEMBL627741,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,7716,,CHEMBL627742,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,N,7717,,CHEMBL627743,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9866,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,N,7718,,CHEMBL627744,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,N,7719,,CHEMBL627745,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,7720,,CHEMBL627746,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,7721,,CHEMBL627747,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,N,7722,,CHEMBL876810,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,N,7723,,CHEMBL627748,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,7724,,CHEMBL627749,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,7725,,CHEMBL627750,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,N,7726,,CHEMBL618728,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,7727,,CHEMBL618729,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA at 15 min,N,7728,,CHEMBL618730,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,N,7729,,CHEMBL618731,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA at 30 min,N,7730,,CHEMBL618732,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,N,7731,,CHEMBL618733,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,N,7732,,CHEMBL618734,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,N,7733,,CHEMBL618735,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,N,7734,,CHEMBL876602,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,N,7735,,CHEMBL618736,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,N,7736,,CHEMBL618737,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,N,7737,,CHEMBL618738,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,N,7738,,CHEMBL618739,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,N,7739,,CHEMBL618740,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,7740,,CHEMBL618741,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,N,7741,,CHEMBL618742,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,9866,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,N,7742,,CHEMBL618743,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17752,Half-life from rat plasma at a single oral dose of 25 mg/kg,N,7743,,CHEMBL618744,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5610,Half-life in male rat,N,7744,,CHEMBL618745,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Half-life in rat after peroral administration at 10 mg/kg concentration,N,7745,,CHEMBL620479,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Half-life in rat after peroral administration at 5 mg/kg concentration,N,7746,,CHEMBL620480,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17771,Half-life in rat at a dose of 3 mg/kg,N,7747,,CHEMBL620481,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1974,Half-life was evaluated in rats,N,7748,,CHEMBL620482,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4239,Half-life was measured in rat,N,7749,,CHEMBL876603,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6681,Half-life period for the compound was determined in rats at 50 mg/kg dose,N,7750,,CHEMBL620483,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17752,Half-life period in rats after intravenous administration at 5 mg/kg,N,7751,,CHEMBL620484,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6046,Half-life period in rat at 10 mg/kg,N,7752,,CHEMBL620485,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",N,7753,,CHEMBL620486,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",N,7754,,CHEMBL620487,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",N,7755,,CHEMBL620488,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4727,Half-life time in rat the dose of 2 mg/kg,N,7756,,CHEMBL620489,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1088,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,N,7757,,CHEMBL620490,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5610,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,N,7758,,CHEMBL620491,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3032,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,7759,,CHEMBL876604,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5199,Oral half life was determined,N,7760,,CHEMBL620492,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14941,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",N,7761,,CHEMBL620493,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4408,Pharmacokinetic property (t1/2) in rat,N,7762,,CHEMBL620494,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2552,Plasma elimination half-life was determined,N,7763,,CHEMBL620495,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5199,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,7764,,CHEMBL620496,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15662,Plasma half life was observed after intravenous administration in rat,N,7765,,CHEMBL620497,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1465,Plasma half-life was determined,N,7766,,CHEMBL620498,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1446,Plasma half-life following oral administration in Fisher rats,N,7767,,CHEMBL620499,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6824,Plasma half-life in rat,N,7768,,CHEMBL620500,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17533,Plasmatic Half-life after intravenous administration to rat,N,7769,,CHEMBL873809,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5979,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,7770,,CHEMBL620501,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4689,Terminal half life after intravenous administration (1 mg/kg) in rat,N,7771,,CHEMBL620502,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4689,Terminal half life in Rat at a oral dose of 5 mg/kg,N,7772,,CHEMBL620503,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2463,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,7773,,CHEMBL620504,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4883,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,N,7774,,CHEMBL876605,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4883,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,N,7775,,CHEMBL620505,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15662,plasma half life was observed after intravenous administration in rat,N,7776,,CHEMBL873811,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3598,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,7777,,CHEMBL624016,10116.0,Expert,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4576,Half life of compound determined in rat,N,7778,,CHEMBL624017,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4576,Mean residence time determined in rat,N,7779,,CHEMBL624018,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4576,Plasma half life determined in rat,N,7780,,CHEMBL624019,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,4910,Compound was evaluated for Tmax in brain after intravenous administration in male rats,N,7781,,CHEMBL624020,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4891,Compound was evaluated for pharmacokinetic parameter maximum time period,N,7782,,CHEMBL624201,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,7783,,CHEMBL872528,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,7784,,CHEMBL624202,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,7785,,CHEMBL624203,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,7786,,CHEMBL624350,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,7787,,CHEMBL621320,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,7788,,CHEMBL621321,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4026,Maximum time (Tmax) required to reach Cmax in rats,N,7789,,CHEMBL621322,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4890,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,7790,,CHEMBL621323,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6571,Maximum time of clearance of compound in rats after peroral administration,N,7791,,CHEMBL621324,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4727,Maximum time at the dose of 2 mg/kg in rat,N,7792,,CHEMBL621325,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17651,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,N,7793,,CHEMBL875837,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17651,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,N,7794,,CHEMBL621326,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14465,Tmax in Guinea pig (PO dose),N,7795,,CHEMBL621327,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14941,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",N,7796,,CHEMBL621328,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5960,Pharmacokinetic parameter (Tmax) in rat,N,7797,,CHEMBL621329,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5022,Pharmacokinetic parameter (Tmax) was estimated,N,7798,,CHEMBL621330,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4408,Pharmacokinetic property (Tmax) in rat,N,7799,,CHEMBL621331,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5983,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,7800,,CHEMBL621332,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4689,T max in Rat at a oral dose of 5 mg/kg,N,7801,,CHEMBL621333,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,T max was determined at 10 mg/kg po dose in rats,N,7802,,CHEMBL621334,10116.0,Intermediate,50597,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),N,7803,,CHEMBL621335,10090.0,Intermediate,50594,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14180,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,N,7804,,CHEMBL621336,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14180,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,N,7805,,CHEMBL621337,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14599,Area under curve was measured after i.v. administration into Beagle dog.,N,7806,,CHEMBL621338,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14599,Area under curve was measured after iv administration into Beagle dog,N,7807,,CHEMBL875838,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14599,Area under curve was measured after po administration into Beagle dog,N,7808,,CHEMBL621339,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14599,Area under curve was measured after po administration into Beagle dog.,N,7809,,CHEMBL621340,9615.0,Intermediate,50588,1
,,,,,A,,0,,,,,BAO_0000218,15675,Area under curve was measured at peroral dose of 3 mg/kg,U,7810,,CHEMBL621341,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12706,Area under curve was measured by using concentration Vs time,U,7811,,CHEMBL621342,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12706,Area under curve was measured by using concentration Vs time; not tested,U,7812,,CHEMBL621343,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,9750,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),N,7813,,CHEMBL621344,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,9750,Area under curve(AUC) was measured in mice after oral administration.,N,7814,,CHEMBL621345,10090.0,Intermediate,50594,1
,,,,,A,,0,,,,,BAO_0000019,14691,Area under curve(AUC) value of the compound,U,7815,,CHEMBL621346,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14691,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,U,7816,,CHEMBL621347,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14691,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,N,7817,,CHEMBL621348,9615.0,Intermediate,50588,1
Blood,,,,,A,,0,,178.0,,,BAO_0000019,2939,Area under curve(carotid artery) was determined by the availability in blood,U,7818,,CHEMBL621349,,Autocuration,22224,1
Blood,,,,,A,,0,,178.0,,,BAO_0000019,2939,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,U,7819,,CHEMBL621350,,Autocuration,22224,1
Blood,,,,,A,,0,,178.0,,,BAO_0000019,2939,Area under curve(carotid artery) was determined by the availability in blood; No data,U,7820,,CHEMBL875839,,Autocuration,22224,1
Blood,,,,,A,,0,,178.0,,,BAO_0000019,2939,Area under curve(portal vein) was determined by the availability in blood,U,7821,,CHEMBL620211,,Autocuration,22224,1
Blood,,,,,A,,0,,178.0,,,BAO_0000019,2939,Area under curve(portal vein) was determined by the availability in blood; ND means no data,U,7822,,CHEMBL620212,,Autocuration,22224,1
Blood,,,,,A,,0,,178.0,,,BAO_0000019,2939,Area under curve(portal vein) was determined by the availability in blood; No data,U,7823,,CHEMBL620213,,Autocuration,22224,1
Plasma,,,,,A,Macaca mulatta,1,,1969.0,,,BAO_0000218,9552,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,7824,,CHEMBL620214,9544.0,Intermediate,50797,1
Plasma,,,,,A,Macaca mulatta,1,,1969.0,,,BAO_0000218,9552,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,7825,,CHEMBL620215,9544.0,Intermediate,50797,1
Plasma,,,,,A,Macaca mulatta,1,,1969.0,,,BAO_0000218,9552,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,N,7826,,CHEMBL620216,9544.0,Intermediate,50797,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,9552,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",N,7827,,CHEMBL620888,9615.0,Intermediate,50588,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,9552,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",N,7828,,CHEMBL620889,9615.0,Intermediate,50588,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000019,9552,Area under plasma concentration vs time curve observed in rats for 0-3 h,U,7829,,CHEMBL620890,,Autocuration,22224,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,11911,Area under plasma time curve determined in male rat,N,7830,,CHEMBL620891,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,16618,Area under the MAP curve measured over 5 min.,U,7831,,CHEMBL620892,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14387,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,N,7832,,CHEMBL621079,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14387,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,N,7833,,CHEMBL621080,10090.0,Intermediate,50594,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12836,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,N,7834,,CHEMBL621081,9615.0,Intermediate,50588,1
,,,,,A,Cricetinae,1,,,,,BAO_0000218,12836,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,N,7835,,CHEMBL621082,10026.0,Intermediate,100712,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12836,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,N,7836,,CHEMBL621083,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14339,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,N,7837,,CHEMBL621084,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14339,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,N,7838,,CHEMBL621085,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14339,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,N,7839,,CHEMBL621086,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,10524,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,7840,,CHEMBL621087,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9994,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),N,7841,,CHEMBL622607,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,11325,Serum AUC in marmosets (IV dose),N,7842,,CHEMBL622608,9615.0,Intermediate,50588,1
,,,,,A,,0,,,,,BAO_0000019,12536,Area under the curve after intravenous administration at a dose of 10 umol/kg,U,7843,,CHEMBL624481,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12536,Area under the curve after intravenous administration at a dose of 2 umol/kg,U,7844,,CHEMBL624482,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12536,Area under the curve after intravenous administration at a dose of 4 umol/kg,U,7845,,CHEMBL624483,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12536,Area under the curve after intravenous administration at a dose of 40 umol/kg,U,7846,,CHEMBL624484,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12536,Area under the curve after intravenous administration at a dose of 5 umol/kg,U,7847,,CHEMBL624485,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15556,Area under the curve for fumarate salt was evaluated in F344 Rats.,N,7848,,CHEMBL624486,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,2809,Area under the curve for the compound was calculated.,U,7849,,CHEMBL624487,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9511,Area under the curve in concentration/ time,U,7850,,CHEMBL624488,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12818,Area under the curve administered intraintestinal in rats.,N,7851,,CHEMBL624489,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12818,Area under the curve administered intravenously in rats.,N,7852,,CHEMBL625184,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,15118,Area under the curve during intravenous administration,U,7853,,CHEMBL625185,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15118,Area under the curve during intravenous administration; Not determined,U,7854,,CHEMBL875954,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15118,Area under the curve during systemic administration,U,7855,,CHEMBL625186,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15118,Area under the curve during systemic administration; Not determined,U,7856,,CHEMBL625187,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2632,Area under the curve was calculated for the compound.,U,7857,,CHEMBL625188,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,N,7858,,CHEMBL625189,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,N,7859,,CHEMBL625190,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,N,7860,,CHEMBL621733,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,N,7861,,CHEMBL621734,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11149,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,N,7862,,CHEMBL621735,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17796,Clearance of the drug was measured in the plasma of rat; No data,N,7863,,CHEMBL621736,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5247,The pharmacokinetic parameter plasma clearance in vivo in rats,N,7864,,CHEMBL621737,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4727,Plasma clearance at the dose of 2 mg/kg in rat,N,7865,,CHEMBL621738,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5654,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,7866,,CHEMBL622806,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5654,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,7867,,CHEMBL623519,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17260,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,7868,,CHEMBL623520,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17065,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,7869,,CHEMBL623521,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17671,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,7870,,CHEMBL623522,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6672,Clearance rate in rat,N,7871,,CHEMBL623523,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6673,Clearance rate in rat,N,7872,,CHEMBL623690,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,7873,,CHEMBL623691,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,7874,,CHEMBL623692,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,7875,,CHEMBL623693,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,7876,,CHEMBL623694,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4413,Clearance of compound after iv administration of 20 mg/kg dose in rat,N,7877,,CHEMBL623695,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,N,7878,,CHEMBL623696,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,N,7879,,CHEMBL623697,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Macaca mulatta,0,,1969.0,,,BAO_0000218,5005,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,7880,,CHEMBL623698,9544.0,Intermediate,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,0,,1969.0,,,BAO_0000218,5005,Compound was tested for its plasma clearance rate in Sprague Dawley rats,U,7881,,CHEMBL623699,10116.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15765,Mean (%CV) PK parameters for CL(mL/min/kg).,N,7882,,CHEMBL623700,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3747,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,N,7883,,CHEMBL623701,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16366,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,N,7884,,CHEMBL623702,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4199,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,N,7885,,CHEMBL623703,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17267,Plasma clearance in rat was determined,N,7886,,CHEMBL623704,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6535,Plasma clearance in rat after administration of 2 mg/kg iv,N,7887,,CHEMBL623705,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6535,Plasma clearance in rat after administration of 2 mg/kg iv,N,7888,,CHEMBL623706,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,Plasma clearance was determined,N,7889,,CHEMBL623707,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5960,Plasma clearance in rat,N,7890,,CHEMBL623708,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5937,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,N,7891,,CHEMBL623709,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5871,Plasma clearance in rat by iv administration,N,7892,,CHEMBL623710,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5874,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,N,7893,,CHEMBL623711,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6504,Plasma clearance in rat p.o.,N,7894,,CHEMBL623712,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6803,Plasma clearance in rats,N,7895,,CHEMBL623713,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,Plasma clearance was determined; ND denotes no data,N,7896,,CHEMBL623714,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,Plasma clearance was determined; ND denotes not determined,N,7897,,CHEMBL623715,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1916,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,7898,,CHEMBL623716,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5199,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,7899,,CHEMBL622980,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16367,Plasma administration to rats,N,7900,,CHEMBL622981,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6362,Plasma clearance of the compound in female Sprague-Dawley rats,N,7901,,CHEMBL622982,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15662,Plasma clearance was observed after intravenous administration in rat,N,7902,,CHEMBL622983,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6215,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,N,7903,,CHEMBL622984,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1466,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,N,7904,,CHEMBL622985,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15662,plasma clearance was observed after intravenous administration in rat,N,7905,,CHEMBL623631,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,In vivo CL/F determined,N,7906,,CHEMBL623632,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2792,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,N,7907,,CHEMBL623633,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2792,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,N,7908,,CHEMBL623634,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5213,Compound was tested for the lower blood clearance in rat,N,7909,,CHEMBL623635,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4687,Evaluated for the low clearance in rat (in vivo),N,7910,,CHEMBL621195,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3371,Pharmacokinetic property (CLb)of the compound was determined in rat,N,7911,,CHEMBL621196,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4690,Rapid clearance after intravenous administration in rat was determined,N,7912,,CHEMBL875287,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5702,Clearance measured in rat,N,7913,,CHEMBL621197,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,740,Compound was evaluated for plasma clearance in rat,N,7914,,CHEMBL621198,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4853,Low plasma clearance was calculated in rat,N,7915,,CHEMBL621199,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5789,Pharmacokinetic property (Clp) in rat,N,7916,,CHEMBL621200,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4527,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,N,7917,,CHEMBL621201,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4527,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,N,7918,,CHEMBL621202,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Plasma clearance after IV dosing at 0.5 mg/kg in rat,N,7919,,CHEMBL621203,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Plasma clearance after IV dosing at 1 mg/kg in rat,N,7920,,CHEMBL621204,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,N,7921,,CHEMBL621205,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,N,7922,,CHEMBL621206,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,7923,,CHEMBL621207,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,N,7924,,CHEMBL621208,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,N,7925,,CHEMBL621209,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,N,7926,,CHEMBL876484,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,7927,,CHEMBL621210,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,N,7928,,CHEMBL621211,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,7929,,CHEMBL621212,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA at 15 min,N,7930,,CHEMBL621213,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,N,7931,,CHEMBL621214,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA at 30 min,N,7932,,CHEMBL621215,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,N,7933,,CHEMBL621216,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,N,7934,,CHEMBL621217,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,N,7935,,CHEMBL621218,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,N,7936,,CHEMBL621219,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,N,7937,,CHEMBL621220,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,N,7938,,CHEMBL621221,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,N,7939,,CHEMBL621222,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,N,7940,,CHEMBL621223,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,N,7941,,CHEMBL876485,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,7942,,CHEMBL621224,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,N,7943,,CHEMBL621225,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9866,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,N,7944,,CHEMBL621226,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,N,7945,,CHEMBL621227,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,7946,,CHEMBL621228,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,7947,,CHEMBL621229,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,N,7948,,CHEMBL621230,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,7949,,CHEMBL621231,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,7950,,CHEMBL621232,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,7951,,CHEMBL621233,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,N,7952,,CHEMBL621234,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,7953,,CHEMBL621235,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,7954,,CHEMBL621236,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,N,7955,,CHEMBL621237,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,N,7956,,CHEMBL876486,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,9866,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,N,7957,,CHEMBL622436,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,9866,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,N,7958,,CHEMBL622437,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,9866,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,N,7959,,CHEMBL622438,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,N,7960,,CHEMBL622439,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,N,7961,,CHEMBL622440,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,N,7962,,CHEMBL622441,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,7963,,CHEMBL622442,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,N,7964,,CHEMBL622443,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,7965,,CHEMBL622444,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,N,7966,,CHEMBL622445,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,7967,,CHEMBL622446,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,7968,,CHEMBL622447,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,N,7969,,CHEMBL622448,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,7970,,CHEMBL622449,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,N,7971,,CHEMBL622450,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,N,7972,,CHEMBL622451,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA at 15 min,N,7973,,CHEMBL622452,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,N,7974,,CHEMBL622453,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA at 30 min,N,7975,,CHEMBL622454,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,N,7976,,CHEMBL622455,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,N,7977,,CHEMBL876024,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,T max was determined at 3 mg/kg po dose in rats,N,7978,,CHEMBL622456,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",N,7979,,CHEMBL622457,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",N,7980,,CHEMBL622458,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,N,7981,,CHEMBL622459,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,N,7982,,CHEMBL873343,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,N,7983,,CHEMBL622460,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4576,Time for maximum plasma concentration determined in rat,N,7984,,CHEMBL622461,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6681,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,7985,,CHEMBL622462,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,N,7986,,CHEMBL622463,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,N,7987,,CHEMBL622464,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,N,7988,,CHEMBL622465,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,N,7989,,CHEMBL622466,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,N,7990,,CHEMBL622467,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6824,Time of maximum plasma concentration in rat,N,7991,,CHEMBL622468,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,7992,,CHEMBL876025,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,7993,,CHEMBL622469,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,7994,,CHEMBL622470,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15662,Time required to reach maximum concentration (Cmax) after oral administration in rat,N,7995,,CHEMBL622471,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1742,Time required to reach maximum concentration in rat plasma,N,7996,,CHEMBL622472,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2774,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,7997,,CHEMBL622473,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5199,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,7998,,CHEMBL624282,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12873,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,7999,,CHEMBL624283,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12873,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,8000,,CHEMBL624284,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1916,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,8001,,CHEMBL624285,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16367,Time to reach Cmax after oral administration to rats,N,8002,,CHEMBL624286,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16366,Time to reach Cmax when a dose of 1 mg/kg is administered orally,N,8003,,CHEMBL624287,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,216,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,N,8004,,CHEMBL624288,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6410,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,N,8005,,CHEMBL624289,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6410,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,N,8006,,CHEMBL873344,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6215,Tmax after peroral administration (10 mg/kg) was determined in rat,N,8007,,CHEMBL619623,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3598,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,N,8008,,CHEMBL621399,10116.0,Expert,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4527,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,N,8009,,CHEMBL621400,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17670,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",N,8010,,CHEMBL621401,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1465,Tmax was determined,N,8011,,CHEMBL621402,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2552,Tmax was determined,N,8012,,CHEMBL621403,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5656,Tmax after oral administration in rat,N,8013,,CHEMBL621121,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17764,Tmax after peroral administration in rats at 2.4 uM/kg,N,8014,,CHEMBL872525,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5610,Tmax in male rat,N,8015,,CHEMBL621122,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6046,Tmax in rat at 10 mg/kg,N,8016,,CHEMBL621123,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5874,Tmax in rat by po administration at a dose of 40 mg/kg,N,8017,,CHEMBL621124,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17596,Tmax in rats,N,8018,,CHEMBL621125,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17804,Tmax was measured in rats after peroral administration at 5 mg/kg,N,8019,,CHEMBL621126,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1908,Tmax value after oral dose at a dose of 10 mg/kg in rats.,N,8020,,CHEMBL621127,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2959,Tmax value after administration of 20 mg/Kg oral dose in rat,N,8021,,CHEMBL621128,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6757,Tmax value at a dose of 10 mg/kg in male SD rats,N,8022,,CHEMBL618263,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6757,Tmax value at a dose of 100 mg/kg in male SD rats,N,8023,,CHEMBL618264,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6757,Tmax value at a dose of 50 mg/kg in male SD rats,N,8024,,CHEMBL618265,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4186,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,8025,,CHEMBL618266,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15662,time required to reach maximum concentration (Cmax) after oral administration in rat,N,8026,,CHEMBL618267,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),N,8027,,CHEMBL618450,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),N,8028,,CHEMBL618451,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5546,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,8029,,CHEMBL618452,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,3173,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,N,8030,,CHEMBL618453,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,3173,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,N,8031,,CHEMBL618454,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,3173,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,N,8032,,CHEMBL618455,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4257,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,N,8033,,CHEMBL618456,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6011,Compound distribution in rat tissues was determined,N,8034,,CHEMBL618457,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5472,Volume of distribution was evaluated in rat,N,8035,,CHEMBL618458,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,N,8036,,CHEMBL618459,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,N,8037,,CHEMBL876733,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,N,8038,,CHEMBL618460,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,N,8039,,CHEMBL618461,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,15469,Area under the curve was determined after oral administration (300 uM/Kg),U,8040,,CHEMBL618462,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,N,8041,,CHEMBL618463,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,N,8042,,CHEMBL618464,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,N,8043,,CHEMBL618465,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,N,8044,,CHEMBL618466,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,N,8045,,CHEMBL618467,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,N,8046,,CHEMBL618468,10116.0,Intermediate,50597,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,12935,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,N,8047,,CHEMBL618469,9615.0,Intermediate,50588,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,12935,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,N,8048,,CHEMBL618470,9615.0,Intermediate,50588,1
,,,,,A,,0,,,,,BAO_0000218,14813,Plasma drug AUC in rat (PO dose),U,8049,,CHEMBL618471,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15792,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,N,8050,,CHEMBL618472,10090.0,Intermediate,50594,1
,,,,,A,,0,,,,,BAO_0000218,3579,Area under was determined at a dose of 30 mg/kg,U,8051,,CHEMBL618473,,Autocuration,22224,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,12487,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,N,8052,,CHEMBL621699,9669.0,Intermediate,50506,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12487,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,N,8053,,CHEMBL621700,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12487,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,N,8054,,CHEMBL621701,10116.0,Intermediate,50597,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,12487,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,N,8055,,CHEMBL621702,9669.0,Intermediate,50506,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12487,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,N,8056,,CHEMBL621703,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12487,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,N,8057,,CHEMBL621704,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",N,8058,,CHEMBL624259,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",N,8059,,CHEMBL624260,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",N,8060,,CHEMBL624430,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",N,8061,,CHEMBL624431,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",N,8062,,CHEMBL624432,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",N,8063,,CHEMBL624433,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",N,8064,,CHEMBL624434,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",N,8065,,CHEMBL624435,10116.0,Intermediate,50597,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12745,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,N,8066,,CHEMBL618570,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12745,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,8067,,CHEMBL618571,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12745,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,N,8068,,CHEMBL618572,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12745,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,8069,,CHEMBL618573,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12745,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,N,8070,,CHEMBL619267,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12745,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,8071,,CHEMBL619431,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12745,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,N,8072,,CHEMBL619432,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12745,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,8073,,CHEMBL619433,10090.0,Intermediate,50594,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000218,13298,AUC in mice after oral dose (50 mg/kg),U,8074,,CHEMBL619434,,Autocuration,22224,1
Serum,,,,,A,Mus musculus,1,,1977.0,,,BAO_0000218,12226,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,N,8075,,CHEMBL619435,10090.0,Intermediate,50594,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000019,12634,AUC (0-4 hr) ug/ml/h,U,8076,,CHEMBL619436,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,N,8077,,CHEMBL619437,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,13889,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,U,8078,,CHEMBL619438,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,10018,Compound was evaluated for Area under curve in mice,N,8079,,CHEMBL619439,10090.0,Intermediate,50594,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,8080,,CHEMBL619440,10116.0,Intermediate,50597,1
,,,,,F,,0,,,,,BAO_0000218,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,U,8081,,CHEMBL619441,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8758,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,8082,,CHEMBL619442,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,U,8083,,CHEMBL875156,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,U,8084,,CHEMBL619443,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,U,8085,,CHEMBL619444,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,U,8086,,CHEMBL623464,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15115,Compound was evaluated for area under curve when administered through oral route in mouse,N,8087,,CHEMBL623465,10090.0,Intermediate,50594,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,N,8088,,CHEMBL623466,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,N,8089,,CHEMBL623467,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6249,Plasma clearance in rat,N,8090,,CHEMBL623468,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2463,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,8091,,CHEMBL622660,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4969,Plasma clearance rate in Sprague-Dawley rats,N,8092,,CHEMBL622661,10116.0,Intermediate,50597,1
,,In vivo,,,F,Rattus norvegicus,1,,,,,BAO_0000218,17720,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,N,8093,,CHEMBL622662,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3457,Pharmacokinetic property (total body clearance) in rat,N,8094,,CHEMBL622663,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5983,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,N,8095,,CHEMBL622664,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6295,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,8096,,CHEMBL622665,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6296,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,8097,,CHEMBL622666,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17686,Cl in rat i.v. at 2 mg/kg concentration,N,8098,,CHEMBL621615,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17764,Clearance of compound after intravenous administration in rats at 24 uM/kg,N,8099,,CHEMBL621616,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5503,Clearance was determined,N,8100,,CHEMBL621617,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4368,Clearance by intravenous administration of 3.4 mg/kg in rat,N,8101,,CHEMBL621618,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6005,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,8102,,CHEMBL621619,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5031,Clearance rate after i.v. administration in rats,N,8103,,CHEMBL621620,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4890,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,8104,,CHEMBL621786,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5182,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,8105,,CHEMBL621787,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5979,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,N,8106,,CHEMBL621788,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5656,Clearance (Cl) after oral administration in rat,N,8107,,CHEMBL621789,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17804,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,N,8108,,CHEMBL621790,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4839,Compound was tested for plasma clearance in rat,N,8109,,CHEMBL621791,10116.0,Intermediate,50597,1
,,In vitro,,,A,Rattus norvegicus,1,Microsomes,,,,BAO_0000218,5041,In vitro microsome metabolism clearance in rat was determined,N,8110,,CHEMBL621792,10116.0,Intermediate,50597,1
,,In vitro,,,A,Rattus norvegicus,1,Microsomes,,,,BAO_0000218,5041,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,N,8111,,CHEMBL621793,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,8112,,CHEMBL621794,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5496,In vivo plasma clearance was determined,N,8113,,CHEMBL621795,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5739,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,N,8114,,CHEMBL621796,10116.0,Intermediate,50597,1
Liver,401.0,In vivo,,Hepatocyte,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,5676,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,N,8115,,CHEMBL621797,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4239,Pharmacokinetic property (Plasma clearance) was measured in rat,N,8116,,CHEMBL621798,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5676,Pharmacokinetic property (clearance) in rat i.v.,N,8117,,CHEMBL621799,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1918,"Plasma Clearance was evaluated in rats, iv",N,8118,,CHEMBL621800,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17800,Plasma clearance (in vivo) in rats was determined,N,8119,,CHEMBL621801,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6056,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,N,8120,,CHEMBL621802,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5496,Plasma clearance was determined,N,8121,,CHEMBL618596,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,N,8122,,CHEMBL618597,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,N,8123,,CHEMBL618598,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17752,Plasma clearance in rats,N,8124,,CHEMBL618599,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4576,Plasma clearance rate determined in rat,N,8125,,CHEMBL618600,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6011,Plasma clearance was determined in rat,N,8126,,CHEMBL618601,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,Plasma clearance was determined,N,8127,,CHEMBL618602,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5948,Plasma clearance value in rat,N,8128,,CHEMBL618603,10116.0,Intermediate,50597,1
Liver,,Ex vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,6125,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,8129,,CHEMBL618604,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4839,Clearance in rat,N,8130,,CHEMBL618605,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17686,Total body clearance in rat i.v. at 2 mg/kg concentration,N,8131,,CHEMBL618606,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6571,Clearance of compound in rats after intravenous administration,N,8132,,CHEMBL618607,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3364,Clearance after iv administration to rats,N,8133,,CHEMBL618608,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,8134,,CHEMBL618609,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,8135,,CHEMBL618610,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,N,8136,,CHEMBL618611,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,8137,,CHEMBL618612,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,8138,,CHEMBL618613,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,8139,,CHEMBL621076,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,8140,,CHEMBL621077,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17670,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",N,8141,,CHEMBL621078,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5970,Clearance in rat,N,8142,,CHEMBL621251,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6495,Clearance in rat after oral administration at 10 mg/kg,N,8143,,CHEMBL621252,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4590,Clearance in rat.,N,8144,,CHEMBL621253,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6193,Clearance rate following an oral dose of 20 mg/kg in rats,N,8145,,CHEMBL621254,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2832,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,N,8146,,CHEMBL621255,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1052,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,N,8147,,CHEMBL621256,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,N,8148,,CHEMBL621257,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,N,8149,,CHEMBL621258,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,N,8150,,CHEMBL621259,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,N,8151,,CHEMBL621260,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,N,8152,,CHEMBL876494,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,N,8153,,CHEMBL621261,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,N,8154,,CHEMBL621262,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,8155,,CHEMBL621263,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9866,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,N,8156,,CHEMBL621264,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,N,8157,,CHEMBL621265,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,N,8158,,CHEMBL621266,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,N,8159,,CHEMBL621267,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,N,8160,,CHEMBL621268,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,N,8161,,CHEMBL621269,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,N,8162,,CHEMBL621270,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,N,8163,,CHEMBL621271,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,N,8164,,CHEMBL621272,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,N,8165,,CHEMBL621273,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,N,8166,,CHEMBL621274,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,N,8167,,CHEMBL876495,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,N,8168,,CHEMBL621275,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,N,8169,,CHEMBL621276,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,N,8170,,CHEMBL621277,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,9866,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,N,8171,,CHEMBL621278,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,9866,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,N,8172,,CHEMBL621279,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,9866,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),N,8173,,CHEMBL621280,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,N,8174,,CHEMBL621281,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,N,8175,,CHEMBL621282,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,8176,,CHEMBL621283,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,N,8177,,CHEMBL621284,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,N,8178,,CHEMBL621285,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,N,8179,,CHEMBL621286,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,N,8180,,CHEMBL623220,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,N,8181,,CHEMBL623221,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,N,8182,,CHEMBL876029,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,N,8183,,CHEMBL623222,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,N,8184,,CHEMBL623223,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,N,8185,,CHEMBL621445,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,8186,,CHEMBL621446,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,8187,,CHEMBL621447,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,8188,,CHEMBL619681,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,8189,,CHEMBL619682,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,8190,,CHEMBL619683,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,8191,,CHEMBL619684,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,8192,,CHEMBL619685,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,8193,,CHEMBL619686,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,8194,,CHEMBL619687,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,8195,,CHEMBL619688,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,8196,,CHEMBL619689,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,8197,,CHEMBL619690,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,8198,,CHEMBL619691,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6062,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,8199,,CHEMBL619692,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3598,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,N,8200,,CHEMBL619693,10116.0,Expert,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1908,Vc value after IV dose at a dose of 5 mg/kg in rats.,N,8201,,CHEMBL619694,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17596,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,N,8202,,CHEMBL619695,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4891,Compound was evaluated for pharmacokinetic parameter volume of distribution,N,8203,,CHEMBL619696,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,740,Compound was evaluated for volume of distribution in rat,N,8204,,CHEMBL619697,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16366,Steady state volume distribution was determined; steady state(ss),N,8205,,CHEMBL619698,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3364,Steady state volume of distribution after iv administration to rats,N,8206,,CHEMBL619699,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2552,Steady state volume of distribution dosing at 3 mg/kg iv,N,8207,,CHEMBL619700,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,406,The compound was evaluated for volume of distribution in rat,N,8208,,CHEMBL619701,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12500,The compound was tested for volume of distribution in rat,N,8209,,CHEMBL619702,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12500,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,N,8210,,CHEMBL620335,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5656,Volume distribution (VD) after oral administration in rat,N,8211,,CHEMBL620336,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17671,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,8212,,CHEMBL620337,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1094,Volume distribution in rat,N,8213,,CHEMBL620520,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5833,Volume distribution in rat,N,8214,,CHEMBL620521,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Volume distribution in rat after peroral administration at 10 mg/kg,N,8215,,CHEMBL875825,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Volume distribution in rat after peroral administration at 5 mg/kg,N,8216,,CHEMBL620522,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6005,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,8217,,CHEMBL620523,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1696,Volume of distribution in rat.,N,8218,,CHEMBL620524,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6672,Volume of distribution in rat,N,8219,,CHEMBL620525,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6673,Volume of distribution in rat,N,8220,,CHEMBL620526,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5871,Volume of distribution in rat by iv administration,N,8221,,CHEMBL620527,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6803,Volume of distribution in rats,N,8222,,CHEMBL620528,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5199,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,8223,,CHEMBL620529,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4727,Volume distribution at the dose of 2 mg/kg in rat,N,8224,,CHEMBL620530,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16367,Steady state volume of distribution was determined,N,8225,,CHEMBL620531,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca mulatta,0,,,,,BAO_0000218,5005,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,8226,,CHEMBL620532,9544.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,5005,Compound was tested for its plasma volume distribution in Sprague Dawley rats,U,8227,,CHEMBL620533,10116.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,5005,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,U,8228,,CHEMBL620534,10116.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15765,Mean (%CV) PK parameters for Vdss(mL/kg).,N,8229,,CHEMBL620535,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,N,8230,,CHEMBL875826,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,N,8231,,CHEMBL620536,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,8232,,CHEMBL620537,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,N,8233,,CHEMBL618526,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5739,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,N,8234,,CHEMBL618527,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5789,Pharmacokinetic property (Vdss) in rat,N,8235,,CHEMBL618528,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4239,Pharmacokinetic property (vdss) was measured in rat,N,8236,,CHEMBL618529,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4709,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,N,8237,,CHEMBL618530,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6642,Volume of distribution in rat,N,8238,,CHEMBL618531,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5247,The pharmacokinetic parameter volume of distribution in vivo in rats,N,8239,,CHEMBL618532,10116.0,Intermediate,50597,1
,,In vivo,,,F,Rattus norvegicus,1,,,,,BAO_0000218,17720,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,N,8240,,CHEMBL618533,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17686,Vdss in rat i.v. at 2 mg/kg concentration,N,8241,,CHEMBL618534,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4689,Volume distribution after intravenous administration (1 mg/kg) in rat,N,8242,,CHEMBL618535,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5654,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,8243,,CHEMBL618536,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5654,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,8244,,CHEMBL618537,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4527,Volume distribution at a dose of 10 uM/kg in rat was determined,N,8245,,CHEMBL618538,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4521,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,8246,,CHEMBL618539,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6057,Volume distribution was calculated in rat,N,8247,,CHEMBL618540,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,Volume distribution was determined,N,8248,,CHEMBL618541,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2938,Volume of distribution after intravenous administration was evaluated in rat,N,8249,,CHEMBL618542,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6679,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,8250,,CHEMBL622544,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",N,8251,,CHEMBL622545,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,8252,,CHEMBL622546,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",N,8253,,CHEMBL622547,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5145,Volume of distribution in steady state was determined in rat,N,8254,,CHEMBL622548,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6467,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,N,8255,,CHEMBL622549,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6467,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,8256,,CHEMBL622550,10116.0,Intermediate,50597,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15115,Compound was evaluated for area under curve when administered through oral route to mouse,N,8257,,CHEMBL622551,10090.0,Intermediate,50594,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,8258,,CHEMBL622552,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8758,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,8259,,CHEMBL622553,10116.0,Intermediate,50597,1
,,In vivo,,,F,,0,,,,,BAO_0000218,8267,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,U,8260,,CHEMBL622554,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8267,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,N,8261,,CHEMBL622555,9615.0,Intermediate,50588,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14239,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,N,8262,,CHEMBL622556,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14239,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,N,8263,,CHEMBL622557,10090.0,Intermediate,50594,1
Blood,,,,,A,Mus musculus,1,,178.0,,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,N,8264,,CHEMBL622558,10090.0,Intermediate,50594,1
Blood,,,,,A,Mus musculus,1,,178.0,,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,N,8265,,CHEMBL622559,10090.0,Intermediate,50594,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,10754,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,N,8266,,CHEMBL622560,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14681,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,8267,,CHEMBL622561,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14681,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,N,8268,,CHEMBL622562,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14681,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,8269,,CHEMBL622563,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,13118,Concentration of compound in Central nervous system,U,8270,,CHEMBL622564,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13118,Concentration of compound in Central nervous system; Not detectable,U,8271,,CHEMBL622565,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13318,"Concentration of diester in the blood, following oral administration in mice",N,8272,,CHEMBL622566,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13318,"Concentration of monoester in the blood, following oral administration in mice",N,8273,,CHEMBL624515,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13318,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,N,8274,,CHEMBL624516,10090.0,Intermediate,50594,1
,,,,,A,,0,,,,,BAO_0000019,15692,Evaluated for Pharmacokinetic property: Area under the curve,U,8275,,CHEMBL624517,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,N,8276,,CHEMBL624518,10090.0,Intermediate,50594,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,N,8277,,CHEMBL624519,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,N,8278,,CHEMBL624520,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,N,8279,,CHEMBL624521,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,N,8280,,CHEMBL624522,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,N,8281,,CHEMBL624523,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,8282,,CHEMBL624409,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",N,8283,,CHEMBL624410,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,8284,,CHEMBL624411,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",N,8285,,CHEMBL623531,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",N,8286,,CHEMBL623532,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",N,8287,,CHEMBL623533,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,8288,,CHEMBL623534,9541.0,Intermediate,100710,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,N,8289,,CHEMBL623535,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,N,8290,,CHEMBL623536,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,N,8291,,CHEMBL623537,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,N,8292,,CHEMBL623538,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,N,8293,,CHEMBL623539,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,N,8294,,CHEMBL623540,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",N,8295,,CHEMBL623541,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",N,8296,,CHEMBL623542,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",N,8297,,CHEMBL623543,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",N,8298,,CHEMBL623544,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",N,8299,,CHEMBL623545,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",N,8300,,CHEMBL623546,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5408,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,8301,,CHEMBL623547,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6827,High i.v. clearance in Dawley rats,N,8302,,CHEMBL623548,10116.0,Intermediate,50597,1
Liver,,In vitro,,,A,Rattus norvegicus,1,Microsomes,2107.0,,,BAO_0000218,17538,In vitro clearance in rat liver microsomes,N,8303,,CHEMBL623549,10116.0,Intermediate,50597,1
Liver,,In vitro,,,A,Rattus norvegicus,1,Microsomes,2107.0,,,BAO_0000218,6331,Intrinsic clearance in rat liver microsomes was determined,N,8304,,CHEMBL623550,10116.0,Intermediate,50597,1
Liver,401.0,In vitro,,Hepatocyte,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,5948,Intrinsic clearance in rat hepatocytes was determined,N,8305,,CHEMBL875276,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4026,Plasma Clearance was determined,N,8306,,CHEMBL621872,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6647,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,N,8307,,CHEMBL621873,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1696,Plasma clearance in rat.,N,8308,,CHEMBL621874,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6597,Plasma clearance in rats,N,8309,,CHEMBL621875,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,347,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,N,8310,,CHEMBL621876,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16423,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,N,8311,,CHEMBL621877,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2879,Plasma clearance was measured in rat,N,8312,,CHEMBL621878,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4883,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,8313,,CHEMBL621879,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5328,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",N,8314,,CHEMBL621880,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5160,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,N,8315,,CHEMBL621881,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,8316,,CHEMBL621882,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17651,Total clearance at 1 mg/kg was determined in rat,N,8317,,CHEMBL875283,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17651,Total clearance at 10 mg/kg was determined in rat,N,8318,,CHEMBL621883,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6596,Clearance in rat,N,8319,,CHEMBL621884,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4796,Plasma clearance rate determined in rats,N,8320,,CHEMBL621885,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6850,Clearance of compound in rat was evaluated,N,8321,,CHEMBL621886,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5932,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,8322,,CHEMBL621887,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3371,Pharmacokinetic property (blood clearance) in rat,N,8323,,CHEMBL621888,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2083,Plasma clearance in rat,N,8324,,CHEMBL621889,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4942,Plasma clearance in rats,N,8325,,CHEMBL621890,10116.0,Intermediate,50597,1
Liver,,In vitro,,,A,Rattus norvegicus,1,Microsomes,2107.0,,,BAO_0000218,6838,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,N,8326,,CHEMBL621891,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5353,Clearance in Dawley rat,N,8327,,CHEMBL621892,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Clearance rat,N,8328,,CHEMBL621893,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),N,8329,,CHEMBL621894,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Clearance rat; Not determined,N,8330,,CHEMBL621895,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.,N,8331,,CHEMBL875284,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,8332,,CHEMBL618699,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,8333,,CHEMBL618700,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6211,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,8334,,CHEMBL618701,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12873,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,8335,,CHEMBL876600,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6570,Clearance of compound in rat after 1 mg/kg i.v. administration,N,8336,,CHEMBL618702,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3341,Compound was evaluated for Hepatic clearance in rat,N,8337,,CHEMBL618703,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4891,In vivo clearance after 5 mg/kg dose,N,8338,,CHEMBL618704,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1094,Compound was tested for plasma clearance in rats,N,8339,,CHEMBL618705,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2938,Hepatic clearance after intravenous administration was evaluated in rat,N,8340,,CHEMBL618706,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17853,Lower clearance in rat (i.v.) at 0.5 mpk,N,8341,,CHEMBL618707,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6049,Pharmacokinetic parameter expressed as plasma clearance in rat,N,8342,,CHEMBL618708,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5789,Pharmacokinetic property (Clp) in rat,N,8343,,CHEMBL618709,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4514,Plasma clearance in Sprague-Dawley rats,N,8344,,CHEMBL618710,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6448,Plasma clearance (Clp) in rat,N,8345,,CHEMBL618711,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6062,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,N,8346,,CHEMBL618712,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5710,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,N,8347,,CHEMBL618713,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4709,Plasma clearance after intravenous administration of 1 mg/kg in rat,N,8348,,CHEMBL618714,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4521,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,8349,,CHEMBL618715,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1742,Plasma clearance in rat was determined,N,8350,,CHEMBL618716,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6057,Plasma clearance measured in rat,N,8351,,CHEMBL876601,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6057,Plasma clearance was calculated in rat,N,8352,,CHEMBL618717,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5145,Plasma clearance in rat,N,8353,,CHEMBL618718,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5833,Plasma clearance in rat,N,8354,,CHEMBL618719,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6453,Plasma clearance in rat,N,8355,,CHEMBL618720,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6640,Plasma clearance in rat,N,8356,,CHEMBL618721,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6305,Plasma clearance in rats,N,8357,,CHEMBL621477,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6642,Plasma clearance in rat,N,8358,,CHEMBL621478,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5472,Plasma clearance was evaluated in rat,N,8359,,CHEMBL621479,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5472,Plasma clearance was evaluated in rat; Not tested,N,8360,,CHEMBL621480,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5144,Plasma clearance rate was determined for the compound in rat,N,8361,,CHEMBL621481,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",N,8362,,CHEMBL621482,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,8363,,CHEMBL621483,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",N,8364,,CHEMBL621484,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,8365,,CHEMBL621485,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,8366,,CHEMBL621486,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,8367,,CHEMBL621487,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,8368,,CHEMBL621488,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,8369,,CHEMBL621489,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,8370,,CHEMBL621490,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,8371,,CHEMBL621491,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,8372,,CHEMBL621492,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,N,8373,,CHEMBL621493,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,8374,,CHEMBL621494,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,8375,,CHEMBL621495,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,8376,,CHEMBL621496,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,8377,,CHEMBL621497,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,8378,,CHEMBL621498,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,8379,,CHEMBL621499,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,N,8380,,CHEMBL618634,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,8381,,CHEMBL618635,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,8382,,CHEMBL618636,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,8383,,CHEMBL619737,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,8384,,CHEMBL619738,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,8385,,CHEMBL624329,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,8386,,CHEMBL624330,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,8387,,CHEMBL624331,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,8388,,CHEMBL624332,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,8389,,CHEMBL624333,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,8390,,CHEMBL624334,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,8391,,CHEMBL624335,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,8392,,CHEMBL620016,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,8393,,CHEMBL620169,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,8394,,CHEMBL620170,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,N,8395,,CHEMBL620171,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,8396,,CHEMBL620172,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,8397,,CHEMBL620173,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,N,8398,,CHEMBL620174,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,8399,,CHEMBL620175,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,8400,,CHEMBL620176,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,13950,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,8401,,CHEMBL620177,10116.0,Intermediate,50597,1
Cerebellum,,,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,8402,,CHEMBL620178,10116.0,Intermediate,50597,1
Cerebellum,,,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,8403,,CHEMBL620179,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,8404,,CHEMBL620180,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6570,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,N,8405,,CHEMBL620181,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6571,Volume of distribution of compound in rats after intravenous administration,N,8406,,CHEMBL620182,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6453,Volume of distribution in rat,N,8407,,CHEMBL620183,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,N,8408,,CHEMBL620184,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,8409,,CHEMBL620185,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,8410,,CHEMBL620186,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5353,Volume of distribution was determined in Dawley rat,N,8411,,CHEMBL620187,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,8412,,CHEMBL620188,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Volume of distribution was reported in Sprague-Dawley rat,N,8413,,CHEMBL620189,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Volumes of distribution in rat after peroral administration,N,8414,,CHEMBL620190,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Volumes of distribution in rat after po administration,N,8415,,CHEMBL620191,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Volumes of distribution in rat after po administration; Not determined,N,8416,,CHEMBL620192,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5676,Pharmacokinetic property (Volume) in rat i.v.,N,8417,,CHEMBL620193,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6410,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,N,8418,,CHEMBL620194,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17670,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",N,8419,,CHEMBL876730,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6495,Volume distribution in rat after oral administration at 10 mg/kg,N,8420,,CHEMBL620195,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5408,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,8421,,CHEMBL620196,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4883,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,8422,,CHEMBL620197,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6647,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,N,8423,,CHEMBL620198,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6495,Volume of distribution in rats,N,8424,,CHEMBL620199,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,N,8425,,CHEMBL620200,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,N,8426,,CHEMBL620201,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,8427,,CHEMBL620202,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,8428,,CHEMBL620203,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,N,8429,,CHEMBL620204,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,8430,,CHEMBL620205,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5960,Pharmacokinetic parameter (Vss) in rat,N,8431,,CHEMBL624664,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5676,Pharmacokinetic property (Volume) in rat i.v.,N,8432,,CHEMBL624665,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5948,Pharmacokinetic property (Vss) in rat,N,8433,,CHEMBL624666,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5979,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,8434,,CHEMBL624667,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,N,8435,,CHEMBL624668,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,8436,,CHEMBL624669,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,8437,,CHEMBL624670,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,8438,,CHEMBL624671,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6448,Steady state volume distribution in rat,N,8439,,CHEMBL624672,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12873,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",N,8440,,CHEMBL624673,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4576,Steady state volume of distribution determined in rat,N,8441,,CHEMBL624674,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,8442,,CHEMBL624675,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1466,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,N,8443,,CHEMBL621728,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5182,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,N,8444,,CHEMBL621729,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5182,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,N,8445,,CHEMBL621730,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6535,Volume distribution in rat after administration of 2 mg/kg iv,N,8446,,CHEMBL621731,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6535,Volume distribution in rat after administration of 2 mg/kg iv,N,8447,,CHEMBL621732,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,Volume in steady state distribution value was determined,N,8448,,CHEMBL621908,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,Volume in steady state distribution value was determined; ND denotes no data,N,8449,,CHEMBL875347,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,Volume in steady state distribution value was determined; ND denotes not determined,N,8450,,CHEMBL621909,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17065,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,8451,,CHEMBL621910,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6597,Volume of distribution at steady state was evaluated in rats,N,8452,,CHEMBL621911,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15662,Volume of distribution at steady state was observed after intravenous administration in rat,N,8453,,CHEMBL621912,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6485,Volume of distribution in steady state was determined in rat,N,8454,,CHEMBL621913,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17655,Volume of distribution in steady state was determined in rat,N,8455,,CHEMBL621914,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6616,Volume of distribution after i.v. administration,N,8456,,CHEMBL621915,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1916,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,8457,,CHEMBL621916,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,8458,,CHEMBL621917,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,8459,,CHEMBL621918,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,16438,Biodistribution of compound (oxidized form) in spleen tissue,N,8460,,CHEMBL621919,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",N,8461,,CHEMBL621920,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",N,8462,,CHEMBL621921,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,8463,,CHEMBL622401,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,8464,,CHEMBL875348,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,8465,,CHEMBL622402,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,N,8466,,CHEMBL622403,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,8467,,CHEMBL622404,10090.0,Intermediate,50594,1
Brain,,In vivo,,,A,Mus musculus,1,,955.0,,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,N,8468,,CHEMBL622405,10090.0,Intermediate,50594,1
Brain,,In vivo,,,A,Mus musculus,1,,955.0,,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,8469,,CHEMBL622406,10090.0,Intermediate,50594,1
Brain,,In vivo,,,A,Mus musculus,1,,955.0,,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,8470,,CHEMBL622407,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,N,8471,,CHEMBL622408,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,8472,,CHEMBL622409,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,8473,,CHEMBL622410,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,N,8474,,CHEMBL622411,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,8475,,CHEMBL627864,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,8476,,CHEMBL627865,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,N,8477,,CHEMBL627866,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,8478,,CHEMBL627751,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,N,8479,,CHEMBL627752,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,8480,,CHEMBL627753,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,8481,,CHEMBL627754,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12467,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,N,8482,,CHEMBL627755,10090.0,Intermediate,50594,1
Brain,,In vivo,,,A,Mus musculus,1,,955.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),N,8483,,CHEMBL627756,10090.0,Intermediate,50594,1
Brain,,In vivo,,,A,Mus musculus,1,,955.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),N,8484,,CHEMBL627757,10090.0,Intermediate,50594,1
Brain,,In vivo,,,A,Mus musculus,1,,955.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),N,8485,,CHEMBL627758,10090.0,Intermediate,50594,1
Brain,,In vivo,,,A,Mus musculus,1,,955.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),N,8486,,CHEMBL627759,10090.0,Intermediate,50594,1
Brain,,In vivo,,,A,Mus musculus,1,,955.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),N,8487,,CHEMBL627760,10090.0,Intermediate,50594,1
Brain,,In vivo,,,A,Mus musculus,1,,955.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),N,8488,,CHEMBL627761,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),N,8489,,CHEMBL876811,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),N,8490,,CHEMBL627762,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),N,8491,,CHEMBL627763,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),N,8492,,CHEMBL627764,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),N,8493,,CHEMBL627765,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),N,8494,,CHEMBL627766,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),N,8495,,CHEMBL627767,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),N,8496,,CHEMBL627768,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),N,8497,,CHEMBL628422,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),N,8498,,CHEMBL628423,10090.0,Intermediate,50594,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5089,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,N,8499,,CHEMBL628424,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5089,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,N,8500,,CHEMBL628425,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4257,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,N,8501,,CHEMBL628426,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6679,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,8502,,CHEMBL628427,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5546,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,8503,,CHEMBL626938,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6141,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,8504,,CHEMBL626939,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,8505,,CHEMBL626940,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,8506,,CHEMBL626941,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Plasma clearance was reported in Sprague-Dawley rat,N,8507,,CHEMBL626942,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4689,Plasma clearance after intravenous administration (1 mg/kg) in rat,N,8508,,CHEMBL876812,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6848,Plasma clearance of compound in rats was evaluated,N,8509,,CHEMBL626943,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6848,Plasma clearance of compound in rats was evaluated; ND indicates not determined,N,8510,,CHEMBL626944,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6467,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,N,8511,,CHEMBL626945,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6467,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,8512,,CHEMBL626946,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4956,Plasma clearance rate in Sprague-Dawley rats,N,8513,,CHEMBL626856,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5529,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),N,8514,,CHEMBL626857,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,406,The compound was evaluated for plasma clearance in rat,N,8515,,CHEMBL626858,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17655,Total plasma clearance in rat,N,8516,,CHEMBL627018,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,3293,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,N,8517,,CHEMBL625331,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,4075,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,N,8518,,CHEMBL625332,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,C max was determined at 10 mg/kg po dose in rats,N,8519,,CHEMBL877590,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,C max was determined at 3 mg/kg po dose in rats,N,8520,,CHEMBL625333,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17594,Cmax after repeated oral dose of compound at 1 mg/kg in rats,N,8521,,CHEMBL625334,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17594,Cmax after single intravenous bolus of 1 mg/kg in rats,N,8522,,CHEMBL625335,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4762,Cmax of compound at 5 mg/kg after po administration was determined in rat,N,8523,,CHEMBL625336,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Cmax 24 hr after 10 mg/kg oral administration in rats,N,8524,,CHEMBL625337,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Cmax 24 hr after 2 mg/kg oral administration in rats,N,8525,,CHEMBL625338,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1466,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,N,8526,,CHEMBL625339,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6535,Cmax in rat after administration of 2 mg/kg iv,N,8527,,CHEMBL625340,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6535,Cmax in rat after administration of 2 mg/kg iv,N,8528,,CHEMBL625341,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3169,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,N,8529,,CHEMBL622687,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6515,Cmax wa determined in rat plasma at 30 mg/kg after po administration,N,8530,,CHEMBL622688,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11149,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,N,8531,,CHEMBL622689,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11149,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,N,8532,,CHEMBL620295,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17858,Cmax after 10 mg/kg oral administration in rat,N,8533,,CHEMBL620296,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Cmax after IV dosing at 0.5 mg/kg in rat; no data,N,8534,,CHEMBL620297,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Cmax after IV dosing at 1 mg/kg in rat; no data,N,8535,,CHEMBL620298,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4426,Cmax after oral administration at 20 mpk in rats,N,8536,,CHEMBL620299,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4426,Cmax after oral administration at 20 mpk in rats; Not performed.,N,8537,,CHEMBL620300,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4426,Cmax after oral administration at 20 mpk in rats d; Not performed.,N,8538,,CHEMBL620301,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5656,Cmax after oral administration in rat,N,8539,,CHEMBL620302,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Cmax after oral administration at a dose of 2 mg/kg in rat,N,8540,,CHEMBL620303,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Cmax after oral administration at a dose of 4 mg/kg in rat,N,8541,,CHEMBL620304,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6113,Cmax in rats after 20 mg/kg oral dose,N,8542,,CHEMBL620305,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17764,Cmax after peroral administration in rats at 2.4 uM/kg,N,8543,,CHEMBL620306,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4756,Cmax at the dose of 2 mg/Kg administered perorally in rats,N,8544,,CHEMBL620307,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4756,Cmax at the dose of 5 mg/Kg administered perorally in rats,N,8545,,CHEMBL620308,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6402,Cmax by administering at 20 mg/kg p.o. in rats,N,8546,,CHEMBL620309,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5610,Cmax in male rat,N,8547,,CHEMBL620310,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5207,Cmax in rat,N,8548,,CHEMBL620311,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6011,Cmax in rat,N,8549,,CHEMBL620312,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6504,Cmax in rat,N,8550,,CHEMBL620313,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6046,Cmax in rat at 10 mg/kg,N,8551,,CHEMBL620314,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6504,Cmax in rat at the dose of 1 mg/kg i.v.,N,8552,,CHEMBL620315,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5874,Cmax in rat by po administration at a dose of 40 mg/kg,N,8553,,CHEMBL620316,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17686,Cmax in rat p.o. at 20 mg/kg concentration,N,8554,,CHEMBL620317,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5836,Cmax in rats,N,8555,,CHEMBL620318,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17596,Cmax in rats,N,8556,,CHEMBL620319,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16423,Cmax was evaluated after 20 uM/kg of peroral administration,N,8557,,CHEMBL620320,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17804,Cmax was measured in rats after peroral administration at 3 mg/kg,N,8558,,CHEMBL620321,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1908,Cmax value after oral dose at a dose of 10 mg/kg in rats.,N,8559,,CHEMBL620322,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,8560,,CHEMBL620323,10116.0,Intermediate,50597,1
Frontal cortex,,,,,A,Rattus norvegicus,1,,1870.0,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,8561,,CHEMBL620324,10116.0,Intermediate,50597,1
Frontal cortex,,,,,A,Rattus norvegicus,1,,1870.0,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,8562,,CHEMBL620325,10116.0,Intermediate,50597,1
Hippocampus,,,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,8563,,CHEMBL620326,10116.0,Intermediate,50597,1
Hippocampus,,,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,8564,,CHEMBL620327,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,8565,,CHEMBL620328,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,8566,,CHEMBL620329,10116.0,Intermediate,50597,1
Midbrain,,,,,A,Rattus norvegicus,1,,1891.0,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,8567,,CHEMBL620330,10116.0,Intermediate,50597,1
Midbrain,,,,,A,Rattus norvegicus,1,,1891.0,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,8568,,CHEMBL875286,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,8569,,CHEMBL620331,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,8570,,CHEMBL620332,10116.0,Intermediate,50597,1
Striatum,,,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,8571,,CHEMBL620333,10116.0,Intermediate,50597,1
Striatum,,,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,8572,,CHEMBL620334,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,8573,,CHEMBL621015,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,8574,,CHEMBL621016,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,8575,,CHEMBL621191,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,8576,,CHEMBL621192,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,8577,,CHEMBL621193,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,8578,,CHEMBL621194,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,8579,,CHEMBL624204,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,8580,,CHEMBL624205,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,8581,,CHEMBL624206,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,8582,,CHEMBL624207,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,8583,,CHEMBL624208,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,8584,,CHEMBL624209,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,8585,,CHEMBL624210,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,8586,,CHEMBL624211,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,8587,,CHEMBL624212,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,8588,,CHEMBL624213,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,8589,,CHEMBL876611,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,8590,,CHEMBL624214,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,8591,,CHEMBL624215,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,8592,,CHEMBL624216,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,8593,,CHEMBL624217,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,8594,,CHEMBL624218,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,8595,,CHEMBL624219,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,8596,,CHEMBL624220,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,8597,,CHEMBL624221,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,8598,,CHEMBL624222,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,8599,,CHEMBL624223,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,8600,,CHEMBL624224,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,8601,,CHEMBL624225,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17764,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,N,8602,,CHEMBL622420,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5031,Volume of steady state distribution after i.v. administration in rats,N,8603,,CHEMBL622421,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6215,Vss after intravenous administration (5.0 mg/kg) was determined in rat,N,8604,,CHEMBL622422,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17671,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,8605,,CHEMBL622423,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17752,Vss was determined,N,8606,,CHEMBL622424,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6596,Vss in rat,N,8607,,CHEMBL622425,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16423,Vss was evaluated after 10 uM/kg of intra arterial administration,N,8608,,CHEMBL876612,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15662,volume of distribution at steady state was observed after intravenous administration in rat,N,8609,,CHEMBL622426,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6062,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,8610,,CHEMBL622427,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5874,Pharmacokinetic (PK) parameter Vz in rat,N,8611,,CHEMBL622428,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4942,Volume distribution in rats,N,8612,,CHEMBL622429,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17796,Volume of distribution in rat; No data,N,8613,,CHEMBL622430,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4890,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,8614,,CHEMBL622431,10116.0,Intermediate,50597,1
Ileum,,,,,A,Rattus norvegicus,1,,2116.0,,,BAO_0000218,15765,% absorption predicted from in vitro rat ileum transport studies,N,8615,,CHEMBL622432,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,8616,,CHEMBL622433,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,8617,,CHEMBL622434,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,N,8618,,CHEMBL622435,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),N,8619,,CHEMBL618748,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,8620,,CHEMBL618749,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,8621,,CHEMBL618750,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,8622,,CHEMBL618751,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13569,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,8623,,CHEMBL618752,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4576,Oral bioavailability in rat,N,8624,,CHEMBL618753,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,750,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,N,8625,,CHEMBL618754,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,750,Oral bioavailability in rat,N,8626,,CHEMBL618755,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4590,Oral bioavailability in rat,N,8627,,CHEMBL618756,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1716,Oral bioavailability in rat,N,8628,,CHEMBL618757,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1974,Bioavailability in rat,N,8629,,CHEMBL618758,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4502,Oral bioavailability in rat (dose 30 mg/kg),N,8630,,CHEMBL621088,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3371,Pharmacokinetic property (cLogP) in rat,N,8631,,CHEMBL621089,10116.0,Intermediate,50597,1
Blood,,,,,F,Rattus norvegicus,1,,178.0,,,BAO_0000218,9099,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,N,8632,,CHEMBL621090,10116.0,Intermediate,50597,1
Blood,,,,,F,Rattus norvegicus,1,,178.0,,,BAO_0000218,9099,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,N,8633,,CHEMBL621091,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4590,Clearance in rat.,N,8634,,CHEMBL876731,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3184,Compound was evaluated for its clearance when administered intravenously in rat,N,8635,,CHEMBL621092,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16456,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,8636,,CHEMBL621093,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4199,Blood: Brain distribution ratio is determined in rat,N,8637,,CHEMBL621094,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4199,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,N,8638,,CHEMBL621095,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4199,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,N,8639,,CHEMBL621096,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,8640,,CHEMBL621097,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent dose excreted in 0-48 hours administered ip to male rat,N,8641,,CHEMBL621098,10116.0,Intermediate,50597,1
Cerebellum,,,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8642,,CHEMBL621099,10116.0,Intermediate,50597,1
Cerebellum,,,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8643,,CHEMBL621100,10116.0,Intermediate,50597,1
Cerebellum,,,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,11977,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,8644,,CHEMBL621101,10116.0,Intermediate,50597,1
Cerebellum,,,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8645,,CHEMBL621102,10116.0,Intermediate,50597,1
Cerebellum,,,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8646,,CHEMBL876732,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11977,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8647,,CHEMBL621103,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8648,,CHEMBL621104,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,8649,,CHEMBL621105,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11977,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8650,,CHEMBL621106,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8651,,CHEMBL621107,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8652,,CHEMBL621108,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8653,,CHEMBL621109,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),N,8654,,CHEMBL621110,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),N,8655,,CHEMBL621111,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),N,8656,,CHEMBL622541,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),N,8657,,CHEMBL622542,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),N,8658,,CHEMBL622543,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),N,8659,,CHEMBL624412,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),N,8660,,CHEMBL624413,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),N,8661,,CHEMBL624414,10090.0,Intermediate,50594,1
Lung,,In vivo,,,A,Mus musculus,1,,2048.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),N,8662,,CHEMBL624415,10090.0,Intermediate,50594,1
Lung,,In vivo,,,A,Mus musculus,1,,2048.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),N,8663,,CHEMBL624416,10090.0,Intermediate,50594,1
Lung,,In vivo,,,A,Mus musculus,1,,2048.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),N,8664,,CHEMBL624417,10090.0,Intermediate,50594,1
Lung,,In vivo,,,A,Mus musculus,1,,2048.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),N,8665,,CHEMBL624418,10090.0,Intermediate,50594,1
Lung,,In vivo,,,A,Mus musculus,1,,2048.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),N,8666,,CHEMBL624419,10090.0,Intermediate,50594,1
Lung,,In vivo,,,A,Mus musculus,1,,2048.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),N,8667,,CHEMBL624420,10090.0,Intermediate,50594,1
Muscle tissue,,In vivo,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),N,8668,,CHEMBL624421,10090.0,Intermediate,50594,1
Muscle tissue,,In vivo,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),N,8669,,CHEMBL624422,10090.0,Intermediate,50594,1
Muscle tissue,,In vivo,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),N,8670,,CHEMBL624423,10090.0,Intermediate,50594,1
Muscle tissue,,In vivo,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),N,8671,,CHEMBL625123,10090.0,Intermediate,50594,1
Muscle tissue,,In vivo,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),N,8672,,CHEMBL625124,10090.0,Intermediate,50594,1
Muscle tissue,,In vivo,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),N,8673,,CHEMBL625125,10090.0,Intermediate,50594,1
Zone of skin,,In vivo,,,A,Mus musculus,1,,14.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),N,8674,,CHEMBL625126,10090.0,Intermediate,50594,1
Zone of skin,,In vivo,,,A,Mus musculus,1,,14.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),N,8675,,CHEMBL626947,10090.0,Intermediate,50594,1
Zone of skin,,In vivo,,,A,Mus musculus,1,,14.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),N,8676,,CHEMBL626948,10090.0,Intermediate,50594,1
Zone of skin,,In vivo,,,A,Mus musculus,1,,14.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),N,8677,,CHEMBL626949,10090.0,Intermediate,50594,1
Zone of skin,,In vivo,,,A,Mus musculus,1,,14.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),N,8678,,CHEMBL626950,10090.0,Intermediate,50594,1
Zone of skin,,In vivo,,,A,Mus musculus,1,,14.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),N,8679,,CHEMBL626951,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),N,8680,,CHEMBL626952,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),N,8681,,CHEMBL626953,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),N,8682,,CHEMBL626954,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),N,8683,,CHEMBL626955,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),N,8684,,CHEMBL626956,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),N,8685,,CHEMBL626957,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),N,8686,,CHEMBL626958,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),N,8687,,CHEMBL626959,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),N,8688,,CHEMBL626960,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),N,8689,,CHEMBL626961,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),N,8690,,CHEMBL627589,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),N,8691,,CHEMBL627590,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,3132,Time taken for EC90 was determined when tested in mouse,N,8692,,CHEMBL627591,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,3132,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,N,8693,,CHEMBL627592,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),N,8694,,CHEMBL627593,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,5727,Half life in mice,N,8695,,CHEMBL627594,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,5302,Half life period in mouse after 10 mg/Kg dose,N,8696,,CHEMBL876813,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,5302,Half life period in mouse after 10 mg/kg dose,N,8697,,CHEMBL627595,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,6348,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,N,8698,,CHEMBL627596,10090.0,Intermediate,50594,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5964,Cmax value at 5 mg/kg po was determined in rat,N,8699,,CHEMBL627597,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6078,Cmax value evaluated in rat,N,8700,,CHEMBL627598,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,5206,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,N,8701,,CHEMBL627599,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2959,Cmax value after administration of 20 mg/Kg oral dose in rat,N,8702,,CHEMBL627600,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5964,Cmax value at 1 mg/kg po in rat,N,8703,,CHEMBL627601,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5964,Cmax value at 5 mg/kg po in rat,N,8704,,CHEMBL627776,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6757,Cmax value at a dose of 10 mg/kg in male SD rats,N,8705,,CHEMBL627777,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6757,Cmax value at a dose of 100 mg/kg in male SD rats,N,8706,,CHEMBL627778,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6757,Cmax value at a dose of 50 mg/kg in male SD rats,N,8707,,CHEMBL627779,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17617,Cmax value in rats at 10 mg/kg,N,8708,,CHEMBL876814,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1445,Cmax value was evaluated in rats at a dose of 20 mg/kg,N,8709,,CHEMBL627780,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6082,Cmax value was determined after peroral administration of 20 mg/kg in rat,N,8710,,CHEMBL627781,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1446,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,8711,,CHEMBL627782,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5407,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,N,8712,,CHEMBL627783,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2690,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,N,8713,,CHEMBL627784,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,N,8714,,CHEMBL627785,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,N,8715,,CHEMBL627786,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4891,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,N,8716,,CHEMBL627787,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,N,8717,,CHEMBL627788,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,N,8718,,CHEMBL626579,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,N,8719,,CHEMBL626580,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3634,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,N,8720,,CHEMBL876815,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1881,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,N,8721,,CHEMBL626581,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1881,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,N,8722,,CHEMBL626582,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,N,8723,,CHEMBL626583,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,8724,,CHEMBL626205,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,8725,,CHEMBL626206,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,8726,,CHEMBL626207,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,8727,,CHEMBL623882,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,N,8728,,CHEMBL623883,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,N,8729,,CHEMBL623884,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3032,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,8730,,CHEMBL623885,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6295,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,N,8731,,CHEMBL623886,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6619,Maximal concentration in rat was determined,N,8732,,CHEMBL623887,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6616,Maximal concentration after i.v. administration,N,8733,,CHEMBL623888,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3249,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,N,8734,,CHEMBL623889,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17791,Maximal plasma concentration in rat after oral administration at 50 mg/kg,N,8735,,CHEMBL623890,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17791,Cmax in rat plasma after oral dose (50 mg/Kg),N,8736,,CHEMBL623891,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1360,Maximal plasma concentration was determined.,N,8737,,CHEMBL623892,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2552,Maximal plasma drug concentration was determined,N,8738,,CHEMBL623893,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6571,Maximal concentration in rats after peroral administration,N,8739,,CHEMBL877616,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6570,Maximum concentration in rat after 2 mg/kg peroral administration,N,8740,,CHEMBL623894,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6567,Maximum concentration in rat plasma after 5 mg/kg oral gavage,N,8741,,CHEMBL623895,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3031,Maximum concentration of compound in rat was evaluated.,N,8742,,CHEMBL623896,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3436,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,N,8743,,CHEMBL623897,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3436,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,N,8744,,CHEMBL623898,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2083,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,N,8745,,CHEMBL623899,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3436,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,N,8746,,CHEMBL623900,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4527,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,N,8747,,CHEMBL623901,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1974,Maximum concentration was evaluated in rats,N,8748,,CHEMBL623902,10116.0,Intermediate,50597,1
Cerebrospinal fluid,,In vivo,,,A,Rattus norvegicus,1,,1359.0,,,BAO_0000218,3307,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,N,8749,,CHEMBL623903,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3307,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,N,8750,,CHEMBL623904,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1916,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,8751,,CHEMBL877617,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1500,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,N,8752,,CHEMBL623905,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1500,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,N,8753,,CHEMBL623906,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4186,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,8754,,CHEMBL623907,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,8755,,CHEMBL623908,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,N,8756,,CHEMBL623909,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,8757,,CHEMBL623910,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,8758,,CHEMBL623911,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,8759,,CHEMBL623912,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,8760,,CHEMBL624616,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,8761,,CHEMBL624617,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,8762,,CHEMBL624618,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,8763,,CHEMBL624619,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,8764,,CHEMBL624794,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,8765,,CHEMBL624795,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,8766,,CHEMBL623921,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,8767,,CHEMBL623922,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,8768,,CHEMBL623923,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,8769,,CHEMBL623924,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,8770,,CHEMBL623925,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,8771,,CHEMBL623926,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,8772,,CHEMBL623927,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,8773,,CHEMBL623928,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,8774,,CHEMBL623929,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,8775,,CHEMBL623930,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,8776,,CHEMBL623931,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,8777,,CHEMBL622165,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,8778,,CHEMBL621249,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,8779,,CHEMBL621250,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,8780,,CHEMBL621448,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,8781,,CHEMBL621449,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,8782,,CHEMBL621450,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,8783,,CHEMBL621451,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,8784,,CHEMBL621452,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,8785,,CHEMBL621453,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,8786,,CHEMBL621454,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,8787,,CHEMBL621455,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,8788,,CHEMBL621456,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,8789,,CHEMBL625145,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,8790,,CHEMBL875847,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,8791,,CHEMBL625146,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,8792,,CHEMBL625147,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,8793,,CHEMBL625148,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,8794,,CHEMBL625149,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,8795,,CHEMBL625150,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,8796,,CHEMBL625151,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,8797,,CHEMBL625152,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,8798,,CHEMBL625153,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,8799,,CHEMBL625154,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,8800,,CHEMBL625155,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,8801,,CHEMBL625156,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11977,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8802,,CHEMBL624354,10116.0,Intermediate,50597,1
Hippocampus,,,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8803,,CHEMBL624355,10116.0,Intermediate,50597,1
Hippocampus,,,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8804,,CHEMBL624356,10116.0,Intermediate,50597,1
Hippocampus,,,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,11977,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8805,,CHEMBL624357,10116.0,Intermediate,50597,1
Hippocampus,,,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8806,,CHEMBL624358,10116.0,Intermediate,50597,1
Striatum,,,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8807,,CHEMBL624359,10116.0,Intermediate,50597,1
Striatum,,,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8808,,CHEMBL624360,10116.0,Intermediate,50597,1
Striatum,,,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,8809,,CHEMBL624361,10116.0,Intermediate,50597,1
Striatum,,,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8810,,CHEMBL624362,10116.0,Intermediate,50597,1
Striatum,,,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8811,,CHEMBL624363,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8812,,CHEMBL624364,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8813,,CHEMBL624365,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8814,,CHEMBL624366,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8815,,CHEMBL624367,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8816,,CHEMBL624368,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8817,,CHEMBL624369,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,8818,,CHEMBL624370,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8819,,CHEMBL625069,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8820,,CHEMBL625070,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8821,,CHEMBL626051,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8822,,CHEMBL626052,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,8823,,CHEMBL626053,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8824,,CHEMBL626054,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8825,,CHEMBL626055,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8826,,CHEMBL626056,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8827,,CHEMBL626057,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8828,,CHEMBL625193,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8829,,CHEMBL625194,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8830,,CHEMBL625195,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8831,,CHEMBL625196,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,8832,,CHEMBL625197,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8833,,CHEMBL625198,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8834,,CHEMBL627929,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8835,,CHEMBL627074,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8836,,CHEMBL627075,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,8837,,CHEMBL627076,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8838,,CHEMBL627077,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8839,,CHEMBL627078,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),N,8840,,CHEMBL627079,10116.0,Intermediate,50597,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,4573,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,N,8841,,CHEMBL873824,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,3132,Half life in mouse plasma was determined at dose 25 mg/kg,N,8842,,CHEMBL627080,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,17718,Half life was determined,N,8843,,CHEMBL627081,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,8844,,CHEMBL627082,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,5961,Half-life in male mice after 1 mg/kg intravenous dose,N,8845,,CHEMBL627083,10090.0,Intermediate,50594,1
Plasma,,,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,17731,Half life in mice plasma,N,8847,,CHEMBL627085,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,17592,Half life in mouse,N,8848,,CHEMBL627086,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,3132,Half life in mouse plasma at dose 25 mg/kg,N,8849,,CHEMBL627087,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,17729,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,N,8850,,CHEMBL627088,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,17729,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,N,8851,,CHEMBL627089,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,17729,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,N,8852,,CHEMBL627090,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,3277,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),N,8853,,CHEMBL627091,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,3760,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",N,8854,,CHEMBL627092,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,3760,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",N,8855,,CHEMBL876785,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,2862,Half-life by iv administration in mouse,N,8856,,CHEMBL627093,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,2862,Half-life by oral administration in mouse,N,8857,,CHEMBL627094,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,5980,Half-life in mice,N,8858,,CHEMBL627095,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,6159,Half-life using mouse brain homogenate,N,8859,,CHEMBL627096,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,6254,Half-life was measured in mice,N,8860,,CHEMBL627097,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,6062,Half-life was measured in mouse after an iv dose of 1 mg/kg,N,8861,,CHEMBL627098,10090.0,Intermediate,50594,1
Blood,,,,,A,Mus musculus,1,,178.0,,,BAO_0000218,1574,Half-life period was determined in mouse blood,N,8862,,CHEMBL627099,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,56,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",N,8863,,CHEMBL627100,10090.0,Intermediate,50594,1
Plasma,,,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,993,Plasma half life in mouse,N,8864,,CHEMBL627101,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,6652,Stability of the peptide in the presence of mouse serum,N,8865,,CHEMBL627102,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,17852,Terminal half life of compound was determined in mouse,N,8866,,CHEMBL627103,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,2675,Terminal half life was evaluated in mice after intravenous administration,N,8867,,CHEMBL627104,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,2675,Terminal half life was evaluated in mice after oral administration,N,8868,,CHEMBL627105,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,N,8869,,CHEMBL876786,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,N,8870,,CHEMBL873825,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,N,8871,,CHEMBL627106,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14239,half life period is evaluated by administering intravenously at 25 mg/kg in mice,N,8872,,CHEMBL626336,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,5506,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",N,8873,,CHEMBL877462,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,5506,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",N,8874,,CHEMBL626337,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,17734,Half life after intraperitoneal administration of 100 mg/kg in mice,N,8875,,CHEMBL626338,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,N,8876,,CHEMBL626339,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,8877,,CHEMBL626340,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,N,8878,,CHEMBL625377,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,N,8879,,CHEMBL625378,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,N,8880,,CHEMBL625379,10090.0,Intermediate,50594,1
,,,,,A,Sus scrofa,0,Microsomes,,,,BAO_0000251,14294,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),U,8881,,CHEMBL625380,9823.0,Autocuration,22224,1
,,,,,A,Sus scrofa,0,Microsomes,,,,BAO_0000251,14294,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),U,8882,,CHEMBL625381,9823.0,Autocuration,22224,1
,,,,,A,Sus scrofa,0,,,,,BAO_0000019,6056,Stability to porcine renal DHP-I,U,8883,,CHEMBL625382,9823.0,Autocuration,22224,1
,,In vivo,,,A,Sus scrofa,0,,,,,BAO_0000218,1317,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,U,8884,,CHEMBL873828,9823.0,Autocuration,22224,1
,,In vivo,,,A,Sus scrofa,0,,,,,BAO_0000218,1317,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,U,8885,,CHEMBL625383,9823.0,Autocuration,22224,1
,,,,,A,Sus scrofa,0,,,,,BAO_0000019,5229,Half-life of the parent prodrug in porcine esterase solution,U,8886,,CHEMBL625384,9823.0,Autocuration,22224,1
,,,,,A,Sus scrofa,0,,,,,BAO_0000019,4231,"First order rate constant, k was determined in in pig liver Esterase",U,8887,,CHEMBL625385,9823.0,Autocuration,22224,1
Liver,,,,,A,Sus scrofa,0,,2107.0,,,BAO_0000221,4231,Half life of the in pig liver Esterase,U,8888,,CHEMBL625386,9823.0,Autocuration,22224,1
Liver,,,,,A,Sus scrofa,0,,2107.0,,,BAO_0000221,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,U,8889,,CHEMBL623571,9823.0,Autocuration,22224,1
Liver,,,,,A,Sus scrofa,0,,2107.0,,,BAO_0000221,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,U,8890,,CHEMBL623572,9823.0,Autocuration,22224,1
Liver,,,,,A,Sus scrofa,0,,2107.0,,,BAO_0000221,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,U,8891,,CHEMBL623573,9823.0,Autocuration,22224,1
Liver,,,,,A,Sus scrofa,0,,2107.0,,,BAO_0000221,3305,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,U,8892,,CHEMBL623574,9823.0,Autocuration,22224,1
Liver,,,,,A,Sus scrofa,0,,2107.0,,,BAO_0000221,3305,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,U,8893,,CHEMBL623575,9823.0,Autocuration,22224,1
Liver,,,,,A,Sus scrofa,0,,2107.0,,,BAO_0000221,2842,Half-life in the presence of pig liver esterase(PLE) was evaluated.,U,8894,,CHEMBL623749,9823.0,Autocuration,22224,1
Liver,,,,,A,Sus scrofa,0,,2107.0,,,BAO_0000221,2842,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,U,8895,,CHEMBL623750,9823.0,Autocuration,22224,1
Liver,,In vitro,,,A,Sus scrofa,0,,2107.0,,,BAO_0000221,889,Half-life in vitro in pig liver,U,8896,,CHEMBL623751,9823.0,Autocuration,22224,1
Liver,,,,,A,Sus scrofa,0,,2107.0,,,BAO_0000221,1904,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,U,8897,,CHEMBL623752,9823.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4186,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,N,8898,,CHEMBL623753,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2774,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,8899,,CHEMBL623754,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1742,Maximum concentration in rat plasma was determined,N,8900,,CHEMBL623755,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3169,Maximum concentration in rats,N,8901,,CHEMBL623756,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3169,Maximum concentration in rats at 1-2 hours,N,8902,,CHEMBL623757,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2081,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,N,8903,,CHEMBL623758,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,3307,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,N,8904,,CHEMBL623759,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4727,Maximum concentration at the dose of 2 mg/kg in rat,N,8905,,CHEMBL623760,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6597,Maximum concentration was evaluated in rats,N,8906,,CHEMBL623761,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,N,8907,,CHEMBL623762,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,N,8908,,CHEMBL877594,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,N,8909,,CHEMBL623763,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,N,8910,,CHEMBL623764,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,N,8911,,CHEMBL623765,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,N,8912,,CHEMBL623766,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,N,8913,,CHEMBL623767,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,N,8914,,CHEMBL623768,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,N,8915,,CHEMBL623769,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,N,8916,,CHEMBL623770,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,N,8917,,CHEMBL623771,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,N,8918,,CHEMBL623772,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,N,8919,,CHEMBL623773,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,N,8920,,CHEMBL623774,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,N,8921,,CHEMBL623775,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14465,Cmax in rat (PO dose),N,8922,,CHEMBL623776,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4723,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,8923,,CHEMBL622191,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4723,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,8924,,CHEMBL622192,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4576,Maximum plasma concentration determined in rat,N,8925,,CHEMBL622193,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12873,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,8926,,CHEMBL622194,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12873,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,8927,,CHEMBL622195,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6824,Maximum plasma concentration in rat,N,8928,,CHEMBL622196,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17065,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,8929,,CHEMBL622197,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2932,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,N,8930,,CHEMBL622198,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2932,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,N,8931,,CHEMBL622199,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2879,Maximum plasma concentration of compound was measured in rat,N,8932,,CHEMBL622200,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2864,Maximum plasma concentration after 20 mg/kg oral administration in rat,N,8933,,CHEMBL622201,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16367,Maximum plasma concentration after oral administration to rats,N,8934,,CHEMBL623990,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17717,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,8935,,CHEMBL623991,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17717,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",N,8936,,CHEMBL623992,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17717,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,8937,,CHEMBL623993,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17717,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,N,8938,,CHEMBL623994,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,F,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17720,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,N,8939,,CHEMBL623995,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,F,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17720,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,N,8940,,CHEMBL623996,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,F,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17720,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,N,8941,,CHEMBL623997,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4516,Maximum plasma concentration dosed orally in rats,N,8942,,CHEMBL623998,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4516,Maximum plasma concentration dosed orally in rats after 6 hours,N,8943,,CHEMBL623999,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4516,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,N,8944,,CHEMBL624000,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5199,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,8945,,CHEMBL624001,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17538,Maximum plasma concentration in rat after po administration,N,8946,,CHEMBL624002,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6685,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",N,8947,,CHEMBL624003,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6685,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",N,8948,,CHEMBL624004,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,8949,,CHEMBL624005,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,8950,,CHEMBL624006,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,8951,,CHEMBL624007,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,8952,,CHEMBL624008,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,8953,,CHEMBL624009,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,8954,,CHEMBL874387,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,8955,,CHEMBL624010,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,8956,,CHEMBL624011,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,8957,,CHEMBL624012,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,8958,,CHEMBL624013,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,8959,,CHEMBL624736,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,8960,,CHEMBL624737,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,8961,,CHEMBL624738,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,8962,,CHEMBL624739,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,8963,,CHEMBL624740,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,8964,,CHEMBL624896,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,8965,,CHEMBL624897,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,8966,,CHEMBL624108,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,8967,,CHEMBL624109,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,8968,,CHEMBL624110,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,8969,,CHEMBL624111,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,8970,,CHEMBL624112,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,8971,,CHEMBL624113,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,8972,,CHEMBL619709,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,8973,,CHEMBL619710,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,8974,,CHEMBL619711,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,8975,,CHEMBL619712,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,8976,,CHEMBL619713,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,8977,,CHEMBL619714,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,8978,,CHEMBL619715,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,8979,,CHEMBL619716,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,8980,,CHEMBL619717,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,8981,,CHEMBL619718,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,8982,,CHEMBL619719,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,8983,,CHEMBL875329,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,8984,,CHEMBL619720,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,8985,,CHEMBL619721,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,8986,,CHEMBL619722,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,8987,,CHEMBL619723,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,8988,,CHEMBL619724,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,8989,,CHEMBL619725,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,8990,,CHEMBL619726,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,8991,,CHEMBL619727,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,8992,,CHEMBL619728,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,8993,,CHEMBL619729,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8994,,CHEMBL619730,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,8995,,CHEMBL619731,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,8996,,CHEMBL619732,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,8997,,CHEMBL619733,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,8998,,CHEMBL619734,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,8999,,CHEMBL619735,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,9000,,CHEMBL875330,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,9001,,CHEMBL628465,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,9002,,CHEMBL628466,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,9003,,CHEMBL628467,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,9004,,CHEMBL628468,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,9005,,CHEMBL628469,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,9006,,CHEMBL628470,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,9007,,CHEMBL628471,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,9008,,CHEMBL628472,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,9009,,CHEMBL625191,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,9010,,CHEMBL625192,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,9011,,CHEMBL875337,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,9012,,CHEMBL626341,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,9013,,CHEMBL626342,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11977,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,9014,,CHEMBL621943,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3748,Half life in rats,N,9015,,CHEMBL621944,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15765,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,N,9016,,CHEMBL621945,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4871,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),N,9017,,CHEMBL621946,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4871,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,9018,,CHEMBL621947,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4872,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),N,9019,,CHEMBL621948,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4872,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,9020,,CHEMBL621949,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5413,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),N,9021,,CHEMBL621950,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5413,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,N,9022,,CHEMBL621951,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,15272,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,N,9023,,CHEMBL621952,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,4689,Stability (%) in rat liver microsomes,N,9024,,CHEMBL621953,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6057,Area under curve was calculated after intravenous administration,N,9025,,CHEMBL621954,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6057,Area under the curve was calculated after iv administration in rat,N,9026,,CHEMBL621955,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6057,Area under the curve was calculated in rat after peroral administration,N,9027,,CHEMBL621956,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6211,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,9028,,CHEMBL621957,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5710,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,N,9029,,CHEMBL621958,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5710,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,N,9030,,CHEMBL621959,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17853,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,N,9031,,CHEMBL621960,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17853,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,N,9032,,CHEMBL621961,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15765,p value of the compound,N,9033,,CHEMBL621962,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,15765,p value of the compound,N,9034,,CHEMBL876787,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15765,p value of the compound,N,9035,,CHEMBL621963,10116.0,Intermediate,50597,1
Stomach,,,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,9036,,CHEMBL622637,10116.0,Intermediate,50597,1
Stomach,,,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,9037,,CHEMBL622638,10116.0,Intermediate,50597,1
Stomach,,,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,9038,,CHEMBL626561,10116.0,Intermediate,50597,1
,,,,,F,Oryctolagus cuniculus,0,,,,,BAO_0000019,7991,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),U,9039,,CHEMBL626562,9986.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),U,9040,,CHEMBL626563,9986.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),U,9041,,CHEMBL626564,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,6253,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,9042,,CHEMBL626565,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,6253,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,9043,,CHEMBL626566,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,3615,Clearance rate in rabbits,U,9044,,CHEMBL626567,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,4059,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,9045,,CHEMBL626568,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,5124,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,9046,,CHEMBL626569,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,5124,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,9047,,CHEMBL626570,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,5124,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,9048,,CHEMBL626571,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,U,9049,,CHEMBL626572,9986.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Oryctolagus cuniculus,0,,1969.0,,,BAO_0000218,4059,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,9050,,CHEMBL626573,9986.0,Autocuration,22224,1
Liver,,,,,A,Oryctolagus cuniculus,0,Microsomes,2107.0,,,BAO_0000251,9659,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,U,9051,,CHEMBL626574,9986.0,Autocuration,22224,1
Liver,,,,,A,Oryctolagus cuniculus,0,Microsomes,2107.0,,,BAO_0000251,9659,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,U,9052,,CHEMBL626575,9986.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,3639,Dose at which bioavailability of intravenously administered compound was tested in rabbit,U,9053,,CHEMBL626576,9986.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,3639,Dose at which bioavailability of perorally administered compound was tested in rabbit,U,9054,,CHEMBL626577,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,3639,The compound was tested for its bioavailability in rabbit (by oral dosage).,U,9055,,CHEMBL626578,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,5124,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,9056,,CHEMBL625263,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,5124,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,9057,,CHEMBL625264,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,5124,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,9058,,CHEMBL625265,9986.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,0,Microsomes,,,,BAO_0000251,14294,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),U,9059,,CHEMBL625266,9986.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,0,Microsomes,,,,BAO_0000251,14294,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),U,9060,,CHEMBL876796,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,U,9061,,CHEMBL625267,9986.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Oryctolagus cuniculus,0,,1969.0,,,BAO_0000218,5124,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,9062,,CHEMBL625268,9986.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Oryctolagus cuniculus,0,,1969.0,,,BAO_0000218,5124,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,9063,,CHEMBL625269,9986.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Oryctolagus cuniculus,0,,1969.0,,,BAO_0000218,5124,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,9064,,CHEMBL624689,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,U,9065,,CHEMBL624690,9986.0,Autocuration,22224,1
Urine,,,,,A,Oryctolagus cuniculus,0,,1088.0,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),U,9066,,CHEMBL624691,9986.0,Autocuration,22224,1
Urine,,,,,A,Oryctolagus cuniculus,0,,1088.0,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),U,9067,,CHEMBL624692,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,4059,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,U,9068,,CHEMBL624693,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,4137,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,U,9069,,CHEMBL624694,9986.0,Autocuration,22224,1
,,In vitro,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000221,11672,In vitro Biological half-life in crude homogenate of rabbit renal cortex,U,9070,,CHEMBL877596,9986.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000019,12886,Time within which only 10% of the drug was degraded,U,9071,,CHEMBL624695,9986.0,Autocuration,22224,1
Liver,,,,,A,Oryctolagus cuniculus,0,,2107.0,,,BAO_0000221,3853,Half life period in rabbit liver homogenate,U,9072,,CHEMBL624696,9986.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000019,3615,Half life value in rabbits,U,9073,,CHEMBL624697,9986.0,Autocuration,22224,1
Blood,,In vivo,,,A,Oryctolagus cuniculus,0,,178.0,,,BAO_0000218,6253,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,9074,,CHEMBL624698,9986.0,Autocuration,22224,1
Blood,,In vivo,,,A,Oryctolagus cuniculus,0,,178.0,,,BAO_0000218,6253,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,9075,,CHEMBL624699,9986.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,0,,,,,BAO_0000218,6077,Half-life period in rabbits following intravenous administration at 2 mg/kg,U,9076,,CHEMBL624700,9986.0,Autocuration,22224,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17617,AUC 0-8 hr value in rats at 10 mg/kg,N,9077,,CHEMBL622903,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17594,AUC after administration at 2000 mg/kg/day in rats,N,9078,,CHEMBL622904,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6149,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,N,9079,,CHEMBL622905,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17260,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,9080,,CHEMBL622906,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17260,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,9081,,CHEMBL622907,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6644,AUC in rat after oral administration at 10.5 mg/kg dose,N,9082,,CHEMBL622908,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6644,AUC in rat after oral administration at 11.2 mg/kg dose,N,9083,,CHEMBL622909,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6644,AUC in rat after oral administration at 9.7 mg/kg dose,N,9084,,CHEMBL622910,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,6495,AUC in rat brain after oral administration at 10 mg/kg,N,9085,,CHEMBL622911,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6504,AUC in rat p.o.,N,9086,,CHEMBL622912,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17686,AUC in rat p.o. at 20 mg/kg concentration,N,9087,,CHEMBL622913,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6495,AUC in rat plasma after oral administration at 10 mg/kg,N,9088,,CHEMBL622914,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,216,AUC in rats,N,9089,,CHEMBL622915,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1908,AUC value after IV dose at a dose of 5 mg/kg in rats.,N,9090,,CHEMBL622916,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1908,AUC value after oral dose at a dose of 10 mg/kg in rats.,N,9091,,CHEMBL622917,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6685,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,9092,,CHEMBL622918,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,216,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,N,9093,,CHEMBL622919,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6049,Maximum plasma concentration was evaluated in rat,N,9094,,CHEMBL622920,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2463,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,9095,,CHEMBL622921,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6679,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,N,9096,,CHEMBL622922,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6681,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,9097,,CHEMBL622923,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4890,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,9098,,CHEMBL877604,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6410,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,N,9099,,CHEMBL622924,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6410,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,N,9100,,CHEMBL622925,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16366,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,N,9101,,CHEMBL622926,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6227,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,N,9102,,CHEMBL623625,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3598,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,N,9103,,CHEMBL623626,10116.0,Expert,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1465,Maximum plasma drug concentration was determined,N,9104,,CHEMBL623627,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4368,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,N,9105,,CHEMBL623628,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15662,Mean peak plasma concentration was observed after intravenous administration in rat,N,9106,,CHEMBL623629,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15662,Mean peak plasma concentration was observed after oral administration in rat,N,9107,,CHEMBL623630,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5355,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,N,9108,,CHEMBL623804,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5355,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,N,9109,,CHEMBL623805,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1567,Peak oral plasma concentration was determined in rats by oral administration,N,9110,,CHEMBL623806,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4026,Peak plasma concentration (Cmax) was determined,N,9111,,CHEMBL623807,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6193,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,N,9112,,CHEMBL623808,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4026,Peak plasma concentration (Cmax) in rats,N,9113,,CHEMBL623809,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6485,Peak plasma concentration at 1 mg/kg peroral administration,N,9114,,CHEMBL623810,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17655,Peak plasma concentration in rat,N,9115,,CHEMBL623811,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14941,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",N,9116,,CHEMBL623812,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5394,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,N,9117,,CHEMBL877605,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4408,Pharmacokinetic property (Cmax) in rat,N,9118,,CHEMBL623813,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5983,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,9119,,CHEMBL623814,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4878,Cmax in rat after 3mg/kg oral dose,N,9120,,CHEMBL623815,10116.0,Intermediate,50597,1
,,In vivo,Sprague-Dawley,,A,Rattus norvegicus,1,,,,,BAO_0000218,5862,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,N,9121,,CHEMBL623816,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4517,Cmax in rats after 20 mg/kg oral dose,N,9122,,CHEMBL623145,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5932,Cmax in rat plasma after 30mg/kg oral dose,N,9123,,CHEMBL623146,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5436,Plasma concentration after oral administration of 100 mg/kg to rats,N,9124,,CHEMBL623147,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,4910,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,9125,,CHEMBL623042,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4950,Tested for the Cmax in rat at 10 mg/kg per orally,N,9126,,CHEMBL623043,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,9127,,CHEMBL623044,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",N,9128,,CHEMBL623045,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3360,Bioavailability as oral Cmax in rats at 30 mins,N,9129,,CHEMBL623046,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3360,Bioavailability as oral Cmax in rats at 6hr,N,9130,,CHEMBL623226,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The maximum concentration of compound was measured at the dose of 100 umol/kg,N,9131,,CHEMBL623227,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The maximum concentration of compound was measured at the dose of 300 umol/kg,N,9132,,CHEMBL623228,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The maximum concentration of compound was measured at the dose of 30 umol/kg,N,9133,,CHEMBL623229,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5160,The maximum plasma levels for the compounds were determined by LC-MS.,N,9134,,CHEMBL623230,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15662,mean peak plasma concentration was observed after intravenous administration in rat,N,9135,,CHEMBL623231,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15662,mean peak plasma concentration was observed after oral administration in rat,N,9136,,CHEMBL623232,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4709,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,N,9137,,CHEMBL623233,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3535,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,N,9138,,CHEMBL623234,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3535,Concentration in plasma (portal) following oral dose in rats at 1 hr,N,9139,,CHEMBL623235,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3535,Concentration in plasma (portal) following oral dose in rats at 2 hr,N,9140,,CHEMBL623236,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3535,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,N,9141,,CHEMBL623237,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3535,Concentration in plasma (systemic) following oral dose in rats at 1 hr,N,9142,,CHEMBL623238,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3535,Concentration in plasma (systemic) following oral dose in rats at 2 hr,N,9143,,CHEMBL623239,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,0,,1969.0,,,BAO_0000218,5005,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,U,9144,,CHEMBL623240,10116.0,Intermediate,22224,1
Hypothalamus,,,,,A,Rattus norvegicus,1,,1898.0,,,BAO_0000218,6326,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",N,9145,,CHEMBL623241,10116.0,Intermediate,50597,1
Hypothalamus,,,,,A,Rattus norvegicus,1,,1898.0,,,BAO_0000218,6326,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",N,9146,,CHEMBL623242,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6326,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",N,9147,,CHEMBL874394,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6326,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",N,9148,,CHEMBL623243,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17411,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9149,,CHEMBL623244,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,9150,,CHEMBL623245,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,9151,,CHEMBL623246,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,9152,,CHEMBL623247,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,9153,,CHEMBL623248,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,9154,,CHEMBL623249,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,9155,,CHEMBL625072,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,9156,,CHEMBL625073,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,9157,,CHEMBL625074,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,9158,,CHEMBL625075,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,N,9159,,CHEMBL625076,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,9160,,CHEMBL625077,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,9161,,CHEMBL625078,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,9162,,CHEMBL874395,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,9163,,CHEMBL625079,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,9164,,CHEMBL625080,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,9165,,CHEMBL625081,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,9166,,CHEMBL625082,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,9167,,CHEMBL625083,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,9168,,CHEMBL625084,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,9169,,CHEMBL625085,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,9170,,CHEMBL625086,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,9171,,CHEMBL625087,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,9172,,CHEMBL625088,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,9173,,CHEMBL622205,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,9174,,CHEMBL622206,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,9175,,CHEMBL622207,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,9176,,CHEMBL622366,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,9177,,CHEMBL622367,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,9178,,CHEMBL875331,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,9179,,CHEMBL622368,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,9180,,CHEMBL622369,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,9181,,CHEMBL622370,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,9182,,CHEMBL622371,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,9183,,CHEMBL622372,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,9184,,CHEMBL622373,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,9185,,CHEMBL622374,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,9186,,CHEMBL622375,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,9187,,CHEMBL622376,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,9188,,CHEMBL622377,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,9189,,CHEMBL622378,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,9190,,CHEMBL622379,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,9191,,CHEMBL622380,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,9192,,CHEMBL622381,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,9193,,CHEMBL622382,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,N,9194,,CHEMBL622383,10116.0,Intermediate,50597,1
Stomach,,,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,6175,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,9195,,CHEMBL875332,10116.0,Intermediate,50597,1
Stomach,,,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,6175,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,9196,,CHEMBL622384,10116.0,Intermediate,50597,1
Stomach,,,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,6175,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,9197,,CHEMBL622385,10116.0,Intermediate,50597,1
Stomach,,,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,6175,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,9198,,CHEMBL622386,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10839,The compound was tested for the plasma binding in rat,N,9199,,CHEMBL622387,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16459,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",N,9200,,CHEMBL622388,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16459,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",N,9201,,CHEMBL622389,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16459,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",N,9202,,CHEMBL622390,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16459,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),N,9203,,CHEMBL622391,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16459,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),N,9204,,CHEMBL622392,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16459,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),N,9205,,CHEMBL622393,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3278,Plasma level at 2 hr after administration of the compound,N,9206,,CHEMBL622394,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3278,plasma level at 2 hr after administration of the compound,N,9207,,CHEMBL622395,10116.0,Intermediate,50597,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 1 min,N,9208,,CHEMBL622396,10116.0,Intermediate,50597,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 10 min,N,9209,,CHEMBL624894,10116.0,Intermediate,50597,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 10 mins,N,9210,,CHEMBL624895,10116.0,Intermediate,50597,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 2 hr,N,9211,,CHEMBL624058,10116.0,Intermediate,50597,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 3 min,N,9212,,CHEMBL624059,10116.0,Intermediate,50597,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 3 mins,N,9213,,CHEMBL624060,10116.0,Intermediate,50597,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 5 min,N,9214,,CHEMBL624061,10116.0,Intermediate,50597,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 5 mins,N,9215,,CHEMBL624062,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16456,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,9216,,CHEMBL624063,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16456,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,9217,,CHEMBL624064,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,723,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,N,9218,,CHEMBL624065,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,723,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,N,9219,,CHEMBL624066,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5160,Half life tested in mature male rat at a dose of 30 mg/kg,N,9220,,CHEMBL877490,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4709,Half life after intravenous administration of 1 mg/kg in rat,N,9221,,CHEMBL874442,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5633,Half life period after administration (30 mg/kg) in rat,N,9222,,CHEMBL626890,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5302,Half life period in rat after 5 mg/Kg dose,N,9223,,CHEMBL626891,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5302,Half life period in rat after 5 mg/kg dose,N,9224,,CHEMBL626892,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Half life period was determined,N,9225,,CHEMBL626893,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Half life period was evaluated in rat,N,9226,,CHEMBL626894,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Half life period was evaluated in rat; 0.5-1.0,N,9227,,CHEMBL626895,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Half life period was evaluated in rat; 5.9-7.5,N,9228,,CHEMBL626896,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14512,Half-life in rat plasma,N,9229,,CHEMBL626897,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6230,Half-life time in rat was determined,N,9230,,CHEMBL626898,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3364,Terminal half-life after iv administration to rats,N,9231,,CHEMBL626899,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6874,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,N,9232,,CHEMBL626900,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,857,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,N,9233,,CHEMBL626901,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,858,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),N,9234,,CHEMBL626902,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,858,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),N,9235,,CHEMBL626903,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5355,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,N,9236,,CHEMBL874443,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5355,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,N,9237,,CHEMBL626904,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6305,Half life in rats,N,9238,,CHEMBL626905,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13501,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,9239,,CHEMBL873830,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17594,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,N,9240,,CHEMBL626906,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4186,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,9241,,CHEMBL631076,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2932,Biological half-life was measured in plasma of rats,N,9242,,CHEMBL631077,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17065,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,9243,,CHEMBL631078,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15765,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,N,9244,,CHEMBL631079,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2713,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,N,9245,,CHEMBL631080,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,N,9246,,CHEMBL631081,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,N,9247,,CHEMBL631239,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,740,Compound was evaluated for plasma half life in rat,N,9248,,CHEMBL631240,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6597,AUC value at a dose of 5 mg/kg (p.o.) in rats,N,9249,,CHEMBL631241,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2959,AUC value after administration of 20 mg/Kg oral dose in rat,N,9250,,CHEMBL631242,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17594,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,N,9251,,CHEMBL631243,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17596,AUC0-96 after administration at 50 mg/kg,N,9252,,CHEMBL874444,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17594,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,N,9253,,CHEMBL631244,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3293,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",N,9254,,CHEMBL631245,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6757,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,N,9255,,CHEMBL627162,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6757,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,N,9256,,CHEMBL627163,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6757,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,N,9257,,CHEMBL627164,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,N,9258,,CHEMBL627165,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,N,9259,,CHEMBL627166,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,N,9260,,CHEMBL627167,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4026,Area under curve (AUC) at a dose of 30 mg/kg in rats,N,9261,,CHEMBL627822,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5355,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,9262,,CHEMBL627823,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5355,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,N,9263,,CHEMBL627824,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5355,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,9264,,CHEMBL627825,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5633,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,N,9265,,CHEMBL627826,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1716,Area under curve (Pharmacokinetic property) was determined,N,9266,,CHEMBL627827,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1716,Area under curve (Pharmacokinetic property) of the compound; Not determined,N,9267,,CHEMBL627828,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4689,Area under curve after intravenous administration (1 mg/kg) in rat,N,9268,,CHEMBL627829,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4527,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,N,9269,,CHEMBL627830,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4527,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,N,9270,,CHEMBL627831,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15662,Area under curve in male SD rats was observed after oral administration in rat,N,9271,,CHEMBL627832,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4413,Area under curve of compound after iv administration of 20 mg/kg dose in rat,N,9272,,CHEMBL627833,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3598,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,N,9273,,CHEMBL627834,10116.0,Expert,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3598,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,N,9274,,CHEMBL628004,10116.0,Expert,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5964,Area under curve at 5 mg/kg po was determined in rat,N,9275,,CHEMBL628005,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4689,Area under curve in Rat at a oral dose of 5 mg/kg,N,9276,,CHEMBL628006,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4186,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,9277,,CHEMBL628007,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,Area under curve was determined,N,9278,,CHEMBL625676,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17858,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,N,9279,,CHEMBL631309,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17804,Area under curve after intravenous administration at 3 mg/kg,N,9280,,CHEMBL631310,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6106,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,N,9281,,CHEMBL631311,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5964,Area under curve at 4 hr in rat,N,9282,,CHEMBL631312,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4026,Area under curve at a dose of 30 mg/kg,N,9283,,CHEMBL631313,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4756,Area under curve at the dose of 2 mg/Kg administered perorally in rats,N,9284,,CHEMBL631314,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4756,Area under curve at the dose of 5 mg/Kg administered perorally in rats,N,9285,,CHEMBL631315,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5862,Area under curve for a 2-mpk po dose in SD rats,N,9286,,CHEMBL631316,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5862,Area under curve in SD rats,N,9287,,CHEMBL631317,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6644,Area under curve in rat after oral administration at 13 mg/kg dose,N,9288,,CHEMBL874471,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5871,Area under curve in rat by po administration at 0-24 hr,N,9289,,CHEMBL631318,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5919,Area under curve in rat plasma,N,9290,,CHEMBL631319,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,N,9291,,CHEMBL631320,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,N,9292,,CHEMBL631321,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,N,9293,,CHEMBL631322,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11149,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,N,9294,,CHEMBL631323,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5302,Area under curve value in rat at a dose of 5 mg/kg,N,9295,,CHEMBL631324,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17796,Area under curve was determined after oral administration in rats,N,9296,,CHEMBL631325,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4890,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,9297,,CHEMBL631326,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6011,Area under curve was determined after peroral administration in rat,N,9298,,CHEMBL631327,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5375,Area under curve was determined at a dose 30 mpk administered orally.,N,9299,,CHEMBL631328,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17764,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,N,9300,,CHEMBL631329,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4368,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,N,9301,,CHEMBL627217,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5610,Area under curve was determined in male rat,N,9302,,CHEMBL626352,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5833,Area under curve was determined in rat after PO administration,N,9303,,CHEMBL626353,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4257,Area under curve was determined in rat after a 3 mg/kg of oral dose,N,9304,,CHEMBL626354,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5937,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,N,9305,,CHEMBL626355,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5932,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,N,9306,,CHEMBL626356,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5932,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,N,9307,,CHEMBL626357,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17411,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9308,,CHEMBL626358,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17411,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9309,,CHEMBL626359,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17771,Peak plasma concentration in rat at a dose of 3 mg/kg,N,9310,,CHEMBL626360,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1628,Plasma concentration at 2 hr in rats was evaluated.,N,9311,,CHEMBL626361,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1628,Plasma concentration at 2 hr in rats was evaluated; Not available,N,9312,,CHEMBL626362,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17411,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9313,,CHEMBL626363,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4910,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,9314,,CHEMBL626970,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4910,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,9315,,CHEMBL626971,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4910,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,9316,,CHEMBL626972,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4910,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,9317,,CHEMBL626973,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4910,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,9318,,CHEMBL626974,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4910,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,9319,,CHEMBL874592,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,N,9320,,CHEMBL626975,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,N,9321,,CHEMBL626976,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,N,9322,,CHEMBL626977,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,N,9323,,CHEMBL626978,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16427,PK study was carried to determine the relative absorption ranking in rat.,N,9324,,CHEMBL626979,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4689,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,N,9325,,CHEMBL626980,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",N,9326,,CHEMBL626981,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",N,9327,,CHEMBL626982,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",N,9328,,CHEMBL626983,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",N,9329,,CHEMBL622522,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",N,9330,,CHEMBL622523,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",N,9331,,CHEMBL622524,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",N,9332,,CHEMBL622525,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",N,9333,,CHEMBL622526,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",N,9334,,CHEMBL619849,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",N,9335,,CHEMBL619850,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",N,9336,,CHEMBL623864,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",N,9337,,CHEMBL623865,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",N,9338,,CHEMBL623866,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",N,9339,,CHEMBL623867,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",N,9340,,CHEMBL877615,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",N,9341,,CHEMBL623868,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",N,9342,,CHEMBL623869,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",N,9343,,CHEMBL623870,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,9344,,CHEMBL623871,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,9345,,CHEMBL623872,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,9346,,CHEMBL622129,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,9347,,CHEMBL622130,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,9348,,CHEMBL622131,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,9349,,CHEMBL622132,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,9350,,CHEMBL622133,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,9351,,CHEMBL622134,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,9352,,CHEMBL622135,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,16435,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,9353,,CHEMBL622136,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,9354,,CHEMBL622137,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,9355,,CHEMBL622138,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,9356,,CHEMBL623017,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,9357,,CHEMBL623018,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,9358,,CHEMBL623019,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,9359,,CHEMBL623020,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,N,9360,,CHEMBL623021,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,9361,,CHEMBL623022,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,9362,,CHEMBL623023,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,9363,,CHEMBL623024,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,9364,,CHEMBL623025,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,9365,,CHEMBL620545,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,9366,,CHEMBL620546,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,9367,,CHEMBL620547,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,9368,,CHEMBL620548,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,9369,,CHEMBL620549,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,9370,,CHEMBL620550,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,9371,,CHEMBL620551,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,9372,,CHEMBL620552,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,9373,,CHEMBL620553,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,9374,,CHEMBL620554,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,9375,,CHEMBL875845,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,9376,,CHEMBL620555,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,9377,,CHEMBL620556,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,9378,,CHEMBL620557,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,9379,,CHEMBL620558,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,9380,,CHEMBL620559,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,9381,,CHEMBL622939,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,9382,,CHEMBL622940,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,9383,,CHEMBL622941,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,9384,,CHEMBL622942,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,9385,,CHEMBL622943,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,9386,,CHEMBL622944,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,9387,,CHEMBL622945,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,9388,,CHEMBL622946,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3341,Compound was evaluated for terminal half life in rat,N,9389,,CHEMBL622947,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3634,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,N,9390,,CHEMBL622948,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3634,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,N,9391,,CHEMBL622949,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4839,Compound was tested for its half life in rat,N,9392,,CHEMBL622950,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Macaca mulatta,0,,1969.0,,,BAO_0000218,5005,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,U,9393,,CHEMBL622951,9544.0,Intermediate,22224,1
Plasma,,,,,A,Rattus norvegicus,0,,1969.0,,,BAO_0000366,5005,Compound was tested for its plasma half life in Sprague Dawley rats,U,9394,,CHEMBL622952,10116.0,Intermediate,22224,1
Plasma,,,,,A,Rattus norvegicus,0,,1969.0,,,BAO_0000366,5005,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,U,9395,,CHEMBL622953,10116.0,Intermediate,22224,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1094,Compound was tested for plasma half-life period in rat,N,9396,,CHEMBL873818,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5031,Elimination half life after i.v. administration of compound in rats,N,9397,,CHEMBL622954,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Elimination half-life after IV dosing at 0.5 mg/kg in rat,N,9398,,CHEMBL622955,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Elimination half-life after IV dosing at 1 mg/kg in rat,N,9399,,CHEMBL875229,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,N,9400,,CHEMBL622956,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,N,9401,,CHEMBL622957,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,5408,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,9402,,CHEMBL622958,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5408,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,9403,,CHEMBL622959,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,5408,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,9404,,CHEMBL622960,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5408,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,9405,,CHEMBL622961,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4687,Evaluated for the half life in rat (in vivo),N,9406,,CHEMBL622962,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6640,Hafl life in rat,N,9407,,CHEMBL622963,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6640,Hafl life rat,N,9408,,CHEMBL622964,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Hafl life rat,N,9409,,CHEMBL622965,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6640,Hafl life rat; Not determined,N,9410,,CHEMBL622966,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Hafl life rat; Not determined,N,9411,,CHEMBL622967,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,17411,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9412,,CHEMBL622968,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,17411,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9413,,CHEMBL622969,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,17411,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9414,,CHEMBL875327,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6570,Half life in rat after 1 mg/kg i.v. administration,N,9415,,CHEMBL628638,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6570,Half life in rat after 2 mg/kg peroral administration,N,9416,,CHEMBL628639,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17411,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9417,,CHEMBL625840,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4722,Half life of 10 mg/kg oral dose determined in rats,N,9418,,CHEMBL625841,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,9419,,CHEMBL625842,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,9420,,CHEMBL625843,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,9421,,CHEMBL625844,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,9422,,CHEMBL873822,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,9423,,CHEMBL625845,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,9424,,CHEMBL627059,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,N,9425,,CHEMBL627060,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,9426,,CHEMBL627061,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4762,Half life of compound at 5 mg/kg after po administration was determined in rat,N,9427,,CHEMBL627709,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5327,Half life of compound determined after intravenous administration to rat,N,9428,,CHEMBL627710,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4847,Half life of compound was determined in rat,N,9429,,CHEMBL627711,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17720,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,N,9430,,CHEMBL627712,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,9431,,CHEMBL627713,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,9432,,CHEMBL627714,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca fascicularis,0,,,,,BAO_0000218,4256,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,U,9433,,CHEMBL627889,9541.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,4256,Half life determined in rat by intravenous administration,U,9434,,CHEMBL627890,10116.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4722,Half life determined in rats after iv administration,N,9435,,CHEMBL627891,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6535,Half life in rat plasma after administration of 2 mg/kg iv,N,9436,,CHEMBL627892,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6535,Half life in rat plasma after administration of 2 mg/kg iv,N,9437,,CHEMBL627893,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1435,Half life in rat plasma was determined,N,9438,,CHEMBL627894,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1435,Half life in rat plasma was determined; NA means not applicable,N,9439,,CHEMBL627895,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5206,Half life in rat was tested,N,9440,,CHEMBL627896,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6080,Half life measured in rat plasma,N,9441,,CHEMBL627897,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4449,Half life recorded in rats,N,9442,,CHEMBL627898,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6057,Half life was calculated,N,9443,,CHEMBL627899,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6057,Half life was calculated in rat,N,9444,,CHEMBL873823,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3747,Half life was determined,N,9445,,CHEMBL627900,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17858,Half life after 10 mg/kg oral administration in rat,N,9446,,CHEMBL627901,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Half life after administering orally a dose of 10 mg/kg to a fasting rat,N,9447,,CHEMBL627902,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Half life after administering orally a dose of 30 mg/kg,N,9448,,CHEMBL627903,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5031,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,N,9449,,CHEMBL627904,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4722,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,N,9450,,CHEMBL627905,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6078,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,N,9451,,CHEMBL627906,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6078,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,N,9452,,CHEMBL627907,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6078,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,N,9453,,CHEMBL876783,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6078,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,N,9454,,CHEMBL627908,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17065,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,9455,,CHEMBL627909,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,N,9456,,CHEMBL627910,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),N,9457,,CHEMBL627911,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),N,9458,,CHEMBL627912,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),N,9459,,CHEMBL627913,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),N,9460,,CHEMBL627914,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16423,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,N,9461,,CHEMBL627915,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16423,Area under the curve was evaluated after 20 uM/kg of peroral administration,N,9462,,CHEMBL627916,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6062,Area under the curve was measured in rat after an iv dose of 1 mg/kg,N,9463,,CHEMBL627917,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6056,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,N,9464,,CHEMBL627918,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5182,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,N,9465,,CHEMBL627919,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6410,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,N,9466,,CHEMBL627920,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6410,Area under the curve was evaluated at an oral dose of 30 mg/kg,N,9467,,CHEMBL627921,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,9468,,CHEMBL627922,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,9469,,CHEMBL876784,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,9470,,CHEMBL627923,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,9471,,CHEMBL626208,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,9472,,CHEMBL626209,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,9473,,CHEMBL626210,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2463,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,9474,,CHEMBL627994,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4709,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,N,9475,,CHEMBL627995,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4075,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,N,9476,,CHEMBL627996,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5394,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,N,9477,,CHEMBL627997,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,N,9478,,CHEMBL627998,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,N,9479,,CHEMBL628640,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,N,9480,,CHEMBL628641,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,N,9481,,CHEMBL628642,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Compound was evaluated for area under the curve expressed as (h*ug/ml),N,9482,,CHEMBL628643,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2591,Compound was tested for area under curve in rat,N,9483,,CHEMBL628644,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6567,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,N,9484,,CHEMBL628645,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6211,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,9485,,CHEMBL628646,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5529,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),N,9486,,CHEMBL628647,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5408,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,9487,,CHEMBL628648,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5408,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,9488,,CHEMBL625358,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5408,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,9489,,CHEMBL625359,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5408,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,9490,,CHEMBL625360,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),N,9491,,CHEMBL625361,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),N,9492,,CHEMBL625362,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),N,9493,,CHEMBL625363,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4796,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,9494,,CHEMBL625364,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,9495,,CHEMBL625365,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,9496,,CHEMBL625366,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,9497,,CHEMBL625367,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",N,9498,,CHEMBL625368,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",N,9499,,CHEMBL625369,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",N,9500,,CHEMBL625370,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",N,9501,,CHEMBL625371,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",N,9502,,CHEMBL625372,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",N,9503,,CHEMBL625373,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",N,9504,,CHEMBL625374,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",N,9505,,CHEMBL877593,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",N,9506,,CHEMBL625375,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",N,9507,,CHEMBL625376,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",N,9508,,CHEMBL621973,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",N,9509,,CHEMBL621974,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",N,9510,,CHEMBL621975,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",N,9511,,CHEMBL622166,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",N,9512,,CHEMBL622167,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",N,9513,,CHEMBL622168,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",N,9514,,CHEMBL622169,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",N,9515,,CHEMBL622170,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",N,9516,,CHEMBL622171,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",N,9517,,CHEMBL622172,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",N,9518,,CHEMBL622173,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",N,9519,,CHEMBL622174,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",N,9520,,CHEMBL622175,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",N,9521,,CHEMBL622176,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",N,9522,,CHEMBL622177,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",N,9523,,CHEMBL622178,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",N,9524,,CHEMBL622179,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",N,9525,,CHEMBL622180,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,9526,,CHEMBL622181,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,9527,,CHEMBL622182,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,9528,,CHEMBL622183,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,9529,,CHEMBL622184,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,9530,,CHEMBL622185,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,9531,,CHEMBL622186,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,9532,,CHEMBL622187,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,9533,,CHEMBL625002,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,N,9534,,CHEMBL622090,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,9535,,CHEMBL622091,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,9536,,CHEMBL622092,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,9537,,CHEMBL622093,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,9538,,CHEMBL622094,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,9539,,CHEMBL622095,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,9540,,CHEMBL622264,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,9541,,CHEMBL622265,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,9542,,CHEMBL622266,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,9543,,CHEMBL622267,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,9544,,CHEMBL622268,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,9545,,CHEMBL622269,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,9546,,CHEMBL625071,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,9547,,CHEMBL621621,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,9548,,CHEMBL621622,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,9549,,CHEMBL621623,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,9550,,CHEMBL621624,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,9551,,CHEMBL621625,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,9552,,CHEMBL621626,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,9553,,CHEMBL621627,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,9554,,CHEMBL621628,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,9555,,CHEMBL875328,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,9556,,CHEMBL621629,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,9557,,CHEMBL621630,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,9558,,CHEMBL621631,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,9559,,CHEMBL621632,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,9560,,CHEMBL621633,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,9561,,CHEMBL621634,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,9562,,CHEMBL621635,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,9563,,CHEMBL621636,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,9564,,CHEMBL621637,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,9565,,CHEMBL621638,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,9566,,CHEMBL618883,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,9567,,CHEMBL618884,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,9568,,CHEMBL628627,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,9569,,CHEMBL628628,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,9570,,CHEMBL628629,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Half life after administering orally a dose of 3 mg/kg,N,9571,,CHEMBL628630,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Half life after administering orally a dose of 3 mg/kg to a fasting rat,N,9572,,CHEMBL628631,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Half life after administering intravenously a dose of 1 mg/kg,N,9573,,CHEMBL628632,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,526,Half life after oral dosing in rats,N,9574,,CHEMBL628633,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,N,9575,,CHEMBL628634,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4368,Half life by intravenous administration of 3.4 mg/kg in rat,N,9576,,CHEMBL627789,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3371,Half life in rat,N,9577,,CHEMBL627790,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6448,Half life in rat,N,9578,,CHEMBL627791,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6453,Half life in rat,N,9579,,CHEMBL627792,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4353,Half life in rat after intravenous administration of the compound,N,9580,,CHEMBL627793,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4353,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,N,9581,,CHEMBL627794,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4353,Half life in rat after po administration of the compound,N,9582,,CHEMBL627795,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4353,Half life in rat after po administration of the compound; ND means Not determined,N,9583,,CHEMBL627796,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4353,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,N,9584,,CHEMBL875335,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4353,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,N,9585,,CHEMBL627797,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5789,Half life in rat i.v.,N,9586,,CHEMBL627798,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17686,Half life in rat i.v. at 2 mg/kg concentration,N,9587,,CHEMBL627799,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6495,Half life in rats,N,9588,,CHEMBL627800,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,484,Half life in rats after intravenous administration,N,9589,,CHEMBL627801,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6467,Half life in rats at the dose of 1.0 mpk by i.v. administration,N,9590,,CHEMBL627802,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6642,Half life in rat,N,9591,,CHEMBL627803,10116.0,Expert,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16367,Half life was evaluated after intravenous administration to rats,N,9592,,CHEMBL873820,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1369,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),N,9593,,CHEMBL627804,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5472,Half life was evaluated in rat,N,9594,,CHEMBL627805,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6049,Half life was evaluated in rat,N,9595,,CHEMBL627806,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5472,Half life was evaluated in rat; Not tested,N,9596,,CHEMBL627107,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16366,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,N,9597,,CHEMBL627108,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11149,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,N,9598,,CHEMBL627109,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11149,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,N,9599,,CHEMBL627110,10116.0,Intermediate,50597,1
,,In vivo,,,A,Primates,0,,,,,BAO_0000218,2891,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,9600,,CHEMBL627111,9443.0,Intermediate,22224,1
,,In vivo,,,A,Primates,0,,,,,BAO_0000218,2891,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,9601,,CHEMBL627112,9443.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,2891,Half life was measured in rat at dose of 30 mg/kg by iv administration,U,9602,,CHEMBL627113,10116.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,2891,Half life was measured in rat at dose of 30 mg/kg by po administration,U,9603,,CHEMBL627114,10116.0,Intermediate,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4026,Half life (t1/2) was determined,N,9604,,CHEMBL627115,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4527,Half life period at a dose of 10 uM/kg in rat was determined,N,9605,,CHEMBL627116,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4527,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,N,9606,,CHEMBL627117,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5503,Half life period was determined,N,9607,,CHEMBL627118,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4426,Half life period after intravenous administration at 20 mpk in rats,N,9608,,CHEMBL627119,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4426,Half life period after intravenous administration at 20 mpk in rats; Not performed.,N,9609,,CHEMBL627120,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6109,Half life period after intravenous administration in rat,N,9610,,CHEMBL626922,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5654,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,9611,,CHEMBL626923,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5654,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,9612,,CHEMBL626924,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4755,Half life period in 80% rat plasma at 37 degree Centigrade,N,9613,,CHEMBL626925,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5862,Half life period in SD rats,N,9614,,CHEMBL626926,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1515,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),N,9615,,CHEMBL626927,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),N,9616,,CHEMBL626928,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,9617,,CHEMBL626929,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,9618,,CHEMBL626930,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5960,Half life period in rat,N,9619,,CHEMBL626931,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6103,Half life period in rat,N,9620,,CHEMBL626932,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6317,Half life period in rat,N,9621,,CHEMBL626933,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6644,Half life period in rat after oral administration at 10.5 mg/kg dose,N,9622,,CHEMBL873826,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6644,Half life period in rat after oral administration at 11.2 mg/kg dose,N,9623,,CHEMBL626934,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6644,Half life period in rat after oral administration at 13 mg/kg dose,N,9624,,CHEMBL626935,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6644,Half life period in rat after oral administration at 9.7 mg/kg dose,N,9625,,CHEMBL626936,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,9626,,CHEMBL626937,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6295,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,9627,,CHEMBL625906,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6296,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,9628,,CHEMBL625907,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16427,PK study was carried to determine AUC (area under curve) value in rat,N,9629,,CHEMBL625908,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16367,Pharmacokinetic parameter AUC after intravenous administration to rats,N,9630,,CHEMBL625909,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16367,Pharmacokinetic parameter AUC after oral administration to rats,N,9631,,CHEMBL625910,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,N,9632,,CHEMBL625911,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,N,9633,,CHEMBL625912,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,N,9634,,CHEMBL626538,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,N,9635,,CHEMBL876794,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,N,9636,,CHEMBL626539,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,N,9637,,CHEMBL626540,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5394,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,N,9638,,CHEMBL626541,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5394,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,N,9639,,CHEMBL626542,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,N,9640,,CHEMBL626543,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,N,9641,,CHEMBL626544,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,N,9642,,CHEMBL626545,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,N,9643,,CHEMBL626546,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Pharmacokinetic parameter area under curve was reported,N,9644,,CHEMBL626547,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4408,Pharmacokinetic property (AUC) in rat,N,9645,,CHEMBL626548,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5983,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,N,9646,,CHEMBL626549,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,N,9647,,CHEMBL626550,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,N,9648,,CHEMBL626551,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5491,Pharmacokinetic property was determined,N,9649,,CHEMBL623777,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5491,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,N,9650,,CHEMBL623778,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5491,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,N,9651,,CHEMBL623779,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4199,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,9652,,CHEMBL623780,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4199,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,N,9653,,CHEMBL622015,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4199,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,N,9654,,CHEMBL622016,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",N,9655,,CHEMBL622017,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",N,9656,,CHEMBL622018,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",N,9657,,CHEMBL622019,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",N,9658,,CHEMBL622020,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16366,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,N,9659,,CHEMBL622021,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16366,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,N,9660,,CHEMBL622022,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5327,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,N,9661,,CHEMBL622023,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6681,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,N,9662,,CHEMBL622024,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12873,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),N,9663,,CHEMBL622693,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12873,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),N,9664,,CHEMBL622694,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,9665,,CHEMBL622695,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,9666,,CHEMBL622696,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",N,9667,,CHEMBL622697,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6619,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",N,9668,,CHEMBL622874,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6619,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",N,9669,,CHEMBL622875,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,9670,,CHEMBL622876,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4796,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,9671,,CHEMBL622877,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4910,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,9672,,CHEMBL622878,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4910,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,N,9673,,CHEMBL622879,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4839,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,N,9674,,CHEMBL877602,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,9675,,CHEMBL622880,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",N,9676,,CHEMBL622881,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,9677,,CHEMBL622882,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",N,9678,,CHEMBL622883,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",N,9679,,CHEMBL622884,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",N,9680,,CHEMBL622885,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8151,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,9681,,CHEMBL622886,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8151,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,9682,,CHEMBL622887,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,9683,,CHEMBL622888,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9684,,CHEMBL622889,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9685,,CHEMBL622890,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9686,,CHEMBL622891,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9687,,CHEMBL877603,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9688,,CHEMBL622892,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9689,,CHEMBL622893,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9690,,CHEMBL622894,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9691,,CHEMBL622895,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8677,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,N,9692,,CHEMBL622896,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9693,,CHEMBL622897,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9694,,CHEMBL622898,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9695,,CHEMBL622899,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9696,,CHEMBL622900,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9697,,CHEMBL624114,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9698,,CHEMBL624115,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9699,,CHEMBL624116,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9700,,CHEMBL624117,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9701,,CHEMBL624118,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9702,,CHEMBL624119,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9703,,CHEMBL624120,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9704,,CHEMBL624121,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9705,,CHEMBL624122,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9706,,CHEMBL624123,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9707,,CHEMBL624124,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9708,,CHEMBL624125,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9709,,CHEMBL624126,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9710,,CHEMBL624127,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9711,,CHEMBL624128,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9712,,CHEMBL624129,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9713,,CHEMBL624130,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9714,,CHEMBL622340,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9715,,CHEMBL622341,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9716,,CHEMBL622342,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9717,,CHEMBL622343,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9718,,CHEMBL622344,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9719,,CHEMBL622345,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9720,,CHEMBL622346,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9721,,CHEMBL622347,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9722,,CHEMBL622348,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9723,,CHEMBL622349,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,9724,,CHEMBL622350,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,9725,,CHEMBL622351,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,9726,,CHEMBL622352,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,9727,,CHEMBL622353,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,9728,,CHEMBL622354,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,9729,,CHEMBL622355,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,9730,,CHEMBL622356,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,9731,,CHEMBL622357,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,9732,,CHEMBL622358,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,9733,,CHEMBL622359,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,9734,,CHEMBL874393,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,9735,,CHEMBL622872,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,9736,,CHEMBL622873,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,9737,,CHEMBL623047,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,9738,,CHEMBL623048,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,9739,,CHEMBL623049,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,9740,,CHEMBL623050,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,9741,,CHEMBL623051,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,9742,,CHEMBL623052,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,9743,,CHEMBL626343,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,9744,,CHEMBL626344,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,9745,,CHEMBL626345,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,9746,,CHEMBL626346,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,9747,,CHEMBL626347,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,9748,,CHEMBL626348,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,9749,,CHEMBL626349,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,9750,,CHEMBL626350,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,9751,,CHEMBL626351,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,9752,,CHEMBL627650,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,9753,,CHEMBL627651,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,9754,,CHEMBL627652,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,9755,,CHEMBL627653,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,N,9756,,CHEMBL627654,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,N,9757,,CHEMBL627835,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,N,9758,,CHEMBL627836,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,N,9759,,CHEMBL627837,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,N,9760,,CHEMBL627838,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,N,9761,,CHEMBL875338,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,N,9762,,CHEMBL627839,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,N,9763,,CHEMBL627840,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,N,9764,,CHEMBL627841,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,N,9765,,CHEMBL627842,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,N,9766,,CHEMBL627843,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,N,9767,,CHEMBL627844,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,N,9768,,CHEMBL627845,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5874,Half life period in rat by iv administration at a dose of 3 mg/kg,N,9769,,CHEMBL627846,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1515,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),N,9770,,CHEMBL627847,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),N,9771,,CHEMBL873821,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,9772,,CHEMBL626079,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,9773,,CHEMBL626080,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5491,Half life period was evaluated in rat plasma,N,9774,,CHEMBL626081,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5491,Half life period was evaluated in rat plasma; Not tested,N,9775,,CHEMBL875344,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1918,Half life period was evaluated in rats,N,9776,,CHEMBL626082,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1918,"Half life period was evaluated in rats, iv",N,9777,,CHEMBL626250,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6113,Half life period after intravenous administration at 5 mg/kg in rat,N,9778,,CHEMBL626251,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5546,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,9779,,CHEMBL626252,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5553,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,N,9780,,CHEMBL626253,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4188,Half life stability of compound was evaluated in rat plasma,N,9781,,CHEMBL626254,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6215,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,N,9782,,CHEMBL626255,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6141,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,9783,,CHEMBL626256,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5182,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,9784,,CHEMBL626257,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5182,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,N,9785,,CHEMBL626258,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5710,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,N,9786,,CHEMBL626259,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5789,Half in rat i.v.,N,9787,,CHEMBL626260,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6011,Half period in rat after intravenous administration,N,9788,,CHEMBL875345,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17594,Half-life after repeated oral dose of compound at 1 mg/kg in rats,N,9789,,CHEMBL626261,10116.0,Intermediate,50597,1
Liver,,In vitro,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12357,Half-life measured in in vitro Cathepsin B assay in rat liver,N,9790,,CHEMBL626262,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5210,Half-life of compound was determined in rats,N,9791,,CHEMBL626263,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17596,Half-life at 10 mg/kg in rat upon intravenous administration,N,9792,,CHEMBL625270,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6672,Half-life determined in rat,N,9793,,CHEMBL625271,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6673,Half-life determined in rat,N,9794,,CHEMBL625272,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,4910,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,N,9795,,CHEMBL625273,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3741,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",N,9796,,CHEMBL625274,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17671,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,9797,,CHEMBL625275,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4910,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,N,9798,,CHEMBL625276,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17537,Half-life in rat plasma,N,9799,,CHEMBL625277,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4965,Half-life in rat plasma was determined,N,9800,,CHEMBL625278,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17537,Half-life in rat plasma; Not tested,N,9801,,CHEMBL625279,10116.0,Intermediate,50597,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,6124,Half-life in rat serum,N,9802,,CHEMBL625280,10116.0,Intermediate,50597,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,6124,Half-life in rat serum; na is not available,N,9803,,CHEMBL876797,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6078,Half-life was calculated in rat,N,9804,,CHEMBL625281,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17668,Half-life was calculated in rat plasma,N,9805,,CHEMBL873827,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3185,Half-life was determined,N,9806,,CHEMBL625282,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4883,Half-life was determined,N,9807,,CHEMBL625283,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2959,Half-life after administration of 20 mg/Kg oral dose in rat,N,9808,,CHEMBL625284,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4029,Half-life after administration of 3.2 mg/kg intravenously in male rat,N,9809,,CHEMBL625285,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4029,Half-life after intravenous administration in female rat,N,9810,,CHEMBL625286,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4029,Half-life after intravenous administration in male rat,N,9811,,CHEMBL625287,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6180,Half-life after intravenous dose in rat,N,9812,,CHEMBL625288,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,1557,Half-life in a rat liver homogenate preparation,N,9813,,CHEMBL625289,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12500,Half-life in plasma of rat,N,9814,,CHEMBL625290,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12500,Half-life in plasma of rat at dose of 3-10 mgkg,N,9815,,CHEMBL876798,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5064,Half-life in rat,N,9816,,CHEMBL625291,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5145,Half-life in rat,N,9817,,CHEMBL625292,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5147,Half-life in rat,N,9818,,CHEMBL625293,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5833,Half-life in rat,N,9819,,CHEMBL622832,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6596,Half-life in rat,N,9820,,CHEMBL622833,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17655,Half-life in rat,N,9821,,CHEMBL622834,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6495,Half-life in rat after oral administration at 10 mg/kg,N,9822,,CHEMBL622835,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17538,Half-life in rat after po administration at a dose of 10 mg/kg,N,9823,,CHEMBL622836,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17538,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,9824,,CHEMBL622837,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10,Half-life in rat at 3 mg/kg dose administered intravenously,N,9825,,CHEMBL622838,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,17669,Half-life in rat brain homogenate,N,9826,,CHEMBL622839,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17065,Half-life in rat plasma,N,9827,,CHEMBL622840,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4333,Half-life in rats,N,9828,,CHEMBL622841,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6827,Half-life in Dawley rats,N,9829,,CHEMBL622842,10116.0,Intermediate,50597,1
Plasma,,In vitro,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,889,Half-life in vitro in rat plasma,N,9830,,CHEMBL622843,10116.0,Intermediate,50597,1
Plasma,,In vitro,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,889,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,N,9831,,CHEMBL622844,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3747,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",N,9832,,CHEMBL622845,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The area under the curve of compound was measured at the dose of 100 umol/kg,N,9833,,CHEMBL622846,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The area under the curve of compound was measured at the dose of 300 umol/kg,N,9834,,CHEMBL622847,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The area under the curve of compound was measured at the dose of 30 umol/kg,N,9835,,CHEMBL622848,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3360,Bioavailability as oral AUC in rats,N,9836,,CHEMBL622849,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5334,The plasma concentration versus time curve (AUC) was determined,N,9837,,CHEMBL622850,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17411,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9838,,CHEMBL876807,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17411,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9839,,CHEMBL622851,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17411,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9840,,CHEMBL622852,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6570,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,N,9841,,CHEMBL622853,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6570,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,N,9842,,CHEMBL622854,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17411,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,9843,,CHEMBL622855,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14941,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",N,9844,,CHEMBL622856,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14941,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",N,9845,,CHEMBL622857,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17538,AUC in rat after po administration at a dose of 10 mg/kg,N,9846,,CHEMBL622858,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17752,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,N,9847,,CHEMBL622859,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Area under curve value 24 hr after 10 mg/kg iv administration in rats,N,9848,,CHEMBL622860,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Area under curve value 24 hr after 10 mg/kg oral administration in rats,N,9849,,CHEMBL622861,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Area under curve value 24 hr after 2 mg/kg iv administration in rats,N,9850,,CHEMBL622862,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Area under curve value 24 hr after 2 mg/kg oral administration in rats,N,9851,,CHEMBL622863,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Area under curve value 6 hr after po administration in rat,N,9852,,CHEMBL623817,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,9853,,CHEMBL623818,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",N,9854,,CHEMBL623819,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,9855,,CHEMBL623820,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,N,9856,,CHEMBL623821,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6642,AUC normalized for dose (AUCN) in rat,N,9857,,CHEMBL623822,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6640,Area under curve in rat after p.o. administration,N,9858,,CHEMBL623823,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Area under curve in rat after p.o. administration,N,9859,,CHEMBL623824,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Area under curve in rat after p.o. administration; Not determined,N,9860,,CHEMBL623825,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Area under curve in rat after peroral administration,N,9861,,CHEMBL622070,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3603,Area under curve (carotid artery) value of the compound,N,9862,,CHEMBL622071,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3550,Bioavailability expressed as the area under curve of rat carotid artery,N,9863,,CHEMBL622072,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15662,Area under curve in male SD rats was observed after intravenous administration in rat,N,9864,,CHEMBL622073,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17720,Area under curve of the compound was determined,N,9865,,CHEMBL622074,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5407,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,N,9866,,CHEMBL622075,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17752,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,N,9867,,CHEMBL622076,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17752,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,N,9868,,CHEMBL622077,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3603,Area under curve (portal vein) value of the compound,N,9869,,CHEMBL622078,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3550,Bioavailability expressed as the area under curve of rat portal vein,N,9870,,CHEMBL622079,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17655,Area Under plasma concentration time curve in rat upon peroral administration,N,9871,,CHEMBL622080,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,N,9872,,CHEMBL877612,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,N,9873,,CHEMBL622081,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats,N,9874,,CHEMBL622082,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats after iv administration,N,9875,,CHEMBL622083,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats; 30-80,N,9876,,CHEMBL622084,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats; 50-60,N,9877,,CHEMBL622085,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats; no data,N,9878,,CHEMBL622086,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats; peptide,N,9879,,CHEMBL622087,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",N,9880,,CHEMBL622088,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",N,9881,,CHEMBL622089,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",N,9882,,CHEMBL623685,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",N,9883,,CHEMBL623686,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9884,,CHEMBL623687,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9885,,CHEMBL623688,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9886,,CHEMBL623689,10116.0,Intermediate,50597,1
Stomach,,In vivo,,,A,Rattus norvegicus,1,,945.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9887,,CHEMBL622485,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9888,,CHEMBL622486,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9889,,CHEMBL877613,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9890,,CHEMBL622487,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9891,,CHEMBL622488,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,9892,,CHEMBL622489,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,6899,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,9893,,CHEMBL622490,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,6899,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,9894,,CHEMBL622491,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,6899,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,N,9895,,CHEMBL622492,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,6899,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,9896,,CHEMBL622493,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,6899,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,9897,,CHEMBL622494,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8677,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,9898,,CHEMBL622495,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,N,9899,,CHEMBL622496,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,6899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,9900,,CHEMBL622497,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2189,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,N,9901,,CHEMBL622498,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,N,9902,,CHEMBL624918,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,N,9903,,CHEMBL624919,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,10839,Biodistribution of compound in rat blood after 5 min of administration,N,9904,,CHEMBL624920,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,10839,Biodistribution of compound in rat blood after 5 min of administration.,N,9905,,CHEMBL624921,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,10839,Biodistribution of compound in rat brain after 5 min of administration,N,9906,,CHEMBL624922,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,10839,Biodistribution of compound in rat heart after 5 min of administration,N,9907,,CHEMBL624923,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,10839,Biodistribution of compound in rat heart after 5 min of administration.,N,9908,,CHEMBL624924,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,10839,Biodistribution of compound in rat kidney after 5 min of administration,N,9909,,CHEMBL624925,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,10839,Biodistribution of compound in rat kidney after 5 min of administration.,N,9910,,CHEMBL624926,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,10839,Biodistribution of compound in rat liver after 5 min of administration,N,9911,,CHEMBL624927,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,10839,Biodistribution of compound in rat liver after 5 min of administration.,N,9912,,CHEMBL874402,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,10839,Biodistribution of compound in rat lung after 5 min of administration,N,9913,,CHEMBL624928,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,10839,Biodistribution of compound in rat lung after 5 min of administration.,N,9914,,CHEMBL624929,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10839,Biodistribution of compound in rat muscle after 5 min of administration,N,9915,,CHEMBL624930,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10839,Biodistribution of compound in rat muscle after 5 min of administration.,N,9916,,CHEMBL624931,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,4043,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,9917,,CHEMBL624932,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,4043,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,9918,,CHEMBL624933,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,4043,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,9919,,CHEMBL624934,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,4043,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,9920,,CHEMBL624935,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4043,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,9921,,CHEMBL624936,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4043,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,9922,,CHEMBL624937,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,4043,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,9923,,CHEMBL624938,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,4043,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,9924,,CHEMBL624939,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4043,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,9925,,CHEMBL624940,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4043,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,9926,,CHEMBL874403,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1446,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,N,9927,,CHEMBL624941,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,9971,Dose required to lower urine osmolality to 300 mOsm/kg in rat,N,9928,,CHEMBL624942,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,9971,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,N,9929,,CHEMBL624943,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5765,% Bioavailability after 1 day of the drug administration in rats,N,9930,,CHEMBL624944,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5765,% Bioavailability after 4 day of the drug administration in rats,N,9931,,CHEMBL624945,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4257,Absolute bioavailability was evaluated in rat,N,9932,,CHEMBL624946,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,N,9933,,CHEMBL624947,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,N,9934,,CHEMBL624948,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,N,9935,,CHEMBL624949,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,N,9936,,CHEMBL622025,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,N,9937,,CHEMBL622026,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,N,9938,,CHEMBL622027,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,N,9939,,CHEMBL622028,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,N,9940,,CHEMBL622029,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,N,9941,,CHEMBL622208,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,N,9942,,CHEMBL622209,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,N,9943,,CHEMBL622210,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,N,9944,,CHEMBL622211,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,N,9945,,CHEMBL622212,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,N,9946,,CHEMBL622213,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,N,9947,,CHEMBL874404,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,N,9948,,CHEMBL620452,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,N,9949,,CHEMBL620453,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,N,9950,,CHEMBL620454,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,N,9951,,CHEMBL624067,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,N,9952,,CHEMBL624068,10116.0,Intermediate,50597,1
Female gonad,,,,,A,Rattus norvegicus,1,,992.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,N,9953,,CHEMBL624069,10116.0,Intermediate,50597,1
Female gonad,,,,,A,Rattus norvegicus,1,,992.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,N,9954,,CHEMBL624070,10116.0,Intermediate,50597,1
Female gonad,,,,,A,Rattus norvegicus,1,,992.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,N,9955,,CHEMBL624071,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,N,9956,,CHEMBL624072,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,N,9957,,CHEMBL624073,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,N,9958,,CHEMBL624788,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,N,9959,,CHEMBL624789,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,N,9960,,CHEMBL624790,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,N,9961,,CHEMBL624791,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,N,9962,,CHEMBL624792,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,N,9963,,CHEMBL624793,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,N,9964,,CHEMBL877491,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,N,9965,,CHEMBL624957,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,N,9966,,CHEMBL624958,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,N,9967,,CHEMBL624959,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11977,Dissociation constant was determined,N,9968,,CHEMBL624960,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14941,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",N,9969,,CHEMBL624961,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,9970,,CHEMBL624962,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",N,9971,,CHEMBL624963,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4755,Observed rate constant in 80% rat plasma at 37 degree Centigrade,N,9972,,CHEMBL624964,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,589,LogP value was evaluated in the in situ rat gut perfusion assay,N,9973,,CHEMBL624965,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,9974,,CHEMBL624966,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5031,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,N,9975,,CHEMBL624967,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17764,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,N,9976,,CHEMBL624968,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17720,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,N,9977,,CHEMBL624969,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,2862,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,N,9978,,CHEMBL624970,10116.0,Expert,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16423,Half-life was evaluated after 10 uM/kg of intra arterial administration,N,9979,,CHEMBL624971,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16423,Half-life was evaluated after 20 uM/kg of peroral administration,N,9980,,CHEMBL624972,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6005,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,9981,,CHEMBL624973,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2938,Half-life was evaluated in plasma of rat,N,9982,,CHEMBL624974,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6410,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,N,9983,,CHEMBL624975,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6410,Half-life was evaluated in rats at an oral dose of 30 mg/kg,N,9984,,CHEMBL877492,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6062,Half-life was measured in rat after an iv dose of 1 mg/kg,N,9985,,CHEMBL624976,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6571,Half-life period of compound in rats after peroral administration,N,9986,,CHEMBL624977,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3136,Half-life period of compound was measured in rat plasma.,N,9987,,CHEMBL626848,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3136,Half-life period of compound was measured in rat plasma; ND is not determined,N,9988,,CHEMBL626849,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3136,Half-life period of compound was measured in rat plasma; not determined,N,9989,,CHEMBL626850,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4521,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,9990,,CHEMBL626851,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5871,Half-life period in rat by iv administration,N,9991,,CHEMBL626852,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6077,Half-life period in rats following intravenous administration at 2 mg/kg,N,9992,,CHEMBL626853,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6679,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,9993,,CHEMBL626854,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5144,Half-life period was determined for the compound in rat,N,9994,,CHEMBL627486,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4498,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",N,9995,,CHEMBL627487,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4498,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",N,9996,,CHEMBL627488,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1908,Half-life value after IV dose at a dose of 5 mg/kg in rats.,N,9997,,CHEMBL627489,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6211,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,9998,,CHEMBL627490,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5529,Half-life was determined in rat after intravenous administration (0.5 mg/kg),N,9999,,CHEMBL873829,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6444,Half-life was determined in rat at a dose of 1 mpk i.v.,N,10000,,CHEMBL627655,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6444,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,10001,,CHEMBL625994,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6444,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,10002,,CHEMBL625995,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5207,Half-life in rat,N,10003,,CHEMBL625996,10116.0,Intermediate,50597,1
Plasma,,In vitro,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,530,In vitro half life in rat plasma,N,10004,,CHEMBL625850,10116.0,Intermediate,50597,1
Plasma,,In vitro,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",N,10005,,CHEMBL625851,10116.0,Intermediate,50597,1
,,In vitro,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3219,In vitro half life in rat,N,10006,,CHEMBL625852,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6109,In vivo half life period after intravenous administration in rat,N,10007,,CHEMBL625853,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,10008,,CHEMBL625854,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,10009,,CHEMBL874450,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,10010,,CHEMBL625855,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,10011,,CHEMBL625856,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,10012,,CHEMBL625857,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,10013,,CHEMBL873831,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17853,Longer half-life in rat (i.v.) at 0.5 mpk,N,10014,,CHEMBL625858,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17853,Longer half-life in rat (p.o.) at 2.0 mpk,N,10015,,CHEMBL625859,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3457,Pharmacokinetic property (half life) in rat,N,10016,,CHEMBL625860,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,N,10017,,CHEMBL625861,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,N,10018,,CHEMBL625862,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,N,10019,,CHEMBL625863,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,N,10020,,CHEMBL625864,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5739,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,N,10021,,CHEMBL625865,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15765,Pharmacokinetic half time was determined intravenously in rats.,N,10022,,CHEMBL625866,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6567,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,N,10023,,CHEMBL625867,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2448,Plasma half life of hydrolysis of the compound,N,10024,,CHEMBL625868,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5423,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,N,10025,,CHEMBL625869,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4853,Plasma half life period was calculated in rat,N,10026,,CHEMBL874451,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4514,Plasma half-life in Sprague-Dawley rats,N,10027,,CHEMBL625870,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4514,Plasma half-life in Sprague-Dawley rats; Not determined,N,10028,,CHEMBL625871,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1500,Plasma half-life in rats,N,10029,,CHEMBL625872,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,1500,Plasma half-life in rats; <MQL,N,10030,,CHEMBL625873,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5334,Plasma half-life period (0-8 h) was determined,N,10031,,CHEMBL625874,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5334,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,N,10032,,CHEMBL625875,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,10033,,CHEMBL625876,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,10034,,CHEMBL631258,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4956,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,N,10035,,CHEMBL631259,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4956,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,N,10036,,CHEMBL631260,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",N,10037,,CHEMBL631261,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",N,10038,,CHEMBL631262,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",N,10039,,CHEMBL631263,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",N,10040,,CHEMBL631264,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",N,10041,,CHEMBL631265,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",N,10042,,CHEMBL631266,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",N,10043,,CHEMBL631267,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",N,10044,,CHEMBL631268,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",N,10045,,CHEMBL631269,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",N,10046,,CHEMBL631270,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,10047,,CHEMBL631271,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",N,10048,,CHEMBL631272,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",N,10049,,CHEMBL631273,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",N,10050,,CHEMBL631274,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",N,10051,,CHEMBL631275,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",N,10052,,CHEMBL626984,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",N,10053,,CHEMBL626985,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,10054,,CHEMBL626986,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",N,10055,,CHEMBL626987,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",N,10056,,CHEMBL626988,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",N,10057,,CHEMBL626989,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",N,10058,,CHEMBL626990,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",N,10059,,CHEMBL626991,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",N,10060,,CHEMBL626992,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",N,10061,,CHEMBL626993,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",N,10062,,CHEMBL874593,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",N,10063,,CHEMBL626994,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",N,10064,,CHEMBL626995,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",N,10065,,CHEMBL626190,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",N,10066,,CHEMBL626191,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",N,10067,,CHEMBL626364,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",N,10068,,CHEMBL626365,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",N,10069,,CHEMBL626366,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",N,10070,,CHEMBL626367,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",N,10071,,CHEMBL626368,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",N,10072,,CHEMBL626369,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",N,10073,,CHEMBL626370,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4498,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",N,10074,,CHEMBL626371,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4498,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",N,10075,,CHEMBL626372,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3603,Bioavailability after a dose of 10 mg/kg p.o.,N,10076,,CHEMBL626373,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6215,Bioavailability after peroral administration (10 mg/kg) was determined in rat,N,10077,,CHEMBL626374,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5710,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,N,10078,,CHEMBL626375,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5710,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),N,10079,,CHEMBL626376,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5676,Bioavailability in rat po was determined,N,10080,,CHEMBL626377,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17667,Bioavailability of compound at 10 mg/kg in rat after oral administration,N,10081,,CHEMBL626378,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17667,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,N,10082,,CHEMBL626379,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6848,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,10083,,CHEMBL626380,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6848,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,10084,,CHEMBL626381,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17267,Bioavailability in rat,N,10085,,CHEMBL626382,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6362,Bioavailability in rat (Sprague-Dawley) (female),N,10086,,CHEMBL626383,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17671,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,10087,,CHEMBL874652,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17671,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),N,10088,,CHEMBL626384,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4333,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,N,10089,,CHEMBL626385,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6077,Bioavailability in rat at an oral dose of 2 mg/kg,N,10090,,CHEMBL626386,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3278,Bioavailability in rat,N,10091,,CHEMBL626387,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5964,Bioavailability in rat,N,10092,,CHEMBL626388,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4884,Bioavailability in rat,N,10093,,CHEMBL626389,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4905,Bioavailability in rat,N,10094,,CHEMBL626390,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4884,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,N,10095,,CHEMBL626391,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6850,Bioavailability in rat,N,10096,,CHEMBL626392,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2864,Oral bioavailability in rat,N,10097,,CHEMBL626393,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5780,Bioavailability was determined in rat,N,10098,,CHEMBL623026,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1465,Bioavailability,N,10099,,CHEMBL623027,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5199,Bioavailability,N,10100,,CHEMBL623028,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5765,Bioavailability in rat after 1 day dosing,N,10101,,CHEMBL623029,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5765,Bioavailability in rat after 4 day dosing,N,10102,,CHEMBL623030,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,N,10103,,CHEMBL623031,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Bioavailability after IV dosing at 1 mg/kg in rat; no data,N,10104,,CHEMBL623032,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Bioavailability after oral administration at a dose of 2 mg/kg in rat,N,10105,,CHEMBL623033,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6518,Bioavailability after oral administration at a dose of 4 mg/kg in rat,N,10106,,CHEMBL623034,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2083,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,N,10107,,CHEMBL623035,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17260,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,10108,,CHEMBL623036,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4956,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,10109,,CHEMBL623037,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4368,Bioavailability by intravenous administration of 3.4 mg/kg in rat,N,10110,,CHEMBL623038,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17752,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,N,10111,,CHEMBL874385,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1446,Bioavailability in rat (Fisher) (fasted),N,10112,,CHEMBL623039,10116.0,Intermediate,50597,1
,,In vivo,,,A,Primates,0,,,,,BAO_0000218,2891,Bioavailability in monkey after po administration of 10 mg/kg dose,U,10113,,CHEMBL623040,9443.0,Intermediate,22224,1
,,In vivo,,,A,Primates,0,,,,,BAO_0000218,2891,Oral bioavailability in monkey (dose 10 mg/kg),U,10114,,CHEMBL623041,9443.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6672,Bioavailability in rat,N,10115,,CHEMBL623741,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6673,Bioavailability in rat,N,10116,,CHEMBL623742,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17655,Bioavailability in rat,N,10117,,CHEMBL623743,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17796,Bioavailability in rat,N,10118,,CHEMBL623744,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17853,Bioavailability in rat (dose 2.0 mg/kg p.o.),N,10119,,CHEMBL623745,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4521,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),N,10120,,CHEMBL623746,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4940,Oral bioavailability in rat (dose 5 mg/kg p.o.),N,10121,,CHEMBL623747,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,2891,Bioavailability in rat after po administration of 30 mg/kg dose,U,10122,,CHEMBL623748,10116.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,2891,Bioavailability in rat after po administration of 30 mg/kg dose,U,10123,,CHEMBL623916,10116.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4521,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,10124,,CHEMBL623917,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17686,Bioavailability in rat (dose 2 mg/kg i.v.),N,10125,,CHEMBL623918,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17796,Bioavailability in rat,N,10126,,CHEMBL874386,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17796,Bioavailability in rat; Only traces detected in rat plasma,N,10127,,CHEMBL623919,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5064,Bioavailability in rat,N,10128,,CHEMBL623920,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5147,Bioavailability upon oral administration of compound,N,10129,,CHEMBL623148,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1916,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),N,10130,,CHEMBL623149,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6049,Bioavailability in rat,N,10131,,CHEMBL623150,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1445,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",N,10132,,CHEMBL623151,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1445,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",N,10133,,CHEMBL623152,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,2862,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,N,10134,,CHEMBL623153,10116.0,Expert,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,2862,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,N,10135,,CHEMBL623154,10116.0,Expert,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4194,In vitro and metabolic stability was determined,N,10136,,CHEMBL623155,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4194,In vitro metabolic stability in rat hepatocytes,N,10137,,CHEMBL623156,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5486,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,N,10138,,CHEMBL623157,10116.0,Intermediate,50597,1
Liver,401.0,In vitro,,Hepatocyte,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,17582,Metabolic rate for compound was observed in rat hepatocytes,N,10139,,CHEMBL623158,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5600,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,N,10140,,CHEMBL623159,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14294,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),N,10141,,CHEMBL874390,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14294,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),N,10142,,CHEMBL623160,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14294,Metabolism of compound in rat S9 microsomes; Trace,N,10143,,CHEMBL623161,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17847,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,N,10144,,CHEMBL623162,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,N,10145,,CHEMBL623163,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,N,10146,,CHEMBL623164,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,N,10147,,CHEMBL623165,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,N,10148,,CHEMBL623166,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,N,10149,,CHEMBL624983,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,N,10150,,CHEMBL624984,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,N,10151,,CHEMBL624985,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,N,10152,,CHEMBL622970,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,N,10153,,CHEMBL622971,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,N,10154,,CHEMBL622972,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,N,10155,,CHEMBL622973,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,N,10156,,CHEMBL622974,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,N,10157,,CHEMBL622975,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,N,10158,,CHEMBL622976,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,N,10159,,CHEMBL622977,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,10160,,CHEMBL624351,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,N,10161,,CHEMBL624352,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,10162,,CHEMBL624353,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,N,10163,,CHEMBL622397,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,N,10164,,CHEMBL622398,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,N,10165,,CHEMBL622399,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,10166,,CHEMBL622400,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,10167,,CHEMBL628428,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,N,10168,,CHEMBL628590,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,10169,,CHEMBL628591,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,N,10170,,CHEMBL628592,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,10171,,CHEMBL628593,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,N,10172,,CHEMBL875333,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,10173,,CHEMBL628594,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4969,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,N,10174,,CHEMBL628595,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6737,Stability in rat plasma was determined,N,10175,,CHEMBL628596,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,6737,Stability in rat plasma was determined; ND= no data,N,10176,,CHEMBL628597,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5089,Tested for plasma half life period in rat (0-8 hr),N,10177,,CHEMBL628598,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5089,Tested for plasma half life period in rat (0-8 hr); Not determined,N,10178,,CHEMBL628599,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1466,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,N,10179,,CHEMBL628600,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1466,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,N,10180,,CHEMBL628601,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4950,Tested for the half life in rat,N,10181,,CHEMBL628602,10116.0,Intermediate,50597,1
,,In vitro,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2412,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,N,10182,,CHEMBL628603,10116.0,Intermediate,50597,1
,,In vitro,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2412,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,N,10183,,CHEMBL628604,10116.0,Intermediate,50597,1
,,In vitro,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2412,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,N,10184,,CHEMBL628605,10116.0,Intermediate,50597,1
,,In vitro,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2412,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,N,10185,,CHEMBL628606,10116.0,Intermediate,50597,1
,,In vitro,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2412,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,N,10186,,CHEMBL628607,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The biological half life the compound was measured at the dose of 100 umol/kg,N,10187,,CHEMBL628608,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15022,The biological half life the compound was measured at the dose of 30 umol/kg,N,10188,,CHEMBL628609,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,406,The compound was evaluated for plasma half life period in rat,N,10189,,CHEMBL628610,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",N,10190,,CHEMBL873819,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",N,10191,,CHEMBL628611,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5247,The pharmacokinetic parameter half-life period in vivo in rats,N,10192,,CHEMBL628612,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,"The pharmacokinetic property, Half-life was determined",N,10193,,CHEMBL628613,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,"The pharmacokinetic property, Half-life in rat in vivo",N,10194,,CHEMBL628614,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,"The pharmacokinetic property, Half-life was determined; ND denotes no data",N,10195,,CHEMBL628615,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",N,10196,,CHEMBL628616,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,3918,The plasma half life period in rats,N,10197,,CHEMBL627924,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,2906,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,N,10198,,CHEMBL627925,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6467,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,10199,,CHEMBL627926,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,t1/2 (apparent elimination)of the compound was determined,N,10200,,CHEMBL627927,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3788,t1/2 value in rat,N,10201,,CHEMBL627928,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17796,Half life in rat,N,10202,,CHEMBL627539,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12873,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,10203,,CHEMBL876790,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5983,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,N,10204,,CHEMBL858186,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15765,Half-life period in fasted rats,N,10205,,CHEMBL627540,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,N,10206,,CHEMBL627541,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,N,10207,,CHEMBL627715,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,429,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,10208,,CHEMBL627716,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17655,Maximum time required to achieve Cmax was determined in rat,N,10209,,CHEMBL627717,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,10210,,CHEMBL627718,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,10211,,CHEMBL627719,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,N,10212,,CHEMBL627720,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6570,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,N,10213,,CHEMBL627721,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6570,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,N,10214,,CHEMBL627722,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10215,,CHEMBL627723,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10216,,CHEMBL626058,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10217,,CHEMBL626059,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10218,,CHEMBL626060,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17720,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,N,10219,,CHEMBL626061,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,10220,,CHEMBL876791,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4723,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,10221,,CHEMBL626062,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4756,Tmax at the dose of 2 mg/Kg administered perorally in rats,N,10222,,CHEMBL626063,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4756,Tmax at the dose of 5 mg/Kg administered perorally in rats,N,10223,,CHEMBL626064,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17720,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,N,10224,,CHEMBL626065,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17720,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,N,10225,,CHEMBL626066,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1466,tmax upon peroral administration of 10.0 mg/Kg dose in rat,N,10226,,CHEMBL626067,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,N,10227,,CHEMBL626068,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,N,10228,,CHEMBL626069,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent total excretion of 3-methoxyacetaminophen glucuronide,N,10229,,CHEMBL626070,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent total excretion of N-methoxyacetaminophen glucuronide,N,10230,,CHEMBL626071,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent total excretion of N-methoxyacetaminophen sulfate,N,10231,,CHEMBL626072,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent total excretion of acetaminophen,N,10232,,CHEMBL626073,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",N,10233,,CHEMBL626741,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17655,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",N,10234,,CHEMBL626742,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17735,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,N,10235,,CHEMBL626743,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5960,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,N,10236,,CHEMBL876792,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17735,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,10237,,CHEMBL626744,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7116,Compound was tested for antidiuretic activity in rats,N,10238,,CHEMBL626745,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,4878,AUC in rat after 3mg/kg oral dose,N,10239,,CHEMBL626746,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,N,10240,,CHEMBL626747,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,N,10241,,CHEMBL626748,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16367,Bioavailability administered orally at a dose of 10 mg/kg to rats,N,10242,,CHEMBL626749,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16366,Oral Bioavailability was determined,N,10243,,CHEMBL626750,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4426,Oral bioavailability in rat,N,10244,,CHEMBL626751,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4426,Oral bioavailability in rat; Not performed.,N,10245,,CHEMBL626913,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,Bioavailability,N,10246,,CHEMBL626914,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5041,Bioavailability was determined; ND denotes no data,N,10247,,CHEMBL626915,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1500,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,N,10248,,CHEMBL626916,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1500,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,N,10249,,CHEMBL626917,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17409,Binding towards rat plasma protein at 10 uM,N,10250,,CHEMBL626918,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17409,Binding towards rat plasma protein at 100 uM,N,10251,,CHEMBL626919,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2959,Bioavailability in rat (dose 20 mg/kg p.o.),N,10252,,CHEMBL626920,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13501,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,10253,,CHEMBL621976,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6567,Bioavailability in rat after 5 mg/kg oral gavage,N,10254,,CHEMBL877599,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6571,Bioavailability in rat,N,10255,,CHEMBL621977,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6715,Bioavailability in rat (dose 1 mg/kg i.v.),N,10256,,CHEMBL621978,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6715,Bioavailability in rat (dose 3 mg/kg p.o.),N,10257,,CHEMBL621979,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2932,Oral bioavailability in rat,N,10258,,CHEMBL621980,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4171,Bioavailability of the compound in rats after administration of 30 mg/kg,N,10259,,CHEMBL621981,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Bioavailability after administration of 10 mg/kg in rats,N,10260,,CHEMBL621982,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17509,Bioavailability after administration of 2 mg/kg in rats,N,10261,,CHEMBL882953,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4527,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,N,10262,,CHEMBL621983,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4026,Bioavailability in dogs was determined; high,N,10263,,CHEMBL621984,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6659,Bioavailability in monkey after intravenous administration at 1 mpk,N,10264,,CHEMBL621985,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6659,Bioavailability in monkey after peroral administration at 10 mpk,N,10265,,CHEMBL621986,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6659,Bioavailability in rat after intravenous administration at 1 mpk,N,10266,,CHEMBL621987,10116.0,Intermediate,50597,1
,,In vivo,,,F,Rattus norvegicus,1,,,,,BAO_0000218,6659,Bioavailability in rat after intravenous administration at 2 mpk,N,10267,,CHEMBL877600,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6659,Bioavailability in rat after peroral administration at 30 mpk,N,10268,,CHEMBL621988,10116.0,Intermediate,50597,1
,,In vivo,,,F,Rattus norvegicus,1,,,,,BAO_0000218,6659,Bioavailability in rat after peroral administration at at 100 mpk,N,10269,,CHEMBL621989,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6597,Bioavailability in rats was evaluated,N,10270,,CHEMBL621990,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1202,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,N,10271,,CHEMBL621991,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1202,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,N,10272,,CHEMBL621992,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1202,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,N,10273,,CHEMBL621993,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1202,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,N,10274,,CHEMBL621994,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5207,Bioavailability in rat,N,10275,,CHEMBL621995,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5970,Bioavailability in rat,N,10276,,CHEMBL621996,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17538,Oral bioavailability in rat (dose 10 mg/kg),N,10277,,CHEMBL621997,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17538,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,10278,,CHEMBL621998,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1466,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,N,10279,,CHEMBL621999,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2879,Oral bioavailability in rat,N,10280,,CHEMBL622000,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2879,Bioavailability was measured in rat after oral administration; 2-4,N,10281,,CHEMBL622001,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2879,Bioavailability was measured in rat after oral administration; 3-7,N,10282,,CHEMBL622002,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3777,Bioavailability in rat (intraduodenal administration),N,10283,,CHEMBL622003,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3777,Bioavailability in rat (intraduodenal administration),N,10284,,CHEMBL877601,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3777,Oral bioavailability in rat,N,10285,,CHEMBL624871,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3777,Oral bioavailability in rat,N,10286,,CHEMBL622004,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5423,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),N,10287,,CHEMBL882954,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,N,10288,,CHEMBL622005,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16365,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,N,10289,,CHEMBL622006,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4239,Bioavailability was measured in rat,N,10290,,CHEMBL622007,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5438,Bioavailability was reported,N,10291,,CHEMBL622008,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,10292,,CHEMBL622009,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,10293,,CHEMBL622010,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4199,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,10294,,CHEMBL622011,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4199,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),N,10295,,CHEMBL622012,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4199,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),N,10296,,CHEMBL622013,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4890,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,10297,,CHEMBL622014,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2792,Bioavailability was determined at 3 mg/kg po dose in rats,N,10298,,CHEMBL624749,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5529,Oral bioavailability in rat (dose 2 mg/kg),N,10299,,CHEMBL624750,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",N,10300,,CHEMBL624751,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,10301,,CHEMBL624752,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6685,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,10302,,CHEMBL624753,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6005,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,N,10303,,CHEMBL624754,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6410,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,10304,,CHEMBL624755,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6410,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,10305,,CHEMBL624756,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6103,Bioavailability in rat,N,10306,,CHEMBL624757,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6410,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,10307,,CHEMBL624758,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6410,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,10308,,CHEMBL622270,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5353,Bioavailability in rat (Sprague-Dawley),N,10309,,CHEMBL622271,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4727,Bioavailability in rat at the dose of 2 mg/kg,N,10310,,CHEMBL622272,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17804,Oral bioavailability in rat,N,10311,,CHEMBL622273,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5809,Bioavailability in rat (cannulated) (dose 2 mg/kg),N,10312,,CHEMBL622274,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17804,Bioavailability value of compound in rats was determined after peroral administration,N,10313,,CHEMBL622275,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3634,Oral bioavailability in rat (dose 20 mg/kg),N,10314,,CHEMBL622276,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3341,Oral bioavailability in rat,N,10315,,CHEMBL622277,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2690,Oral bioavailability in rat (dose 5 mg/kg),N,10316,,CHEMBL622278,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3184,Oral bioavailability in rat,N,10317,,CHEMBL622279,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,740,Oral bioavailability in rat,N,10318,,CHEMBL622280,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1806,Compound was evaluated for oral bioavailability in rats; 15-27 %,N,10319,,CHEMBL624083,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4891,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,N,10320,,CHEMBL624084,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3634,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),N,10321,,CHEMBL624085,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,64,Compound was tested for bioavailability in rats,N,10322,,CHEMBL624086,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4839,Bioavailability in rat,N,10323,,CHEMBL624087,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1094,Oral bioavailability in rat,N,10324,,CHEMBL624088,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca mulatta,0,,,,,BAO_0000218,5005,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,U,10325,,CHEMBL624089,9544.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,5005,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),U,10326,,CHEMBL624090,10116.0,Intermediate,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4687,Evaluated for the bioavailability in rat (in vivo),N,10327,,CHEMBL624091,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17804,F value of compound in rats was determined after peroral administration,N,10328,,CHEMBL624092,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,10329,,CHEMBL624093,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,10330,,CHEMBL624094,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,10331,,CHEMBL624095,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,10332,,CHEMBL624096,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1088,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",N,10333,,CHEMBL624097,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1742,Maximum fall in carotid flow in rat,N,10334,,CHEMBL624098,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4689,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,N,10335,,CHEMBL874392,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2463,Oral bioavailability in rat (dose 5 mg/kg),N,10336,,CHEMBL624099,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5654,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,10337,,CHEMBL624100,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5654,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,10338,,CHEMBL624101,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6874,Oral bioavailability in rat (male Wistar),N,10339,,CHEMBL624102,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5633,Oral bioavailability after administration (30 mg/kg) in rat; good,N,10340,,CHEMBL624103,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5496,Oral bioavailability at the dose of 2 mg/kg in rat,N,10341,,CHEMBL624104,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2358,Oral bioavailability determined in rats,N,10342,,CHEMBL624105,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16456,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),N,10343,,CHEMBL624106,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5302,Oral bioavailability in rat (dose single 10 mg/kg),N,10344,,CHEMBL624107,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5302,Oral bioavailability in rat (dose single 10 mg/kg),N,10345,,CHEMBL623943,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5302,Oral bioavailability in rat (dose 5 mg/kg,N,10346,,CHEMBL623944,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,N,10347,,CHEMBL623945,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,N,10348,,CHEMBL623946,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,N,10349,,CHEMBL623947,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,N,10350,,CHEMBL623948,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,N,10351,,CHEMBL623949,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,N,10352,,CHEMBL623950,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,N,10353,,CHEMBL874398,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,N,10354,,CHEMBL623951,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,N,10355,,CHEMBL623952,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,N,10356,,CHEMBL623953,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,N,10357,,CHEMBL623954,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,N,10358,,CHEMBL623955,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,N,10359,,CHEMBL623956,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,N,10360,,CHEMBL627807,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,N,10361,,CHEMBL627808,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,N,10362,,CHEMBL627809,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,N,10363,,CHEMBL627810,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",N,10364,,CHEMBL627811,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",N,10365,,CHEMBL627812,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",N,10366,,CHEMBL627813,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",N,10367,,CHEMBL627814,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",N,10368,,CHEMBL875336,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",N,10369,,CHEMBL627815,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",N,10370,,CHEMBL627816,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",N,10371,,CHEMBL627817,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",N,10372,,CHEMBL627818,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",N,10373,,CHEMBL627819,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",N,10374,,CHEMBL627820,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",N,10375,,CHEMBL627821,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,10376,,CHEMBL628464,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,N,10377,,CHEMBL626239,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,N,10378,,CHEMBL626240,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,N,10379,,CHEMBL626241,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,N,10380,,CHEMBL626242,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,N,10381,,CHEMBL626243,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,10382,,CHEMBL626244,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,N,10383,,CHEMBL626907,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,10384,,CHEMBL626908,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,10385,,CHEMBL626909,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,10386,,CHEMBL626910,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent total excretion of acetaminophen cysteine conjugate,N,10387,,CHEMBL875342,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent total excretion of acetaminophen glucuronide,N,10388,,CHEMBL626911,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent total excretion of acetaminophen sulfate,N,10389,,CHEMBL626912,10116.0,Intermediate,50597,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,7449,Percent total excretion of acetaminophen-mercapturic acid,N,10390,,CHEMBL627065,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,3172,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,N,10391,,CHEMBL627066,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16456,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,10392,,CHEMBL627067,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,ratrat,0,,2385.0,,,BAO_0000218,10839,Biodistribution of compound in rat muscle after 5 min of administration,U,10393,,CHEMBL627068,8656.0,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,ratrat,0,,2385.0,,,BAO_0000218,10839,Biodistribution of compound in rat muscle after 5 min of administration.,U,10394,,CHEMBL627069,8656.0,Autocuration,22224,1
,,In vivo,,,A,Ovis aries,0,,,,,BAO_0000218,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,10395,,CHEMBL627070,9940.0,Autocuration,22224,1
,,In vivo,,,A,Ovis aries,0,,,,,BAO_0000218,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,10396,,CHEMBL627071,9940.0,Autocuration,22224,1
,,In vivo,,,A,Ovis aries,0,,,,,BAO_0000218,5334,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,10397,,CHEMBL627072,9940.0,Autocuration,22224,1
,,In vivo,,,A,Ovis aries,0,,,,,BAO_0000218,5334,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,10398,,CHEMBL627073,9940.0,Autocuration,22224,1
,,In vivo,,,A,Ovis aries,0,,,,,BAO_0000218,5334,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,10399,,CHEMBL625387,9940.0,Autocuration,22224,1
,,In vivo,,,A,Ovis aries,0,,,,,BAO_0000218,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,10400,,CHEMBL625388,9940.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Ovis aries,0,,1969.0,,,BAO_0000218,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,10401,,CHEMBL625389,9940.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Ovis aries,0,,1969.0,,,BAO_0000218,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,10402,,CHEMBL875343,9940.0,Autocuration,22224,1
,,,,,A,Serpentes,1,,,,,BAO_0000218,1735,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),N,10403,,CHEMBL876795,8570.0,Intermediate,50497,1
,,,,,A,Serpentes,1,,,,,BAO_0000218,1469,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,N,10404,,CHEMBL626552,8570.0,Intermediate,50497,1
,,,,,A,Serpentes,1,,,,,BAO_0000218,1336,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,N,10405,,CHEMBL626553,8570.0,Intermediate,50497,1
Plasma,,,,,A,Homo sapiens,0,,1969.0,,,BAO_0000366,12403,The human biological plasma half life of the compound,U,10406,,CHEMBL626554,9606.0,Autocuration,22224,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,10407,,CHEMBL626555,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,N,10408,,CHEMBL626556,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,N,10409,,CHEMBL626557,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,N,10410,,CHEMBL626558,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,N,10411,,CHEMBL626559,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,N,10412,,CHEMBL626560,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,N,10413,,CHEMBL876803,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,N,10414,,CHEMBL627964,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,N,10415,,CHEMBL627965,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,N,10416,,CHEMBL627966,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,N,10417,,CHEMBL627967,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,N,10418,,CHEMBL627968,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,N,10419,,CHEMBL627969,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8004,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,N,10420,,CHEMBL627970,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8004,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,N,10421,,CHEMBL627971,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8004,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,N,10422,,CHEMBL627972,10116.0,Intermediate,50597,1
,,,,,B,Homo sapiens,9,,,,,BAO_0000357,15917,Dissociation constant against binding to human cyclophilin A,D,10423,,CHEMBL856029,9606.0,Expert,180,1
,,,,,B,Bos taurus,8,,,,,BAO_0000019,12396,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,H,10424,,CHEMBL627973,9913.0,Expert,11591,1
,,,,,A,,0,,,,,BAO_0000019,7065,-Log C was determined by performing the electroshock minimum test,U,10425,,CHEMBL627974,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7065,-Log C was determined by performing the foot shock test,U,10426,,CHEMBL627975,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7065,-Log C was determined by performing the incl screen test,U,10427,,CHEMBL627976,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7065,-Log C was determined by performing the maximum electroshock test,U,10428,,CHEMBL627977,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7065,-Log C was determined by performing the pentylenetetrazole test,U,10429,,CHEMBL627978,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12415,Tested for experimental arotinoid inhibitory dose,U,10430,,CHEMBL627979,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10256,Negative log transformed activity,U,10431,,CHEMBL876804,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7991,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",U,10432,,CHEMBL627980,,Autocuration,22224,1
,,,,,A,Cavia porcellus,1,,,,,BAO_0000218,14342,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,N,10433,,CHEMBL627981,10141.0,Intermediate,50512,1
,,,,,A,Cavia porcellus,1,,,,,BAO_0000218,14342,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,N,10434,,CHEMBL627982,10141.0,Intermediate,50512,1
,,,,,A,Cavia porcellus,1,,,,,BAO_0000218,14342,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,N,10435,,CHEMBL627983,10141.0,Intermediate,50512,1
Ileum,,,,,A,Cavia porcellus,1,,2116.0,,,BAO_0000218,14342,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,N,10436,,CHEMBL627984,10141.0,Intermediate,50512,1
,,,,,P,,0,,,,,BAO_0000100,6047,Solubility in water was determined; values expressed as -log,U,10437,,CHEMBL627985,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,17269,Ratio of Kcat to that of Km was determined,U,10438,,CHEMBL627986,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10026,Observed first order rate constant,U,10439,,CHEMBL627987,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14583,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,U,10440,,CHEMBL627988,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,N,10441,,CHEMBL627989,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,N,10442,,CHEMBL627990,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4029,Oral Bioavailability after administration of 10 mg/kg in male rat,N,10443,,CHEMBL876805,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17735,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),N,10444,,CHEMBL627991,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4576,Oral bioavailability in rat,N,10445,,CHEMBL627992,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17582,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,10446,,CHEMBL627993,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17651,Oral bioavailability at 1 mg/kg was determined in rat,N,10447,,CHEMBL622817,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17651,Oral bioavailability at 10 mg/kg was determined in rat,N,10448,,CHEMBL622818,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17670,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",N,10449,,CHEMBL622819,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5045,Oral bioavailability in rat,N,10450,,CHEMBL872267,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1696,Oral bioavailability in rat,N,10451,,CHEMBL622820,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17764,Oral bioavailability after intravenous administration in rats at 24 uM/kg,N,10452,,CHEMBL622821,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6448,Oral bioavailability in rat,N,10453,,CHEMBL622822,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6596,Oral bioavailability in rat,N,10454,,CHEMBL622823,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17547,Oral bioavailability in rat,N,10455,,CHEMBL622824,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17771,Oral bioavailability in rat at a dose of 3 mg/kg,N,10456,,CHEMBL622825,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6495,Oral bioavailability in rat after oral administration at 10 mg/kg,N,10457,,CHEMBL622901,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4558,Oral bioavailability in rat,N,10458,,CHEMBL622902,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17596,Oral bioavailability in rat,N,10459,,CHEMBL621844,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6827,Oral bioavailability in Dawley rats,N,10460,,CHEMBL621845,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4026,Oral bioavailability,N,10461,,CHEMBL621846,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10,Oral bioavailability in rat (dose 30 mg/kg),N,10462,,CHEMBL621847,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,10463,,CHEMBL877609,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Bioavailability in rat (dose 3 mg/kg i.v.),N,10464,,CHEMBL621848,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,10465,,CHEMBL621849,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,10466,,CHEMBL622030,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4796,Percent oral bioavailability determined in rats,N,10467,,CHEMBL622031,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4883,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,10468,,CHEMBL622032,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2137,The compound was evaluated for bioavailability in rats; 32-51,N,10469,,CHEMBL622033,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2959,Bioavailability in rat (dose 20 mg/kg p.o.),N,10470,,CHEMBL622034,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1361,Oral bioavailability in rat,N,10471,,CHEMBL622035,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4727,Bioavailability percent in rat at the dose of 2 mg/kg,N,10472,,CHEMBL882966,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16423,Bioavailability was evaluated after 20 uM/kg of peroral administration,N,10473,,CHEMBL622036,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5206,Oral bioavailability in rat,N,10474,,CHEMBL622037,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6448,Oral bioavailability in rat,N,10475,,CHEMBL622038,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17723,Bioavailability in rats,N,10476,,CHEMBL622039,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,N,10477,,CHEMBL622040,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,N,10478,,CHEMBL622041,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,N,10479,,CHEMBL622042,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,N,10480,,CHEMBL622043,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,N,10481,,CHEMBL622044,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,N,10482,,CHEMBL622045,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,N,10483,,CHEMBL622046,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,N,10484,,CHEMBL622047,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,N,10485,,CHEMBL877610,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,N,10486,,CHEMBL622048,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,N,10487,,CHEMBL622049,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,N,10488,,CHEMBL622050,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,N,10489,,CHEMBL622051,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,N,10490,,CHEMBL622052,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,N,10491,,CHEMBL622053,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,N,10492,,CHEMBL622054,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,N,10493,,CHEMBL622055,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5237,Oral bioavailability in rats was determined; High,N,10494,,CHEMBL622056,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5503,Oral bioavailability in the rat was determined,N,10495,,CHEMBL622057,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15765,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,N,10496,,CHEMBL628008,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15660,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),N,10497,,CHEMBL622058,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10498,,CHEMBL622059,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10499,,CHEMBL622060,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10500,,CHEMBL622061,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5978,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10501,,CHEMBL622062,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5656,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,N,10502,,CHEMBL622063,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3598,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,N,10503,,CHEMBL877611,10116.0,Expert,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4216,Oral bioavailability of compound in Sprague Dawley rats,N,10504,,CHEMBL622064,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17839,Oral bioavailability of compound in rat,N,10505,,CHEMBL622065,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6570,Oral bioavailability in rat (dose 2 mg/kg),N,10506,,CHEMBL622066,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5334,Oral bioavailability of compound in rat was determined,N,10507,,CHEMBL622067,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6886,Oral bioavailability of compound in rats,N,10508,,CHEMBL622068,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5210,Oral bioavailability of compound was determined in rats,N,10509,,CHEMBL622069,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4170,Oral bioavailability at a dose of 30 mg/kg in rats,N,10510,,CHEMBL624796,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6028,Oral bioavailability in rat (dose 10 mg/kg),N,10511,,CHEMBL624797,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6028,Oral bioavailability in rat (dose 10 mg/kg),N,10512,,CHEMBL623053,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6078,Oral bioavailability evaluated in rat,N,10513,,CHEMBL623054,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6168,Oral bioavailability in fasted rat,N,10514,,CHEMBL623055,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6168,Oral bioavailability in fed rat,N,10515,,CHEMBL623056,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5160,Oral bioavailability in rat (mature male) (dose 30 mg/kg),N,10516,,CHEMBL623057,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6057,Oral bioavailability in rat,N,10517,,CHEMBL623058,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6535,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,10518,,CHEMBL623059,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6535,Oral bioavailability in rat after administration of 10 mg/kg po,N,10519,,CHEMBL623060,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4194,Oral bioavailability in rat,N,10520,,CHEMBL623061,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6230,Oral bioavailability in rat,N,10521,,CHEMBL623062,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6619,Oral bioavailability in rat,N,10522,,CHEMBL623063,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17607,Oral bioavailability in rat,N,10523,,CHEMBL623064,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4942,Oral bioavailability in ratrs,N,10524,,CHEMBL623065,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4942,Oral bioavailability in rat,N,10525,,CHEMBL623066,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6646,Oral bioavailability in rat,N,10526,,CHEMBL623067,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5237,Oral bioavailability in rats was determined; High,N,10527,,CHEMBL623068,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6646,Oral bioavailability in rat,N,10528,,CHEMBL623069,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4449,Oral bioavailability in rat,N,10529,,CHEMBL623070,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6057,Oral bioavailability was calculated in rat,N,10530,,CHEMBL623071,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2552,Oral bioavailability,N,10531,,CHEMBL623072,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5496,Oral bioavailability,N,10532,,CHEMBL623073,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6484,Oral bioavailability,N,10533,,CHEMBL623074,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6485,Oral bioavailability,N,10534,,CHEMBL623075,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6616,Oral bioavailability after i.v. administration,N,10535,,CHEMBL623076,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4969,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,10536,,CHEMBL623077,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5862,Oral bioavailability in rat (Sprague-Dawley),N,10537,,CHEMBL623078,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4514,Oral bioavailability in Sprague-Dawley rats,N,10538,,CHEMBL623079,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4514,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,10539,,CHEMBL623080,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4514,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,10540,,CHEMBL623081,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5546,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,N,10541,,CHEMBL623082,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6168,Oral bioavailability in fasted rat,N,10542,,CHEMBL874400,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6168,Oral bioavailability in fed rat,N,10543,,CHEMBL623083,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3624,Oral bioavailability in rat,N,10544,,CHEMBL623084,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5213,Oral bioavailability in rat,N,10545,,CHEMBL623085,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5496,Oral bioavailability in rat,N,10546,,CHEMBL623086,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5553,Oral bioavailability in rat,N,10547,,CHEMBL623087,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5833,Oral bioavailability in rat,N,10548,,CHEMBL623088,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5836,Oral bioavailability in rat,N,10549,,CHEMBL623089,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5865,Oral bioavailability in rat,N,10550,,CHEMBL623090,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5960,Oral bioavailability in rat,N,10551,,CHEMBL623091,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6249,Oral bioavailability in rat,N,10552,,CHEMBL623092,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6448,Oral bioavailability in rat,N,10553,,CHEMBL623093,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6453,Oral bioavailability in rat,N,10554,,CHEMBL874401,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6640,Oral bioavailability in rat,N,10555,,CHEMBL623094,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17607,Oral bioavailability in rat,N,10556,,CHEMBL623095,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Oral bioavailability in rat after peroral administration at 10 mg/kg,N,10557,,CHEMBL623096,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5939,Oral bioavailability in rat after peroral administration at 5 mg/kg,N,10558,,CHEMBL624913,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6281,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),N,10559,,CHEMBL624914,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5874,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,N,10560,,CHEMBL624915,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5213,Oral bioavailability in rat; Not measured,N,10561,,CHEMBL624916,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4964,Oral bioavailability in rat,N,10562,,CHEMBL624917,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,N,10563,,CHEMBL625157,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,6251,In vitro metabolic potential in rat liver microsomes,N,10564,,CHEMBL625158,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1568,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",N,10565,,CHEMBL625159,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3032,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",N,10566,,CHEMBL625160,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3748,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,N,10567,,CHEMBL625161,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,401,Oral bioavailability in rat,N,10568,,CHEMBL625162,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6512,Oral bioavailability in rat,N,10569,,CHEMBL625163,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17617,Oral bioavailability in rats at 10 mg/kg,N,10570,,CHEMBL625164,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6679,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,10571,,CHEMBL625165,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6742,Oral bioavailability in rat,N,10572,,CHEMBL625166,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,589,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,N,10573,,CHEMBL625167,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,589,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,N,10574,,CHEMBL625168,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3185,Plasma clearance of the compound,N,10575,,CHEMBL625169,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17596,Plasma clearance at 10 mg/kg in rat upon intravenous administration,N,10576,,CHEMBL626264,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2713,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,N,10577,,CHEMBL626265,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12500,The compound was tested for plasma clearance in rat,N,10578,,CHEMBL626266,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12500,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,N,10579,,CHEMBL626267,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2713,Plasma concentration upon oral administration of 1 mg/Kg in rats,N,10580,,CHEMBL626268,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1446,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,N,10581,,CHEMBL626269,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6227,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,N,10582,,CHEMBL626270,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4709,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,N,10583,,CHEMBL626271,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",N,10584,,CHEMBL626272,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,10585,,CHEMBL626273,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,10586,,CHEMBL875346,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",N,10587,,CHEMBL626274,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4514,Compound was tested for protein binding in rat plasma,N,10588,,CHEMBL626275,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2713,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,N,10589,,CHEMBL624646,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2713,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,N,10590,,CHEMBL624647,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,5340,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,N,10591,,CHEMBL624648,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12058,Area under curve ratio was determined (po/iv) in rat,N,10592,,CHEMBL624649,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,N,10593,,CHEMBL624650,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,N,10594,,CHEMBL624651,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,N,10595,,CHEMBL624652,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6495,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,N,10596,,CHEMBL624653,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6078,Ratio of AUCbrain to AUCplasma,N,10597,,CHEMBL624654,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5656,Ratio of brain to plasma,N,10598,,CHEMBL624655,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4910,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,N,10599,,CHEMBL624656,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4910,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,10600,,CHEMBL624657,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4910,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,10601,,CHEMBL624658,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10130,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,N,10602,,CHEMBL624659,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10130,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,N,10603,,CHEMBL624660,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10130,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,N,10604,,CHEMBL624661,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5213,Steady state brain :blood ratio was determined,N,10605,,CHEMBL624662,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4910,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,10606,,CHEMBL625199,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4910,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,10607,,CHEMBL625200,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4910,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,10608,,CHEMBL625201,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4910,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,10609,,CHEMBL625202,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2083,Percentage recovery after 3h incubation with rat hapatocytes was determined,N,10610,,CHEMBL625203,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2082,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,N,10611,,CHEMBL625204,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2082,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,N,10612,,CHEMBL625205,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6351,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,N,10613,,CHEMBL625206,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,14583,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",U,10614,,CHEMBL625207,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14583,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,U,10615,,CHEMBL625208,,Autocuration,22224,1
,495.0,,,Caco-2,A,Homo sapiens,1,,,,,BAO_0000218,4608,In vivo absorption in Caco-2 cell line monolayers was determined,N,10616,,CHEMBL625209,9606.0,Intermediate,50587,1
,,,,,P,,0,,,,,BAO_0000100,13668,Calculated partition coefficient (clogP),U,10617,,CHEMBL625210,,Autocuration,22229,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5669,Area under curve was determine after peroral administration at 10 mpk in Rat,N,10618,,CHEMBL625211,10116.0,Intermediate,50597,1
,,,,,A,Macaca mulatta,1,,,,,BAO_0000218,5669,Area under curve was determine after peroral administration at 10 mpk in Rhesus,N,10619,,CHEMBL625212,9544.0,Intermediate,50797,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5669,Area under curve was determine after peroral administration at 160 mpk in Rat,N,10620,,CHEMBL625213,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5669,Area under curve was determine after peroral administration at 20 mpk in Rat,N,10621,,CHEMBL625214,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5669,Area under curve was determine after peroral administration at 50 mpk in Rat,N,10622,,CHEMBL874542,10116.0,Intermediate,50597,1
,,,,,P,,0,,,,,BAO_0000100,6472,Calculated partition coefficient (clogP) (AlogP),U,10623,,CHEMBL625215,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,15106,Activated partial thromboplastin time measured,U,10624,,CHEMBL625216,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,15207,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),U,10625,,CHEMBL625217,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,15207,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),U,10626,,CHEMBL625218,,Autocuration,22224,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,13941,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,N,10627,,CHEMBL622864,9615.0,Intermediate,50588,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13941,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,N,10628,,CHEMBL622865,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13941,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,N,10629,,CHEMBL622866,10116.0,Intermediate,50597,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,13941,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,N,10630,,CHEMBL622867,9615.0,Intermediate,50588,1
Plasma,,,,,A,Cavia porcellus,1,,1969.0,,,BAO_0000218,15240,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,N,10631,,CHEMBL876808,10141.0,Intermediate,50512,1
Brain,,,,,A,,0,,955.0,,,BAO_0000019,10655,AUC in brain,U,10632,,CHEMBL627725,,Autocuration,22224,1
Serum,,,,,A,,0,,1977.0,,,BAO_0000019,10655,AUC in serum,U,10633,,CHEMBL627726,,Autocuration,22224,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000019,6504,AUC was determined,U,10634,,CHEMBL627727,,Autocuration,22224,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000019,10615,AUC of the compound.,U,10635,,CHEMBL627728,,Autocuration,22224,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000019,10353,AUC value (0-4 hr),U,10636,,CHEMBL627729,,Autocuration,22224,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000019,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",U,10637,,CHEMBL627730,,Autocuration,22224,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000019,14907,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,U,10638,,CHEMBL627731,,Autocuration,22224,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000019,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",U,10639,,CHEMBL627732,,Autocuration,22224,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000019,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",U,10640,,CHEMBL627733,,Autocuration,22224,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16359,AUC(area under curve) was determined after intravenous administration in rats,N,10641,,CHEMBL627734,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16359,AUC(area under curve) was determined after oral administration in rats,N,10642,,CHEMBL627735,10116.0,Intermediate,50597,1
Plasma,,,,,A,Cavia porcellus,1,,1969.0,,,BAO_0000218,15240,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,N,10643,,CHEMBL627736,10141.0,Intermediate,50512,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15240,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,N,10644,,CHEMBL876809,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,15469,Area Under Curve after oral dosing of 100 uM/Kg,U,10645,,CHEMBL627737,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15469,Area Under Curve after oral dosing of 30 uM/Kg,U,10646,,CHEMBL627738,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13520,Area Under Curve was measured by ploting the graph between concentration verses time,U,10647,,CHEMBL627739,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,N,10648,,CHEMBL626143,9615.0,Intermediate,50588,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,U,10649,,CHEMBL626144,314293.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,N,10650,,CHEMBL626145,9986.0,Intermediate,50592,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,N,10651,,CHEMBL626146,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12032,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,N,10652,,CHEMBL626147,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,10291,Area under curve (AUC) was determined,U,10653,,CHEMBL626148,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,5767,Area under curve (AUC) following ip administration at 1 mg/kg,U,10654,,CHEMBL626149,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,1434,Area under curve (AUC) was determined; ND is Not determined,U,10655,,CHEMBL626150,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14925,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,N,10656,,CHEMBL626151,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14925,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,N,10657,,CHEMBL626152,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14925,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,N,10658,,CHEMBL626153,9615.0,Intermediate,50588,1
,,,,,A,,0,,,,,BAO_0000019,1434,Area under curve (AUR) was determined,U,10659,,CHEMBL626154,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11883,Area under curve at 1 uM/dg administered intravenously,U,10660,,CHEMBL626155,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11883,Area under curve at 10 uM/dg administered perorally,U,10661,,CHEMBL626156,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11883,Area under curve at 2 uM/dg administered intravenously,U,10662,,CHEMBL626157,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11883,Area under curve at 20 uM/dg administered perorally,U,10663,,CHEMBL626158,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15233,Area under curve at a peroral dose of 3 mg/kg in dog,N,10664,,CHEMBL626159,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15233,Area under curve at a peroral dose of 3 mg/kg in rat,N,10665,,CHEMBL626160,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15233,Area under curve at an iv dose of 1 mg/kg in dog,N,10666,,CHEMBL626161,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15233,Area under curve at an iv dose of 1 mg/kg in rat,N,10667,,CHEMBL626162,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,12978,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,U,10668,,CHEMBL626163,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12978,Area under curve gives the effective duration for the angiotensin II antagonist effect.,U,10669,,CHEMBL626164,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,11355,Area under curve measured as conc vs time after intravenous administration to mice.,N,10670,,CHEMBL626165,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,11355,Area under curve measured as conc vs time after peroral administration to mice.,N,10671,,CHEMBL626166,10090.0,Intermediate,50594,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,10672,,CHEMBL626167,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,N,10673,,CHEMBL626168,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,N,10674,,CHEMBL877463,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,N,10675,,CHEMBL626169,9615.0,Intermediate,50588,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,N,10676,,CHEMBL626170,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,N,10677,,CHEMBL626171,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,N,10678,,CHEMBL626172,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,N,10679,,CHEMBL626173,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,N,10680,,CHEMBL626174,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,N,10681,,CHEMBL626175,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,N,10682,,CHEMBL626176,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,N,10683,,CHEMBL626177,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,N,10684,,CHEMBL622499,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,N,10685,,CHEMBL622500,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,N,10686,,CHEMBL622501,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,N,10687,,CHEMBL622502,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,N,10688,,CHEMBL622503,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,N,10689,,CHEMBL877614,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,N,10690,,CHEMBL624839,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,N,10691,,CHEMBL624840,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,N,10692,,CHEMBL624841,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,N,10693,,CHEMBL624842,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,N,10694,,CHEMBL624843,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,N,10695,,CHEMBL624844,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,N,10696,,CHEMBL624845,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,N,10697,,CHEMBL621904,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,N,10698,,CHEMBL621905,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,N,10699,,CHEMBL874382,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,N,10700,,CHEMBL621906,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,N,10701,,CHEMBL621907,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,N,10702,,CHEMBL622096,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,N,10703,,CHEMBL622097,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,N,10704,,CHEMBL622098,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,N,10705,,CHEMBL622099,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,N,10706,,CHEMBL622100,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,N,10707,,CHEMBL622101,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,N,10708,,CHEMBL622102,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,N,10709,,CHEMBL622103,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,N,10710,,CHEMBL622104,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,N,10711,,CHEMBL622105,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,N,10712,,CHEMBL622106,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,N,10713,,CHEMBL622107,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,N,10714,,CHEMBL622108,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,N,10715,,CHEMBL622109,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,N,10716,,CHEMBL622110,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,N,10717,,CHEMBL622111,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,N,10718,,CHEMBL874383,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,N,10719,,CHEMBL622112,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,N,10720,,CHEMBL622113,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,N,10721,,CHEMBL622114,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,N,10722,,CHEMBL622115,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,N,10723,,CHEMBL622116,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6193,Oral bioavailability in rat,N,10724,,CHEMBL622117,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6803,Oral bioavailability in rat,N,10725,,CHEMBL622118,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6647,Oral bioavailability in rats at 6 mg/kg,N,10726,,CHEMBL622119,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6647,Oral bioavailability in rat (dose 6 mg/kg),N,10727,,CHEMBL622120,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6647,Oral bioavailability in rats at 6 mg/kg dose; Not tested,N,10728,,CHEMBL622121,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6640,Oral bioavailability in rat,N,10729,,CHEMBL622122,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Oral bioavailability in rat,N,10730,,CHEMBL622123,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6641,Oral bioavailability in rat,N,10731,,CHEMBL622124,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6642,Bioavailability in rat,N,10732,,CHEMBL622125,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5472,Oral bioavailability,N,10733,,CHEMBL622126,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6141,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,10734,,CHEMBL620455,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4390,Oral bioavailability in rat,N,10735,,CHEMBL620456,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5472,Oral bioavailability in rat,N,10736,,CHEMBL620457,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5472,Oral bioavailability was evaluated; Not tested,N,10737,,CHEMBL620458,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5438,Oral bioavailability,N,10738,,CHEMBL620459,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4883,Oral bioavailability in rat by oral dosing,N,10739,,CHEMBL620460,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1908,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,10740,,CHEMBL620461,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4853,Oral bioavailability in rat (Sprague-Dawley),N,10741,,CHEMBL620462,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,10742,,CHEMBL620463,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,10743,,CHEMBL620464,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,10744,,CHEMBL620465,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),N,10745,,CHEMBL620466,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4853,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,N,10746,,CHEMBL620467,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4853,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,N,10747,,CHEMBL620468,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12873,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,N,10748,,CHEMBL620469,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12873,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,N,10749,,CHEMBL620470,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3169,Oral bioavailability in rat,N,10750,,CHEMBL620471,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6305,Oral bioavailability in rat,N,10751,,CHEMBL620472,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4762,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,N,10752,,CHEMBL620473,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17847,Oral bioavailability in rat,N,10753,,CHEMBL620474,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6211,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),N,10754,,CHEMBL620475,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6011,Oral bioavailability in rat,N,10755,,CHEMBL620476,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6317,Oral bioavailability in rat,N,10756,,CHEMBL620477,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6644,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,N,10757,,CHEMBL620478,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6644,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,N,10758,,CHEMBL618768,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6644,Oral bioavailability in rat after oral administration at 13 mg/kg dose,N,10759,,CHEMBL618769,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6644,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,N,10760,,CHEMBL618770,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6113,Oral bioavailability (dose 20 mg/kg p.o.),N,10761,,CHEMBL618771,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5937,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,N,10762,,CHEMBL618772,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5711,Oral bioavailability in rat at 10 mg/kg of the compound,N,10763,,CHEMBL618773,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,10764,,CHEMBL875842,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Bioavailability in rat (dose 3 mg/kg i.v.),N,10765,,CHEMBL618774,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,10766,,CHEMBL618775,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17717,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,10767,,CHEMBL618776,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4722,Percent bioavailability (F) in rats after iv administration,N,10768,,CHEMBL618777,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4722,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,N,10769,,CHEMBL618778,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4353,Bioavailability in rat (dose 5 uM/kg p.o.),N,10770,,CHEMBL618779,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15662,Oral bioavailability,N,10771,,CHEMBL618780,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4756,Bioavailability in rat (dose 2 mg/kg p.o.),N,10772,,CHEMBL618781,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,4756,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,N,10773,,CHEMBL618782,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3436,Oral bioavailability in rat (dose 20 mg/kg),N,10774,,CHEMBL618783,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17800,Oral bioavailability in rat,N,10775,,CHEMBL618784,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15762,Percent oral bioavailability evaluated in rat,N,10776,,CHEMBL618785,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5089,Oral bioavailability in rat,N,10777,,CHEMBL618786,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5089,Percent oral bioavailability in rat; Not determined,N,10778,,CHEMBL618787,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3185,Oral bioavailability in rat,N,10779,,CHEMBL618788,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5145,Bioavailability in rat,N,10780,,CHEMBL618789,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3457,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),N,10781,,CHEMBL618790,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3457,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),N,10782,,CHEMBL618791,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5983,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,N,10783,,CHEMBL875843,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5739,Oral bioavailability in rat (dose 20 mg/kg p.o.),N,10784,,CHEMBL618792,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,3579,Cmax at a dose of 30 mg/kg in rat,N,10785,,CHEMBL623395,10116.0,Intermediate,50597,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,17788,Cmax in monkeys at a dose of 1 mg/kg,U,10786,,CHEMBL623396,314293.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14956,Cmax in rat,N,10787,,CHEMBL623397,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17788,Cmax in rats at a dose of 1 mg/kg,N,10788,,CHEMBL623398,10116.0,Intermediate,50597,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,9750,Cmax was measured in mice after an oral dose of 50 mg/kg.,N,10789,,CHEMBL623399,10090.0,Intermediate,50594,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12767,"Cmax value at a dose of 12.7 uM/kg, po",U,10790,,CHEMBL623400,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12767,"Cmax value at a dose of 6.3 uM/kg, iv",U,10791,,CHEMBL623401,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12767,"Cmax value at a dose of 7.1 uM/kg, iv",U,10792,,CHEMBL623402,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12703,Cmax value of compound was determined after 1 hr,U,10793,,CHEMBL623403,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15778,Cmax value of the compound,U,10794,,CHEMBL623404,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12818,Cmax value administered intraintestinal in rats.,N,10795,,CHEMBL625997,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14964,Cmax value administered perorally was determined in rat; Not determined,N,10796,,CHEMBL625998,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15808,Cmax value at the dose of 2.3 mg/kg,U,10797,,CHEMBL625999,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15808,Cmax value at the dose of 5 mg/kg,U,10798,,CHEMBL626000,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15778,Cmax value in the period of 8 hr after dosing. ,U,10799,,CHEMBL626001,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,3715,Cmax value at a oral dose of 20 mg/kg; Not tested,U,10800,,CHEMBL626002,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,3715,Cmax value at a oral dose of 20 mg/kg,U,10801,,CHEMBL626003,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,1446,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,10802,,CHEMBL626004,10116.0,Intermediate,50597,1
,,In vivo,,,A,Cavia porcellus,1,,,,,BAO_0000218,15240,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,N,10803,,CHEMBL626005,10141.0,Intermediate,50512,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15240,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,N,10804,,CHEMBL626006,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14810,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,N,10805,,CHEMBL626007,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,14239,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,N,10806,,CHEMBL626008,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Canis lupus familiaris,1,,2107.0,,,BAO_0000218,12555,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,N,10807,,CHEMBL626009,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,10754,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,N,10808,,CHEMBL626010,9615.0,Intermediate,50588,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,N,10809,,CHEMBL626011,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,N,10810,,CHEMBL626012,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,N,10811,,CHEMBL626013,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,N,10812,,CHEMBL626014,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,N,10813,,CHEMBL877496,10090.0,Intermediate,50594,1
,,In vivo,,,F,Canis lupus familiaris,1,,,,,BAO_0000218,14600,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,N,10814,,CHEMBL626015,9615.0,Intermediate,50588,1
,,In vivo,,,F,Canis lupus familiaris,1,,,,,BAO_0000218,14600,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,N,10815,,CHEMBL626016,9615.0,Intermediate,50588,1
,,In vivo,,,F,Canis lupus familiaris,1,,,,,BAO_0000218,14600,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,N,10816,,CHEMBL626017,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,13543,Bioavailability as maximal plasma concentration in dogs,N,10817,,CHEMBL626018,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,13543,Bioavailability as maximal plasma concentration in dogs,N,10818,,CHEMBL626692,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13543,Bioavailability as maximal plasma concentration in rats,N,10819,,CHEMBL626693,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,0,,1969.0,,,BAO_0000218,13543,Bioavailability as maximal plasma concentration in rats,U,10820,,CHEMBL626694,10116.0,Autocuration,22224,1
Blood,,In vivo,,,A,Canis lupus familiaris,1,,178.0,,,BAO_0000218,14600,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,10821,,CHEMBL626695,9615.0,Intermediate,50588,1
Blood,,In vivo,,,A,Canis lupus familiaris,1,,178.0,,,BAO_0000218,14600,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,10822,,CHEMBL626696,9615.0,Intermediate,50588,1
Blood,,In vivo,,,A,Canis lupus familiaris,1,,178.0,,,BAO_0000218,14600,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,10823,,CHEMBL626697,9615.0,Intermediate,50588,1
Blood,,In vivo,,,A,Canis lupus familiaris,1,,178.0,,,BAO_0000218,14600,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,N,10824,,CHEMBL626859,9615.0,Intermediate,50588,1
Blood,,In vivo,,,A,Canis lupus familiaris,1,,178.0,,,BAO_0000218,14600,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,10825,,CHEMBL626860,9615.0,Intermediate,50588,1
Blood,,In vivo,,,A,Canis lupus familiaris,1,,178.0,,,BAO_0000218,14600,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,10826,,CHEMBL626861,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14681,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,10827,,CHEMBL626296,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15905,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,U,10828,,CHEMBL626297,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,15905,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,U,10829,,CHEMBL626298,,Autocuration,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13304,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",N,10830,,CHEMBL626299,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,N,10831,,CHEMBL626300,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,N,10832,,CHEMBL626301,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,N,10833,,CHEMBL626962,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,N,10834,,CHEMBL626963,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,N,10835,,CHEMBL626964,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Macaca fascicularis,1,,1969.0,,,BAO_0000218,14839,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,N,10836,,CHEMBL626965,9541.0,Intermediate,100710,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10837,,CHEMBL626966,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10838,,CHEMBL626967,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Macaca fascicularis,1,,1969.0,,,BAO_0000218,14839,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,N,10839,,CHEMBL626968,9541.0,Intermediate,100710,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,N,10840,,CHEMBL626969,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,N,10841,,CHEMBL627126,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,N,10842,,CHEMBL631276,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,N,10843,,CHEMBL631277,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,N,10844,,CHEMBL631278,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,N,10845,,CHEMBL874457,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,N,10846,,CHEMBL631279,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,N,10847,,CHEMBL631280,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,N,10848,,CHEMBL631281,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,N,10849,,CHEMBL631968,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,N,10850,,CHEMBL631969,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,N,10851,,CHEMBL631970,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,N,10852,,CHEMBL631971,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,N,10853,,CHEMBL631972,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,N,10854,,CHEMBL630435,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,N,10855,,CHEMBL630436,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,N,10856,,CHEMBL630437,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,N,10857,,CHEMBL630438,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,N,10858,,CHEMBL630439,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,N,10859,,CHEMBL630440,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,N,10860,,CHEMBL630441,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,N,10861,,CHEMBL630442,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,N,10862,,CHEMBL625234,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,N,10863,,CHEMBL625235,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,N,10864,,CHEMBL625236,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,N,10865,,CHEMBL625237,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,N,10866,,CHEMBL626125,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,N,10867,,CHEMBL626126,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,N,10868,,CHEMBL626127,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,N,10869,,CHEMBL626128,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,N,10870,,CHEMBL626129,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,N,10871,,CHEMBL626130,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,N,10872,,CHEMBL626131,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,N,10873,,CHEMBL626132,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,N,10874,,CHEMBL626752,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,N,10875,,CHEMBL626753,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,N,10876,,CHEMBL626754,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,N,10877,,CHEMBL626755,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,N,10878,,CHEMBL626756,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,N,10879,,CHEMBL626757,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,N,10880,,CHEMBL626758,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,N,10881,,CHEMBL626759,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,N,10882,,CHEMBL626760,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,10883,,CHEMBL626394,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,N,10884,,CHEMBL626395,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,10885,,CHEMBL626396,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,10886,,CHEMBL626397,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,10887,,CHEMBL626398,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,10888,,CHEMBL626399,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,N,10889,,CHEMBL874653,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,10890,,CHEMBL626400,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,10891,,CHEMBL626401,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,10892,,CHEMBL626402,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,10893,,CHEMBL626403,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,10894,,CHEMBL626404,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,N,10895,,CHEMBL626405,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,10896,,CHEMBL625529,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,10897,,CHEMBL625530,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,10898,,CHEMBL625531,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,10899,,CHEMBL625532,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,10900,,CHEMBL625533,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,N,10901,,CHEMBL875474,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,10902,,CHEMBL625534,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,10903,,CHEMBL625535,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,10904,,CHEMBL625536,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,10905,,CHEMBL625537,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,10906,,CHEMBL625538,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,N,10907,,CHEMBL625539,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,10908,,CHEMBL625540,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,10909,,CHEMBL625541,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,10910,,CHEMBL625542,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,10911,,CHEMBL625543,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,10912,,CHEMBL625544,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,N,10913,,CHEMBL625545,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,10914,,CHEMBL625546,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,N,10915,,CHEMBL625547,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,10916,,CHEMBL625548,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,10917,,CHEMBL625549,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,10918,,CHEMBL625550,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,10919,,CHEMBL625551,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,10920,,CHEMBL875475,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,10921,,CHEMBL625552,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,10922,,CHEMBL625553,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,10923,,CHEMBL625554,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,10924,,CHEMBL625555,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,10925,,CHEMBL625556,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,N,10926,,CHEMBL624986,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,10927,,CHEMBL624987,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,10928,,CHEMBL624988,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,N,10929,,CHEMBL624989,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,N,10930,,CHEMBL624990,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,N,10931,,CHEMBL874391,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,N,10932,,CHEMBL624991,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,N,10933,,CHEMBL624992,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,N,10934,,CHEMBL624993,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,N,10935,,CHEMBL624994,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,N,10936,,CHEMBL624995,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,N,10937,,CHEMBL624996,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,N,10938,,CHEMBL624997,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,N,10939,,CHEMBL624998,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,N,10940,,CHEMBL624999,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,N,10941,,CHEMBL882955,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,N,10942,,CHEMBL625000,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,N,10943,,CHEMBL625001,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,N,10944,,CHEMBL625089,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,N,10945,,CHEMBL625090,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,N,10946,,CHEMBL625091,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,N,10947,,CHEMBL625092,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,N,10948,,CHEMBL625093,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,N,10949,,CHEMBL625094,9615.0,Intermediate,50588,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,N,10950,,CHEMBL625095,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,2249,Compound was evaluated for its bioavailability in the dogs,N,10951,,CHEMBL625096,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2249,Compound was evaluated for its bioavailability in the rats,N,10952,,CHEMBL625097,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,17515,Compound was evaluated for oral bioavailability,U,10953,,CHEMBL882956,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14541,Compound was evaluated for percentage of Oral bioavailability in rats,N,10954,,CHEMBL625098,10116.0,Intermediate,50597,1
,,In vivo,,,A,Cavia porcellus,0,,,,,BAO_0000218,12797,Bioavailability in guinea pig,U,10955,,CHEMBL625099,10141.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12797,Compound was evaluated for the oral bioavailability in rat,N,10956,,CHEMBL625100,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12797,Compound was evaluated for the oral bioavailability in dog,N,10957,,CHEMBL625101,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12797,Compound was evaluated for the oral bioavailability in rat,N,10958,,CHEMBL874396,10116.0,Intermediate,50597,1
,,In vivo,,,F,Canis lupus familiaris,0,,,,,BAO_0000218,11727,Bioavailability in dog (dosed i.v.),U,10959,,CHEMBL625102,9615.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13249,Compound was tested for in vivo bioavailability in dog,N,10960,,CHEMBL625103,9615.0,Intermediate,50588,1
,,In vivo,,,A,Cricetinae,1,,,,,BAO_0000218,13249,Compound was tested for in vivo bioavailability in hamsters,N,10961,,CHEMBL625104,10026.0,Intermediate,100712,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,13249,Compound was tested for in vivo bioavailability in monkey,U,10962,,CHEMBL625105,314293.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13249,Compound was tested for in vivo bioavailability in rat,N,10963,,CHEMBL625106,10116.0,Intermediate,50597,1
,,In vivo,,,A,Mus musculus,0,,,,,BAO_0000218,9552,Oral bioavailability in mouse,U,10964,,CHEMBL625107,10090.0,Autocuration,22224,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,9552,Compound was tested for percent of oral bioavailability in mice; 56-74,N,10965,,CHEMBL625108,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,0,,,,,BAO_0000218,14839,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),U,10966,,CHEMBL625109,10090.0,Autocuration,22224,1
,,In vivo,,,A,Macaca fascicularis,0,,,,,BAO_0000218,14839,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),U,10967,,CHEMBL625110,9541.0,Autocuration,22224,1
,,In vivo,,,A,Macaca fascicularis,0,,,,,BAO_0000218,14839,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),U,10968,,CHEMBL625111,9541.0,Autocuration,22224,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14839,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),N,10969,,CHEMBL625112,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14839,Oral bioavailability in nude mice,N,10970,,CHEMBL875334,10090.0,Intermediate,50594,1
,,In vivo,,,A,Primates,0,,,,,BAO_0000218,11219,Bioavailability in monkey (i.d. dosing),U,10971,,CHEMBL628617,9443.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,9552,Bioavailability in rat,U,10972,,CHEMBL628618,10116.0,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,U,10973,,CHEMBL628619,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,U,10974,,CHEMBL628620,,Autocuration,22224,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,10975,,CHEMBL628621,9541.0,Intermediate,100710,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,10976,,CHEMBL628622,9541.0,Intermediate,100710,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,10977,,CHEMBL628623,9541.0,Intermediate,100710,1
Plasma,,In vivo,,,A,Macaca fascicularis,1,,1969.0,,,BAO_0000218,14839,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,N,10978,,CHEMBL628624,9541.0,Intermediate,100710,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10979,,CHEMBL628625,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Macaca fascicularis,1,,1969.0,,,BAO_0000218,14839,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,N,10980,,CHEMBL628626,9541.0,Intermediate,100710,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10981,,CHEMBL627041,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10982,,CHEMBL627042,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10983,,CHEMBL627043,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,13932,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,U,10984,,CHEMBL627044,,Autocuration,22224,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,11637,Cmax in mouse plasma,N,10985,,CHEMBL627045,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,11637,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,U,10986,,CHEMBL627046,,Autocuration,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13960,Maximal plasma concentration in rat,N,10987,,CHEMBL627047,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15905,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,N,10988,,CHEMBL627048,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14062,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,N,10989,,CHEMBL627049,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14062,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,N,10990,,CHEMBL627050,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14062,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,N,10991,,CHEMBL627051,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14062,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,N,10992,,CHEMBL627052,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14062,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,N,10993,,CHEMBL627053,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14062,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,N,10994,,CHEMBL627054,10116.0,Intermediate,50597,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,10995,,CHEMBL627055,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,10996,,CHEMBL627056,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,10997,,CHEMBL627057,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,10998,,CHEMBL627058,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,10999,,CHEMBL626211,10090.0,Intermediate,50594,1
,,In vivo,,,A,,0,,,,,BAO_0000218,10291,Maximum Concentration of the compound.,U,11000,,CHEMBL626212,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14599,Maximum Concentration was measured after iv administration into Beagle dog,N,11001,,CHEMBL626213,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14599,Maximum Concentration was measured after iv administration into Beagle dog.,N,11002,,CHEMBL626214,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14599,Maximum Concentration was measured after po administration into Beagle dog,N,11003,,CHEMBL626215,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14599,Maximum Concentration was measured after po administration into Beagle dog.,N,11004,,CHEMBL626216,9615.0,Intermediate,50588,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,12767,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,U,11005,,CHEMBL626217,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,12767,Maximum blood level reached after an iv dose of 12.2 uM/kg,U,11006,,CHEMBL626218,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,12767,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,U,11007,,CHEMBL626219,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,12767,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,U,11008,,CHEMBL626220,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,12767,Maximum blood level reached after an oral dose of 5.0 mg/kg,U,11009,,CHEMBL626221,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,12767,Maximum blood level reached at dose of 10.6 uM/kg orally,U,11010,,CHEMBL626222,,Autocuration,22224,1
,,In vivo,,,A,Cavia porcellus,1,,,,,BAO_0000218,14706,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,N,11011,,CHEMBL626223,10141.0,Intermediate,50512,1
,,In vivo,,,A,Cavia porcellus,1,,,,,BAO_0000218,14706,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,N,11012,,CHEMBL626224,10141.0,Intermediate,50512,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14793,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,N,11013,,CHEMBL626225,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14793,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,N,11014,,CHEMBL626226,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14793,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,N,11015,,CHEMBL626227,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14793,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,N,11016,,CHEMBL626228,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,11017,,CHEMBL626229,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,N,11018,,CHEMBL626921,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,N,11019,,CHEMBL876793,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,N,11020,,CHEMBL625309,10116.0,Intermediate,50597,1
,,In vivo,,,A,Bacillus subtilis,1,,,,,BAO_0000218,10524,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,11021,,CHEMBL625310,1423.0,Intermediate,50278,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,11871,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,U,11022,,CHEMBL625311,314293.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11871,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,N,11023,,CHEMBL625312,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,3437,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,U,11024,,CHEMBL625313,,Autocuration,22224,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,12038,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,N,11025,,CHEMBL625314,10090.0,Intermediate,50594,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12038,Maximum concentration in male rats after iv administration of 20 mg/kg,N,11026,,CHEMBL625315,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,N,11027,,CHEMBL625316,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,N,11028,,CHEMBL625317,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,N,11029,,CHEMBL625318,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,N,11030,,CHEMBL625319,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,N,11031,,CHEMBL625320,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,N,11032,,CHEMBL625321,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,N,11033,,CHEMBL625322,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,N,11034,,CHEMBL876801,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,N,11035,,CHEMBL625323,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,N,11036,,CHEMBL625324,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,N,11037,,CHEMBL625325,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,N,11038,,CHEMBL625326,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,N,11039,,CHEMBL625327,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,N,11040,,CHEMBL625328,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,N,11041,,CHEMBL625329,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,N,11042,,CHEMBL625330,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,N,11043,,CHEMBL627774,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,N,11044,,CHEMBL627775,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,N,11045,,CHEMBL627949,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,N,11046,,CHEMBL627950,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,N,11047,,CHEMBL627951,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,N,11048,,CHEMBL627952,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,N,11049,,CHEMBL627953,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,N,11050,,CHEMBL627954,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,N,11051,,CHEMBL627955,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,N,11052,,CHEMBL627956,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,N,11053,,CHEMBL876802,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,N,11054,,CHEMBL627957,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,N,11055,,CHEMBL627958,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,N,11056,,CHEMBL627959,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,N,11057,,CHEMBL627960,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,N,11058,,CHEMBL627961,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,N,11059,,CHEMBL627962,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,11060,,CHEMBL627963,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,11061,,CHEMBL624759,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,11062,,CHEMBL624760,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9796,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,11063,,CHEMBL624761,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9796,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,11064,,CHEMBL877607,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,11065,,CHEMBL624762,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,11066,,CHEMBL624763,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,11067,,CHEMBL624764,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,11068,,CHEMBL624765,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,11069,,CHEMBL624766,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,11070,,CHEMBL624767,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,N,11071,,CHEMBL624768,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,11072,,CHEMBL624769,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,11073,,CHEMBL624770,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,11074,,CHEMBL624771,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,11075,,CHEMBL624772,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,N,11076,,CHEMBL624773,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,11077,,CHEMBL624774,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,11078,,CHEMBL624775,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,11079,,CHEMBL624776,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,11080,,CHEMBL624777,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,11081,,CHEMBL624778,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,N,11082,,CHEMBL624779,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,11083,,CHEMBL624780,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,11084,,CHEMBL624781,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,11085,,CHEMBL877608,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,11086,,CHEMBL624782,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,11087,,CHEMBL624783,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,N,11088,,CHEMBL624784,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,11089,,CHEMBL624785,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,11090,,CHEMBL624786,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,11091,,CHEMBL624787,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,11092,,CHEMBL628676,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,N,11093,,CHEMBL621842,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,11094,,CHEMBL621843,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,11095,,CHEMBL623873,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,11096,,CHEMBL623874,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,11097,,CHEMBL623875,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,11098,,CHEMBL623876,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,N,11099,,CHEMBL623877,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,11100,,CHEMBL623878,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,N,11101,,CHEMBL623879,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,11102,,CHEMBL623880,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,11103,,CHEMBL623881,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,11104,,CHEMBL623957,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,11105,,CHEMBL623958,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,11106,,CHEMBL623959,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,11107,,CHEMBL623960,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,11108,,CHEMBL623961,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,11109,,CHEMBL623962,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,11110,,CHEMBL624676,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,11111,,CHEMBL624677,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,N,11112,,CHEMBL624678,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,11113,,CHEMBL624679,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,11114,,CHEMBL624680,9615.0,Intermediate,50588,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,U,11115,,CHEMBL624849,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,U,11116,,CHEMBL624850,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,U,11117,,CHEMBL874399,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,U,11118,,CHEMBL624851,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,U,11119,,CHEMBL624852,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,13359,Oral bioavailability in rat (dose 10 mg/kg),U,11120,,CHEMBL624853,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,16618,Oral bioavailability in rat (Sprague-Dawley),U,11121,,CHEMBL624854,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,13960,Oral bioavailability in rat,U,11122,,CHEMBL624855,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,13917,Oral bioavailability in rats was determined in vivo,U,11123,,CHEMBL624856,10116.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,14266,Oral bioavailability in dog,U,11124,,CHEMBL882957,9615.0,Autocuration,22224,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,12359,Oral bioavailability of compound in monkey,U,11125,,CHEMBL624857,314293.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12359,Oral bioavailability of compound in rat,N,11126,,CHEMBL622202,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,12359,Bioavailability in rat of PMEA prodrug,U,11127,,CHEMBL622203,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12359,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,N,11128,,CHEMBL625522,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca mulatta,0,,,,,BAO_0000218,10791,Serum conc at 3 hours following 25 mg/kg dose,U,11129,,CHEMBL622868,9544.0,Autocuration,22224,1
Urine,,In vivo,,,A,Macaca mulatta,0,,1088.0,,,BAO_0000218,10791,Urine conc 0-5 hours following 25 mg/kg dose,U,11130,,CHEMBL622869,9544.0,Autocuration,22224,1
Urine,,In vivo,,,A,Macaca mulatta,0,,1088.0,,,BAO_0000218,10791,Urine conc 0-24 hours following 25 mg/kg dose,U,11131,,CHEMBL622870,9544.0,Autocuration,22224,1
,,In vivo,,,A,Chlorocebus aethiops,0,,,,,BAO_0000218,138,Oral bioavailability in African green monkeys; 20-25,U,11132,,CHEMBL622871,9534.0,Autocuration,22224,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14521,Oral bioavailability in cynomolgus monkey.,N,11133,,CHEMBL620560,9541.0,Intermediate,100710,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,13953,Oral bioavailability in dog,U,11134,,CHEMBL620561,9615.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12836,Oral bioavailability in dog at 10 mg/kg oral dose,N,11135,,CHEMBL620562,9615.0,Intermediate,50588,1
,,In vivo,,,A,Cricetinae,1,,,,,BAO_0000218,12836,Oral bioavailability in hamster at 10 mg/kg oral dose,N,11136,,CHEMBL620563,10026.0,Intermediate,100712,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12836,Oral bioavailability in rat at 10 mg/kg oral dose,N,11137,,CHEMBL620564,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,14521,Oral bioavailability in rat,U,11138,,CHEMBL872265,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,13953,Oral bioavailability in rat,U,11139,,CHEMBL620565,10116.0,Autocuration,22224,1
,,In vivo,,,A,Eutheria,0,,,,,BAO_0000218,6799,Oral bioavailability,U,11140,,CHEMBL620566,9347.0,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11311,Oral bioavailability was determined; range 49-102%,U,11141,,CHEMBL620567,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,4013,Oral bioavailability was determined in dogs,N,11142,,CHEMBL620568,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,4013,Oral bioavailability in rat,U,11143,,CHEMBL620569,10116.0,Autocuration,22224,1
,,In vivo,,,A,Eutheria,0,,,,,BAO_0000218,17591,Oral bioavailability,U,11144,,CHEMBL620570,9347.0,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,17591,Oral bioavailability was determined; Not orally available,U,11145,,CHEMBL620571,,Autocuration,22224,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,15011,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),N,11146,,CHEMBL620572,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,0,,,,,BAO_0000218,15011,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),U,11147,,CHEMBL620573,10090.0,Autocuration,22224,1
,,In vivo,,,A,Mus musculus,0,,,,,BAO_0000218,15011,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,U,11148,,CHEMBL620574,10090.0,Autocuration,22224,1
,,In vivo,,,A,Macaca mulatta,0,,,,,BAO_0000218,9552,Oral bioavailability in Rhesus monkey,U,11149,,CHEMBL620575,9544.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,9552,Oral bioavailability in dog (female mongrel),U,11150,,CHEMBL620576,9615.0,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,3639,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,U,11151,,CHEMBL875846,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,13397,Oral bioavailability in dog,U,11152,,CHEMBL620577,9615.0,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,3031,Percentage Bioavailability was evaluated.,U,11153,,CHEMBL620578,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,12818,Bioavailability in rat administered i.d.,U,11154,,CHEMBL620579,10116.0,Autocuration,22224,1
,,In vivo,,,A,Eutheria,0,,,,,BAO_0000218,4847,Bioavailability,U,11155,,CHEMBL621248,9347.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,12421,Bioavailability in dog (male Beagle) i.v. administration,U,11156,,CHEMBL625390,9615.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,11966,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",U,11157,,CHEMBL625391,10116.0,Autocuration,22224,1
,,In vivo,,,A,Primates,0,,,,,BAO_0000218,11218,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),U,11158,,CHEMBL872266,9443.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,13129,Oral bioavailability in rat (Sprague-Dawley) (male),U,11159,,CHEMBL625392,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12350,The oral bioavailability was measured on rats after oral administration,N,11160,,CHEMBL625393,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2231,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,11161,,CHEMBL625394,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca mulatta,1,,,,,BAO_0000218,2231,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,11162,,CHEMBL625395,9544.0,Intermediate,50797,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,12187,Bioavailability in rat (dose 10 mg/kg i.d.),U,11163,,CHEMBL625396,10116.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,12421,Bioavailability in dog (male Beagle) i.v. administration,U,11164,,CHEMBL625397,9615.0,Autocuration,22224,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11165,,CHEMBL625398,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11166,,CHEMBL625399,10090.0,Intermediate,50594,1
Cerebellum,,In vivo,,,A,Mus musculus,1,,2037.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11167,,CHEMBL626074,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11168,,CHEMBL626075,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2231,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,11169,,CHEMBL626076,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Macaca mulatta,1,,1969.0,,,BAO_0000218,2231,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,11170,,CHEMBL626077,9544.0,Intermediate,50797,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),N,11171,,CHEMBL626078,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),U,11172,,CHEMBL625846,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),U,11173,,CHEMBL625847,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15633,Maximum concentration observed in rats at an oral dose of 50 mg/kg,N,11174,,CHEMBL625848,10116.0,Expert,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14258,Maximum concentration of compound in plasma administered orally to rats,N,11175,,CHEMBL625849,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14224,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",N,11176,,CHEMBL626023,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14224,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",N,11177,,CHEMBL626024,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14224,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",N,11178,,CHEMBL626025,9615.0,Intermediate,50588,1
,,In vivo,,,A,,0,,,,,BAO_0000218,5566,Maximum concentration after 10 mg/kg by oral administration,U,11179,,CHEMBL626026,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,16935,Maximum concentration at a dose of 1.5 mg/kg,U,11180,,CHEMBL626027,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,16935,Maximum concentration at a dose of 2.0 mg/kg,U,11181,,CHEMBL626028,,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14224,Maximum concentration in dog plasma,N,11182,,CHEMBL626029,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,12536,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,U,11183,,CHEMBL626030,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,12536,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,U,11184,,CHEMBL626031,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,12536,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,U,11185,,CHEMBL626032,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,12536,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,U,11186,,CHEMBL626033,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,12536,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,U,11187,,CHEMBL626034,,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,9994,Maximum concentration in plasma after oral administration in dog (25 mg/kg),N,11188,,CHEMBL626035,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,1434,Maximum concentration in plasma at Tmax,U,11189,,CHEMBL626036,,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,12836,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,N,11190,,CHEMBL626037,9615.0,Expert,50588,1
Plasma,,In vivo,,,A,Cricetinae,1,,1969.0,,,BAO_0000218,12836,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,N,11191,,CHEMBL626038,10026.0,Intermediate,100712,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12836,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,N,11192,,CHEMBL626039,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12545,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,N,11193,,CHEMBL626040,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Oryctolagus cuniculus,1,,1969.0,,,BAO_0000218,13856,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,N,11194,,CHEMBL626041,9986.0,Intermediate,50592,1
,,In vivo,,,A,,0,,,,,BAO_0000218,3550,Maximum concentration was calculated,U,11195,,CHEMBL626042,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,2632,Maximum concentration was calculated.,U,11196,,CHEMBL626043,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,5566,Maximum concentration at a peroral dose of 10 mg/kg,U,11197,,CHEMBL626044,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11883,Maximum concentration of the drug at 10 uM/dg administered perorally,U,11198,,CHEMBL626045,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11883,Maximum concentration of the drug at 2 uM/dg administered intravenously,U,11199,,CHEMBL626046,,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14122,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",N,11200,,CHEMBL626047,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Cricetinae,1,,1969.0,,,BAO_0000218,14122,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",N,11201,,CHEMBL626048,10026.0,Intermediate,100712,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14122,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",N,11202,,CHEMBL626049,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,N,11203,,CHEMBL626050,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,N,11204,,CHEMBL874541,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Cricetinae,1,,1969.0,,,BAO_0000218,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,N,11205,,CHEMBL622826,10026.0,Intermediate,100712,1
Plasma,,In vivo,,,A,Cricetinae,1,,1969.0,,,BAO_0000218,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,N,11206,,CHEMBL622827,10026.0,Intermediate,100712,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,N,11207,,CHEMBL622828,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14080,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,N,11208,,CHEMBL622829,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11911,Maximum concentration reached following intravenous administration in male rat,N,11209,,CHEMBL876806,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13204,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,N,11210,,CHEMBL622830,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13204,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,N,11211,,CHEMBL622831,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14346,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,N,11212,,CHEMBL626794,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,N,11213,,CHEMBL626795,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,N,11214,,CHEMBL626796,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14346,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,N,11215,,CHEMBL626797,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14127,Maximum drug concentration is determined after oral dosing in rats.,N,11216,,CHEMBL626798,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14339,Maximum observed concentration in oral (5 mg/kg) fasted dogs,N,11217,,CHEMBL626799,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14339,Maximum observed concentration in oral (5 mg/kg) fed dogs,N,11218,,CHEMBL626800,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,13494,Maximum plasma concentration,U,11219,,CHEMBL626801,,Autocuration,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14925,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,N,11220,,CHEMBL876816,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14474,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,N,11221,,CHEMBL626802,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14474,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,N,11222,,CHEMBL626803,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,13917,Maximum plasma concentration following oral administration of 30 umol/kg,U,11223,,CHEMBL626804,,Autocuration,22224,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,N,11224,,CHEMBL626805,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,11225,,CHEMBL626309,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,11226,,CHEMBL626310,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,11227,,CHEMBL626311,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,11228,,CHEMBL626312,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,11229,,CHEMBL626313,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,11230,,CHEMBL626314,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,11231,,CHEMBL626315,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,11232,,CHEMBL626316,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,9796,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,11233,,CHEMBL626317,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),N,11234,,CHEMBL626318,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),N,11235,,CHEMBL626319,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),N,11236,,CHEMBL626320,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),N,11237,,CHEMBL875053,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),N,11238,,CHEMBL626321,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),N,11239,,CHEMBL626322,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),N,11240,,CHEMBL626323,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),N,11241,,CHEMBL626324,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),N,11242,,CHEMBL626325,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),N,11243,,CHEMBL626326,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),N,11244,,CHEMBL626327,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),N,11245,,CHEMBL626328,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8684,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",N,11246,,CHEMBL626329,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8684,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",N,11247,,CHEMBL626330,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8684,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",N,11248,,CHEMBL626331,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8684,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",N,11249,,CHEMBL626332,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8684,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",N,11250,,CHEMBL626333,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8684,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",N,11251,,CHEMBL626334,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8684,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",N,11252,,CHEMBL626335,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8684,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",N,11253,,CHEMBL624798,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8684,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",N,11254,,CHEMBL624799,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8684,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",N,11255,,CHEMBL624800,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8684,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",N,11256,,CHEMBL624801,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8684,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",N,11257,,CHEMBL624802,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8684,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",N,11258,,CHEMBL624803,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8684,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",N,11259,,CHEMBL624804,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8684,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",N,11260,,CHEMBL624805,10116.0,Intermediate,50597,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,8684,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",N,11261,,CHEMBL624806,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",N,11262,,CHEMBL624807,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",N,11263,,CHEMBL624808,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",N,11264,,CHEMBL624809,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",N,11265,,CHEMBL624810,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",N,11266,,CHEMBL877618,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",N,11267,,CHEMBL624811,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",N,11268,,CHEMBL624812,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",N,11269,,CHEMBL624813,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",N,11270,,CHEMBL624814,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",N,11271,,CHEMBL624815,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",N,11272,,CHEMBL624816,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",N,11273,,CHEMBL624817,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,11274,,CHEMBL624818,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,N,11275,,CHEMBL624819,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,11276,,CHEMBL624820,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,11277,,CHEMBL624821,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,11278,,CHEMBL624822,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,11279,,CHEMBL624823,9615.0,Intermediate,50588,1
,,,,,A,Escherichia coli,1,,,,,BAO_0000218,15599,Observed diffusion coefficient in organic solvent for Escherichia coli,N,11280,,CHEMBL624824,562.0,Intermediate,50212,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9614,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,11281,,CHEMBL624825,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9614,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,11282,,CHEMBL624826,10116.0,Intermediate,50597,1
Cardiac atrium,,,,,A,Rattus norvegicus,1,,2081.0,,,BAO_0000218,9614,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,11283,,CHEMBL876817,10116.0,Intermediate,50597,1
Cardiac atrium,,,,,A,Rattus norvegicus,1,,2081.0,,,BAO_0000218,9614,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,11284,,CHEMBL624827,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9614,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,11285,,CHEMBL624828,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9614,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,11286,,CHEMBL624829,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9614,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,11287,,CHEMBL624830,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9614,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,11288,,CHEMBL624831,10116.0,Intermediate,50597,1
Cardiac atrium,,,,,A,Rattus norvegicus,1,,2081.0,,,BAO_0000218,9614,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,11289,,CHEMBL624832,10116.0,Intermediate,50597,1
Cardiac atrium,,,,,A,Rattus norvegicus,1,,2081.0,,,BAO_0000218,9614,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,11290,,CHEMBL624833,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9614,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,11291,,CHEMBL624834,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9614,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,11292,,CHEMBL624835,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9614,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,11293,,CHEMBL624836,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,9614,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,11294,,CHEMBL624837,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,N,11295,,CHEMBL624838,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,N,11296,,CHEMBL622188,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,N,11297,,CHEMBL622189,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,N,11298,,CHEMBL622190,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,N,11299,,CHEMBL625170,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,11300,,CHEMBL625171,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,11301,,CHEMBL625172,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,N,11302,,CHEMBL625173,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,N,11303,,CHEMBL625174,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,N,11304,,CHEMBL625175,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,N,11305,,CHEMBL625176,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,11306,,CHEMBL625177,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,N,11307,,CHEMBL625178,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,N,11308,,CHEMBL625179,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,11309,,CHEMBL625180,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,10677,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",U,11310,,CHEMBL625181,,Autocuration,22224,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,9750,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,N,11311,,CHEMBL625182,10090.0,Intermediate,50594,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,11312,,CHEMBL625183,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,11313,,CHEMBL875848,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,11314,,CHEMBL622260,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,11315,,CHEMBL622261,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,11316,,CHEMBL622262,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,11317,,CHEMBL622263,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,11318,,CHEMBL622418,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,11319,,CHEMBL622419,10116.0,Intermediate,50597,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11320,,CHEMBL623388,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11321,,CHEMBL623389,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11322,,CHEMBL623390,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11323,,CHEMBL623391,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11324,,CHEMBL623392,10090.0,Intermediate,50594,1
Cerebellum,,In vivo,,,A,Mus musculus,1,,2037.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11325,,CHEMBL623393,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11326,,CHEMBL623394,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11327,,CHEMBL618885,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11328,,CHEMBL618886,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11329,,CHEMBL618887,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,11330,,CHEMBL619535,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),N,11331,,CHEMBL619536,10090.0,Intermediate,50594,1
Cerebellum,,In vivo,,,A,Mus musculus,1,,2037.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,11332,,CHEMBL619537,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),N,11333,,CHEMBL619705,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),N,11334,,CHEMBL619706,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),N,11335,,CHEMBL619707,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),N,11336,,CHEMBL619708,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11337,,CHEMBL625219,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11338,,CHEMBL625220,10090.0,Intermediate,50594,1
Cerebellum,,In vivo,,,A,Mus musculus,1,,2037.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11339,,CHEMBL625221,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11340,,CHEMBL625222,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11341,,CHEMBL625223,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11342,,CHEMBL625224,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,11343,,CHEMBL625225,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8829,Biodistribution in Rat blood after 24 hours of iv administration,N,11344,,CHEMBL625226,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8829,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,N,11345,,CHEMBL625227,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8829,Biodistribution in Rat blood after 30 minutes of iv administration,N,11346,,CHEMBL625228,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8829,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,N,11347,,CHEMBL875354,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8829,Biodistribution in Rat blood after 5 minutes of iv administration,N,11348,,CHEMBL625229,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8829,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,N,11349,,CHEMBL625230,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8829,Biodistribution in Rat heart after 24 hours of iv administration,N,11350,,CHEMBL625231,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8829,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,N,11351,,CHEMBL625900,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8829,Biodistribution in Rat heart after 30 minutes of iv administration,N,11352,,CHEMBL625901,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8829,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,N,11353,,CHEMBL625902,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8829,Biodistribution in Rat heart after 5 minutes of iv administration,N,11354,,CHEMBL625903,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8829,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,N,11355,,CHEMBL625904,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8829,Biodistribution in Rat liver after 24 hours of iv administration,N,11356,,CHEMBL625905,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8829,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,N,11357,,CHEMBL627861,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8829,Biodistribution in Rat liver after 30 minutes of iv administration,N,11358,,CHEMBL627862,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8829,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,11359,,CHEMBL627863,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8829,Biodistribution in Rat liver after 30 minutes of iv administration,N,11360,,CHEMBL627769,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,13249,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,11361,,CHEMBL627770,9615.0,Intermediate,50588,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,13622,Cmax in cynomolgus monkey (PO dose),N,11362,,CHEMBL627771,9541.0,Intermediate,100710,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13622,Cmax in rat (PO dose),N,11363,,CHEMBL627772,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13622,Cmax in rat (PO dose),N,11364,,CHEMBL627773,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13494,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,N,11365,,CHEMBL621922,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12170,Cmax in rat plasma after oral dose (10 mg/kg),N,11366,,CHEMBL621923,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,12170,Cmax in plasma after oral dose (10 mg/kg),U,11367,,CHEMBL621924,,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,17025,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,N,11368,,CHEMBL621925,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Simiiformes,0,,1969.0,,,BAO_0000218,17025,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,U,11369,,CHEMBL621926,314293.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Oryctolagus cuniculus,1,,1969.0,,,BAO_0000218,17025,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,N,11370,,CHEMBL621927,9986.0,Intermediate,50592,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17025,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,N,11371,,CHEMBL621928,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14187,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,N,11372,,CHEMBL621929,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,14816,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,N,11373,,CHEMBL621930,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17820,Maximum plasma concentration after oral dosing in rat,N,11374,,CHEMBL621931,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14380,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,11375,,CHEMBL621932,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14380,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,11376,,CHEMBL621933,,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14691,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,N,11377,,CHEMBL621934,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14691,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,N,11378,,CHEMBL621935,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13375,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,N,11379,,CHEMBL621936,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,6236,Maximum plasma concentration was determined,U,11380,,CHEMBL621937,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14380,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,11381,,CHEMBL621938,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14380,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,11382,,CHEMBL621939,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14380,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,U,11383,,CHEMBL621940,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14380,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,U,11384,,CHEMBL621941,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14380,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,11385,,CHEMBL621942,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14380,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,11386,,CHEMBL626178,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14380,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,U,11387,,CHEMBL626179,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14380,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,U,11388,,CHEMBL626180,,Autocuration,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13622,Plasma Cmax in rat (PO dose),N,11389,,CHEMBL626181,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Maximum serum concentration after po dose of 5.22 mg/kg in rats,N,11390,,CHEMBL626182,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Maximum serum concentration after po dose of 5.46 mg/kg in rats,N,11391,,CHEMBL626183,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,N,11392,,CHEMBL626184,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15372,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,N,11393,,CHEMBL626185,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14925,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,N,11394,,CHEMBL626186,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14925,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,N,11395,,CHEMBL877589,9615.0,Intermediate,50588,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11883,Maximum concentration of the drug at 1 uM/dg administered intravenously,U,11396,,CHEMBL626187,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11883,Maximum concentration of the drug at 20 uM/dg administered perorally,U,11397,,CHEMBL626188,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,U,11398,,CHEMBL626189,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,11399,,CHEMBL626855,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,11400,,CHEMBL623781,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,11401,,CHEMBL623782,,Autocuration,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16360,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,N,11402,,CHEMBL623783,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,3673,Cmax in dog plasma after 1mg/kg oral dose,N,11403,,CHEMBL623784,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14431,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,N,11404,,CHEMBL623785,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14431,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,N,11405,,CHEMBL623786,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14964,Oral maximum concentration in rat,N,11406,,CHEMBL623787,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14964,Oral maximum concentration in rat,N,11407,,CHEMBL623788,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,14209,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,N,11408,,CHEMBL623789,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,11355,Peak concentration in blood after intravenous administration to mice,N,11409,,CHEMBL623790,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,11355,Peak concentration in blood after peroral administration to mice,N,11410,,CHEMBL623791,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,11966,Peak concentration in rat plasma was determined,N,11411,,CHEMBL623792,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Simiiformes,0,,1969.0,,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,U,11412,,CHEMBL623793,314293.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,N,11413,,CHEMBL623794,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,N,11414,,CHEMBL623795,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",N,11415,,CHEMBL623796,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",N,11416,,CHEMBL623797,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",N,11417,,CHEMBL623798,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",N,11418,,CHEMBL623799,10116.0,Intermediate,50597,1
Intestine,,,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8684,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",N,11419,,CHEMBL624490,10116.0,Intermediate,50597,1
Intestine,,,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8684,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",N,11420,,CHEMBL624491,10116.0,Intermediate,50597,1
Intestine,,,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8684,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",N,11421,,CHEMBL624492,10116.0,Intermediate,50597,1
Intestine,,,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8684,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",N,11422,,CHEMBL624493,10116.0,Intermediate,50597,1
Intestine,,,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8684,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",N,11423,,CHEMBL877595,10116.0,Intermediate,50597,1
Intestine,,,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8684,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",N,11424,,CHEMBL624494,10116.0,Intermediate,50597,1
Intestine,,,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8684,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",N,11425,,CHEMBL624495,10116.0,Intermediate,50597,1
Intestine,,,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,8684,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",N,11426,,CHEMBL624681,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",N,11427,,CHEMBL624682,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",N,11428,,CHEMBL624683,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",N,11429,,CHEMBL624684,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",N,11430,,CHEMBL624685,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",N,11431,,CHEMBL624686,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",N,11432,,CHEMBL624687,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",N,11433,,CHEMBL624688,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",N,11434,,CHEMBL627161,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",N,11435,,CHEMBL622127,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",N,11436,,CHEMBL622128,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",N,11437,,CHEMBL874384,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",N,11438,,CHEMBL624898,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",N,11439,,CHEMBL624899,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",N,11440,,CHEMBL624900,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",N,11441,,CHEMBL624901,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",N,11442,,CHEMBL624902,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",N,11443,,CHEMBL624903,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",N,11444,,CHEMBL624904,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",N,11445,,CHEMBL624905,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",N,11446,,CHEMBL624906,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",N,11447,,CHEMBL624907,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",N,11448,,CHEMBL624908,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",N,11449,,CHEMBL624909,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",N,11450,,CHEMBL624910,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8684,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",N,11451,,CHEMBL624911,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8684,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",N,11452,,CHEMBL874388,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8684,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",N,11453,,CHEMBL624912,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8684,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",N,11454,,CHEMBL622930,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8684,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",N,11455,,CHEMBL623121,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8684,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",N,11456,,CHEMBL623122,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8684,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",N,11457,,CHEMBL623123,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,8684,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",N,11458,,CHEMBL623124,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",N,11459,,CHEMBL623125,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",N,11460,,CHEMBL623126,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",N,11461,,CHEMBL623127,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",N,11462,,CHEMBL623128,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",N,11463,,CHEMBL623129,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",N,11464,,CHEMBL623130,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",N,11465,,CHEMBL623131,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",N,11466,,CHEMBL623132,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,11467,,CHEMBL623133,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,11468,,CHEMBL623134,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,11469,,CHEMBL874389,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,11470,,CHEMBL623135,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,11471,,CHEMBL623136,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,11472,,CHEMBL623137,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,11473,,CHEMBL623138,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,11474,,CHEMBL623139,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,11475,,CHEMBL623140,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,11476,,CHEMBL623141,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,11477,,CHEMBL623142,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,11478,,CHEMBL623143,10116.0,Intermediate,50597,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,14571,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,N,11479,,CHEMBL623144,10090.0,Intermediate,50594,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,14571,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,N,11480,,CHEMBL623405,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,11481,,CHEMBL624074,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,11482,,CHEMBL624075,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,11483,,CHEMBL624076,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,11484,,CHEMBL624077,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,11485,,CHEMBL624078,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,11486,,CHEMBL624079,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,11487,,CHEMBL624261,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,11488,,CHEMBL624262,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,11489,,CHEMBL624263,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,11490,,CHEMBL624264,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,11491,,CHEMBL624265,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,11492,,CHEMBL624266,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,11493,,CHEMBL624267,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,11494,,CHEMBL624268,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,11495,,CHEMBL875227,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,11496,,CHEMBL624269,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,11497,,CHEMBL624270,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,11498,,CHEMBL624271,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,11499,,CHEMBL624272,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,11500,,CHEMBL624273,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12064,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,N,11501,,CHEMBL624274,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12064,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,N,11502,,CHEMBL624275,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12064,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,N,11503,,CHEMBL624276,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12038,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,N,11504,,CHEMBL624277,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,14314,% dose converted to 2-amino-5-chlorophenyl sulfate,U,11505,,CHEMBL624278,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14314,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),U,11506,,CHEMBL624279,,Autocuration,22224,1
Feces,,,,,A,Rattus norvegicus,1,,1988.0,,,BAO_0000218,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,11507,,CHEMBL624280,10116.0,Intermediate,50597,1
Feces,,,,,A,Rattus norvegicus,1,,1988.0,,,BAO_0000218,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,11508,,CHEMBL624281,10116.0,Intermediate,50597,1
Feces,,,,,A,Rattus norvegicus,1,,1988.0,,,BAO_0000218,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,11509,,CHEMBL622933,10116.0,Intermediate,50597,1
Feces,,,,,A,Rattus norvegicus,1,,1988.0,,,BAO_0000218,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,11510,,CHEMBL622934,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8829,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,11511,,CHEMBL622935,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8829,Biodistribution in Rat liver after 5 minutes of iv administration,N,11512,,CHEMBL622936,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8829,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,N,11513,,CHEMBL875228,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8829,Biodistribution in Rat lung after 24 hours of iv administration,N,11514,,CHEMBL622937,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8829,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,N,11515,,CHEMBL622938,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8829,Biodistribution in Rat lung after 30 minutes of iv administration,N,11516,,CHEMBL619736,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8829,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,N,11517,,CHEMBL625117,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8829,Biodistribution in Rat lung after 5 minutes of iv administration,N,11518,,CHEMBL625118,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8829,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,N,11519,,CHEMBL625119,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,14972,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",N,11520,,CHEMBL625120,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14972,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",N,11521,,CHEMBL625121,10116.0,Intermediate,50597,1
Thalamus,,In vivo,,,A,Rattus norvegicus,1,,10000006.0,,,BAO_0000218,14972,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",N,11522,,CHEMBL625122,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11523,,CHEMBL622204,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11524,,CHEMBL877503,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11525,,CHEMBL627127,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,,0,,10000000.0,,,BAO_0000218,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,U,11526,,CHEMBL627128,,Autocuration,22224,1
Hippocampus,,In vivo,,,A,,0,,10000000.0,,,BAO_0000218,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,U,11527,,CHEMBL627129,,Autocuration,22224,1
Hippocampus,,In vivo,,,A,,0,,10000000.0,,,BAO_0000218,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,U,11528,,CHEMBL627130,,Autocuration,22224,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11529,,CHEMBL627131,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11530,,CHEMBL627132,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11531,,CHEMBL627133,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11532,,CHEMBL627134,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11533,,CHEMBL627135,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11534,,CHEMBL627136,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11535,,CHEMBL628435,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11536,,CHEMBL628436,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11537,,CHEMBL628437,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11538,,CHEMBL628438,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11539,,CHEMBL628439,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11540,,CHEMBL628440,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11541,,CHEMBL628441,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11542,,CHEMBL628442,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11543,,CHEMBL628443,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11544,,CHEMBL628444,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11545,,CHEMBL628445,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11546,,CHEMBL877504,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11547,,CHEMBL628446,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11548,,CHEMBL626874,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11549,,CHEMBL626875,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11550,,CHEMBL626876,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11551,,CHEMBL626877,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11552,,CHEMBL626878,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11553,,CHEMBL626879,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Simiiformes,0,,1969.0,,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,U,11554,,CHEMBL626880,314293.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,N,11555,,CHEMBL626881,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,N,11556,,CHEMBL626882,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14470,Peak plasma concentration was measured in dogs,N,11557,,CHEMBL626883,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,11558,,CHEMBL626884,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,11559,,CHEMBL626885,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,11560,,CHEMBL626886,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,11561,,CHEMBL626887,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,11562,,CHEMBL626888,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,N,11563,,CHEMBL626889,9615.0,Intermediate,50588,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,U,11564,,CHEMBL626761,314293.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,N,11565,,CHEMBL626762,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,N,11566,,CHEMBL626763,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,N,11567,,CHEMBL626764,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,N,11568,,CHEMBL626765,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,N,11569,,CHEMBL626766,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,N,11570,,CHEMBL626767,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,N,11571,,CHEMBL626768,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,N,11572,,CHEMBL626769,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,N,11573,,CHEMBL874463,9615.0,Intermediate,50588,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,U,11574,,CHEMBL626770,314293.0,Autocuration,22224,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,U,11575,,CHEMBL626771,314293.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,N,11576,,CHEMBL626772,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14731,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,11577,,CHEMBL626773,9541.0,Intermediate,100710,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14731,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,N,11578,,CHEMBL626774,10090.0,Intermediate,50594,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13376,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,11579,,CHEMBL626775,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13376,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,11580,,CHEMBL626776,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14443,Maximum concentration (Cmax) in rat when administered orally,N,11581,,CHEMBL626777,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Simiiformes,0,,1969.0,,,BAO_0000218,13465,Maximal concentration in monkey plasma after 25 mg/kg oral dose,U,11582,,CHEMBL626778,314293.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,16359,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",U,11583,,CHEMBL626779,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,16359,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",U,11584,,CHEMBL626780,10116.0,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,15618,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,U,11585,,CHEMBL626781,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14554,Pharmacokinetic profile Cmax was evaluated in rats,N,11586,,CHEMBL632164,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),N,11587,,CHEMBL632165,9615.0,Intermediate,50588,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),N,11588,,CHEMBL632166,10090.0,Intermediate,50594,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),N,11589,,CHEMBL632167,9615.0,Intermediate,50588,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),N,11590,,CHEMBL632168,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Rattus norvegicus,0,,1969.0,,,BAO_0000218,2021,Cmax in rat plasma,U,11591,,CHEMBL632169,10116.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,5932,Cmax in dog plasma after 30mg/kg oral dose,N,11592,,CHEMBL632170,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5932,Cmax in rat plasma after 30mg/kg oral dose,N,11593,,CHEMBL632171,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17320,Plasma level in rats at 30 mg/kg,N,11594,,CHEMBL632172,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,15831,Tested for maximum plasma concentration in mice,N,11595,,CHEMBL632173,10090.0,Intermediate,50594,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,11596,,CHEMBL632174,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14941,The Cmax values in female wistar rats.,N,11597,,CHEMBL632175,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,15343,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,N,11598,,CHEMBL632176,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15343,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,N,11599,,CHEMBL632177,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14856,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,N,11600,,CHEMBL632178,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13129,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,N,11601,,CHEMBL632179,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,N,11602,,CHEMBL632180,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,N,11603,,CHEMBL632181,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,N,11604,,CHEMBL632182,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Mus musculus,0,,178.0,,,BAO_0000218,15478,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,U,11605,,CHEMBL632183,10090.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15341,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,N,11606,,CHEMBL632184,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15341,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,N,11607,,CHEMBL874470,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",N,11608,,CHEMBL631302,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",N,11609,,CHEMBL631303,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",N,11610,,CHEMBL631304,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",N,11611,,CHEMBL631305,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",N,11612,,CHEMBL631306,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",N,11613,,CHEMBL631307,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",N,11614,,CHEMBL631308,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8684,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",N,11615,,CHEMBL625557,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8684,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",N,11616,,CHEMBL625558,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8684,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",N,11617,,CHEMBL625559,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8684,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",N,11618,,CHEMBL625560,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8684,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",N,11619,,CHEMBL625561,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8684,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",N,11620,,CHEMBL625562,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8684,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",N,11621,,CHEMBL875320,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8684,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",N,11622,,CHEMBL625563,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,8684,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",N,11623,,CHEMBL625564,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8684,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",N,11624,,CHEMBL625565,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8684,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",N,11625,,CHEMBL625566,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8684,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",N,11626,,CHEMBL625567,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8684,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",N,11627,,CHEMBL625568,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8684,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",N,11628,,CHEMBL628217,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8684,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",N,11629,,CHEMBL628218,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8684,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",N,11630,,CHEMBL628219,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8684,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",N,11631,,CHEMBL628220,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the blood after 120 min of intravenous administration,U,11632,,CHEMBL628221,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the blood after 15 min of intravenous administration,U,11633,,CHEMBL628222,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the blood after 30 min of intravenous administration,U,11634,,CHEMBL628223,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the blood after 5 min of intravenous administration,U,11635,,CHEMBL628224,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the blood after 60 min of intravenous administration,U,11636,,CHEMBL628225,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the blood after 90 min of intravenous administration,U,11637,,CHEMBL628226,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the bone after 120 min of intravenous administration,U,11638,,CHEMBL628227,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the bone after 15 min of intravenous administration,U,11639,,CHEMBL875481,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the bone after 30 min of intravenous administration,U,11640,,CHEMBL628228,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the bone after 5 min of intravenous administration,U,11641,,CHEMBL628229,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the bone after 60 min of intravenous administration,U,11642,,CHEMBL628230,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the bone after 90 min of intravenous administration,U,11643,,CHEMBL628231,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the heart after 120 min of intravenous administration,U,11644,,CHEMBL628232,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the heart after 15 min of intravenous administration,U,11645,,CHEMBL628233,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the heart after 30 min of intravenous administration,U,11646,,CHEMBL628234,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the heart after 5 min of intravenous administration,U,11647,,CHEMBL628235,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the heart after 60 min of intravenous administration,U,11648,,CHEMBL628236,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the heart after 90 min of intravenous administration,U,11649,,CHEMBL628237,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the kidneys after 120 min of intravenous administration,U,11650,,CHEMBL628238,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the kidneys after 15 min of intravenous administration,U,11651,,CHEMBL628239,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the kidneys after 30 min of intravenous administration,U,11652,,CHEMBL628240,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the kidneys after 5 min of intravenous administration,U,11653,,CHEMBL628241,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the kidneys after 60 min of intravenous administration,U,11654,,CHEMBL628242,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the kidneys after 90 min of intravenous administration,U,11655,,CHEMBL875482,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the liver after 120 min of intravenous administration,U,11656,,CHEMBL628243,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the liver after 15 min of intravenous administration,U,11657,,CHEMBL628244,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the liver after 30 min of intravenous administration,U,11658,,CHEMBL628245,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the liver after 5 min of intravenous administration,U,11659,,CHEMBL628246,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the liver after 60 min of intravenous administration,U,11660,,CHEMBL628247,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the liver after 90 min of intravenous administration,U,11661,,CHEMBL628248,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the lung after 120 min of intravenous administration,U,11662,,CHEMBL628249,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",N,11663,,CHEMBL625452,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",N,11664,,CHEMBL625453,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",N,11665,,CHEMBL625454,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",N,11666,,CHEMBL623844,10090.0,Intermediate,50594,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,N,11667,,CHEMBL623845,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,N,11668,,CHEMBL623846,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,U,11669,,CHEMBL623847,,Autocuration,22224,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,11670,,CHEMBL623848,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,11671,,CHEMBL623849,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,11672,,CHEMBL623850,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,11673,,CHEMBL623851,9541.0,Intermediate,100710,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,12187,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,11674,,CHEMBL623852,314293.0,Autocuration,22224,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,11675,,CHEMBL624551,9669.0,Intermediate,50506,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,12187,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,11676,,CHEMBL624552,9669.0,Intermediate,50506,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,11677,,CHEMBL624553,314293.0,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,U,11678,,CHEMBL624554,314293.0,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,11679,,CHEMBL624555,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12187,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,11680,,CHEMBL624741,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14122,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",N,11681,,CHEMBL624742,9615.0,Intermediate,50588,1
,,,,,A,Cricetinae,1,,,,,BAO_0000218,14122,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",N,11682,,CHEMBL624743,10026.0,Intermediate,100712,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14122,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",N,11683,,CHEMBL877606,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,U,11684,,CHEMBL624744,,Autocuration,22224,1
Blood,,,,,A,,0,,178.0,,,BAO_0000218,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,11685,,CHEMBL624745,,Autocuration,22224,1
Blood,,,,,A,,0,,178.0,,,BAO_0000218,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,11686,,CHEMBL624746,,Autocuration,22224,1
Blood,,,,,A,,0,,178.0,,,BAO_0000218,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,11687,,CHEMBL624747,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,16360,Oral absorption expressed as Area under curve was determined,U,11688,,CHEMBL624748,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,3673,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,N,11689,,CHEMBL622504,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14122,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",N,11690,,CHEMBL622505,9615.0,Intermediate,50588,1
,,,,,A,Cricetinae,1,,,,,BAO_0000218,14122,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,11691,,CHEMBL622506,10026.0,Intermediate,100712,1
,,,,,A,Cricetinae,1,,,,,BAO_0000218,14122,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,11692,,CHEMBL622507,10026.0,Intermediate,100712,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14122,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",N,11693,,CHEMBL622508,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,13889,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,U,11694,,CHEMBL622509,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,11695,,CHEMBL622510,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17279,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),N,11696,,CHEMBL622511,10116.0,Intermediate,50597,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,11697,,CHEMBL622512,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,11698,,CHEMBL622513,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,N,11699,,CHEMBL622514,9541.0,Intermediate,100710,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,11700,,CHEMBL622515,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,N,11701,,CHEMBL622516,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,11702,,CHEMBL622517,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,N,11703,,CHEMBL622518,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,N,11704,,CHEMBL622519,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11705,,CHEMBL622520,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11706,,CHEMBL622521,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Mus musculus,1,,14.0,,,BAO_0000218,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11707,,CHEMBL625113,10090.0,Intermediate,50594,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11708,,CHEMBL625114,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11709,,CHEMBL874397,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11710,,CHEMBL625115,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11711,,CHEMBL625116,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11712,,CHEMBL623932,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11713,,CHEMBL623933,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11714,,CHEMBL623934,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11715,,CHEMBL623935,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,11716,,CHEMBL623936,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,11717,,CHEMBL623937,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,11718,,CHEMBL623938,10116.0,Intermediate,50597,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,11719,,CHEMBL623939,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,11720,,CHEMBL623940,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,11721,,CHEMBL623941,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,11722,,CHEMBL627216,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,11723,,CHEMBL623942,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,15383,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,11724,,CHEMBL618793,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,15383,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,11725,,CHEMBL618794,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,15383,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,11726,,CHEMBL618795,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,11727,,CHEMBL618796,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,11728,,CHEMBL618797,10090.0,Intermediate,50594,1
Kidney,,,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,11729,,CHEMBL618798,10090.0,Intermediate,50594,1
Kidney,,,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,11730,,CHEMBL618799,10090.0,Intermediate,50594,1
Kidney,,,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,11731,,CHEMBL618800,10090.0,Intermediate,50594,1
Kidney,,,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,11732,,CHEMBL618801,10090.0,Intermediate,50594,1
Kidney,,,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,11733,,CHEMBL618802,10090.0,Intermediate,50594,1
Kidney,,,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,11734,,CHEMBL618803,10090.0,Intermediate,50594,1
Liver,,,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,11735,,CHEMBL618804,10090.0,Intermediate,50594,1
Liver,,,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,11736,,CHEMBL618805,10090.0,Intermediate,50594,1
Liver,,,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,11737,,CHEMBL618806,10090.0,Intermediate,50594,1
Liver,,,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,11738,,CHEMBL618807,10090.0,Intermediate,50594,1
Liver,,,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,11739,,CHEMBL618808,10090.0,Intermediate,50594,1
Liver,,,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,11740,,CHEMBL618809,10090.0,Intermediate,50594,1
Muscle tissue,,,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,15383,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,11741,,CHEMBL618810,10090.0,Intermediate,50594,1
Muscle tissue,,,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,11742,,CHEMBL618811,10090.0,Intermediate,50594,1
Muscle tissue,,,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,11743,,CHEMBL875844,10090.0,Intermediate,50594,1
Muscle tissue,,,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,11744,,CHEMBL618812,10090.0,Intermediate,50594,1
Muscle tissue,,,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,11745,,CHEMBL618813,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,11746,,CHEMBL618814,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,11747,,CHEMBL618815,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,11748,,CHEMBL618816,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,11749,,CHEMBL618817,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,11750,,CHEMBL620544,10090.0,Intermediate,50594,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,N,11751,,CHEMBL626230,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,N,11752,,CHEMBL626231,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,N,11753,,CHEMBL626232,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,N,11754,,CHEMBL626233,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,N,11755,,CHEMBL626234,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,N,11756,,CHEMBL875341,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Homo sapiens,1,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (100 mg/kg) administered orally in human,N,11757,,CHEMBL626235,9606.0,Intermediate,50587,1
Plasma,,In vivo,,,A,Callithrix,0,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,U,11758,,CHEMBL626236,9481.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Simiiformes,0,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,U,11759,,CHEMBL626237,314293.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,N,11760,,CHEMBL626238,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Homo sapiens,1,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (200 mg/kg) administered orally in human,N,11761,,CHEMBL622412,9606.0,Intermediate,50587,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,N,11762,,CHEMBL623114,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Callithrix,0,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,U,11763,,CHEMBL623115,9481.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Simiiformes,0,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (25 mg/kg) administered orally in monkey,U,11764,,CHEMBL623116,314293.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,0,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (30 mg/kg) administered orally in dog,U,11765,,CHEMBL623117,9615.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Homo sapiens,1,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (400 mg/kg) administered orally in human,N,11766,,CHEMBL623118,9606.0,Intermediate,50587,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,N,11767,,CHEMBL623119,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (50 mg/kg) administered orally in rat,N,11768,,CHEMBL623120,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Homo sapiens,1,,1969.0,,,BAO_0000218,14215,The maximum plasma concentration (800 mg/kg) administered orally in human,N,11769,,CHEMBL623286,9606.0,Intermediate,50587,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14067,The maximum plasma concentration was measured on rats,N,11770,,CHEMBL623287,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12350,The maximum plasma concentration was measured on rats after oral administration,N,11771,,CHEMBL623288,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14813,Plasma drug Cmax in rat (PO dose),N,11772,,CHEMBL623289,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12536,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,U,11773,,CHEMBL623290,,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14169,maximum Plasma concentration in Dog was determined after Peroral administration,N,11774,,CHEMBL623291,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14169,maximum Plasma concentration in Rats was determined after Peroral administration,N,11775,,CHEMBL623292,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,11776,,CHEMBL623293,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Simiiformes,0,,1969.0,,,BAO_0000218,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,11777,,CHEMBL623294,314293.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,11778,,CHEMBL623295,10116.0,Intermediate,50597,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14387,maximum concentration was measured when administered through oral route in mice,N,11779,,CHEMBL623296,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15115,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,N,11780,,CHEMBL875349,10090.0,Intermediate,50594,1
,,,,,A,Simiiformes,0,,,,,BAO_0000019,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,U,11781,,CHEMBL623297,314293.0,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000019,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,U,11782,,CHEMBL623298,314293.0,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000019,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,U,11783,,CHEMBL623299,314293.0,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16359,Pharmacokinetic parameter was evaluated in rats,N,11784,,CHEMBL623300,10116.0,Intermediate,50597,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12829,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,11785,,CHEMBL623301,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12829,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,N,11786,,CHEMBL623302,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12829,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,11787,,CHEMBL623303,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12829,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,N,11788,,CHEMBL623304,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12829,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,N,11789,,CHEMBL623305,10090.0,Intermediate,50594,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,N,11790,,CHEMBL623306,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,N,11791,,CHEMBL623307,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,N,11792,,CHEMBL623308,10116.0,Intermediate,50597,1
Plasma,,,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,N,11793,,CHEMBL623309,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13509,Plasma Concentration after 120 min of oral administration to mice,N,11794,,CHEMBL623310,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13509,Plasma Concentration after 30 min of oral administration to mice,N,11795,,CHEMBL623311,10090.0,Intermediate,50594,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,13509,Plasma Concentration after 60 min of oral administration to mice,N,11796,,CHEMBL623312,9541.0,Intermediate,100710,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13509,Plasma Concentration after 60 min of oral administration to mice; Not determined,N,11797,,CHEMBL875350,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13509,Plasma Concentration after 90 min of oral administration to mice,N,11798,,CHEMBL628635,10090.0,Intermediate,50594,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12064,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,N,11799,,CHEMBL628636,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12064,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,N,11800,,CHEMBL628637,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12064,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,N,11801,,CHEMBL628058,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,N,11802,,CHEMBL628059,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,N,11803,,CHEMBL628060,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the lung after 15 min of intravenous administration,U,11804,,CHEMBL628061,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the lung after 30 min of intravenous administration,U,11805,,CHEMBL628062,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the lung after 5 min of intravenous administration,U,11806,,CHEMBL628063,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the lung after 60 min of intravenous administration,U,11807,,CHEMBL628064,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8926,Distribution in the lung after 90 min of intravenous administration,U,11808,,CHEMBL628065,,Autocuration,22224,1
Muscle tissue,,,,,A,,0,,2385.0,,,BAO_0000019,8926,Distribution in the muscle after 120 min of intravenous administration,U,11809,,CHEMBL628066,,Autocuration,22224,1
Muscle tissue,,,,,A,,0,,2385.0,,,BAO_0000019,8926,Distribution in the muscle after 15 min of intravenous administration,U,11810,,CHEMBL628067,,Autocuration,22224,1
Muscle tissue,,,,,A,Mus musculus,1,,2385.0,,,BAO_0000218,8926,Distribution in the muscle after 30 min of intravenous administration,N,11811,,CHEMBL874646,10090.0,Intermediate,50594,1
Muscle tissue,,,,,A,,0,,2385.0,,,BAO_0000019,8926,Distribution in the muscle after 5 min of intravenous administration,U,11812,,CHEMBL628068,,Autocuration,22224,1
Muscle tissue,,,,,A,,0,,2385.0,,,BAO_0000019,8926,Distribution in the muscle after 60 min of intravenous administration,U,11813,,CHEMBL628069,,Autocuration,22224,1
Muscle tissue,,,,,A,,0,,2385.0,,,BAO_0000019,8926,Distribution in the muscle after 90 min of intravenous administration,U,11814,,CHEMBL628070,,Autocuration,22224,1
Spleen,,,,,A,,0,,2106.0,,,BAO_0000019,8926,Distribution in the spleen after 120 min of intravenous administration,U,11815,,CHEMBL628071,,Autocuration,22224,1
Spleen,,,,,A,,0,,2106.0,,,BAO_0000019,8926,Distribution in the spleen after 15 min of intravenous administration,U,11816,,CHEMBL628072,,Autocuration,22224,1
Spleen,,,,,A,,0,,2106.0,,,BAO_0000019,8926,Distribution in the spleen after 30 min of intravenous administration,U,11817,,CHEMBL628073,,Autocuration,22224,1
Spleen,,,,,A,,0,,2106.0,,,BAO_0000019,8926,Distribution in the spleen after 5 min of intravenous administration,U,11818,,CHEMBL628074,,Autocuration,22224,1
Spleen,,,,,A,,0,,2106.0,,,BAO_0000019,8926,Distribution in the spleen after 60 min of intravenous administration,U,11819,,CHEMBL628075,,Autocuration,22224,1
Spleen,,,,,A,,0,,2106.0,,,BAO_0000019,8926,Distribution in the spleen after 90 min of intravenous administration,U,11820,,CHEMBL628076,,Autocuration,22224,1
Adrenal cortex,,,,,A,Rattus norvegicus,1,,1235.0,,,BAO_0000218,7570,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,11821,,CHEMBL628077,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7570,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,N,11822,,CHEMBL628078,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7570,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,N,11823,,CHEMBL628079,10116.0,Intermediate,50597,1
Female gonad,,,,,A,Rattus norvegicus,1,,992.0,,,BAO_0000218,7570,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,N,11824,,CHEMBL628080,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,7570,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,N,11825,,CHEMBL628081,10116.0,Intermediate,50597,1
Adrenal cortex,,,,,A,Rattus norvegicus,1,,1235.0,,,BAO_0000218,7570,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,11826,,CHEMBL628082,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7570,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,N,11827,,CHEMBL874647,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7570,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,N,11828,,CHEMBL626406,10116.0,Intermediate,50597,1
Female gonad,,,,,A,Rattus norvegicus,1,,992.0,,,BAO_0000218,7570,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,N,11829,,CHEMBL626407,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,7570,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,N,11830,,CHEMBL626408,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",N,11831,,CHEMBL626409,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",N,11832,,CHEMBL626410,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",N,11833,,CHEMBL626411,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",N,11834,,CHEMBL626412,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",N,11835,,CHEMBL626413,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",N,11836,,CHEMBL626414,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",N,11837,,CHEMBL626415,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",N,11838,,CHEMBL626416,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",N,11839,,CHEMBL627062,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",N,11840,,CHEMBL627063,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",N,11841,,CHEMBL627064,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",N,11842,,CHEMBL627227,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",N,11843,,CHEMBL627228,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",N,11844,,CHEMBL627229,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",N,11845,,CHEMBL625792,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",N,11846,,CHEMBL625793,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",N,11847,,CHEMBL625794,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",N,11848,,CHEMBL625795,10116.0,Intermediate,50597,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13792,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,N,11849,,CHEMBL625796,10090.0,Intermediate,50594,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13376,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,11850,,CHEMBL625797,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13376,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,11851,,CHEMBL625798,9615.0,Intermediate,50588,1
,,,,,A,,0,,,,,BAO_0000218,14380,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,11852,,CHEMBL875613,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,11853,,CHEMBL625799,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,U,11854,,CHEMBL625800,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,11855,,CHEMBL625801,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,11856,,CHEMBL625802,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,11857,,CHEMBL625803,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14380,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,U,11858,,CHEMBL625804,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,U,11859,,CHEMBL622530,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,N,11860,,CHEMBL622531,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,11861,,CHEMBL622532,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,11862,,CHEMBL623176,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,11863,,CHEMBL623177,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,11864,,CHEMBL623178,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,N,11865,,CHEMBL623179,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,11866,,CHEMBL623180,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,11867,,CHEMBL623181,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,11868,,CHEMBL624131,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),N,11869,,CHEMBL624132,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,11870,,CHEMBL624133,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,N,11871,,CHEMBL624846,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,11872,,CHEMBL624847,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,11873,,CHEMBL624848,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,11874,,CHEMBL625012,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,11875,,CHEMBL625013,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,N,11876,,CHEMBL625014,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),N,11877,,CHEMBL625015,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,11878,,CHEMBL625016,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,N,11879,,CHEMBL625017,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,11880,,CHEMBL625018,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),N,11881,,CHEMBL625019,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),N,11882,,CHEMBL625020,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,N,11883,,CHEMBL625021,10090.0,Intermediate,50594,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,11884,,CHEMBL625022,10116.0,Intermediate,50597,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14731,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,N,11885,,CHEMBL625023,10090.0,Intermediate,50594,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14731,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,N,11886,,CHEMBL625024,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14731,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,11887,,CHEMBL627626,9541.0,Intermediate,100710,1
Brain,,,,,A,,0,,955.0,,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,11888,,CHEMBL627627,,Autocuration,22224,1
Serum,,,,,A,,0,,1977.0,,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,U,11889,,CHEMBL627628,,Autocuration,22224,1
Brain,,,,,A,,0,,955.0,,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,11890,,CHEMBL627629,,Autocuration,22224,1
Serum,,,,,A,,0,,1977.0,,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,U,11891,,CHEMBL627630,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),U,11892,,CHEMBL627631,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),U,11893,,CHEMBL629515,,Autocuration,22224,1
Spleen,,,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,15383,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,11894,,CHEMBL629516,10090.0,Intermediate,50594,1
Spleen,,,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,15383,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,11895,,CHEMBL629517,10090.0,Intermediate,50594,1
Spleen,,,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,15383,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,11896,,CHEMBL629518,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,11897,,CHEMBL877499,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,11898,,CHEMBL629519,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,11899,,CHEMBL629520,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,11900,,CHEMBL629521,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),N,11901,,CHEMBL629522,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),N,11902,,CHEMBL629523,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),N,11903,,CHEMBL629524,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),N,11904,,CHEMBL629525,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),N,11905,,CHEMBL629526,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),N,11906,,CHEMBL629527,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),N,11907,,CHEMBL629528,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),N,11908,,CHEMBL629529,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),N,11909,,CHEMBL629530,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),N,11910,,CHEMBL629531,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),N,11911,,CHEMBL628656,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),N,11912,,CHEMBL628657,10090.0,Intermediate,50594,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",N,11913,,CHEMBL628658,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,11914,,CHEMBL628659,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,11915,,CHEMBL877500,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,11916,,CHEMBL628660,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,11917,,CHEMBL628661,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,11918,,CHEMBL628662,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,11919,,CHEMBL628663,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,11920,,CHEMBL628664,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,11921,,CHEMBL628665,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,11922,,CHEMBL628666,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,11923,,CHEMBL628667,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,11924,,CHEMBL628668,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,11925,,CHEMBL628669,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,11926,,CHEMBL628670,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,11927,,CHEMBL628671,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,13751,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,11928,,CHEMBL628672,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,13751,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,11929,,CHEMBL630300,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,13751,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,11930,,CHEMBL629787,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,13751,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,11931,,CHEMBL629788,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,11932,,CHEMBL629789,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,11933,,CHEMBL629790,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,11934,,CHEMBL629791,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,11935,,CHEMBL629792,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,11936,,CHEMBL629793,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,11937,,CHEMBL629794,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,N,11938,,CHEMBL874459,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,N,11939,,CHEMBL629795,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,N,11940,,CHEMBL629796,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,N,11941,,CHEMBL629797,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,N,11942,,CHEMBL629798,10116.0,Intermediate,50597,1
Adrenal gland,,In vivo,,,A,Rattus norvegicus,1,,2369.0,,,BAO_0000218,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,11943,,CHEMBL629799,10116.0,Intermediate,50597,1
Adrenal gland,,In vivo,,,A,Rattus norvegicus,1,,2369.0,,,BAO_0000218,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,11944,,CHEMBL629800,10116.0,Intermediate,50597,1
Adrenal gland,,In vivo,,,A,Rattus norvegicus,1,,2369.0,,,BAO_0000218,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,11945,,CHEMBL629801,10116.0,Intermediate,50597,1
Adrenal gland,,In vivo,,,A,Rattus norvegicus,1,,2369.0,,,BAO_0000218,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,N,11946,,CHEMBL629802,10116.0,Intermediate,50597,1
Adrenal gland,,In vivo,,,A,Rattus norvegicus,1,,2369.0,,,BAO_0000218,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,11947,,CHEMBL629803,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,10911,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,11948,,CHEMBL629804,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,10911,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,11949,,CHEMBL629805,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,10911,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,11950,,CHEMBL629806,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,10911,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,11951,,CHEMBL629807,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,10911,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,11952,,CHEMBL629808,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,11953,,CHEMBL629809,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,11954,,CHEMBL629810,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,11955,,CHEMBL629811,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,11956,,CHEMBL629812,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,N,11957,,CHEMBL629813,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,11958,,CHEMBL874460,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10911,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,11959,,CHEMBL629814,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10911,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,11960,,CHEMBL629815,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10911,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,11961,,CHEMBL629816,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10911,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,11962,,CHEMBL629817,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,11963,,CHEMBL626643,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,11964,,CHEMBL626644,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,11965,,CHEMBL626806,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,11966,,CHEMBL626807,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,10911,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,11967,,CHEMBL627261,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,10911,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,11968,,CHEMBL627262,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,10911,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,11969,,CHEMBL627263,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,10911,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,11970,,CHEMBL627264,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,10911,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,11971,,CHEMBL627265,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,10911,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,11972,,CHEMBL627266,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,10911,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,11973,,CHEMBL627267,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,10911,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,11974,,CHEMBL627268,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10911,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,11975,,CHEMBL627269,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10911,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,11976,,CHEMBL627270,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",N,11977,,CHEMBL627271,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",N,11978,,CHEMBL627946,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",N,11979,,CHEMBL875472,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",N,11980,,CHEMBL627947,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",N,11981,,CHEMBL627948,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",N,11982,,CHEMBL628113,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",N,11983,,CHEMBL628114,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",N,11984,,CHEMBL628115,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",N,11985,,CHEMBL628116,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",N,11986,,CHEMBL628117,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",N,11987,,CHEMBL628118,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",N,11988,,CHEMBL628119,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",N,11989,,CHEMBL628120,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",N,11990,,CHEMBL628121,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",N,11991,,CHEMBL628122,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",N,11992,,CHEMBL627297,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",N,11993,,CHEMBL627298,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",N,11994,,CHEMBL627299,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",N,11995,,CHEMBL627300,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",N,11996,,CHEMBL627301,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",N,11997,,CHEMBL627302,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",N,11998,,CHEMBL627303,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",N,11999,,CHEMBL627304,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",N,12000,,CHEMBL627305,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,12001,,CHEMBL627306,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",N,12002,,CHEMBL623982,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",N,12003,,CHEMBL623983,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",N,12004,,CHEMBL623984,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",N,12005,,CHEMBL623985,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",N,12006,,CHEMBL623986,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",N,12007,,CHEMBL623987,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",N,12008,,CHEMBL623988,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",N,12009,,CHEMBL623989,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",N,12010,,CHEMBL622215,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",N,12011,,CHEMBL622216,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",N,12012,,CHEMBL877481,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),U,12013,,CHEMBL622217,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13701,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,12014,,CHEMBL622218,10090.0,Intermediate,50594,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14554,Pharmacokinetic profile AUC was evaluated in rats,N,12015,,CHEMBL622219,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,6241,Pharmacokinetic property (Area under curve),U,12016,,CHEMBL622220,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",N,12017,,CHEMBL622221,9615.0,Intermediate,50588,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",N,12018,,CHEMBL622222,10090.0,Intermediate,50594,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",N,12019,,CHEMBL622223,9615.0,Intermediate,50588,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",N,12020,,CHEMBL622224,10090.0,Intermediate,50594,1
,,,,,A,,0,,,,,BAO_0000019,13118,Plasma concentration (AUC) was determined,U,12021,,CHEMBL622225,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13118,Plasma concentration (AUC) was determined; Not detectable,U,12022,,CHEMBL622226,,Autocuration,22224,1
,,,,,A,Cavia porcellus,1,,,,,BAO_0000218,9562,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),N,12023,,CHEMBL624154,10141.0,Intermediate,50512,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,N,12024,,CHEMBL624155,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,12025,,CHEMBL624156,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,N,12026,,CHEMBL624157,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,N,12027,,CHEMBL624158,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,N,12028,,CHEMBL624159,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,N,12029,,CHEMBL624160,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,N,12030,,CHEMBL624161,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,N,12031,,CHEMBL624162,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13317,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,N,12032,,CHEMBL624163,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,12033,,CHEMBL624164,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14941,The AUC(0-infinity) values in female wistar rats.,N,12034,,CHEMBL624165,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,12035,,CHEMBL624166,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",N,12036,,CHEMBL624167,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14941,The AUC(0-t)values in female wistar rats.,N,12037,,CHEMBL624168,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14067,The Area under the concentration time curve of compound was measured on rats,N,12038,,CHEMBL624169,10116.0,Intermediate,50597,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,14215,The area under curve (100 mg/kg) administered orally in humans,N,12039,,CHEMBL624170,9606.0,Intermediate,50587,1
,,,,,A,Callithrix,0,,,,,BAO_0000218,14215,The area under curve (12.5 mg/kg) administered intravenously in marmoset,U,12040,,CHEMBL624171,9481.0,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,14215,The area under curve (12.5 mg/kg) administered intravenously in monkey,U,12041,,CHEMBL624172,314293.0,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14215,The area under curve (15 mg/kg) administered intravenously in dog,N,12042,,CHEMBL624173,9615.0,Intermediate,50588,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,14215,The area under curve (200 mg/kg) administered orally in humans,N,12043,,CHEMBL877488,9606.0,Intermediate,50587,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14215,The area under curve (25 mg/kg) administered intravenously in rat,N,12044,,CHEMBL624174,10116.0,Intermediate,50597,1
,,,,,A,Callithrix,0,,,,,BAO_0000218,14215,The area under curve (25 mg/kg) administered orally in marmoset,U,12045,,CHEMBL624175,9481.0,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,14215,The area under curve (25 mg/kg) administered orally in monkey,U,12046,,CHEMBL624176,314293.0,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14215,The area under curve (30 mg/kg) administered orally in dog,N,12047,,CHEMBL624177,9615.0,Intermediate,50588,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,14215,The area under curve (400 mg/kg) administered orally in humans,N,12048,,CHEMBL624178,9606.0,Intermediate,50587,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14215,The area under curve (50 mg/kg) administered orally in fasted rat,N,12049,,CHEMBL624179,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14215,The area under curve (50 mg/kg) administered orally in rat,N,12050,,CHEMBL627689,10116.0,Intermediate,50597,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,14215,The area under curve (800 mg/kg) administered orally in humans,N,12051,,CHEMBL627690,9606.0,Intermediate,50587,1
,,,,,A,,0,,,,,BAO_0000019,11324,The compound was evaluated for area under the curve,U,12052,,CHEMBL627691,,Autocuration,22224,1
,,,,,A,Callithrix,0,,,,,BAO_0000019,11324,The compound was evaluated for area under the curve in marmosets,U,12053,,CHEMBL627692,9481.0,Autocuration,22224,1
,,,,,A,Callithrix,0,,,,,BAO_0000019,11324,The compound was evaluated for area under the curve in marmosets,U,12054,,CHEMBL627693,9481.0,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,12055,,CHEMBL627694,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,N,12056,,CHEMBL627695,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),U,12057,,CHEMBL627696,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,12058,,CHEMBL627697,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,12059,,CHEMBL627698,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,N,12060,,CHEMBL627699,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13807,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,N,12061,,CHEMBL627700,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14127,Total drug exposure is determined after oral dosing in rats.,N,12062,,CHEMBL627701,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,15116,Total drug exposure (5 mg/kg) when administered intravenously,U,12063,,CHEMBL627702,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,15116,Total drug exposure (5 mg/kg) when administered orally,U,12064,,CHEMBL627703,,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,12065,,CHEMBL626873,314293.0,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,12066,,CHEMBL629583,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,12067,,CHEMBL629584,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,12068,,CHEMBL629585,9615.0,Intermediate,50588,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,12069,,CHEMBL629586,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,12070,,CHEMBL629587,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,12071,,CHEMBL629588,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,12072,,CHEMBL629589,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,12073,,CHEMBL629590,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,12074,,CHEMBL629591,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,12075,,CHEMBL629592,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,12076,,CHEMBL629593,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,12077,,CHEMBL629594,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,12078,,CHEMBL629595,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,12079,,CHEMBL630290,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,12080,,CHEMBL627137,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,12081,,CHEMBL627138,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,12082,,CHEMBL627139,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,12083,,CHEMBL627140,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,12084,,CHEMBL627141,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,12085,,CHEMBL627142,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,12086,,CHEMBL627143,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,12087,,CHEMBL874449,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,12088,,CHEMBL627144,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,12089,,CHEMBL627145,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,12090,,CHEMBL627146,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,12091,,CHEMBL627147,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13751,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,12092,,CHEMBL627148,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,12093,,CHEMBL627149,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,12094,,CHEMBL632160,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,12095,,CHEMBL632161,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,12096,,CHEMBL632162,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,12097,,CHEMBL632163,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,12098,,CHEMBL874469,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,12099,,CHEMBL627182,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,12100,,CHEMBL627183,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,12101,,CHEMBL627184,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,12102,,CHEMBL627185,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,12103,,CHEMBL627186,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,12104,,CHEMBL627187,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,12105,,CHEMBL627188,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,12106,,CHEMBL627189,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13751,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,12107,,CHEMBL627190,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13751,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,12108,,CHEMBL627191,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13751,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,12109,,CHEMBL627192,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13751,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,12110,,CHEMBL627193,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10911,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,12111,,CHEMBL874590,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10911,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,12112,,CHEMBL627194,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10911,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,12113,,CHEMBL627195,10116.0,Intermediate,50597,1
Female gonad,,In vivo,,,A,Rattus norvegicus,1,,992.0,,,BAO_0000218,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,12114,,CHEMBL627196,10116.0,Intermediate,50597,1
Female gonad,,In vivo,,,A,Rattus norvegicus,1,,992.0,,,BAO_0000218,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,12115,,CHEMBL627197,10116.0,Intermediate,50597,1
Female gonad,,In vivo,,,A,Rattus norvegicus,1,,992.0,,,BAO_0000218,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,12116,,CHEMBL627198,10116.0,Intermediate,50597,1
Female gonad,,In vivo,,,A,Rattus norvegicus,1,,992.0,,,BAO_0000218,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,N,12117,,CHEMBL627199,10116.0,Intermediate,50597,1
Female gonad,,In vivo,,,A,Rattus norvegicus,1,,992.0,,,BAO_0000218,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,12118,,CHEMBL627200,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,10911,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,12119,,CHEMBL627201,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,10911,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,12120,,CHEMBL627202,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,10911,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,12121,,CHEMBL627203,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,10911,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,12122,,CHEMBL627204,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,10911,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,12123,,CHEMBL627205,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,10911,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,12124,,CHEMBL627206,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,10911,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,12125,,CHEMBL627207,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,10911,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,12126,,CHEMBL627208,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,12127,,CHEMBL627209,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,12128,,CHEMBL627210,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,12129,,CHEMBL627211,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,12130,,CHEMBL627212,10116.0,Intermediate,50597,1
Uterus,,In vivo,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,10911,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,12131,,CHEMBL627213,10116.0,Intermediate,50597,1
Uterus,,In vivo,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,10911,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,12132,,CHEMBL626599,10116.0,Intermediate,50597,1
Uterus,,In vivo,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,10911,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,12133,,CHEMBL626600,10116.0,Intermediate,50597,1
Uterus,,In vivo,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,10911,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,12134,,CHEMBL626601,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,8081,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,U,12135,,CHEMBL627484,,Autocuration,22224,1
Plasma,,,,,A,Macaca fascicularis,1,,1969.0,,,BAO_0000218,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),N,12136,,CHEMBL627485,9541.0,Intermediate,100710,1
Plasma,,,,,A,Macaca fascicularis,1,,1969.0,,,BAO_0000218,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,N,12137,,CHEMBL628147,9541.0,Intermediate,100710,1
Plasma,,,,,A,Macaca fascicularis,1,,1969.0,,,BAO_0000218,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,N,12138,,CHEMBL628148,9541.0,Intermediate,100710,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),N,12139,,CHEMBL628149,9615.0,Intermediate,50588,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,N,12140,,CHEMBL628150,9615.0,Intermediate,50588,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,N,12141,,CHEMBL628318,9615.0,Intermediate,50588,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,N,12142,,CHEMBL628319,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,12143,,CHEMBL875609,9615.0,Intermediate,50588,1
,,,,,A,,0,,,,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,U,12144,,CHEMBL628320,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,U,12145,,CHEMBL628321,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,U,12146,,CHEMBL628322,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,U,12147,,CHEMBL628323,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,U,12148,,CHEMBL628324,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,U,12149,,CHEMBL628325,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,U,12150,,CHEMBL628326,,Autocuration,22224,1
Adrenal medulla,,,,,A,Canis lupus familiaris,1,,1236.0,,,BAO_0000218,9614,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",N,12151,,CHEMBL628327,9615.0,Intermediate,50588,1
Adrenal medulla,,,,,A,Canis lupus familiaris,1,,1236.0,,,BAO_0000218,9614,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",N,12152,,CHEMBL628328,9615.0,Intermediate,50588,1
Blood,,,,,A,Canis lupus familiaris,1,,178.0,,,BAO_0000218,9614,"Concentration of compound in blood of dog 1, after administering intravenously",N,12153,,CHEMBL628329,9615.0,Intermediate,50588,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",N,12154,,CHEMBL628330,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",N,12155,,CHEMBL628331,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",N,12156,,CHEMBL628332,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",N,12157,,CHEMBL628333,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",N,12158,,CHEMBL628334,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",N,12159,,CHEMBL628335,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",N,12160,,CHEMBL628336,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,12161,,CHEMBL628337,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",N,12162,,CHEMBL628338,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",N,12163,,CHEMBL875610,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",N,12164,,CHEMBL628339,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",N,12165,,CHEMBL628340,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",N,12166,,CHEMBL628341,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",N,12167,,CHEMBL622214,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",N,12168,,CHEMBL623167,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",N,12169,,CHEMBL623168,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",N,12170,,CHEMBL623169,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",N,12171,,CHEMBL623170,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",N,12172,,CHEMBL627224,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",N,12173,,CHEMBL875634,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",N,12174,,CHEMBL627225,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",N,12175,,CHEMBL627226,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",N,12176,,CHEMBL626083,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",N,12177,,CHEMBL626084,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",N,12178,,CHEMBL626085,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",N,12179,,CHEMBL626086,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",N,12180,,CHEMBL626087,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",N,12181,,CHEMBL626088,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",N,12182,,CHEMBL626089,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",N,12183,,CHEMBL626090,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",N,12184,,CHEMBL626091,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",N,12185,,CHEMBL626092,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",N,12186,,CHEMBL626093,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",N,12187,,CHEMBL626094,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",N,12188,,CHEMBL626095,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",N,12189,,CHEMBL626096,10116.0,Intermediate,50597,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,12190,,CHEMBL626097,314293.0,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,12191,,CHEMBL626098,10116.0,Intermediate,50597,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000218,1806,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,U,12192,,CHEMBL626099,,Autocuration,22224,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000218,1806,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,U,12193,,CHEMBL626100,,Autocuration,22224,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,17237,AUC 0-inf in dog,N,12194,,CHEMBL626101,9615.0,Intermediate,50588,1
Plasma,,,,,A,Cavia porcellus,1,,1969.0,,,BAO_0000218,17237,AUC 0-inf in guinea pig,N,12195,,CHEMBL626102,10141.0,Intermediate,50512,1
Plasma,,,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,17237,AUC 0-t in dog,N,12196,,CHEMBL626103,9615.0,Intermediate,50588,1
Plasma,,,,,A,Cavia porcellus,1,,1969.0,,,BAO_0000218,17237,AUC 0-t in guinea pig,N,12197,,CHEMBL628391,10141.0,Intermediate,50512,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15194,The compound was tested for brain to plasma partition in rat,N,12198,,CHEMBL628392,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15194,The compound was tested for brain to plasma partition in rat.,N,12199,,CHEMBL628393,10116.0,Intermediate,50597,1
Blood,,,,,A,,0,,178.0,,,BAO_0000019,8787,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,U,12200,,CHEMBL628394,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,N,12201,,CHEMBL628395,9615.0,Intermediate,50588,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,U,12202,,CHEMBL628396,314293.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,12203,,CHEMBL628397,9986.0,Intermediate,50592,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,N,12204,,CHEMBL628398,10116.0,Intermediate,50597,1
,,,,,A,Macaca mulatta,1,,,,,BAO_0000218,4236,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,N,12205,,CHEMBL628399,9544.0,Intermediate,50797,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15343,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,N,12206,,CHEMBL628400,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15343,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,N,12207,,CHEMBL874907,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,17720,Area under curve of the compound was determined,U,12208,,CHEMBL628401,,Autocuration,22224,1
Plasma,,,,,A,Simiiformes,0,,1969.0,,,BAO_0000218,17788,AUC in monkeys at a dose of 1 mg/kg,U,12209,,CHEMBL628402,314293.0,Autocuration,22224,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,17788,AUC in rats at a dose of 1 mg/kg,N,12210,,CHEMBL628403,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,8778,Compound was evaluated for the overall absorbance loss at pH of 2,U,12211,,CHEMBL628404,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8778,Compound was evaluated for the overall absorbance loss at pH of 4,U,12212,,CHEMBL628405,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8778,Compound was evaluated for the overall absorbance loss at pH of 7,U,12213,,CHEMBL628406,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,2249,Compound was evaluated for its absorption in the rats,N,12214,,CHEMBL628407,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,12215,,CHEMBL628408,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,N,12216,,CHEMBL629171,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,12217,,CHEMBL629172,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,N,12218,,CHEMBL629173,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum,N,12219,,CHEMBL629174,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 10-17,N,12220,,CHEMBL629175,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 10-18,N,12221,,CHEMBL629176,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 10-19,N,12222,,CHEMBL629177,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 12-15,N,12223,,CHEMBL629178,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 13-19,N,12224,,CHEMBL631869,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 14-17,N,12225,,CHEMBL631870,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 15-18,N,12226,,CHEMBL631871,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 2-5,N,12227,,CHEMBL631872,10116.0,Intermediate,50597,1
Ileum,,,,,A,,0,,2116.0,,,BAO_0000221,15286,In vitro percent permeability into rat ileum; Range is 23-42,U,12228,,CHEMBL875775,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 28-36,N,12229,,CHEMBL631873,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 29-35,N,12230,,CHEMBL631874,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 46-66,N,12231,,CHEMBL631875,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 50-68,N,12232,,CHEMBL631876,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 78-81,N,12233,,CHEMBL631877,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,N,12234,,CHEMBL631878,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; nd indicates not detected,N,12235,,CHEMBL631879,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; nt indicates not detected,N,12236,,CHEMBL631880,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15286,In vitro percent permeability into rat ileum; nt indicates not tested,N,12237,,CHEMBL631881,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13770,Compound was tested for oral absorption in bile-duct cannulated rats,N,12238,,CHEMBL631882,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13770,Compound was tested for oral absorption in bile-duct cannulated rats.,N,12239,,CHEMBL630749,10116.0,Intermediate,50597,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,5202,Oral absorption using Caco-2 cell monolayers.,N,12240,,CHEMBL630750,9606.0,Intermediate,50587,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,14920,Percent of the drug absorbed after administration to humans was determined,N,12241,,CHEMBL630253,9606.0,Intermediate,50587,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,12242,,CHEMBL630254,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,12243,,CHEMBL630255,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,12244,,CHEMBL630256,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13751,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,12245,,CHEMBL875781,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13751,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,12246,,CHEMBL630257,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13751,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,12247,,CHEMBL630258,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15807,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",N,12248,,CHEMBL630259,10116.0,Intermediate,50597,1
Striatum,,,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,15807,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",N,12249,,CHEMBL630260,10116.0,Intermediate,50597,1
Striatum,,,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,15807,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",N,12250,,CHEMBL630261,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,N,12251,,CHEMBL630262,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,N,12252,,CHEMBL630263,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,N,12253,,CHEMBL630264,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,N,12254,,CHEMBL630265,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,N,12255,,CHEMBL630266,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,N,12256,,CHEMBL630267,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,N,12257,,CHEMBL630268,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,N,12258,,CHEMBL630269,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,N,12259,,CHEMBL630270,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,N,12260,,CHEMBL630141,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,N,12261,,CHEMBL630142,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,N,12262,,CHEMBL630143,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,N,12263,,CHEMBL630144,10116.0,Intermediate,50597,1
Prostate gland,,,,,A,Rattus norvegicus,1,,2367.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,N,12264,,CHEMBL630145,10116.0,Intermediate,50597,1
Prostate gland,,,,,A,Rattus norvegicus,1,,2367.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,N,12265,,CHEMBL630146,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,N,12266,,CHEMBL630147,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,N,12267,,CHEMBL630148,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,N,12268,,CHEMBL630149,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,N,12269,,CHEMBL630150,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,N,12270,,CHEMBL630151,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,N,12271,,CHEMBL632031,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,N,12272,,CHEMBL632032,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,N,12273,,CHEMBL632033,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,N,12274,,CHEMBL632034,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,N,12275,,CHEMBL632035,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,N,12276,,CHEMBL632036,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,N,12277,,CHEMBL632037,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,12278,,CHEMBL632038,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,12279,,CHEMBL632039,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,12280,,CHEMBL632040,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,12281,,CHEMBL632041,10116.0,Intermediate,50597,1
Blood,,,,,A,Canis lupus familiaris,1,,178.0,,,BAO_0000218,9614,"Concentration of compound in blood of dog 2, after administering intravenously",N,12282,,CHEMBL632042,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9614,"Concentration of compound in left ventricle of dog 1, after administering intravenously",N,12283,,CHEMBL632043,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9614,"Concentration of compound in left ventricle of dog 2, after administering intravenously",N,12284,,CHEMBL632044,9615.0,Intermediate,50588,1
Liver,,,,,A,Canis lupus familiaris,1,,2107.0,,,BAO_0000218,9614,"Concentration of compound in liver of dog 1, after administering intravenously",N,12285,,CHEMBL632045,9615.0,Intermediate,50588,1
Liver,,,,,A,Canis lupus familiaris,1,,2107.0,,,BAO_0000218,9614,"Concentration of compound in liver of dog 2, after administering intravenously",N,12286,,CHEMBL632046,9615.0,Intermediate,50588,1
Lung,,,,,A,Canis lupus familiaris,1,,2048.0,,,BAO_0000218,9614,"Concentration of compound in lung of dog 1, after administering intravenously",N,12287,,CHEMBL632047,9615.0,Intermediate,50588,1
Lung,,,,,A,Canis lupus familiaris,1,,2048.0,,,BAO_0000218,9614,"Concentration of compound in lung of dog 2, after administering intravenously",N,12288,,CHEMBL632048,9615.0,Intermediate,50588,1
Muscle tissue,,,,,A,Canis lupus familiaris,1,,2385.0,,,BAO_0000218,9614,"Concentration of compound in muscle of dog 1, after administering intravenously",N,12289,,CHEMBL632049,9615.0,Intermediate,50588,1
Muscle tissue,,,,,A,Canis lupus familiaris,1,,2385.0,,,BAO_0000218,9614,"Concentration of compound in muscle of dog 2, after administering intravenously",N,12290,,CHEMBL876418,9615.0,Intermediate,50588,1
Spleen,,,,,A,Canis lupus familiaris,1,,2106.0,,,BAO_0000218,9614,"Concentration of compound in spleen of dog 1,after administering intravenously",N,12291,,CHEMBL632050,9615.0,Intermediate,50588,1
Spleen,,,,,A,Canis lupus familiaris,1,,2106.0,,,BAO_0000218,9614,"Concentration of compound in spleen of dog 2, after administering intravenously",N,12292,,CHEMBL632051,9615.0,Intermediate,50588,1
,,,,,F,,0,,,,,BAO_0000218,10353,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,U,12293,,CHEMBL632052,,Autocuration,22224,1
,,,,,F,,0,,,,,BAO_0000218,10353,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,U,12294,,CHEMBL632053,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,10353,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,12295,,CHEMBL632054,,Autocuration,22224,1
,,,,,F,,0,,,,,BAO_0000218,10353,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,12296,,CHEMBL632055,,Autocuration,22224,1
,,,,,F,,0,,,,,BAO_0000218,10353,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,U,12297,,CHEMBL631181,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,U,12298,,CHEMBL631182,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,12299,,CHEMBL631183,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,12300,,CHEMBL631184,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,12301,,CHEMBL629774,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,12302,,CHEMBL629775,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,12303,,CHEMBL876549,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,12304,,CHEMBL628172,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,12305,,CHEMBL628173,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,U,12306,,CHEMBL628174,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,U,12307,,CHEMBL628175,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,12308,,CHEMBL628176,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,12309,,CHEMBL628177,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,12310,,CHEMBL628178,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,12311,,CHEMBL628179,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,12312,,CHEMBL628180,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,U,12313,,CHEMBL628181,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,12314,,CHEMBL628182,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,12315,,CHEMBL628183,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,U,12316,,CHEMBL628184,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,12317,,CHEMBL628185,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,12318,,CHEMBL875617,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,12319,,CHEMBL628186,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,12320,,CHEMBL628187,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,12321,,CHEMBL628188,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,12322,,CHEMBL628189,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,U,12323,,CHEMBL628190,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,12324,,CHEMBL628191,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,U,12325,,CHEMBL626513,,Autocuration,22224,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",N,12326,,CHEMBL626514,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",N,12327,,CHEMBL626515,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",N,12328,,CHEMBL626516,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",N,12329,,CHEMBL626517,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",N,12330,,CHEMBL626518,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",N,12331,,CHEMBL626519,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",N,12332,,CHEMBL626520,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",N,12333,,CHEMBL626521,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",N,12334,,CHEMBL626522,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",N,12335,,CHEMBL626523,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",N,12336,,CHEMBL626524,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",N,12337,,CHEMBL626688,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",N,12338,,CHEMBL626689,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",N,12339,,CHEMBL626690,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",N,12340,,CHEMBL626691,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",N,12341,,CHEMBL627319,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",N,12342,,CHEMBL624052,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",N,12343,,CHEMBL624053,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8085,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,12344,,CHEMBL624054,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8085,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,12345,,CHEMBL624055,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8085,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,12346,,CHEMBL624056,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8085,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,12347,,CHEMBL624057,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8085,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,12348,,CHEMBL622281,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8085,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,12349,,CHEMBL622282,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8085,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,12350,,CHEMBL622283,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8085,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,12351,,CHEMBL622284,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8085,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,12352,,CHEMBL622285,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,8085,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,12353,,CHEMBL622286,10116.0,Intermediate,50597,1
,,,,,P,,0,,,,,BAO_0000100,7657,Distribution coefficient (D %) between octanol and buffer of pH 7.4,U,12354,,CHEMBL622287,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8935,Partition coefficient (logD7.4),N,12355,,CHEMBL622288,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13792,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,12356,,CHEMBL622289,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,13792,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,12357,,CHEMBL622290,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13792,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,12358,,CHEMBL622291,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,13792,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,12359,,CHEMBL622292,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13792,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,12360,,CHEMBL622293,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,13792,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,12361,,CHEMBL622294,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13792,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,12362,,CHEMBL622295,10090.0,Intermediate,50594,1
Brain,,,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13792,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,12363,,CHEMBL622296,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,N,12364,,CHEMBL874409,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,12365,,CHEMBL622297,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,12366,,CHEMBL622298,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,12367,,CHEMBL622299,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,12368,,CHEMBL622300,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,12369,,CHEMBL622301,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,12370,,CHEMBL622302,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,12371,,CHEMBL622303,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,12372,,CHEMBL622304,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,N,12373,,CHEMBL622305,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,12374,,CHEMBL622306,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,N,12375,,CHEMBL626864,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,12376,,CHEMBL626865,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,N,12377,,CHEMBL626866,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,12378,,CHEMBL626867,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,12379,,CHEMBL626868,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,N,12380,,CHEMBL626869,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,12381,,CHEMBL626870,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,N,12382,,CHEMBL626871,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,12383,,CHEMBL626872,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,12384,,CHEMBL632185,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,N,12385,,CHEMBL632186,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,12904,Amount of acetic acid produced by the compound,U,12386,,CHEMBL629310,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12904,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,U,12387,,CHEMBL629311,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9663,Log of (Cbrain/Cblood) in rats,N,12388,,CHEMBL629312,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000221,7652,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,12389,,CHEMBL629313,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000221,7652,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,12390,,CHEMBL629314,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000221,7652,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,12391,,CHEMBL629315,,Autocuration,22224,1
,,,,,B,,0,,,,,BAO_0000219,7652,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),U,12392,,CHEMBL629316,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000221,7652,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,12393,,CHEMBL629317,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,12394,,CHEMBL629318,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),U,12395,,CHEMBL877497,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),U,12396,,CHEMBL629319,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,12397,,CHEMBL629320,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),U,12398,,CHEMBL629496,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),U,12399,,CHEMBL629497,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),U,12400,,CHEMBL629498,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),U,12401,,CHEMBL629499,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,12402,,CHEMBL629500,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),U,12403,,CHEMBL629501,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),U,12404,,CHEMBL629502,,Autocuration,22224,1
,,In vivo,,,F,,0,,,,,BAO_0000218,8267,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,U,12405,,CHEMBL629503,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8267,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,N,12406,,CHEMBL629504,9615.0,Intermediate,50588,1
,,,,,A,,0,,,,,BAO_0000019,14479,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,U,12407,,CHEMBL629505,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,17515,Compound was evaluated for total body clearance,U,12408,,CHEMBL629506,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,17515,Compound was evaluated for volume of distribution at steady state,U,12409,,CHEMBL629507,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8142,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,U,12410,,CHEMBL877498,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14849,Percentage of the diamine which is monoprotonated at pH 7.4,U,12411,,CHEMBL629508,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,U,12412,,CHEMBL629509,,Autocuration,22224,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,12413,,CHEMBL629510,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,12414,,CHEMBL629511,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,12415,,CHEMBL629512,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,12416,,CHEMBL629513,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,12417,,CHEMBL629514,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,12418,,CHEMBL628447,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,12419,,CHEMBL628448,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,12420,,CHEMBL628449,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,12421,,CHEMBL631119,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,12422,,CHEMBL631120,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,12423,,CHEMBL631121,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,N,12424,,CHEMBL874458,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,12425,,CHEMBL631122,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,12426,,CHEMBL631123,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,12427,,CHEMBL631124,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,12428,,CHEMBL631125,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,12429,,CHEMBL631290,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,12430,,CHEMBL631291,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,12431,,CHEMBL631292,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,12432,,CHEMBL631293,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,12433,,CHEMBL631294,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,12434,,CHEMBL631295,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,12435,,CHEMBL631296,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,12436,,CHEMBL631297,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,10263,Maximum biodistribution (Bmax) was determined.,U,12437,,CHEMBL631298,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,N,12438,,CHEMBL631299,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,N,12439,,CHEMBL631300,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,N,12440,,CHEMBL631301,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,N,12441,,CHEMBL630291,10090.0,Intermediate,50594,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,U,12442,,CHEMBL630292,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,U,12443,,CHEMBL630293,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,U,12444,,CHEMBL630294,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,U,12445,,CHEMBL630295,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,U,12446,,CHEMBL630296,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,U,12447,,CHEMBL626782,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,U,12448,,CHEMBL626783,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,U,12449,,CHEMBL626784,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,U,12450,,CHEMBL626785,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,U,12451,,CHEMBL626786,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,12452,,CHEMBL626787,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,12453,,CHEMBL626788,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,12454,,CHEMBL625927,,Autocuration,22224,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12455,,CHEMBL625928,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,12456,,CHEMBL625929,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,12457,,CHEMBL625930,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",N,12458,,CHEMBL625931,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,N,12459,,CHEMBL627230,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12460,,CHEMBL627231,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,12461,,CHEMBL627232,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,12462,,CHEMBL627233,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12463,,CHEMBL875470,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12464,,CHEMBL627234,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12465,,CHEMBL627235,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12466,,CHEMBL627236,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12467,,CHEMBL627237,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12468,,CHEMBL627238,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12469,,CHEMBL627239,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12470,,CHEMBL627240,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12471,,CHEMBL627241,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12472,,CHEMBL627242,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,N,12473,,CHEMBL627243,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,12474,,CHEMBL627244,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12475,,CHEMBL627245,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12476,,CHEMBL627246,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12477,,CHEMBL627247,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12478,,CHEMBL627248,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12479,,CHEMBL627249,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12480,,CHEMBL625569,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12481,,CHEMBL625570,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12482,,CHEMBL625571,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,12483,,CHEMBL625572,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,12484,,CHEMBL625573,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,N,12485,,CHEMBL625574,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,12486,,CHEMBL626245,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12487,,CHEMBL626246,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,12488,,CHEMBL626247,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,12489,,CHEMBL626248,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,12490,,CHEMBL626249,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,12491,,CHEMBL626420,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,12492,,CHEMBL626421,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,12493,,CHEMBL626422,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,12494,,CHEMBL626423,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,12495,,CHEMBL626424,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12023,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,N,12496,,CHEMBL626425,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12023,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,N,12497,,CHEMBL875476,10116.0,Intermediate,50597,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,12023,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,N,12498,,CHEMBL626426,9541.0,Intermediate,100710,1
,,,,,P,,0,,,,,BAO_0000100,10580,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,U,12499,,CHEMBL626427,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,10580,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,U,12500,,CHEMBL626428,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,16032,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,U,12501,,CHEMBL626429,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,16032,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,U,12502,,CHEMBL625025,,Autocuration,22224,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,12503,,CHEMBL625026,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,12504,,CHEMBL625027,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,12505,,CHEMBL874410,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,12506,,CHEMBL625028,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,12507,,CHEMBL625029,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,12508,,CHEMBL625030,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,12509,,CHEMBL625031,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,12510,,CHEMBL625032,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,12511,,CHEMBL625033,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,12512,,CHEMBL625034,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,12513,,CHEMBL624872,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,12514,,CHEMBL624873,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,12515,,CHEMBL624874,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,12516,,CHEMBL624875,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,12517,,CHEMBL624876,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,12518,,CHEMBL624877,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,12519,,CHEMBL624878,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,12520,,CHEMBL624879,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,12521,,CHEMBL624880,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,N,12522,,CHEMBL624881,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",N,12523,,CHEMBL624882,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,12524,,CHEMBL624883,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,12525,,CHEMBL624884,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,12526,,CHEMBL624885,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,12527,,CHEMBL624886,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,12528,,CHEMBL624887,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,12529,,CHEMBL624888,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,12530,,CHEMBL624889,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,12531,,CHEMBL624890,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,12532,,CHEMBL621964,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,12533,,CHEMBL621965,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,12534,,CHEMBL621966,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,12535,,CHEMBL621967,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,12536,,CHEMBL622164,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),U,12537,,CHEMBL623097,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),U,12538,,CHEMBL623098,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,U,12539,,CHEMBL623099,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,U,12540,,CHEMBL623100,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",N,12541,,CHEMBL628673,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",N,12542,,CHEMBL628674,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",N,12543,,CHEMBL628675,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",N,12544,,CHEMBL627644,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",N,12545,,CHEMBL627645,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",N,12546,,CHEMBL627646,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",N,12547,,CHEMBL627647,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",N,12548,,CHEMBL627648,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12902,Free level in rat plasma,N,12549,,CHEMBL627649,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,6614,Level reaching in blood plasma of rat or human was determined,U,12550,,CHEMBL628313,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9663,Log (Cbrain/Cblood) in rats,N,12551,,CHEMBL628314,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,17658,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,U,12552,,CHEMBL628315,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,17658,Mean percentage of compound transport through membrane; expressed as membrane transport,U,12553,,CHEMBL628316,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14314,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,U,12554,,CHEMBL628317,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7385,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,U,12555,,CHEMBL628473,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7385,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",U,12556,,CHEMBL628474,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7385,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,U,12557,,CHEMBL628475,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,1329,Net water uptake by a carrier mediated transport (%cm) mechanism,U,12558,,CHEMBL628476,,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,12187,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,12559,,CHEMBL628477,314293.0,Autocuration,22224,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,12560,,CHEMBL628478,9669.0,Intermediate,50506,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,12561,,CHEMBL628479,9669.0,Intermediate,50506,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,12562,,CHEMBL628480,314293.0,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",U,12563,,CHEMBL628481,314293.0,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,12564,,CHEMBL628482,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,12565,,CHEMBL628483,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,9278,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,12566,,CHEMBL628484,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,9278,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,12567,,CHEMBL628485,10116.0,Intermediate,50597,1
Plasma,,,,,A,Macaca fascicularis,1,,1969.0,,,BAO_0000218,9278,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",N,12568,,CHEMBL628486,9541.0,Intermediate,100710,1
Plasma,,,,,A,Homo sapiens,1,,1969.0,,,BAO_0000218,9278,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",N,12569,,CHEMBL628487,9606.0,Intermediate,50587,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,9278,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,12570,,CHEMBL628488,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,9278,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,12571,,CHEMBL628489,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,9278,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,12572,,CHEMBL628490,10116.0,Intermediate,50597,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,12573,,CHEMBL628491,9541.0,Intermediate,100710,1
,,,,,A,Macaca fascicularis,1,,,,,BAO_0000218,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,12574,,CHEMBL877507,9541.0,Intermediate,100710,1
,,,,,A,,0,,,,,BAO_0000218,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,U,12575,,CHEMBL628492,,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000019,12041,% metabolized in monkey S-9 after 2 hours (10 ug/mL),U,12576,,CHEMBL628493,314293.0,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000019,12041,% metabolized in monkey S-9 after 2 hours (1 ug/ml),U,12577,,CHEMBL628494,314293.0,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000019,12041,% metabolized in monkey S-9 after 2 hours (10 ug/ml),U,12578,,CHEMBL628495,314293.0,Autocuration,22224,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,6737,Permeability in Caco-2 assay at 10E-6,N,12579,,CHEMBL628496,9606.0,Intermediate,50587,1
Brain,,,,,A,,0,,955.0,,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,12580,,CHEMBL628497,,Autocuration,22224,1
Brain,,,,,A,,0,,955.0,,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,12581,,CHEMBL628498,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,5676,Plasma protein binding was determined,U,12582,,CHEMBL628499,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,U,12583,,CHEMBL627656,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,U,12584,,CHEMBL627657,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,U,12585,,CHEMBL626808,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,U,12586,,CHEMBL626809,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,U,12587,,CHEMBL626810,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,U,12588,,CHEMBL626811,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,U,12589,,CHEMBL874465,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,U,12590,,CHEMBL626812,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,U,12591,,CHEMBL626813,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,14793,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,U,12592,,CHEMBL626814,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14000,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,U,12593,,CHEMBL626815,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,5948,Partition coefficient (logP),U,12594,,CHEMBL628566,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,12595,,CHEMBL628567,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,10778,Calculated partition coefficient (clogP),U,12596,,CHEMBL628568,,Autocuration,22229,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,17237,C max in dog,N,12597,,CHEMBL628569,9615.0,Intermediate,50588,1
,,In vivo,,,A,Cavia porcellus,1,,,,,BAO_0000218,17237,C max in guinea pig,N,12598,,CHEMBL628570,10141.0,Intermediate,50512,1
,,In vivo,,,A,,0,,,,,BAO_0000218,2809,C max value was evaluated,U,12599,,CHEMBL628571,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Cmax value after oral dose of 0.1 mg//kg,U,12600,,CHEMBL628572,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Cmax value after oral dose of 0.3 mg/kg,U,12601,,CHEMBL628573,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Cmax value after oral dose of 1 mg/kg,U,12602,,CHEMBL628574,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Cmax value after oral dose of 10 mg/kg,U,12603,,CHEMBL628575,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Cmax value after oral dose of 23.4 mg/kg,U,12604,,CHEMBL628576,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Cmax value after oral dose of 3 mg/kg,U,12605,,CHEMBL628577,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Cmax value after oral dose of 3.87 mg/kg,U,12606,,CHEMBL628578,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12768,Cmax value in female Beagle dogs,N,12607,,CHEMBL874466,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12768,Cmax value in male rats,N,12608,,CHEMBL628579,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,12780,Cmax value in rat plasma when administered 20 mg/kg perorally,N,12609,,CHEMBL628580,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,12610,,CHEMBL628581,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,12611,,CHEMBL628582,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,17025,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,N,12612,,CHEMBL628583,9615.0,Intermediate,50588,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,17025,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,U,12613,,CHEMBL625782,314293.0,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,17025,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,N,12614,,CHEMBL625783,9986.0,Intermediate,50592,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17025,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,N,12615,,CHEMBL625784,10116.0,Intermediate,50597,1
Plasma,,,,,A,Macaca mulatta,1,,1969.0,,,BAO_0000218,4236,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,N,12616,,CHEMBL625785,9544.0,Intermediate,50797,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15791,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,N,12617,,CHEMBL625786,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,11149,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,U,12618,,CHEMBL874467,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,12619,,CHEMBL625787,9615.0,Intermediate,50588,1
,,,,,A,Human immunodeficiency virus,1,,,,,BAO_0000218,15778,cytotoxicity against HIV protease enzyme.,N,12620,,CHEMBL625964,12721.0,Intermediate,50677,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12745,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,N,12621,,CHEMBL625965,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12745,Apparent clearance in mice after oral administration of 100 mg/kg of dose,N,12622,,CHEMBL625966,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,13941,The plasma clearance in dog.,N,12623,,CHEMBL625967,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13941,The plasma clearance in rat.,N,12624,,CHEMBL625968,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,16449,Clearance from plasma in male Sprague-Dawley rats,N,12625,,CHEMBL625969,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Macaca fascicularis,1,,1969.0,,,BAO_0000218,16449,Clearance from plasma in male cynomolgus monkeys,N,12626,,CHEMBL625970,9541.0,Intermediate,100710,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14224,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",N,12627,,CHEMBL625971,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14224,Clearance of compound in dog plasma,N,12628,,CHEMBL625972,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Homo sapiens,1,,1969.0,,,BAO_0000218,14224,Clearance of compound in human plasma,N,12629,,CHEMBL625973,9606.0,Intermediate,50587,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14317,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,N,12630,,CHEMBL625974,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14317,Clearance of compound when administered intravenously as an individual dose to a single dog.,N,12631,,CHEMBL625975,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14224,"Clearance (10 mg/kg, intravenously) in dog plasma",N,12632,,CHEMBL625976,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,17237,Clearance value in dog,N,12633,,CHEMBL625977,9615.0,Intermediate,50588,1
,,In vivo,,,A,Cavia porcellus,1,,,,,BAO_0000218,17237,Clearance value in guinea pig,N,12634,,CHEMBL625978,10141.0,Intermediate,50512,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14187,Clearance values in rats after iv administration.,N,12635,,CHEMBL874468,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,4806,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,U,12636,,CHEMBL625421,,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,15025,In vivo clearance (5 mg/kg) was determined in rabbits,N,12637,,CHEMBL625422,9986.0,Intermediate,50592,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13197,Plasma Clearance rate was determined for the compound in rats,N,12638,,CHEMBL625423,10116.0,Intermediate,50597,1
,,In vivo,,,A,Saimiri,0,,,,,BAO_0000218,13197,Plasma Clearance rate was determined for the compound in squirrel monkeys,U,12639,,CHEMBL625424,9520.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13960,Plasma clearance in rat,N,12640,,CHEMBL625425,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,17820,Plasma clearance of the compound,U,12641,,CHEMBL625426,,Autocuration,22224,1
,,In vivo,,,A,Cavia porcellus,1,,,,,BAO_0000218,14706,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,N,12642,,CHEMBL625427,10141.0,Intermediate,50512,1
,,In vivo,,,A,Cavia porcellus,1,,,,,BAO_0000218,14706,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,N,12643,,CHEMBL625428,10141.0,Intermediate,50512,1
,,In vivo,,,A,,0,,,,,BAO_0000218,6504,Plasma clearance was determined,U,12644,,CHEMBL625429,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14925,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,N,12645,,CHEMBL625430,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13197,Plasma clearance rate was determined for the compound in rats,N,12646,,CHEMBL625431,10116.0,Intermediate,50597,1
,,In vivo,,,A,Saimiri,0,,,,,BAO_0000218,13197,Plasma clearance rate was determined for the compound in squirrel monkeys,U,12647,,CHEMBL627307,9520.0,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,3437,Slow clearance (CL) was determined,U,12648,,CHEMBL627308,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,12649,,CHEMBL627309,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,12650,,CHEMBL627310,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,12651,,CHEMBL627311,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,12652,,CHEMBL627312,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,12653,,CHEMBL627313,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,12654,,CHEMBL627314,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,12655,,CHEMBL627315,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,12656,,CHEMBL627316,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,12657,,CHEMBL627317,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,12658,,CHEMBL627318,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,12659,,CHEMBL627999,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,12660,,CHEMBL628000,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,12661,,CHEMBL628001,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,12662,,CHEMBL628002,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,12663,,CHEMBL625610,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,12664,,CHEMBL625611,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,12665,,CHEMBL625612,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,12666,,CHEMBL625613,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,12667,,CHEMBL875479,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,12668,,CHEMBL625614,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,12669,,CHEMBL625615,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,12670,,CHEMBL626302,,Autocuration,22224,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,12671,,CHEMBL626303,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8374,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,12672,,CHEMBL627420,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,N,12673,,CHEMBL627421,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,N,12674,,CHEMBL625695,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,N,12675,,CHEMBL625696,10116.0,Intermediate,50597,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,10009,Distribution of compound in mice brain was measured after 1 hr,N,12676,,CHEMBL875606,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,10009,Distribution of compound in mice brain was measured after 24 hr r,N,12677,,CHEMBL625697,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,10009,Distribution of compound in mice brain was measured after 2 hr,N,12678,,CHEMBL625698,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,10009,Distribution of compound in mice brain was measured after 3 hr,N,12679,,CHEMBL625699,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,10009,Distribution of compound in mice brain was measured after 6 hr,N,12680,,CHEMBL625700,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,10009,Distribution of compound in mice liver was measured after 1 hr,N,12681,,CHEMBL625701,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,10009,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,N,12682,,CHEMBL625702,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,10009,Distribution of compound in mice liver was measured after 2 hr,N,12683,,CHEMBL625703,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,10009,Distribution of compound in mice liver was measured after 3 hr,N,12684,,CHEMBL625704,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,10009,Distribution of compound in mice liver was measured after 6 hr,N,12685,,CHEMBL625705,10090.0,Intermediate,50594,1
Adrenal medulla,,,,,A,Canis lupus familiaris,1,,1236.0,,,BAO_0000218,8170,Distribution in dog adrenal medulla 30 min after administration.,N,12686,,CHEMBL625706,9615.0,Intermediate,50588,1
Adrenal medulla,,,,,A,Canis lupus familiaris,1,,1236.0,,,BAO_0000218,8170,Distribution in dog adrenal medulla 72 hours after administration.,N,12687,,CHEMBL625707,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog Ovary 24 hours after administration.,N,12688,,CHEMBL625708,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog Ovary 72 hours after administration.,N,12689,,CHEMBL625709,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog adipose 24 hours after administration.,N,12690,,CHEMBL624180,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog adipose 72 hours after administration.,N,12691,,CHEMBL624181,9615.0,Intermediate,50588,1
Adrenal cortex,,,,,A,Canis lupus familiaris,1,,1235.0,,,BAO_0000218,8170,Distribution in female dog adrenal cortex 72 hours after administration.,N,12692,,CHEMBL624182,9615.0,Intermediate,50588,1
Adrenal cortex,,,,,A,Canis lupus familiaris,1,,1235.0,,,BAO_0000218,8170,Distribution in female dog adrenal cortex 72 hours after administration.,N,12693,,CHEMBL624183,9615.0,Intermediate,50588,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,12694,,CHEMBL624184,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,12695,,CHEMBL877489,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,12696,,CHEMBL624185,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,12697,,CHEMBL624186,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,12698,,CHEMBL624187,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,12699,,CHEMBL624188,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,12700,,CHEMBL624189,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,12701,,CHEMBL624190,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,12702,,CHEMBL624191,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,12703,,CHEMBL624192,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,12704,,CHEMBL624193,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,12705,,CHEMBL624194,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,12706,,CHEMBL624891,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,12707,,CHEMBL624892,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,12708,,CHEMBL624893,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,12709,,CHEMBL627632,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,12710,,CHEMBL627633,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,12711,,CHEMBL627634,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,12712,,CHEMBL627635,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,12713,,CHEMBL627636,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,12714,,CHEMBL626816,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,12715,,CHEMBL626817,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,12716,,CHEMBL626818,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,12717,,CHEMBL626819,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,12718,,CHEMBL626820,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,12719,,CHEMBL626821,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,12720,,CHEMBL626822,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,12721,,CHEMBL626823,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,12722,,CHEMBL626824,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,12723,,CHEMBL626825,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,12724,,CHEMBL626826,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,12725,,CHEMBL626827,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,12726,,CHEMBL626828,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,12727,,CHEMBL626829,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,12728,,CHEMBL626830,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,12729,,CHEMBL627150,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,12730,,CHEMBL627151,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,12731,,CHEMBL627152,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,12732,,CHEMBL627153,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,12904,Rate of acetate production by the compound was determined,U,12733,,CHEMBL627154,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12904,Rate of acetate production by the compound was determined; Not determined,U,12734,,CHEMBL627155,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3730,Rate of hydrolysis of nitrocefin by compound was evaluated in water,U,12735,,CHEMBL627156,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3627,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,U,12736,,CHEMBL627157,,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,13799,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,12737,,CHEMBL627158,9986.0,Intermediate,50592,1
Plasma,,,,,A,Oryctolagus cuniculus,1,,1969.0,,,BAO_0000218,13799,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,12738,,CHEMBL627159,9986.0,Intermediate,50592,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13799,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,12739,,CHEMBL627160,10090.0,Intermediate,50594,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13799,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,12740,,CHEMBL628540,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13799,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,12741,,CHEMBL628541,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13799,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,12742,,CHEMBL628542,10116.0,Intermediate,50597,1
,,,,,P,,0,,,,,BAO_0000100,6629,Solubility after at a pH 1.2,U,12743,,CHEMBL628543,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6629,Solubility after at pH 1.2,U,12744,,CHEMBL628544,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6629,Solubility after injection of water,U,12745,,CHEMBL628545,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,14000,Statistical significance of IC 50 values; Expressed as R value,U,12746,,CHEMBL628546,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8267,Systemic availability with respect to methyldopa was determined,U,12747,,CHEMBL874455,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13799,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,N,12748,,CHEMBL628547,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,13799,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,N,12749,,CHEMBL628548,10116.0,Intermediate,50597,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",N,12750,,CHEMBL628549,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",N,12751,,CHEMBL628550,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",N,12752,,CHEMBL628551,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",N,12753,,CHEMBL628552,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",N,12754,,CHEMBL628553,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",N,12755,,CHEMBL628554,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",N,12756,,CHEMBL628555,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",N,12757,,CHEMBL628556,9986.0,Intermediate,50592,1
Kidney,,,,,A,Oryctolagus cuniculus,1,,2113.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",N,12758,,CHEMBL628557,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",N,12759,,CHEMBL628558,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",N,12760,,CHEMBL628559,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",N,12761,,CHEMBL628560,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",N,12762,,CHEMBL874456,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",N,12763,,CHEMBL628561,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",N,12764,,CHEMBL628562,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",N,12765,,CHEMBL628563,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",N,12766,,CHEMBL628564,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",N,12767,,CHEMBL628565,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",N,12768,,CHEMBL631248,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",N,12769,,CHEMBL631249,9986.0,Intermediate,50592,1
Kidney,,,,,A,Oryctolagus cuniculus,1,,2113.0,,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",N,12770,,CHEMBL627214,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",N,12771,,CHEMBL874591,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",N,12772,,CHEMBL627215,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,N,12773,,CHEMBL625471,9986.0,Intermediate,50592,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,N,12774,,CHEMBL625472,9986.0,Intermediate,50592,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,N,12775,,CHEMBL625473,9986.0,Intermediate,50592,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13317,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,N,12776,,CHEMBL625474,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15341,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,N,12777,,CHEMBL625475,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15341,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,N,12778,,CHEMBL625476,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15341,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,N,12779,,CHEMBL625477,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15341,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,N,12780,,CHEMBL625478,10116.0,Intermediate,50597,1
esophageal tunica muscularis mucosae,,In vitro,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12801,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,N,12781,,CHEMBL625479,10116.0,Intermediate,50597,1
esophageal tunica muscularis mucosae,,In vitro,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12801,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,N,12782,,CHEMBL625480,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14856,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,N,12783,,CHEMBL625481,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14062,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,N,12784,,CHEMBL625482,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14062,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,N,12785,,CHEMBL625483,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14062,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,N,12786,,CHEMBL625484,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14062,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,N,12787,,CHEMBL625485,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,N,12788,,CHEMBL625486,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,N,12789,,CHEMBL625487,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,N,12790,,CHEMBL625488,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,N,12791,,CHEMBL625489,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,N,12792,,CHEMBL625490,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,N,12793,,CHEMBL625491,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,N,12794,,CHEMBL625492,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Homo sapiens,1,,1969.0,,,BAO_0000218,15711,plasma clearance in human,N,12795,,CHEMBL625493,9606.0,Intermediate,50587,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14886,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,12796,,CHEMBL625494,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14886,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,12797,,CHEMBL625495,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14886,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,12798,,CHEMBL625496,10116.0,Intermediate,50597,1
,,,,,P,,0,,,,,BAO_0000100,4115,1-Octanol/water partition coefficient measured at 7.4,U,12799,,CHEMBL625497,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,13733,Calculated partition coefficient (clogP),U,12800,,CHEMBL625498,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,12102,Partition coefficient (logP),U,12801,,CHEMBL625499,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,12676,Calculated partition coefficient (clogP),U,12802,,CHEMBL625500,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,13733,Calculated partition coefficient (clogP),U,12803,,CHEMBL625501,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,13740,Calculated partition coefficient (clogP),U,12804,,CHEMBL625502,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,12766,Calculated partition coefficient (clogP) (relative to BAY K 8644),U,12805,,CHEMBL625503,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,2764,Calculated partition coefficient (clogP),U,12806,,CHEMBL625504,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,12355,Calculated partition coefficient (clogP),U,12807,,CHEMBL625505,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,11314,Calculated partition coefficient of the compound,U,12808,,CHEMBL625506,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,12706,Partition coefficient (logP),U,12809,,CHEMBL625507,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,12645,Calculated partition coefficient (clogP),U,12810,,CHEMBL625508,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,13668,Calculated partition coefficient (clogP),U,12811,,CHEMBL625509,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,12819,Calculated partition coefficient (clogP),U,12812,,CHEMBL625510,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,13668,Calculated partition coefficient (clogP),U,12813,,CHEMBL883125,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,13017,Calculated partition coefficient (clogP),U,12814,,CHEMBL625511,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,2448,Partition coefficient of the compound,U,12815,,CHEMBL874650,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11526,Partition coefficient of the compound,U,12816,,CHEMBL625512,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12426,Partition coefficient of compound was determined,U,12817,,CHEMBL625513,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2448,Partition coefficient was determined,U,12818,,CHEMBL625514,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,12001,Calculated partition coefficient (clogP),U,12819,,CHEMBL625515,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,12426,partition coefficient of compound was determined,U,12820,,CHEMBL625516,,Autocuration,22229,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13204,The total body administered intravenously in dog,N,12821,,CHEMBL625517,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13204,The total body administered intravenously in rats,N,12822,,CHEMBL625518,10116.0,Intermediate,50597,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13889,Time taken for the administration to female NIH mice weighing 25-30 g.,N,12823,,CHEMBL625519,10090.0,Intermediate,50594,1
,,,,,A,,0,,,,,BAO_0000019,13889,Time taken for the administration,U,12824,,CHEMBL625520,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,17025,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,N,12825,,CHEMBL874651,9615.0,Intermediate,50588,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,17025,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,U,12826,,CHEMBL625521,314293.0,Autocuration,22224,1
,,In vivo,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,17025,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,12827,,CHEMBL623171,9986.0,Intermediate,50592,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,17025,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,N,12828,,CHEMBL623853,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,15067,Plasma clearance for the compound was determined.,U,12829,,CHEMBL623854,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,3091,CLog P value of the compound,U,12830,,CHEMBL874405,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,15592,Calculated partition coefficient (clogP),U,12831,,CHEMBL623855,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,14738,Calculated partition coefficient (clogP),U,12832,,CHEMBL623856,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,14738,ClogP value of the compound; nd ='no data',U,12833,,CHEMBL623857,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,14738,ClogP value of the compound; nd ='not determined',U,12834,,CHEMBL623858,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,6076,CLog P was determined,U,12835,,CHEMBL623859,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,17840,Calculated partition coefficient (clogP),U,12836,,CHEMBL839829,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,13589,CLogP was calculated,U,12837,,CHEMBL623860,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,17655,CLogP value was determined,U,12838,,CHEMBL623861,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,5867,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,U,12839,,CHEMBL623862,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,5867,Calculated partition coefficient (clogP),U,12840,,CHEMBL874406,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,10783,Calculated partition coefficient (clogP),U,12841,,CHEMBL623863,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,14849,Calculated partition coefficient (clogP),U,12842,,CHEMBL624021,,Autocuration,22229,1
Adrenal medulla,,,,,A,Canis lupus familiaris,1,,1236.0,,,BAO_0000218,8170,Distribution in female dog adrenal medulla 24 hours after administration.,N,12843,,CHEMBL624022,9615.0,Intermediate,50588,1
Adrenal medulla,,,,,A,Canis lupus familiaris,1,,1236.0,,,BAO_0000218,8170,Distribution in female dog adrenal medulla 72 hours after administration.,N,12844,,CHEMBL624023,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog bile 24 hours after administration.,N,12845,,CHEMBL624024,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog bile 72 hr after administration.,N,12846,,CHEMBL624025,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog blood 24 hours after administration.,N,12847,,CHEMBL624026,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog blood 72 hours after administration.,N,12848,,CHEMBL624027,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog heart 24 hours after administration.,N,12849,,CHEMBL624028,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog heart 72 hours after administration.,N,12850,,CHEMBL624029,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog kidney 24 hours after administration.,N,12851,,CHEMBL624030,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog kidney 72 hours after administration.,N,12852,,CHEMBL624031,9615.0,Intermediate,50588,1
Intestine,,,,,A,Canis lupus familiaris,1,,160.0,,,BAO_0000218,8170,Distribution in female dog large intestine 24 hours after administration.,N,12853,,CHEMBL624032,9615.0,Intermediate,50588,1
Intestine,,,,,A,Canis lupus familiaris,1,,160.0,,,BAO_0000218,8170,Distribution in female dog large intestine 72 hours after administration.,N,12854,,CHEMBL874407,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog liver 24 hours after administration.,N,12855,,CHEMBL624033,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog liver 72 hours after administration.,N,12856,,CHEMBL624034,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog lung 24 hours after administration.,N,12857,,CHEMBL624035,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog lung 72 hours after administration.,N,12858,,CHEMBL624036,9615.0,Intermediate,50588,1
Muscle tissue,,,,,A,Canis lupus familiaris,1,,2385.0,,,BAO_0000218,8170,Distribution in female dog muscle 24 hours after administration.,N,12859,,CHEMBL624037,9615.0,Intermediate,50588,1
Muscle tissue,,,,,A,Canis lupus familiaris,1,,2385.0,,,BAO_0000218,8170,Distribution in female dog muscle 72 hours after administration.,N,12860,,CHEMBL624038,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog pancreas 24 hours after administration.,N,12861,,CHEMBL624039,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8170,Distribution in female dog pancreas 72 hours after administration.,N,12862,,CHEMBL624040,9615.0,Intermediate,50588,1
Intestine,,,,,A,Canis lupus familiaris,1,,160.0,,,BAO_0000218,8170,Distribution in female dog small intestine 24 hours after administration.,N,12863,,CHEMBL624041,9615.0,Intermediate,50588,1
Intestine,,,,,A,Canis lupus familiaris,1,,160.0,,,BAO_0000218,8170,Distribution in female dog small intestine 72 hours after administration.,N,12864,,CHEMBL624042,9615.0,Intermediate,50588,1
Spleen,,,,,A,Canis lupus familiaris,1,,2106.0,,,BAO_0000218,8170,Distribution in female dog spleen 24 hours after administration.,N,12865,,CHEMBL624043,9615.0,Intermediate,50588,1
Spleen,,,,,A,Canis lupus familiaris,1,,2106.0,,,BAO_0000218,8170,Distribution in female dog spleen 72 hours after administration.,N,12866,,CHEMBL624044,9615.0,Intermediate,50588,1
Stomach,,,,,A,Canis lupus familiaris,1,,945.0,,,BAO_0000218,8170,Distribution in female dog stomach 24 hours after administration.,N,12867,,CHEMBL624045,9615.0,Intermediate,50588,1
Stomach,,,,,A,Canis lupus familiaris,1,,945.0,,,BAO_0000218,8170,Distribution in female dog stomach 72 hours after administration.,N,12868,,CHEMBL624046,9615.0,Intermediate,50588,1
Thyroid gland,,,,,A,Canis lupus familiaris,1,,2046.0,,,BAO_0000218,8170,Distribution in female dog thyroid 24 hours after administration.,N,12869,,CHEMBL624047,9615.0,Intermediate,50588,1
Thyroid gland,,,,,A,Canis lupus familiaris,1,,2046.0,,,BAO_0000218,8170,Distribution in female dog thyroid 72 hours after administration.,N,12870,,CHEMBL624048,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8170,Distribution in female dog urine 24 hours after administration.,N,12871,,CHEMBL874408,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8170,Distribution in female dog urine 72 hr after administration.,N,12872,,CHEMBL624049,9615.0,Intermediate,50588,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000218,14283,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,U,12873,,CHEMBL624050,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,5623,Plasma concentration at 7 hr after intravenous dosing,U,12874,,CHEMBL624051,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,N,12875,,CHEMBL623278,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,N,12876,,CHEMBL623279,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 1 hr in rats,N,12877,,CHEMBL623280,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 2 hr in rats,N,12878,,CHEMBL623963,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 4 hr in rats,N,12879,,CHEMBL623964,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 6 hr in rats,N,12880,,CHEMBL623965,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,N,12881,,CHEMBL623966,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,N,12882,,CHEMBL874415,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,N,12883,,CHEMBL623967,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,N,12884,,CHEMBL623968,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,N,12885,,CHEMBL623969,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,N,12886,,CHEMBL628409,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,N,12887,,CHEMBL628410,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,N,12888,,CHEMBL628411,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,N,12889,,CHEMBL628412,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,12553,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,U,12890,,CHEMBL628413,,Autocuration,22224,1
Plasma,,,,,A,,0,,1969.0,,,BAO_0000019,14548,The concentration in plasmat; Not determined,U,12891,,CHEMBL628414,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in blood,N,12892,,CHEMBL628415,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in brown fat,N,12893,,CHEMBL628416,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in heart,N,12894,,CHEMBL628417,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in liver,N,12895,,CHEMBL874908,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in plasma,N,12896,,CHEMBL628418,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,N,12897,,CHEMBL628419,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,N,12898,,CHEMBL628420,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,1629,Water solubility at 37 degree C.,U,12899,,CHEMBL628421,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,12900,,CHEMBL626726,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,12901,,CHEMBL626727,,Autocuration,22229,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,12902,,CHEMBL626728,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,12903,,CHEMBL626729,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,12904,,CHEMBL626730,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,12905,,CHEMBL626731,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,12906,,CHEMBL626732,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,12907,,CHEMBL626733,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,12908,,CHEMBL626734,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,12909,,CHEMBL626735,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,12910,,CHEMBL874909,10116.0,Intermediate,50597,1
Heart,,,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,12911,,CHEMBL626736,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,12912,,CHEMBL626737,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,12913,,CHEMBL630999,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,12914,,CHEMBL631000,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,12915,,CHEMBL631001,10116.0,Intermediate,50597,1
Kidney,,,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,12916,,CHEMBL631002,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,12917,,CHEMBL631003,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,12918,,CHEMBL631004,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,12919,,CHEMBL631005,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,12920,,CHEMBL631006,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,12921,,CHEMBL631007,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,12922,,CHEMBL631008,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,12923,,CHEMBL631009,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,12924,,CHEMBL631010,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,12925,,CHEMBL631011,10116.0,Intermediate,50597,1
Lung,,,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,12926,,CHEMBL631012,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,12927,,CHEMBL630271,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,12928,,CHEMBL630272,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,12929,,CHEMBL630273,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,12930,,CHEMBL630274,10116.0,Intermediate,50597,1
Thyroid gland,,,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,12931,,CHEMBL630275,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,N,12932,,CHEMBL875782,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,N,12933,,CHEMBL630276,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,N,12934,,CHEMBL630277,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,N,12935,,CHEMBL630278,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,N,12936,,CHEMBL630279,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,U,12937,,CHEMBL630280,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,12938,,CHEMBL630281,,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,N,12939,,CHEMBL630282,9986.0,Intermediate,50592,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,N,12940,,CHEMBL630283,9986.0,Intermediate,50592,1
,,,,,A,,0,,,,,BAO_0000019,5797,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),U,12941,,CHEMBL630284,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7849,Alkylating activity was determined,U,12942,,CHEMBL630285,,Autocuration,22224,1
,,,,,A,,0,Microsomes,,,,BAO_0000251,14220,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),U,12943,,CHEMBL630286,,Autocuration,22224,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,8650,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",N,12944,,CHEMBL630069,9986.0,Intermediate,50592,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",N,12945,,CHEMBL630070,9986.0,Intermediate,50592,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",N,12946,,CHEMBL630071,9986.0,Intermediate,50592,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",N,12947,,CHEMBL630072,9986.0,Intermediate,50592,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",N,12948,,CHEMBL875110,9986.0,Intermediate,50592,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7116,Compound was tested for antidiuretic activity in rats,N,12949,,CHEMBL630073,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,14131,Compound was tested for inactivation kinetic values,U,12950,,CHEMBL630074,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,7415,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,U,12951,,CHEMBL630075,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13178,Dissociation rate calculated from the first-order equation using the t1/2 value,U,12952,,CHEMBL630076,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,8815,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,U,12953,,CHEMBL630077,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,1450,Aqueous solubility was measured,U,12954,,CHEMBL630078,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,1450,Aqueous solubility was measured at a pH 4,U,12955,,CHEMBL630079,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,1450,Aqueous solubility (pH 7),U,12956,,CHEMBL630080,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,1450,Aqueous solubility was measured at a pH 9,U,12957,,CHEMBL630081,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",U,12958,,CHEMBL630082,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,12959,,CHEMBL630083,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,12960,,CHEMBL630084,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,15032,Aqueous solubility of the compound,U,12961,,CHEMBL629198,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,9964,Aqueous solubility at 37 degree Celsius at pH 7.38,U,12962,,CHEMBL629199,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,14962,Aqueous solubility in pH 7.4 phosphate buffer,U,12963,,CHEMBL629200,,Autocuration,22229,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12487,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,N,12964,,CHEMBL629201,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12487,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,N,12965,,CHEMBL629202,9615.0,Intermediate,50588,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,10026,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,N,12966,,CHEMBL875111,9606.0,Intermediate,50587,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,10026,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,N,12967,,CHEMBL629203,9606.0,Intermediate,50587,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,10026,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,N,12968,,CHEMBL629204,9606.0,Intermediate,50587,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,10026,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,N,12969,,CHEMBL629205,9606.0,Intermediate,50587,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,10026,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,N,12970,,CHEMBL629206,9606.0,Intermediate,50587,1
,,,,,A,,0,,,,,BAO_0000019,10026,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,U,12971,,CHEMBL631185,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7415,Compound was evaluated for the average bile flow rat in rats,N,12972,,CHEMBL631186,10116.0,Intermediate,50597,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,17025,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,12973,,CHEMBL631187,9986.0,Intermediate,50592,1
,,,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,17025,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,12974,,CHEMBL631188,9986.0,Intermediate,50592,1
,,,,,A,,0,,,,,BAO_0000019,10184,Average half life period was determined,U,12975,,CHEMBL876419,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10184,Average half life period was determined,U,12976,,CHEMBL631189,,Autocuration,22224,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,12977,,CHEMBL631190,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,12978,,CHEMBL631191,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,N,12979,,CHEMBL631192,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,N,12980,,CHEMBL632400,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,12981,,CHEMBL630564,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,12982,,CHEMBL630565,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,N,12983,,CHEMBL630566,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,N,12984,,CHEMBL631229,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,N,12985,,CHEMBL631230,10298.0,Intermediate,50602,1
,,,,,P,,0,,,,,BAO_0000100,6030,Calculated partition coefficient (clogP),U,12986,,CHEMBL876428,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6147,Calculated partition coefficient (clogP),U,12987,,CHEMBL631231,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,14556,Calculated partition coefficient (clogP) (MacLogP),U,12988,,CHEMBL631232,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,768,Hydrophilicity was determined,U,12989,,CHEMBL631233,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,14452,Calculated partition coefficient (clogP),U,12990,,CHEMBL631234,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,5237,Increased absorption was determined,U,12991,,CHEMBL883126,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,14378,Lipophilicity value was evaluated,U,12992,,CHEMBL631235,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,14418,Log P value of the compound.,U,12993,,CHEMBL631236,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,5249,Partition coefficient of compound was determined,U,12994,,CHEMBL631237,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,14621,Calculated partition coefficient (clogP),U,12995,,CHEMBL631238,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,12542,Calculated partition coefficient (clogP),U,12996,,CHEMBL876429,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,12542,Partition coefficient was measured by medchem software; Not calculated,U,12997,,CHEMBL631414,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,12542,Partition coefficient was measured by octanol-water using standard shake-flask method,U,12998,,CHEMBL631415,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,15462,Calculated partition coefficient (clogP),U,12999,,CHEMBL631416,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,14884,Partition coefficient (logP),U,13000,,CHEMBL631417,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,16526,Calculated partition coefficient (clogP),U,13001,,CHEMBL631418,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,13693,The Octanol/Water partition coefficient CLogP,U,13002,,CHEMBL631419,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,13693,The pharmacokinetic parameter C Log p was reported,U,13003,,CHEMBL631420,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,13779,Calculated partition coefficient (clogP),U,13004,,CHEMBL631421,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,14772,Calculated partition coefficient (clogP),U,13005,,CHEMBL631422,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,14393,Calculated partition coefficient (clogP),U,13006,,CHEMBL631423,,Autocuration,22229,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,13007,,CHEMBL876430,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,N,13008,,CHEMBL631424,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,13744,Compound was administered intravenously in dog to evaluate plasma clearance values,N,13009,,CHEMBL631425,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Simiiformes,0,,1969.0,,,BAO_0000218,13744,Compound was administered intravenously in monkey to evaluate plasma clearance values,U,13010,,CHEMBL631426,314293.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Mus musculus,1,,1969.0,,,BAO_0000218,13744,Compound was administered intravenously in mouse to evaluate plasma clearance values,N,13011,,CHEMBL631427,10090.0,Intermediate,50594,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,13207,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,N,13012,,CHEMBL631428,9615.0,Intermediate,50588,1
Liver,,In vitro,,,A,Macaca mulatta,1,Microsomes,2107.0,,,BAO_0000218,5669,Intrinsic clearance in Rhesus liver microsome,N,13013,,CHEMBL631429,9544.0,Intermediate,50797,1
Liver,,In vitro,,,A,Canis lupus familiaris,1,Microsomes,2107.0,,,BAO_0000218,5669,Intrinsic clearance in dog liver microsome,N,13014,,CHEMBL631430,9615.0,Intermediate,50588,1
Liver,,In vitro,,,A,Rattus norvegicus,1,Microsomes,2107.0,,,BAO_0000218,5669,Intrinsic clearance in rat liver microsome,N,13015,,CHEMBL631431,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Macaca mulatta,1,,1969.0,,,BAO_0000218,4853,Low plasma clearance was calculated in rhesus monkey,N,13016,,CHEMBL631432,9544.0,Intermediate,50797,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,N,13017,,CHEMBL631433,9615.0,Intermediate,50588,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Plasma clearance after intravenous dose of 0.3 mg/kg,U,13018,,CHEMBL631434,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Plasma clearance after intravenous dose of 1 mg/kg,U,13019,,CHEMBL631435,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Plasma clearance after intravenous dose of 3 mg/kg,U,13020,,CHEMBL631436,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,11954,Plasma clearance after intravenous dose of 3.87 mg/kg,U,13021,,CHEMBL631437,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5669,Plasma clearance after peroral administration at 10 mpk in Rat,N,13022,,CHEMBL631438,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca mulatta,1,,,,,BAO_0000218,5669,Plasma clearance after peroral administration at 10 mpk in Rhesus,N,13023,,CHEMBL876431,9544.0,Intermediate,50797,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,5669,Plasma clearance after peroral administration at 10 mpk in dog,N,13024,,CHEMBL631439,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13662,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,N,13025,,CHEMBL631440,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,8272,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),U,13026,,CHEMBL631441,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13410,Critical Micellar concentration was determined,U,13027,,CHEMBL631442,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13410,Critical Micellar concentration of the compound. was determined,U,13028,,CHEMBL626525,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12628,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,U,13029,,CHEMBL627168,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9675,Critical micellar concentration was measured in water by the dye solubilization method,U,13030,,CHEMBL875618,,Autocuration,22224,1
,,,,,B,,0,,,,,BAO_0000019,12628,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,U,13031,,CHEMBL626612,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12766,CMR value (relative to BAY K 8644),U,13032,,CHEMBL626613,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7849,Carbamoylating activity was determined,U,13033,,CHEMBL626614,,Autocuration,22224,1
,,,,,A,Simiiformes,0,,,,,BAO_0000218,12187,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,U,13034,,CHEMBL626615,314293.0,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2040,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,U,13035,,CHEMBL626616,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2040,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,U,13036,,CHEMBL626617,,Autocuration,22224,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,14180,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,N,13037,,CHEMBL626618,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14180,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,N,13038,,CHEMBL626619,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14474,"Clearance rate at 0.46 mg/kg, iv, in dogs",N,13039,,CHEMBL626620,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14474,"Clearance rate at 5.5 mg/kg, iv, in rat",N,13040,,CHEMBL626621,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,13041,,CHEMBL626622,9541.0,Intermediate,100710,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,13042,,CHEMBL626623,9541.0,Intermediate,100710,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,13043,,CHEMBL626624,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14548,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,13044,,CHEMBL626625,10116.0,Intermediate,50597,1
Liver,,Ex vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,6125,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,13045,,CHEMBL626626,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,6874,Tested for the total clearance of the compound,U,13046,,CHEMBL626627,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15343,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,N,13047,,CHEMBL626628,9615.0,Intermediate,50588,1
,,In vivo,,,A,,0,,,,,BAO_0000218,6236,Total body clearance was determined,U,13048,,CHEMBL626629,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,13049,,CHEMBL626630,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,13050,,CHEMBL626631,10116.0,Intermediate,50597,1
,,,,,P,,0,,,,,BAO_0000100,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,13051,,CHEMBL626632,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,8194,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,13052,,CHEMBL626633,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,8194,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,U,13053,,CHEMBL626634,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,13054,,CHEMBL626635,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,13055,,CHEMBL626636,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,13056,,CHEMBL626637,,Autocuration,22229,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),N,13057,,CHEMBL626638,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,N,13058,,CHEMBL626639,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,N,13059,,CHEMBL626640,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,N,13060,,CHEMBL626641,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,N,13061,,CHEMBL627272,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,N,13062,,CHEMBL627273,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),N,13063,,CHEMBL627441,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),N,13064,,CHEMBL628355,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),N,13065,,CHEMBL628356,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),N,13066,,CHEMBL628357,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),N,13067,,CHEMBL628358,4754.0,Intermediate,50339,1
,,,,,A,Pneumocystis carinii,1,,,,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),N,13068,,CHEMBL622307,4754.0,Intermediate,50339,1
,,,,,A,,0,,,,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,U,13069,,CHEMBL622527,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,U,13070,,CHEMBL622528,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,U,13071,,CHEMBL622529,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,U,13072,,CHEMBL622992,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,U,13073,,CHEMBL622993,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,U,13074,,CHEMBL622994,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10633,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",N,13075,,CHEMBL622995,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10633,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",N,13076,,CHEMBL622996,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10633,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",N,13077,,CHEMBL622997,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10633,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",N,13078,,CHEMBL622998,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000218,5767,Cp max following ip administration at 1 mg/kg,U,13079,,CHEMBL622999,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,3302,Maximum concentration in plasma was reported at 0.5 hour,U,13080,,CHEMBL623000,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,3302,Maximum concentration in plasma was reported at 2 hour,U,13081,,CHEMBL623001,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12467,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,N,13082,,CHEMBL623002,10090.0,Intermediate,50594,1
,,,,,P,,0,,,,,BAO_0000100,11778,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),U,13083,,CHEMBL623003,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,4321,Steady state concentration was evaluated,U,13084,,CHEMBL623004,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14884,Partition coefficient (logP),U,13085,,CHEMBL623005,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15234,Partition coefficient (logD7.4),U,13086,,CHEMBL623006,,Autocuration,22224,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,14198,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,N,13087,,CHEMBL623007,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,N,13088,,CHEMBL623008,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,13089,,CHEMBL876654,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,N,13090,,CHEMBL623009,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,N,13091,,CHEMBL623010,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,N,13092,,CHEMBL623011,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,N,13093,,CHEMBL623012,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,U,13094,,CHEMBL623013,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,13095,,CHEMBL623014,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,U,13096,,CHEMBL623015,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,U,13097,,CHEMBL623016,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,U,13098,,CHEMBL624858,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,N,13099,,CHEMBL624859,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,13100,,CHEMBL624860,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,13101,,CHEMBL624861,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,N,13102,,CHEMBL624862,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,N,13103,,CHEMBL624863,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,13104,,CHEMBL876655,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,13105,,CHEMBL624864,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,13106,,CHEMBL624865,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,13107,,CHEMBL624866,9615.0,Intermediate,50588,1
,,,,,F,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,N,13108,,CHEMBL624867,9615.0,Expert,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,13109,,CHEMBL624868,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,N,13110,,CHEMBL628450,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,13111,,CHEMBL628451,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,13112,,CHEMBL628452,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,13113,,CHEMBL628453,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,N,13114,,CHEMBL628454,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,13115,,CHEMBL628455,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,13116,,CHEMBL628456,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,13117,,CHEMBL628457,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,N,13118,,CHEMBL877505,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,N,13119,,CHEMBL628458,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,13120,,CHEMBL628459,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,13121,,CHEMBL628460,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,13122,,CHEMBL628461,9615.0,Intermediate,50588,1
,,,,,B,,0,,,,,BAO_0000218,6996,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",U,13123,,CHEMBL628462,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,13124,,CHEMBL628463,9615.0,Intermediate,50588,1
,,,,,F,Rattus norvegicus,1,,,,,BAO_0000218,6996,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",N,13125,,CHEMBL625666,10116.0,Expert,50597,1
,,,,,B,,0,,,,,BAO_0000218,6996,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,U,13126,,CHEMBL625667,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,13127,,CHEMBL625668,10116.0,Expert,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,13128,,CHEMBL625669,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,7114,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,U,13129,,CHEMBL625670,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7114,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,N,13130,,CHEMBL625671,10116.0,Intermediate,50597,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,N,13131,,CHEMBL625672,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,N,13132,,CHEMBL625673,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,N,13133,,CHEMBL625674,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,N,13134,,CHEMBL625675,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,13135,,CHEMBL627637,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,N,13136,,CHEMBL627638,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,N,13137,,CHEMBL627639,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,N,13138,,CHEMBL627640,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,N,13139,,CHEMBL627641,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,13140,,CHEMBL627642,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,13141,,CHEMBL877506,10298.0,Intermediate,50602,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,13142,,CHEMBL627275,10090.0,Intermediate,50594,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,11219,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",N,13143,,CHEMBL627643,9669.0,Intermediate,50506,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,11219,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,13144,,CHEMBL631246,9669.0,Intermediate,50506,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,11219,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,13145,,CHEMBL631247,9669.0,Intermediate,50506,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,13146,,CHEMBL629532,9669.0,Intermediate,50506,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,N,13147,,CHEMBL629533,9669.0,Intermediate,50506,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,13148,,CHEMBL629534,9669.0,Intermediate,50506,1
,,,,,A,Mustela putorius furo,1,,,,,BAO_0000218,11219,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,N,13149,,CHEMBL629535,9669.0,Intermediate,50506,1
,,,,,A,,0,,,,,BAO_0000019,14837,Pharmacokinetic parameter :drug bound to plasma was reported,U,13150,,CHEMBL625932,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14837,compound was evaluated for drug bound in plasma,U,13151,,CHEMBL625933,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15343,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,N,13152,,CHEMBL625934,10116.0,Intermediate,50597,1
,,,,,A,Eutheria,0,,,,,BAO_0000218,13761,Bioavailability,U,13153,,CHEMBL625935,9347.0,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,N,13154,,CHEMBL625936,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,N,13155,,CHEMBL625937,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13249,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,13156,,CHEMBL625938,9615.0,Intermediate,50588,1
Bile,,,,,A,Rattus norvegicus,1,,1970.0,,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,N,13157,,CHEMBL625939,10116.0,Intermediate,50597,1
Bile,,,,,A,Rattus norvegicus,1,,1970.0,,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,N,13158,,CHEMBL625940,10116.0,Intermediate,50597,1
Bile,,,,,A,Rattus norvegicus,1,,1970.0,,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,N,13159,,CHEMBL874464,10116.0,Intermediate,50597,1
Bile,,,,,A,Rattus norvegicus,1,,1970.0,,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,N,13160,,CHEMBL625941,10116.0,Intermediate,50597,1
Bile,,,,,A,Rattus norvegicus,1,,1970.0,,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,N,13161,,CHEMBL625942,10116.0,Intermediate,50597,1
Bile,,,,,A,Rattus norvegicus,1,,1970.0,,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,N,13162,,CHEMBL625943,10116.0,Intermediate,50597,1
Serum,,,,,A,Homo sapiens,1,,1977.0,,,BAO_0000218,15549,In vitro protein binding in human serum at 5 ug/ml,N,13163,,CHEMBL625944,9606.0,Intermediate,50587,1
,,,,,A,,0,,,,,BAO_0000019,10929,Serum protein binding ability was measured,U,13164,,CHEMBL625945,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15444,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),U,13165,,CHEMBL625946,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,12860,Oral bioavailability in dog,U,13166,,CHEMBL625947,9615.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,N,13167,,CHEMBL625948,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,Absolute oral bioavailability at an iv dose of 14 mg/kg,U,13168,,CHEMBL625949,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,U,13169,,CHEMBL625950,,Autocuration,22224,1
,,In vivo,,,A,Eutheria,0,,,,,BAO_0000218,15173,Oral bioavailability (dose 15 mg/kg i.v.),U,13170,,CHEMBL625951,9347.0,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,U,13171,,CHEMBL625952,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,U,13172,,CHEMBL625953,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,U,13173,,CHEMBL625954,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,U,13174,,CHEMBL882959,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,11767,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,N,13175,,CHEMBL625955,9615.0,Intermediate,50588,1
,,In vivo,,,A,Mustela putorius furo,0,,,,,BAO_0000218,11219,Bioavailability in ferret,U,13176,,CHEMBL625956,9669.0,Autocuration,22224,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,12186,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,N,13177,,CHEMBL625957,9541.0,Intermediate,100710,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,13178,,CHEMBL625958,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,13179,,CHEMBL625959,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,13180,,CHEMBL626642,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,13181,,CHEMBL631330,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,13182,,CHEMBL631331,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,13183,,CHEMBL631332,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,13184,,CHEMBL631333,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,13185,,CHEMBL632018,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,13186,,CHEMBL632019,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,13187,,CHEMBL632020,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,13188,,CHEMBL632021,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,13189,,CHEMBL632022,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,13190,,CHEMBL632023,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,13191,,CHEMBL632024,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,13192,,CHEMBL874472,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,13193,,CHEMBL632025,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,13194,,CHEMBL632026,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,13195,,CHEMBL632027,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,13196,,CHEMBL632028,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,13197,,CHEMBL626430,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,13198,,CHEMBL626431,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,13199,,CHEMBL626432,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,13200,,CHEMBL626433,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,13201,,CHEMBL626434,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,13202,,CHEMBL627280,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,13203,,CHEMBL627281,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,13204,,CHEMBL627282,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,7199,Total body clearance was measured at given dose,U,13205,,CHEMBL627283,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000218,7199,Total body clearance was measured at given dose.,U,13206,,CHEMBL627284,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7095,Metabolic clearance from the body in rat,N,13207,,CHEMBL627285,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,7095,Renal clearance from the body,U,13208,,CHEMBL627286,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7095,Renal clearance from the body in rat,N,13209,,CHEMBL875477,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12528,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,N,13210,,CHEMBL627287,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12528,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,N,13211,,CHEMBL627288,9615.0,Intermediate,50588,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7095,Total clearance from the body in rat,N,13212,,CHEMBL627289,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14223,Clearance into cortex from rat plasma or PBS,N,13213,,CHEMBL627290,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,U,13214,,CHEMBL627291,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,U,13215,,CHEMBL627292,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,U,13216,,CHEMBL627293,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,U,13217,,CHEMBL627294,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,U,13218,,CHEMBL875478,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13979,Clearance was determined,U,13219,,CHEMBL627295,,Autocuration,22224,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14315,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,N,13220,,CHEMBL627296,10090.0,Intermediate,50594,1
,,In vivo,,,A,Oryctolagus cuniculus,1,,,,,BAO_0000218,14315,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,N,13221,,CHEMBL626119,9986.0,Intermediate,50592,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14315,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,N,13222,,CHEMBL626120,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12174,Clearance in rat after iv dose (100 ug/kg),N,13223,,CHEMBL626121,10116.0,Intermediate,50597,1
,,In vivo,,,A,Cavia porcellus,0,,,,,BAO_0000218,12797,Clearance in guinea pig,U,13224,,CHEMBL626122,10141.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12797,Compound was evaluated for clearance in rat,N,13225,,CHEMBL626123,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12797,Compound was evaluated for the clearance in dog,N,13226,,CHEMBL623456,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12797,Compound was evaluated for the clearance in rat,N,13227,,CHEMBL623457,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11500,Compound was tested in vivo for clearance after iv administration in the rat,N,13228,,CHEMBL623458,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,IV clearance determined at an iv dose of 14 mg/kg,U,13229,,CHEMBL623459,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,IV clearance determined at an iv dose of 15.2 mg/kg,U,13230,,CHEMBL875484,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,IV clearance determined at an iv dose of 15 mg/kg,U,13231,,CHEMBL623460,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,IV clearance determined at an peroral dose of 30 mg/kg.,U,13232,,CHEMBL623461,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,IV clearance determined at an peroral dose of 30.2 mg/kg.,U,13233,,CHEMBL623462,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,IV clearance determined at an peroral dose of 30.3 mg/kg.,U,13234,,CHEMBL627386,,Autocuration,22224,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,N,13235,,CHEMBL627387,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,N,13236,,CHEMBL627388,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,N,13237,,CHEMBL627389,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,N,13238,,CHEMBL627390,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,N,13239,,CHEMBL627391,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,13240,,CHEMBL627392,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,N,13241,,CHEMBL627393,10116.0,Intermediate,50597,1
Trachea,,In vivo,,,A,Rattus norvegicus,1,,3126.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,N,13242,,CHEMBL627394,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,N,13243,,CHEMBL627395,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,13244,,CHEMBL875485,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,N,13245,,CHEMBL627396,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,N,13246,,CHEMBL627397,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,N,13247,,CHEMBL627398,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,N,13248,,CHEMBL627399,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,N,13249,,CHEMBL627400,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,N,13250,,CHEMBL627401,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,N,13251,,CHEMBL627402,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,N,13252,,CHEMBL627403,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,N,13253,,CHEMBL627404,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,13254,,CHEMBL623101,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,N,13255,,CHEMBL877480,10116.0,Intermediate,50597,1
Trachea,,In vivo,,,A,Rattus norvegicus,1,,3126.0,,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,N,13256,,CHEMBL623102,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,N,13257,,CHEMBL623103,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,13258,,CHEMBL623104,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,N,13259,,CHEMBL623105,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,N,13260,,CHEMBL623106,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,N,13261,,CHEMBL623107,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,N,13262,,CHEMBL623108,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,N,13263,,CHEMBL623109,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,N,13264,,CHEMBL623110,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,N,13265,,CHEMBL623111,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,N,13266,,CHEMBL625060,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,N,13267,,CHEMBL625061,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,13268,,CHEMBL625062,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,N,13269,,CHEMBL625063,10116.0,Intermediate,50597,1
Trachea,,In vivo,,,A,Rattus norvegicus,1,,3126.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,N,13270,,CHEMBL625064,10116.0,Intermediate,50597,1
Bone,,In vivo,,,A,Rattus norvegicus,1,,10000001.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,N,13271,,CHEMBL625065,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,13272,,CHEMBL625066,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,N,13273,,CHEMBL625067,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,N,13274,,CHEMBL625068,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,N,13275,,CHEMBL622159,10116.0,Intermediate,50597,1
Intestine,,In vivo,,,A,Rattus norvegicus,1,,160.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,N,13276,,CHEMBL622160,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,N,13277,,CHEMBL622161,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,N,13278,,CHEMBL622162,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,N,13279,,CHEMBL622163,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,N,13280,,CHEMBL622313,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,13281,,CHEMBL622314,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,N,13282,,CHEMBL622315,10116.0,Intermediate,50597,1
Trachea,,In vivo,,,A,Rattus norvegicus,1,,3126.0,,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,N,13283,,CHEMBL622316,10116.0,Intermediate,50597,1
,,,,,A,Escherichia coli,1,,,,,BAO_0000218,15599,Normal diffusion coefficient in water for Escherichia coli,N,13284,,CHEMBL877486,562.0,Intermediate,50212,1
,,,,,A,,0,,,,,BAO_0000019,8204,Average max percent decrease in RVR (renal vascular resistance) was determined,U,13285,,CHEMBL622317,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8204,Average max percent decrease in RVR (renal vascular resistance) was determined.,U,13286,,CHEMBL622318,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6154,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,U,13287,,CHEMBL622319,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6154,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,U,13288,,CHEMBL622320,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6154,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,U,13289,,CHEMBL622321,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6154,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,U,13290,,CHEMBL622322,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7114,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,U,13291,,CHEMBL622323,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7114,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,N,13292,,CHEMBL622324,10116.0,Intermediate,50597,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,13293,,CHEMBL622325,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,13294,,CHEMBL622326,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",N,13295,,CHEMBL877487,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,13296,,CHEMBL622327,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",N,13297,,CHEMBL622328,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,13298,,CHEMBL622329,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,13299,,CHEMBL622330,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,13300,,CHEMBL622331,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,13301,,CHEMBL622332,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",N,13302,,CHEMBL622333,9615.0,Intermediate,50588,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,13303,,CHEMBL627658,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",U,13304,,CHEMBL630428,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,13305,,CHEMBL630429,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",U,13306,,CHEMBL630430,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",U,13307,,CHEMBL630431,314293.0,Autocuration,22224,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,13308,,CHEMBL630432,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,13309,,CHEMBL630433,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,13310,,CHEMBL630434,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,13311,,CHEMBL629372,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",N,13312,,CHEMBL629553,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,13313,,CHEMBL629554,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,13314,,CHEMBL874447,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,13315,,CHEMBL629555,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,13316,,CHEMBL629556,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",N,13317,,CHEMBL629557,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,13318,,CHEMBL629558,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,13319,,CHEMBL629559,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,13320,,CHEMBL629560,10116.0,Intermediate,50597,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,13321,,CHEMBL629561,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,13322,,CHEMBL629562,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,13323,,CHEMBL629563,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,13324,,CHEMBL629564,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,13325,,CHEMBL629565,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,13326,,CHEMBL629566,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,13327,,CHEMBL629567,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,13328,,CHEMBL629568,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",N,13329,,CHEMBL629569,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,13330,,CHEMBL629570,9615.0,Intermediate,50588,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,13331,,CHEMBL629571,314293.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,13332,,CHEMBL629572,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,13333,,CHEMBL629573,10116.0,Autocuration,22224,1
,,In vivo,,,A,Eutheria,0,,,,,BAO_0000218,4985,Bioavailability (dose 20 mg/kg),U,13334,,CHEMBL629574,9347.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,15145,Bioavailability in dog,U,13335,,CHEMBL629575,9615.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,14080,Bioavailability in rat (Sprague-Dawley) (male),U,13336,,CHEMBL874448,10116.0,Autocuration,22224,1
,,In vivo,,,A,Primates,0,,,,,BAO_0000218,11219,Bioavailability in monkey (dose 10 mg/kg i.d.),U,13337,,CHEMBL629576,9443.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,15145,Bioavailability in rat,U,13338,,CHEMBL629577,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,15145,Bioavailability in rat,U,13339,,CHEMBL629578,10116.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,1202,Bioavailability in dog (dose 3.0 mg/kg p.o.),U,13340,,CHEMBL629579,9615.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,1202,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,U,13341,,CHEMBL882958,9615.0,Autocuration,22224,1
,,In vivo,,,A,Pan troglodytes,1,,,,,BAO_0000218,1202,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,N,13342,,CHEMBL629580,9598.0,Intermediate,50505,1
,,In vivo,,,A,Eutheria,0,,,,,BAO_0000218,4026,Bioavailability,U,13343,,CHEMBL629581,9347.0,Autocuration,22224,1
,,In vivo,,,A,Saimiri,0,,,,,BAO_0000218,1492,Bioavailability in squirrel monkey,U,13344,,CHEMBL629582,9520.0,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,12793,Bioavailability was evaluated in dog,N,13345,,CHEMBL628522,9615.0,Intermediate,50588,1
,,In vivo,,,A,Cricetinae,1,,,,,BAO_0000218,12793,Bioavailability was evaluated in hamster,N,13346,,CHEMBL625432,10026.0,Intermediate,100712,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,12793,Bioavailability in rat,U,13347,,CHEMBL625433,10116.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,13348,,CHEMBL625434,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,14793,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,N,13349,,CHEMBL625435,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,14793,Bioavailability in rat (dose 10 mg/kg p.o.),U,13350,,CHEMBL625436,10116.0,Autocuration,22224,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,14731,Bioavailability was measured in cynomolgus monkeys.,N,13351,,CHEMBL874588,9541.0,Intermediate,100710,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14731,Bioavailability was measured in nude mice.,N,13352,,CHEMBL625437,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mustela putorius furo,0,,,,,BAO_0000218,12187,Bioavailability in ferret (dose 10 mg/kg i.d.),U,13353,,CHEMBL625438,9669.0,Autocuration,22224,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,12187,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),U,13354,,CHEMBL625439,314293.0,Autocuration,22224,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,12187,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",U,13355,,CHEMBL625440,314293.0,Autocuration,22224,1
,,In vivo,,,A,Simiiformes,0,,,,,BAO_0000218,12187,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),U,13356,,CHEMBL625441,314293.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,12187,Bioavailability in rat (dose 10 mg/kg i.d.),U,13357,,CHEMBL625442,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12187,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,13358,,CHEMBL625443,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,17431,Bioavailability was determined; extremely poor,U,13359,,CHEMBL625444,,Autocuration,22224,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,13318,% bioavailability in mice after oral administration of prodrug,N,13360,,CHEMBL625445,10090.0,Intermediate,50594,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,N,13361,,CHEMBL625446,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,N,13362,,CHEMBL882960,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,N,13363,,CHEMBL625447,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,N,13364,,CHEMBL625448,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,N,13365,,CHEMBL625449,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),N,13366,,CHEMBL874589,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,N,13367,,CHEMBL625450,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,N,13368,,CHEMBL625451,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,N,13369,,CHEMBL626584,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,N,13370,,CHEMBL626585,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,N,13371,,CHEMBL626586,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,N,13372,,CHEMBL626587,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,N,13373,,CHEMBL626588,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,N,13374,,CHEMBL626589,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,N,13375,,CHEMBL626590,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,N,13376,,CHEMBL626591,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,N,13377,,CHEMBL627181,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,N,13378,,CHEMBL628083,9615.0,Intermediate,50588,1
,,In vivo,,,A,,0,,,,,BAO_0000218,15173,IV clearance determined at an peroral dose of 15 mg/kg.,U,13379,,CHEMBL628084,,Autocuration,22224,1
,,In vivo,,,F,Hymenolepis nana,1,,,,,BAO_0000218,7732,Mouse oral clearance was measured against Hymenolepiasis nana.,N,13380,,CHEMBL628085,102285.0,Expert,50064,1
,,In vivo,,,F,Heligmosomoides polygyrus,1,,,,,BAO_0000218,7732,Mouse oral clearance was measured against Nematospiroides dubius,N,13381,,CHEMBL628086,6339.0,Expert,50545,1
,,In vivo,,,F,,0,,,,,BAO_0000218,7732,Mouse oral clearance was measured against N. dubius; NT is Not Tested,U,13382,,CHEMBL628087,,Autocuration,22224,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,7732,Mouse oral clearance was measured against N. nana; NT is Not Tested,N,13383,,CHEMBL628088,10090.0,Intermediate,50594,1
,,In vivo,,,B,,0,,,,,BAO_0000218,7732,Mouse oral clearance was measured against N. nana; NT is Not Tested,U,13384,,CHEMBL628089,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,U,13385,,CHEMBL628090,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,U,13386,,CHEMBL628091,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,U,13387,,CHEMBL628092,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,U,13388,,CHEMBL628093,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,U,13389,,CHEMBL875607,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,U,13390,,CHEMBL625710,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,U,13391,,CHEMBL625711,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,U,13392,,CHEMBL625712,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,U,13393,,CHEMBL625713,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,13376,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,N,13394,,CHEMBL625714,9615.0,Intermediate,50588,1
,,In vivo,,,A,Macaca mulatta,1,,,,,BAO_0000218,13477,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,N,13395,,CHEMBL625715,9544.0,Intermediate,50797,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,N,13396,,CHEMBL625716,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13477,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,N,13397,,CHEMBL625717,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13313,Plasma clearance was determined for the compound in rats,N,13398,,CHEMBL625718,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,N,13399,,CHEMBL625719,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,N,13400,,CHEMBL625720,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,N,13401,,CHEMBL625721,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,N,13402,,CHEMBL625722,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13129,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,N,13403,,CHEMBL625723,10116.0,Intermediate,50597,1
,,In vivo,,,A,Heligmosomoides polygyrus,1,,,,,BAO_0000218,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,N,13404,,CHEMBL625724,6339.0,Intermediate,50545,1
,,In vivo,,,A,Heligmosomoides polygyrus,1,,,,,BAO_0000218,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,N,13405,,CHEMBL625725,6339.0,Intermediate,50545,1
,,In vivo,,,A,Heligmosomoides polygyrus,1,,,,,BAO_0000218,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,N,13406,,CHEMBL625726,6339.0,Intermediate,50545,1
,,In vivo,,,A,Heligmosomoides polygyrus,1,,,,,BAO_0000218,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,N,13407,,CHEMBL875608,6339.0,Intermediate,50545,1
,,In vivo,,,A,Heligmosomoides polygyrus,1,,,,,BAO_0000218,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,N,13408,,CHEMBL625727,6339.0,Intermediate,50545,1
Urine,,In vivo,,,A,Rattus norvegicus,0,,1088.0,,,BAO_0000218,9278,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,U,13409,,CHEMBL625728,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,9278,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,13410,,CHEMBL625729,10116.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,9278,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,U,13411,,CHEMBL625730,10116.0,Autocuration,22224,1
Urine,,In vivo,,,A,Rattus norvegicus,0,,1088.0,,,BAO_0000218,9278,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,13412,,CHEMBL625731,10116.0,Autocuration,22224,1
Urine,,In vivo,,,A,Rattus norvegicus,0,,1088.0,,,BAO_0000218,9278,Urinary clearance was determined in rat at 25 mg/kg os dosage,U,13413,,CHEMBL626417,10116.0,Autocuration,22224,1
Urine,,In vivo,,,A,Homo sapiens,1,,1088.0,,,BAO_0000218,9278,Urinary clearance was determined at 100 mg/kg oral dosage in human,N,13414,,CHEMBL626418,9606.0,Intermediate,50587,1
Urine,,In vivo,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,9278,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,N,13415,,CHEMBL626419,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,5932,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,N,13416,,CHEMBL626592,9615.0,Intermediate,50588,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,5932,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,13417,,CHEMBL626593,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5182,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,13418,,CHEMBL626594,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,10499,Clearance rate in dogs,N,13419,,CHEMBL625035,9615.0,Intermediate,50588,1
,,In vitro,,,A,,0,,,,,BAO_0000019,6051,Compound was measured for intrinsic clearance,U,13420,,CHEMBL625036,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,17508,Calculated partition coefficient (clogP),U,13421,,CHEMBL625037,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6228,Calculated partition coefficient (clogP),U,13422,,CHEMBL625038,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6231,Calculated partition coefficient (clogP),U,13423,,CHEMBL625039,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,17740,Calculated partition coefficient (clogP),U,13424,,CHEMBL625040,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6495,Calculated partition coefficient (clogP),U,13425,,CHEMBL625041,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,2171,Calculated partition coefficient (clogP),U,13426,,CHEMBL625042,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,3255,Partition coefficient of the compound,U,13427,,CHEMBL874411,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6821,Permeability,U,13428,,CHEMBL625043,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,2685,Calculated partition coefficient (clogP),U,13429,,CHEMBL625044,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,17584,Partition coefficient (logD),U,13430,,CHEMBL625045,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,13431,,CHEMBL625046,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,13432,,CHEMBL625047,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,16479,Calculated partition coefficient (clogP),U,13433,,CHEMBL625048,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,11997,Calculated partition coefficient (clogP),U,13434,,CHEMBL625049,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,2988,Calculated logarithm of partition coefficient (P) was determined,U,13435,,CHEMBL625050,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,931,Calculated partition coefficient (clogP),U,13436,,CHEMBL625051,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,4381,Calculated partition coefficient (clogP),U,13437,,CHEMBL874412,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,4397,Calculated partition coefficient (clogP),U,13438,,CHEMBL625052,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,5889,Calculated partition coefficient (clogP),U,13439,,CHEMBL625053,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,6154,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,U,13440,,CHEMBL623250,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6154,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,U,13441,,CHEMBL623251,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6154,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,U,13442,,CHEMBL623252,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6154,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,U,13443,,CHEMBL623253,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6154,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,U,13444,,CHEMBL623254,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6154,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,U,13445,,CHEMBL623255,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6887,Percent degradation of compound at a pH of 1 over a 18 hr period,U,13446,,CHEMBL626831,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6887,Percent degradation of compound at pH of 1 over an 18 hr period,U,13447,,CHEMBL877494,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14116,Delta Logarithm of Partition Coefficient value was determined.,U,13448,,CHEMBL626832,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11137,Delta logPoct-cyc,U,13449,,CHEMBL626833,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,7230,Lipophilicity estimated on reversed phase TLC,U,13450,,CHEMBL626834,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15741,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,U,13451,,CHEMBL626835,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9663,Delta logPoct-cyc,U,13452,,CHEMBL626836,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,9663,Change in logarithm of partition coefficient of the compound,U,13453,,CHEMBL626837,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,13807,Delta logD (pH 6.5),U,13454,,CHEMBL626838,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,13807,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",U,13455,,CHEMBL626839,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,17425,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,U,13456,,CHEMBL626840,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12143,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),U,13457,,CHEMBL626841,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000219,12608,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,U,13458,,CHEMBL626842,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000219,12608,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,U,13459,,CHEMBL626843,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8649,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,N,13460,,CHEMBL626844,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8649,Amount of deuterium retained was reported after normal workup in rats,N,13461,,CHEMBL877495,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8649,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,N,13462,,CHEMBL626845,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8649,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,N,13463,,CHEMBL626846,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8649,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,13464,,CHEMBL626847,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8649,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,13465,,CHEMBL628677,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8649,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,N,13466,,CHEMBL628678,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,9659,Compound was subjected to electrochemical oxidation,U,13467,,CHEMBL628679,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9659,Compound was subjected to photochemical oxidation,U,13468,,CHEMBL628680,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9659,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,U,13469,,CHEMBL628681,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9659,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,U,13470,,CHEMBL628682,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9659,Oxidation of compound by methemoglobin in presence of hydroperoxide,U,13471,,CHEMBL628683,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9607,Percent diffusion through fuzzy rat skin after 48 h of incubation,N,13472,,CHEMBL628684,10116.0,Intermediate,50597,1
,,,,,P,,0,,,,,BAO_0000100,7057,Dissociation constant (pKa),U,13473,,CHEMBL877501,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,7057,Dissociation constant value of the compound; ND means not determined.,U,13474,,CHEMBL628685,,Autocuration,22224,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7911,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,N,13475,,CHEMBL628686,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,7911,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,13476,,CHEMBL628687,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7911,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,N,13477,,CHEMBL628688,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7911,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,13478,,CHEMBL628689,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7911,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,N,13479,,CHEMBL628690,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,7911,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,13480,,CHEMBL629363,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,7911,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,N,13481,,CHEMBL629364,10116.0,Intermediate,50597,1
Spleen,,,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,7911,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,13482,,CHEMBL629365,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7911,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,N,13483,,CHEMBL629366,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,7911,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,N,13484,,CHEMBL629367,10116.0,Intermediate,50597,1
Feces,,,,,A,Rattus norvegicus,1,,1988.0,,,BAO_0000218,7911,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,13485,,CHEMBL629368,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,7911,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,13486,,CHEMBL877502,10116.0,Intermediate,50597,1
Cerebellum,,,,,A,Mus musculus,1,,2037.0,,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,N,13487,,CHEMBL629369,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,N,13488,,CHEMBL629370,10090.0,Intermediate,50594,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",U,13489,,CHEMBL629371,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,13490,,CHEMBL626276,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,13491,,CHEMBL626277,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,13492,,CHEMBL631250,314293.0,Autocuration,22224,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,13493,,CHEMBL631251,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,13494,,CHEMBL631252,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",N,13495,,CHEMBL631253,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,13496,,CHEMBL631254,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,13497,,CHEMBL631255,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,13498,,CHEMBL631256,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,13499,,CHEMBL631257,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",N,13500,,CHEMBL628009,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,13501,,CHEMBL628010,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,13502,,CHEMBL628011,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",N,13503,,CHEMBL628012,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,13504,,CHEMBL628013,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,13505,,CHEMBL628014,10116.0,Intermediate,50597,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",N,13506,,CHEMBL628015,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,13507,,CHEMBL628016,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",N,13508,,CHEMBL874461,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,13509,,CHEMBL628017,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,13510,,CHEMBL628018,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,13511,,CHEMBL628019,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,13512,,CHEMBL628020,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,13513,,CHEMBL628021,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,13514,,CHEMBL628022,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,13515,,CHEMBL628023,9615.0,Intermediate,50588,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,13516,,CHEMBL628024,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",U,13517,,CHEMBL628025,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,13518,,CHEMBL628026,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,13519,,CHEMBL628027,314293.0,Autocuration,22224,1
Urine,,,,,A,Simiiformes,0,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,13520,,CHEMBL628028,314293.0,Autocuration,22224,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,13521,,CHEMBL628029,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",N,13522,,CHEMBL628030,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,13523,,CHEMBL628031,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",N,13524,,CHEMBL628032,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,13525,,CHEMBL628033,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",N,13526,,CHEMBL628034,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,13527,,CHEMBL628035,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",N,13528,,CHEMBL628036,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,13529,,CHEMBL874462,10116.0,Intermediate,50597,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,N,13530,,CHEMBL628037,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,N,13531,,CHEMBL628123,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,N,13532,,CHEMBL628124,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,N,13533,,CHEMBL628125,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,N,13534,,CHEMBL628126,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),N,13535,,CHEMBL628127,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,N,13536,,CHEMBL628128,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,N,13537,,CHEMBL628129,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,N,13538,,CHEMBL628130,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,N,13539,,CHEMBL628131,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,N,13540,,CHEMBL628132,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,N,13541,,CHEMBL628133,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,N,13542,,CHEMBL628134,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,N,13543,,CHEMBL628135,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,N,13544,,CHEMBL628136,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,N,13545,,CHEMBL628137,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,N,13546,,CHEMBL628138,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,N,13547,,CHEMBL628139,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,N,13548,,CHEMBL628140,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,N,13549,,CHEMBL628141,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,N,13550,,CHEMBL628142,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,N,13551,,CHEMBL628143,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,N,13552,,CHEMBL628144,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,N,13553,,CHEMBL628145,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,N,13554,,CHEMBL628146,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,N,13555,,CHEMBL625355,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,N,13556,,CHEMBL625356,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,N,13557,,CHEMBL625357,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,N,13558,,CHEMBL625527,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),N,13559,,CHEMBL875473,9615.0,Intermediate,50588,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,N,13560,,CHEMBL625528,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,N,13561,,CHEMBL626304,10116.0,Intermediate,50597,1
Artery,,In vivo,,,A,Canis lupus familiaris,1,,1637.0,,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,N,13562,,CHEMBL624138,9615.0,Intermediate,50588,1
,,,,,P,,0,,,,,BAO_0000100,6448,Calculated partition coefficient (clogP),U,13563,,CHEMBL624139,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,17221,Calculated partition coefficient (clogP),U,13564,,CHEMBL624140,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6545,Calculated partition coefficient (clogP),U,13565,,CHEMBL624141,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,577,Calculated partition coefficient (clogP),U,13566,,CHEMBL624142,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6285,Calculated partition coefficient (clogP),U,13567,,CHEMBL624143,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6500,Calculated partition coefficient (clogP),U,13568,,CHEMBL624144,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6716,Calculated partition coefficient (clogP),U,13569,,CHEMBL624145,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,13658,Calculated partition coefficient (clogP),U,13570,,CHEMBL624146,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6549,Calculated partition coefficient (clogP),U,13571,,CHEMBL624147,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,14685,Calculated partition coefficient (clogP) (MacLogP),U,13572,,CHEMBL883123,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,6893,Partition coefficient (logP),U,13573,,CHEMBL624148,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3687,Kinetic parameter was determined,U,13574,,CHEMBL874416,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,4207,Calculated partition coefficient (clogP),U,13575,,CHEMBL624149,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,4626,Calculated partition coefficient (clogP),U,13576,,CHEMBL624150,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,1021,Lipophilicity was determined,U,13577,,CHEMBL624151,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,3777,Lipophilicity was determined,U,13578,,CHEMBL624152,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,17533,Lipophilicity was determined,U,13579,,CHEMBL622139,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,6524,Calculated partition coefficient (clogP),U,13580,,CHEMBL622140,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,17533,Lipophilicity was determined,U,13581,,CHEMBL622141,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,6480,Lipophilicity in octanol-water,U,13582,,CHEMBL622142,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,17606,Calculated partition coefficient (clogP),U,13583,,CHEMBL622143,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,6863,Octanol-water partition coefficient was determined,U,13584,,CHEMBL622144,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,1356,Partition coefficient (logP),U,13585,,CHEMBL877473,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,3326,Calculated partition coefficient (clogP),U,13586,,CHEMBL622145,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,1356,Partition coefficient was determined; ND means not determined,U,13587,,CHEMBL622146,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,12984,Calculated partition coefficient (clogP),U,13588,,CHEMBL622147,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,17363,Partition coefficient of the compound,U,13589,,CHEMBL622148,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,6827,Permeability was determined,U,13590,,CHEMBL883124,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,261,The compound was evaluated for the partition coefficient,U,13591,,CHEMBL622149,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,2685,Partition coefficient (logP),U,13592,,CHEMBL622150,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,414,The lipophilicity was reported,U,13593,,CHEMBL622151,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,15769,logarithm of the octanol-water partition coefficient for the compound,U,13594,,CHEMBL622152,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,17248,Clogp value was determined,U,13595,,CHEMBL622153,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,16935,Clp at a dose of 1.5 mg/kg,U,13596,,CHEMBL877474,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,16935,Clp at a dose of 2.0 mg/kg,U,13597,,CHEMBL622154,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14832,"Clp, plasma clearance at a dose of 10 mg/kg",U,13598,,CHEMBL622155,,Autocuration,22224,1
Plasma,,In vivo,,,A,,0,,1969.0,,,BAO_0000218,14832,"Clp, plasma clearance at a dose of 50 mg/kg",U,13599,,CHEMBL622156,,Autocuration,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2399,Compound was tested for plasma clearance in rat,N,13600,,CHEMBL622157,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,2399,Compound was tested for plasma clearance in rat; Not determined,N,13601,,CHEMBL622158,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6227,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,N,13602,,CHEMBL622807,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca mulatta,1,,,,,BAO_0000218,6227,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,N,13603,,CHEMBL622808,9544.0,Intermediate,50797,1
,,In vivo,,,A,,0,,,,,BAO_0000218,5623,Plasma clearance by iv administration at a dose 0.003 ug/mL,U,13604,,CHEMBL622809,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,4854,Plasma clearance determined,U,13605,,CHEMBL622810,,Autocuration,22224,1
,,In vivo,,,A,Cricetinae,1,,,,,BAO_0000218,4493,Plasma clearance after iv administration at 3 mg/kg in hamster,N,13606,,CHEMBL876653,10026.0,Intermediate,100712,1
,,In vivo,,,A,Cricetinae,1,,,,,BAO_0000218,4493,Plasma clearance after iv administration at 4 mg/kg in hamster,N,13607,,CHEMBL622811,10026.0,Intermediate,100712,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14956,Rate of clearance in rat was determined,N,13608,,CHEMBL622986,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15372,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,N,13609,,CHEMBL622987,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15372,Total plasma clearance after iv dose of 5.10 mg/kg in rats,N,13610,,CHEMBL622988,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15372,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,N,13611,,CHEMBL622989,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15372,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,N,13612,,CHEMBL622990,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Simiiformes,0,,1969.0,,,BAO_0000218,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,13613,,CHEMBL622991,314293.0,Autocuration,22224,1
Plasma,,In vivo,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,13614,,CHEMBL622227,10116.0,Intermediate,50597,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,13615,,CHEMBL622228,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14964,Clpl value in rat,N,13616,,CHEMBL622229,10116.0,Intermediate,50597,1
,,In vivo,,,A,Cavia porcellus,1,,,,,BAO_0000218,15240,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,N,13617,,CHEMBL622230,10141.0,Intermediate,50512,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16449,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,N,13618,,CHEMBL622231,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca fascicularis,1,,,,,BAO_0000218,16449,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,N,13619,,CHEMBL622232,9541.0,Intermediate,100710,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12902,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,U,13620,,CHEMBL622233,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12902,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,U,13621,,CHEMBL622234,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12902,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,U,13622,,CHEMBL622235,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12902,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,U,13623,,CHEMBL622236,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12902,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,U,13624,,CHEMBL622237,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12902,Cmax in minutes at a po dose of 10.0(pmol/g/h).,U,13625,,CHEMBL877482,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12902,Cmax in minutes at a po dose of 20.0(pmol/g/h).,U,13626,,CHEMBL622238,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,12902,Cmax in minutes at a po dose of 40.0(pmol/g/h).,U,13627,,CHEMBL622239,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,11149,Cmax was calculated as maximum concentration reached in the blood,U,13628,,CHEMBL622240,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,11149,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,U,13629,,CHEMBL622241,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5669,Cmax was determine after peroral administration at 10 mpk in Rat,N,13630,,CHEMBL631013,10116.0,Intermediate,50597,1
,,In vivo,,,A,Macaca mulatta,1,,,,,BAO_0000218,5669,Cmax was determine after peroral administration at 10 mpk in Rhesus,N,13631,,CHEMBL631014,9544.0,Intermediate,50797,1
,,In vivo,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,5669,Cmax was determine after peroral administration at 10 mpk in dog,N,13632,,CHEMBL631015,9615.0,Intermediate,50588,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5669,Cmax was determine after peroral administration at 160 mpk in Rat,N,13633,,CHEMBL631016,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5669,Cmax was determine after peroral administration at 20 mpk in Rat,N,13634,,CHEMBL631017,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,5669,Cmax was determine after peroral administration at 50 mpk in Rat,N,13635,,CHEMBL631018,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,4236,Cmax was determined,U,13636,,CHEMBL631019,,Autocuration,22224,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,N,13637,,CHEMBL875761,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,N,13638,,CHEMBL631020,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,N,13639,,CHEMBL631669,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,N,13640,,CHEMBL631670,10090.0,Intermediate,50594,1
Striatum,,,,,A,Mus musculus,1,,2435.0,,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,N,13641,,CHEMBL631671,10090.0,Intermediate,50594,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,N,13642,,CHEMBL631672,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,N,13643,,CHEMBL631673,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,N,13644,,CHEMBL631856,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,N,13645,,CHEMBL631857,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,N,13646,,CHEMBL631858,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,N,13647,,CHEMBL631859,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,N,13648,,CHEMBL631860,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,N,13649,,CHEMBL631861,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,N,13650,,CHEMBL631862,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,N,13651,,CHEMBL631863,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,N,13652,,CHEMBL631864,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,N,13653,,CHEMBL631865,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,N,13654,,CHEMBL631866,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,N,13655,,CHEMBL629360,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,N,13656,,CHEMBL629361,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,N,13657,,CHEMBL629362,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,N,13658,,CHEMBL630740,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,N,13659,,CHEMBL630741,10116.0,Intermediate,50597,1
Blood,,,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,N,13660,,CHEMBL630742,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,N,13661,,CHEMBL630743,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,N,13662,,CHEMBL630744,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,N,13663,,CHEMBL630745,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,N,13664,,CHEMBL630746,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,N,13665,,CHEMBL630747,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,N,13666,,CHEMBL630748,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,N,13667,,CHEMBL632056,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,N,13668,,CHEMBL632057,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,N,13669,,CHEMBL632058,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,N,13670,,CHEMBL632059,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,N,13671,,CHEMBL632060,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,N,13672,,CHEMBL632061,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,N,13673,,CHEMBL629207,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,N,13674,,CHEMBL629208,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,N,13675,,CHEMBL629209,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,N,13676,,CHEMBL629210,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,N,13677,,CHEMBL629211,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,N,13678,,CHEMBL629212,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,N,13679,,CHEMBL629213,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,13680,,CHEMBL629214,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",N,13681,,CHEMBL629215,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",N,13682,,CHEMBL635154,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,13683,,CHEMBL629216,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,N,13684,,CHEMBL629217,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,13685,,CHEMBL629218,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,13686,,CHEMBL629219,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,13687,,CHEMBL629220,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,13688,,CHEMBL629221,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,13689,,CHEMBL631127,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,N,13690,,CHEMBL631128,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,13691,,CHEMBL631129,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,13692,,CHEMBL631130,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,13693,,CHEMBL631131,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,13694,,CHEMBL631132,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,13695,,CHEMBL631133,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,N,13696,,CHEMBL631134,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,13697,,CHEMBL875120,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,13698,,CHEMBL631135,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,13699,,CHEMBL631136,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,13700,,CHEMBL631137,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,13701,,CHEMBL631138,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,N,13702,,CHEMBL631139,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,13703,,CHEMBL631140,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,13704,,CHEMBL631141,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,13705,,CHEMBL631142,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,13706,,CHEMBL631143,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,13707,,CHEMBL631144,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,N,13708,,CHEMBL631145,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,13709,,CHEMBL631146,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,N,13710,,CHEMBL631147,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,13711,,CHEMBL631148,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,13712,,CHEMBL631149,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,13713,,CHEMBL631150,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,13714,,CHEMBL631151,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,13715,,CHEMBL631152,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,13716,,CHEMBL631443,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,13717,,CHEMBL631444,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,13718,,CHEMBL631445,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,13719,,CHEMBL631446,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),N,13720,,CHEMBL631447,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,13721,,CHEMBL631448,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,N,13722,,CHEMBL631449,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,13723,,CHEMBL631450,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,13724,,CHEMBL629724,9615.0,Intermediate,50588,1
Zone of skin,,In vivo,,,A,Mus musculus,1,,14.0,,,BAO_0000218,9716,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13725,,CHEMBL629725,10090.0,Intermediate,50594,1
Zone of skin,,In vivo,,,A,Mus musculus,1,,14.0,,,BAO_0000218,9716,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13726,,CHEMBL629726,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,9716,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13727,,CHEMBL629727,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,9716,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13728,,CHEMBL630404,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,9716,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13729,,CHEMBL630405,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,9716,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13730,,CHEMBL630406,10090.0,Intermediate,50594,1
Stomach,,In vivo,,,A,Mus musculus,1,,945.0,,,BAO_0000218,9716,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13731,,CHEMBL630407,10090.0,Intermediate,50594,1
Stomach,,In vivo,,,A,Mus musculus,1,,945.0,,,BAO_0000218,9716,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13732,,CHEMBL630573,10090.0,Intermediate,50594,1
Stomach,,In vivo,,,A,Mus musculus,1,,945.0,,,BAO_0000218,9716,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13733,,CHEMBL630574,10090.0,Intermediate,50594,1
Stomach,,In vivo,,,A,Mus musculus,1,,945.0,,,BAO_0000218,9716,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13734,,CHEMBL630575,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,9716,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13735,,CHEMBL630576,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,9716,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13736,,CHEMBL630577,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,9716,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13737,,CHEMBL630578,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,9716,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,13738,,CHEMBL630579,10090.0,Intermediate,50594,1
Kidney,,,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),N,13739,,CHEMBL630580,10090.0,Intermediate,50594,1
Kidney,,,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,N,13740,,CHEMBL630581,10090.0,Intermediate,50594,1
Kidney,,,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),N,13741,,CHEMBL630582,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,N,13742,,CHEMBL630583,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),N,13743,,CHEMBL630584,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,N,13744,,CHEMBL630585,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),N,13745,,CHEMBL630586,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,N,13746,,CHEMBL630587,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),N,13747,,CHEMBL630588,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,N,13748,,CHEMBL630589,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),N,13749,,CHEMBL630590,10090.0,Intermediate,50594,1
Feces,,,,,A,,0,,1988.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in feces at 24 h,U,13750,,CHEMBL630591,,Autocuration,22224,1
Feces,,,,,A,,0,,1988.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),U,13751,,CHEMBL630592,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,U,13752,,CHEMBL630593,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),U,13753,,CHEMBL630594,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),U,13754,,CHEMBL630595,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),U,13755,,CHEMBL630596,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 0-24 h,U,13756,,CHEMBL630597,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),U,13757,,CHEMBL630598,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 0-4 h,U,13758,,CHEMBL630599,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),U,13759,,CHEMBL630600,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 4-24 h,U,13760,,CHEMBL630601,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),U,13761,,CHEMBL630602,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),U,13762,,CHEMBL630603,,Autocuration,22224,1
Urine,,,,,A,,0,,1088.0,,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),U,13763,,CHEMBL630604,,Autocuration,22224,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13764,,CHEMBL624869,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13765,,CHEMBL624870,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,13766,,CHEMBL623189,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13767,,CHEMBL623190,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13768,,CHEMBL623191,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13769,,CHEMBL623192,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13770,,CHEMBL623193,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,13771,,CHEMBL623194,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13772,,CHEMBL623195,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13773,,CHEMBL623196,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,N,13774,,CHEMBL623197,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,13775,,CHEMBL623198,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,13776,,CHEMBL623199,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,N,13777,,CHEMBL623200,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,N,13778,,CHEMBL623201,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,N,13779,,CHEMBL623202,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,N,13780,,CHEMBL623203,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,N,13781,,CHEMBL623204,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,N,13782,,CHEMBL623205,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,13783,,CHEMBL623206,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,N,13784,,CHEMBL623207,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,N,13785,,CHEMBL623208,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,13786,,CHEMBL623209,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,13787,,CHEMBL623210,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,13788,,CHEMBL623211,10116.0,Intermediate,50597,1
Uterus,,,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,13789,,CHEMBL623212,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,12640,Tested in vitro for intrinsic activity relative to quinpirole,U,13790,,CHEMBL623213,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14218,"Relative ion enhancement, determined in pulsed ultrafiltration",U,13791,,CHEMBL623214,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11296,% ionization at the pH 7.4 at 37 degree Centigrade,U,13792,,CHEMBL623215,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10929,Percentage ionization was measured,U,13793,,CHEMBL623216,,Autocuration,22224,1
,,,,,A,Bos taurus,1,,,,,BAO_0000218,13841,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,N,13794,,CHEMBL623217,9913.0,Intermediate,50591,1
,,,,,A,,0,,,,,BAO_0000019,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,U,13795,,CHEMBL623218,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,U,13796,,CHEMBL623913,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,U,13797,,CHEMBL623914,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,8826,Compound was evaluated for the partition coefficient in octanol/water,U,13798,,CHEMBL623915,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,8826,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),U,13799,,CHEMBL624080,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,9884,Equilibrium constant measured by the pulse radiolysis at pH 7,U,13800,,CHEMBL624081,,Autocuration,22224,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,9827,In vitro hydrolytic rate constant determined in human blood,N,13801,,CHEMBL624082,9606.0,Intermediate,50587,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,N,13802,,CHEMBL625054,9606.0,Intermediate,50587,1
,,,,,A,,0,,,,,BAO_0000019,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,U,13803,,CHEMBL877485,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,N,13804,,CHEMBL625055,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,N,13805,,CHEMBL625056,10090.0,Intermediate,50594,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,10009,In vitro oxidation of compound in presence of human plasma,N,13806,,CHEMBL625057,9606.0,Intermediate,50587,1
,,,,,A,,0,,,,,BAO_0000019,10009,In vitro oxidation of compound in presence of hydrogen peroxide,U,13807,,CHEMBL625058,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,10009,In vitro oxidation of compound in presence of mouse brain homogenate,N,13808,,CHEMBL625059,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,10009,In vitro oxidation of compound in presence of mouse liver homogenate,N,13809,,CHEMBL629536,10090.0,Intermediate,50594,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,13810,,CHEMBL629537,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,13811,,CHEMBL629538,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,13812,,CHEMBL629539,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,13813,,CHEMBL874445,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,13814,,CHEMBL629540,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,13815,,CHEMBL629541,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,13816,,CHEMBL629542,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,13817,,CHEMBL630243,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,13818,,CHEMBL630244,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,13819,,CHEMBL630245,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,13820,,CHEMBL630246,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,13821,,CHEMBL630247,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,13822,,CHEMBL630248,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13100,Biodistribution in rat blood at 240 minutes after dose administration.,N,13823,,CHEMBL630249,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13100,Biodistribution in rat blood at 30 minutes after dose administration.,N,13824,,CHEMBL630250,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13100,Biodistribution in rat blood at 360 minutes after dose administration.,N,13825,,CHEMBL630251,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13100,Biodistribution in rat blood at 3 hr after dose administration.,N,13826,,CHEMBL630252,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13100,Biodistribution in rat blood at 60 minutes after dose administration.,N,13827,,CHEMBL630408,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,13100,Biodistribution in rat cerebellum at 120 minutes after dose administration.,N,13828,,CHEMBL630409,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,13100,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,N,13829,,CHEMBL874446,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,13100,Biodistribution in rat cerebellum at 15 minutes after dose administration.,N,13830,,CHEMBL630410,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,13100,Biodistribution in rat cerebellum at 240 minutes after dose administration.,N,13831,,CHEMBL630411,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,13100,Biodistribution in rat cerebellum at 30 minutes after dose administration.,N,13832,,CHEMBL630412,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,13100,Biodistribution in rat cerebellum at 360 minutes after dose administration.,N,13833,,CHEMBL630413,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,13100,Biodistribution in rat cerebellum at 3 hr after dose administration.,N,13834,,CHEMBL630414,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,13100,Biodistribution in rat cerebellum at 60 minutes after dose administration.,N,13835,,CHEMBL630415,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat cortex at 120 minutes after dose administration.,N,13836,,CHEMBL630416,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat cortex at 1440 minutes after dose administration.,N,13837,,CHEMBL630417,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat cortex at 15 minutes after dose administration.,N,13838,,CHEMBL630418,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat cortex at 240 minutes after dose administration.,N,13839,,CHEMBL630419,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat cortex at 30 minutes after dose administration.,N,13840,,CHEMBL630420,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat cortex at 360 minutes after dose administration.,N,13841,,CHEMBL630421,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat cortex at 3 hr after dose administration.,N,13842,,CHEMBL630422,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat cortex at 60 minutes after dose administration.,N,13843,,CHEMBL630423,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13100,Biodistribution in rat heart at 120 minutes after dose administration.,N,13844,,CHEMBL630424,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13100,Biodistribution in rat heart at 15 minutes after dose administration.,N,13845,,CHEMBL630425,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13100,Biodistribution in rat heart at 240 minutes after dose administration.,N,13846,,CHEMBL629462,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13100,Biodistribution in rat heart at 30 minutes after dose administration.,N,13847,,CHEMBL630426,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13100,Biodistribution in rat heart at 360 minutes after dose administration.,N,13848,,CHEMBL630427,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13100,Biodistribution in rat heart at 3 hr after dose administration.,N,13849,,CHEMBL625877,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13100,Biodistribution in rat heart at 60 minutes after dose administration.,N,13850,,CHEMBL625878,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,13100,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,N,13851,,CHEMBL625879,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,13100,Biodistribution in rat hippocampus at 240 minutes after dose administration.,N,13852,,CHEMBL625880,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,13100,Biodistribution in rat hippocampus at 30 minutes after dose administration.,N,13853,,CHEMBL625881,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,13100,Biodistribution in rat hippocampus at 360 minutes after dose administration.,N,13854,,CHEMBL625882,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,13100,Biodistribution in rat hippocampus at 15 minutes after dose administration.,N,13855,,CHEMBL625883,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13100,Biodistribution in rat kidney at 120 minutes after dose administration.,N,13856,,CHEMBL625884,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13100,Biodistribution in rat kidney at 1440 minutes after dose administration.,N,13857,,CHEMBL625885,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13100,Biodistribution in rat kidney at 15 minutes after dose administration.,N,13858,,CHEMBL628649,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13100,Biodistribution in rat kidney at 240 minutes after dose administration.,N,13859,,CHEMBL628650,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13100,Biodistribution in rat kidney at 30 minutes after dose administration.,N,13860,,CHEMBL628651,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13100,Biodistribution in rat kidney at 360 minutes after dose administration.,N,13861,,CHEMBL628652,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13100,Biodistribution in rat kidney at 60 minutes after dose administration.,N,13862,,CHEMBL628653,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13100,Biodistribution in rat liver at 120 minutes after dose administration.,N,13863,,CHEMBL628654,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13100,Biodistribution in rat liver at 1440 minutes after dose administration.,N,13864,,CHEMBL628655,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13100,Biodistribution in rat liver at 15 minutes after dose administration.,N,13865,,CHEMBL625238,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13100,Biodistribution in rat liver at 240 minutes after dose administration.,N,13866,,CHEMBL625239,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13100,Biodistribution in rat liver at 30 minutes after dose administration.,N,13867,,CHEMBL625240,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13100,Biodistribution in rat liver at 360 minutes after dose administration.,N,13868,,CHEMBL625241,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13100,Biodistribution in rat liver at 60 minutes after dose administration.,N,13869,,CHEMBL625242,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13100,Biodistribution in rat lung at 120 minutes after dose administration.,N,13870,,CHEMBL874587,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13100,Biodistribution in rat lung at 1440 minutes after dose administration.,N,13871,,CHEMBL625405,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13100,Biodistribution in rat lung at 15 minutes after dose administration.,N,13872,,CHEMBL625406,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13100,Biodistribution in rat lung at 240 minutes after dose administration.,N,13873,,CHEMBL625407,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13100,Biodistribution in rat lung at 30 minutes after dose administration.,N,13874,,CHEMBL625408,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13100,Biodistribution in rat lung at 360 minutes after dose administration.,N,13875,,CHEMBL625409,10116.0,Intermediate,50597,1
Thoracic aorta,,,,,A,Rattus norvegicus,1,,1515.0,,,BAO_0000218,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,N,13876,,CHEMBL625410,10116.0,Intermediate,50597,1
Thoracic aorta,,,,,A,Rattus norvegicus,1,,1515.0,,,BAO_0000218,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,N,13877,,CHEMBL625411,10116.0,Intermediate,50597,1
Thoracic aorta,,,,,A,Rattus norvegicus,1,,1515.0,,,BAO_0000218,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,N,13878,,CHEMBL625412,10116.0,Intermediate,50597,1
Thoracic aorta,,,,,A,Rattus norvegicus,1,,1515.0,,,BAO_0000218,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,N,13879,,CHEMBL625413,10116.0,Intermediate,50597,1
Thoracic aorta,,,,,A,Rattus norvegicus,1,,1515.0,,,BAO_0000218,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips v,N,13880,,CHEMBL625414,10116.0,Intermediate,50597,1
Thoracic aorta,,,,,A,Rattus norvegicus,1,,1515.0,,,BAO_0000218,12361,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,N,13881,,CHEMBL625415,10116.0,Intermediate,50597,1
Thoracic aorta,,,,,A,Rattus norvegicus,1,,1515.0,,,BAO_0000218,12361,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,N,13882,,CHEMBL625416,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12712,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,N,13883,,CHEMBL625417,10116.0,Intermediate,50597,1
Feces,,,,,A,Rattus norvegicus,1,,1988.0,,,BAO_0000218,7415,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,N,13884,,CHEMBL625418,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,7415,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,N,13885,,CHEMBL625419,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7415,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,N,13886,,CHEMBL625420,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7415,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,N,13887,,CHEMBL626996,10116.0,Intermediate,50597,1
Feces,,,,,A,Rattus norvegicus,1,,1988.0,,,BAO_0000218,7415,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",N,13888,,CHEMBL626997,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,7415,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",N,13889,,CHEMBL626998,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7415,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",N,13890,,CHEMBL626999,10116.0,Intermediate,50597,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8050,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,N,13891,,CHEMBL627000,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8050,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,N,13892,,CHEMBL627001,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8050,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,N,13893,,CHEMBL627002,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8050,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,N,13894,,CHEMBL627003,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,N,13895,,CHEMBL627004,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,N,13896,,CHEMBL627005,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,N,13897,,CHEMBL874594,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,N,13898,,CHEMBL627006,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,N,13899,,CHEMBL627007,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,N,13900,,CHEMBL627884,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,N,13901,,CHEMBL627885,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,N,13902,,CHEMBL627886,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,N,13903,,CHEMBL627887,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,N,13904,,CHEMBL627888,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,N,13905,,CHEMBL628057,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,N,13906,,CHEMBL627405,10090.0,Intermediate,50594,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,13907,,CHEMBL627406,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,13908,,CHEMBL627407,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,13909,,CHEMBL627408,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,13910,,CHEMBL627409,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,13911,,CHEMBL875486,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,13912,,CHEMBL627410,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,13913,,CHEMBL627411,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,13914,,CHEMBL627412,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,13915,,CHEMBL627413,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,13916,,CHEMBL627414,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,13917,,CHEMBL627415,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,N,13918,,CHEMBL627416,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,13919,,CHEMBL627417,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,13920,,CHEMBL627418,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,13921,,CHEMBL627419,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,13922,,CHEMBL627320,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,13923,,CHEMBL627321,9615.0,Intermediate,50588,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13924,,CHEMBL627322,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13925,,CHEMBL627323,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,13926,,CHEMBL627491,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13927,,CHEMBL627492,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13928,,CHEMBL627493,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13929,,CHEMBL627494,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13930,,CHEMBL627495,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,13931,,CHEMBL627496,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13932,,CHEMBL627497,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13933,,CHEMBL627498,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13934,,CHEMBL627499,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13935,,CHEMBL627500,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,13936,,CHEMBL627501,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13937,,CHEMBL625616,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13938,,CHEMBL625617,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13939,,CHEMBL625618,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13940,,CHEMBL625619,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,13941,,CHEMBL625620,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13942,,CHEMBL625621,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13943,,CHEMBL625622,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13944,,CHEMBL625788,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13945,,CHEMBL625789,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,13946,,CHEMBL625790,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13947,,CHEMBL625791,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13948,,CHEMBL622334,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13949,,CHEMBL622335,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13950,,CHEMBL622336,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,13951,,CHEMBL622337,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13952,,CHEMBL622338,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13953,,CHEMBL622339,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13954,,CHEMBL624153,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13955,,CHEMBL628430,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,13956,,CHEMBL628431,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13957,,CHEMBL628432,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,13958,,CHEMBL628433,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,13959,,CHEMBL628434,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,13960,,CHEMBL626789,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",N,13961,,CHEMBL626790,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,13962,,CHEMBL626791,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,13963,,CHEMBL626792,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,13964,,CHEMBL626793,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,13965,,CHEMBL627436,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,13966,,CHEMBL627437,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,13967,,CHEMBL627438,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,13968,,CHEMBL627439,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,13969,,CHEMBL627440,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,13970,,CHEMBL627602,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,13971,,CHEMBL627603,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,13972,,CHEMBL627604,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,13973,,CHEMBL627605,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,13974,,CHEMBL627606,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,13975,,CHEMBL627607,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,13976,,CHEMBL627608,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,13977,,CHEMBL627609,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,13978,,CHEMBL627610,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,13979,,CHEMBL627611,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,13980,,CHEMBL627612,10116.0,Intermediate,50597,1
,,,,,P,,0,,,,,BAO_0000100,8362,Octanol:water partition coefficient is evaluated,U,13981,,CHEMBL627613,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,8257,Partition coefficient in 1-octanol/water system,U,13982,,CHEMBL627614,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,8257,Partition coefficient in 1-octanol/water system measured using radio active compounds,U,13983,,CHEMBL627615,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,9468,Partition coefficient in octanol/water system was determined,U,13984,,CHEMBL627616,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,9468,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,U,13985,,CHEMBL627617,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10568,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,U,13986,,CHEMBL627618,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10568,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",U,13987,,CHEMBL627619,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15359,Pseudo-first-order rate constant of the compound,U,13988,,CHEMBL627620,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15359,Pseudo-first-order rate constant with 1-min time point,U,13989,,CHEMBL627621,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15359,Pseudo-first-order rate constant without 1-min time point,U,13990,,CHEMBL627622,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,U,13991,,CHEMBL627623,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,U,13992,,CHEMBL627624,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,U,13993,,CHEMBL627625,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15704,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,U,13994,,CHEMBL628523,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15287,The alkaline hydrolysis second order rate constant(K OH) of the compound,U,13995,,CHEMBL628524,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7516,The efflux rate constant of the compound,U,13996,,CHEMBL628525,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12973,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,13997,,CHEMBL625732,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,13998,,CHEMBL625733,,Autocuration,22224,1
,,,,,F,,0,,,,,BAO_0000019,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,13999,,CHEMBL625734,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,U,14000,,CHEMBL625913,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8696,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,U,14001,,CHEMBL625914,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15052,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,U,14002,,CHEMBL625915,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15052,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,U,14003,,CHEMBL625916,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10503,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),U,14004,,CHEMBL625917,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,14005,,CHEMBL625918,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,14006,,CHEMBL625919,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,14007,,CHEMBL625920,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,14008,,CHEMBL874453,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",U,14009,,CHEMBL625921,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10503,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,U,14010,,CHEMBL625922,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,14011,,CHEMBL625923,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,14012,,CHEMBL625924,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,14013,,CHEMBL625925,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,14014,,CHEMBL625926,,Autocuration,22224,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13100,Biodistribution in rat lung at 60 minutes after dose administration.,N,14015,,CHEMBL627704,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,N,14016,,CHEMBL627705,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,N,14017,,CHEMBL627706,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,N,14018,,CHEMBL627707,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,N,14019,,CHEMBL627708,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,N,14020,,CHEMBL628361,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,N,14021,,CHEMBL628362,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,13100,Biodistribution in rat striatum at 120 minutes after dose administration.,N,14022,,CHEMBL628363,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,13100,Biodistribution in rat striatum at 1440 minutes after dose administration.,N,14023,,CHEMBL628364,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,13100,Biodistribution in rat striatum at 15 minutes after dose administration.,N,14024,,CHEMBL628365,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,13100,Biodistribution in rat striatum at 240 minutes after dose administration.,N,14025,,CHEMBL874454,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,13100,Biodistribution in rat striatum at 30 minutes after dose administration.,N,14026,,CHEMBL628531,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,13100,Biodistribution in rat striatum at 360 minutes after dose administration.,N,14027,,CHEMBL628532,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,13100,Biodistribution in rat striatum at 3 hr after dose administration.,N,14028,,CHEMBL628533,10116.0,Intermediate,50597,1
Striatum,,In vivo,,,A,Rattus norvegicus,1,,2435.0,,,BAO_0000218,13100,Biodistribution in rat striatum at 60 minutes after dose administration.,N,14029,,CHEMBL628534,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,13100,Biodistribution in rat thyroid at 120 minutes after dose administration.,N,14030,,CHEMBL628535,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,13100,Biodistribution in rat thyroid at 1440 minutes after dose administration.,N,14031,,CHEMBL628536,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,13100,Biodistribution in rat thyroid at 15 minutes after dose administration.,N,14032,,CHEMBL628537,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,13100,Biodistribution in rat thyroid at 240 minutes after dose administration.,N,14033,,CHEMBL628538,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,13100,Biodistribution in rat thyroid at 30 minutes after dose administration.,N,14034,,CHEMBL628539,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,13100,Biodistribution in rat thyroid at 360 minutes after dose administration.,N,14035,,CHEMBL630297,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,13100,Biodistribution in rat thyroid at 60 minutes after dose administration.,N,14036,,CHEMBL630298,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13100,Biodistribution in rest of brain of rat 120 minutes after dose administration.,N,14037,,CHEMBL630299,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,N,14038,,CHEMBL628094,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,N,14039,,CHEMBL628095,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,N,14040,,CHEMBL874648,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,N,14041,,CHEMBL628096,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,N,14042,,CHEMBL628097,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,N,14043,,CHEMBL628098,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",U,14044,,CHEMBL628099,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,14045,,CHEMBL628100,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13331,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),U,14046,,CHEMBL628101,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",U,14047,,CHEMBL628102,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",U,14048,,CHEMBL628103,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,14049,,CHEMBL628104,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",U,14050,,CHEMBL628105,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",U,14051,,CHEMBL628106,,Autocuration,22224,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,N,14052,,CHEMBL628107,10116.0,Intermediate,50597,1
Urine,,,,,F,,0,,1088.0,,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,U,14053,,CHEMBL628108,,Autocuration,22224,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,N,14054,,CHEMBL628109,10116.0,Intermediate,50597,1
Urine,,,,,F,,0,,1088.0,,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,U,14055,,CHEMBL625299,,Autocuration,22224,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,N,14056,,CHEMBL625300,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,N,14057,,CHEMBL625301,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,N,14058,,CHEMBL625302,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,N,14059,,CHEMBL874649,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13248,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,N,14060,,CHEMBL625303,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13248,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,N,14061,,CHEMBL625463,10116.0,Intermediate,50597,1
Liver,,,,,A,Homo sapiens,1,,2107.0,,,BAO_0000218,14527,In vitro metabolism in human liver microsomes,N,14062,,CHEMBL625464,9606.0,Intermediate,50587,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,3008,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,N,14063,,CHEMBL625465,9606.0,Intermediate,50587,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,14064,,CHEMBL625466,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,14065,,CHEMBL625467,9615.0,Intermediate,50588,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,14066,,CHEMBL625468,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,N,14067,,CHEMBL625469,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,14068,,CHEMBL625470,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,14069,,CHEMBL632418,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,14070,,CHEMBL627250,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,N,14071,,CHEMBL627251,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,N,14072,,CHEMBL627252,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,14073,,CHEMBL627253,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,N,14074,,CHEMBL627254,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,14075,,CHEMBL875471,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,N,14076,,CHEMBL627255,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,14077,,CHEMBL627256,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,N,14078,,CHEMBL627257,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,14079,,CHEMBL627258,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,N,14080,,CHEMBL627259,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,14081,,CHEMBL627260,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,N,14082,,CHEMBL623256,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,14083,,CHEMBL874413,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,N,14084,,CHEMBL623257,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,14085,,CHEMBL623258,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,N,14086,,CHEMBL623259,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,N,14087,,CHEMBL623260,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,14088,,CHEMBL623261,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,N,14089,,CHEMBL623262,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,N,14090,,CHEMBL623263,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,14091,,CHEMBL623264,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,14092,,CHEMBL623265,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,14093,,CHEMBL623266,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,N,14094,,CHEMBL623267,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,N,14095,,CHEMBL623268,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,14096,,CHEMBL623269,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,14097,,CHEMBL623270,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,14098,,CHEMBL623271,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,N,14099,,CHEMBL623272,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,14100,,CHEMBL623273,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,N,14101,,CHEMBL623274,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,14102,,CHEMBL874414,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,N,14103,,CHEMBL623275,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,14104,,CHEMBL629150,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,14105,,CHEMBL623276,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,14106,,CHEMBL623277,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,N,14107,,CHEMBL623112,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,N,14108,,CHEMBL623113,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,14109,,CHEMBL623800,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,14110,,CHEMBL623801,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,14111,,CHEMBL623802,10116.0,Intermediate,50597,1
Uterus,,In vivo,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,12017,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14112,,CHEMBL623803,10116.0,Intermediate,50597,1
Uterus,,In vivo,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,12017,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14113,,CHEMBL623970,10116.0,Intermediate,50597,1
Uterus,,In vivo,,,A,Rattus norvegicus,1,,995.0,,,BAO_0000218,12017,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14114,,CHEMBL623971,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),N,14115,,CHEMBL623972,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),N,14116,,CHEMBL623973,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),N,14117,,CHEMBL623974,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),N,14118,,CHEMBL623975,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),N,14119,,CHEMBL623976,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),N,14120,,CHEMBL623977,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),N,14121,,CHEMBL623978,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),N,14122,,CHEMBL623979,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),N,14123,,CHEMBL623980,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),N,14124,,CHEMBL623981,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),N,14125,,CHEMBL626278,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),N,14126,,CHEMBL626279,10116.0,Intermediate,50597,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14045,Biodistribution in mice bladder plus excreted urine was determined,N,14127,,CHEMBL626280,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14045,"Percentage biodistribution in mouse blood, 10 minutes post injection",N,14128,,CHEMBL626281,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14045,"Percentage biodistribution in mouse blood, 30 minutes post injection",N,14129,,CHEMBL626282,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14045,"Percentage biodistribution in mouse blood, 5 minutes post injection",N,14130,,CHEMBL626283,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14045,"Percentage biodistribution in mouse blood, 60 minutes post injection",N,14131,,CHEMBL626284,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse brain, 10 minutes post injection",N,14132,,CHEMBL626285,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse brain, 30 minutes post injection",N,14133,,CHEMBL626286,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse brain, 5 minutes post injection",N,14134,,CHEMBL626287,10090.0,Intermediate,50594,1
Brain,,,,,A,Mus musculus,1,,955.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse brain, 60 minutes post injection",N,14135,,CHEMBL626288,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14045,"Percentage biodistribution in mouse heart, 10 minutes post injection",N,14136,,CHEMBL626289,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14045,"Percentage biodistribution in mouse heart, 30 minutes post injection",N,14137,,CHEMBL626290,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14045,"Percentage biodistribution in mouse heart, 5 minutes post injection",N,14138,,CHEMBL626291,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14045,"Percentage biodistribution in mouse heart, 60 minutes post injection",N,14139,,CHEMBL839888,10090.0,Intermediate,50594,1
Intestine,,,,,A,Mus musculus,1,,160.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse intestine, 10 minutes post injection",N,14140,,CHEMBL626292,10090.0,Intermediate,50594,1
Intestine,,,,,A,Mus musculus,1,,160.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse intestine, 30 minutes post injection",N,14141,,CHEMBL626293,10090.0,Intermediate,50594,1
Intestine,,,,,A,Mus musculus,1,,160.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse intestine, 5 minutes post injection",N,14142,,CHEMBL626294,10090.0,Intermediate,50594,1
Intestine,,,,,A,Mus musculus,1,,160.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse intestine, 60 minutes post injection",N,14143,,CHEMBL626295,10090.0,Intermediate,50594,1
Liver,,,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse liver, 10 minutes post injection",N,14144,,CHEMBL627659,10090.0,Intermediate,50594,1
Liver,,,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse liver, 30 minutes of post injection",N,14145,,CHEMBL627660,10090.0,Intermediate,50594,1
Liver,,,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,14045,"Percentage biodistribution in mouse liver, 5 minutes post injection",N,14146,,CHEMBL627661,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,14045,Biodistribution in mice liver at 60 minutes of post injection,N,14147,,CHEMBL627662,10090.0,Intermediate,50594,1
Lung,,In vivo,,,A,Mus musculus,1,,2048.0,,,BAO_0000218,14045,Biodistribution in mice lungs at 10 min of post injection,N,14148,,CHEMBL627663,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14045,"Percentage biodistribution in mouse lung, 30 minutes post injection",N,14149,,CHEMBL627664,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,14045,"Percentage biodistribution in mousee lung, 5 minutes post injection",N,14150,,CHEMBL627665,10090.0,Intermediate,50594,1
Lung,,In vivo,,,A,Mus musculus,1,,2048.0,,,BAO_0000218,14045,Biodistribution in mice lungs at 60 min of post injection,N,14151,,CHEMBL627666,10090.0,Intermediate,50594,1
Spleen,,,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,14045,Percentage biodistribution in mouse spleen,N,14152,,CHEMBL627667,10090.0,Intermediate,50594,1
Stomach,,,,,A,Mus musculus,1,,945.0,,,BAO_0000218,14045,Percentage biodistribution in mouse stomach,N,14153,,CHEMBL627668,10090.0,Intermediate,50594,1
Urine,,,,,A,Mus musculus,1,,1088.0,,,BAO_0000218,11745,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,N,14154,,CHEMBL627669,10090.0,Intermediate,50594,1
Urinary bladder,,In vivo,,,A,,0,,1255.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,U,14155,,CHEMBL627670,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,U,14156,,CHEMBL627671,,Autocuration,22224,1
Bone element,,In vivo,,,A,,0,,1474.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,U,14157,,CHEMBL627672,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,U,14158,,CHEMBL627673,,Autocuration,22224,1
Kidney,,In vivo,,,A,,0,,2113.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,U,14159,,CHEMBL627674,,Autocuration,22224,1
Liver,,In vivo,,,A,,0,,2107.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,U,14160,,CHEMBL627675,,Autocuration,22224,1
Lung,,In vivo,,,A,,0,,2048.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,U,14161,,CHEMBL627676,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,U,14162,,CHEMBL627677,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",U,14163,,CHEMBL627678,,Autocuration,22224,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,7095,Affinity for protein binding expressed as association constant in fresh rat serum,N,14164,,CHEMBL627679,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,12185,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,14165,,CHEMBL627680,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12185,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,14166,,CHEMBL627681,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12185,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,14167,,CHEMBL627682,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12185,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,14168,,CHEMBL627683,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12686,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,U,14169,,CHEMBL627684,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,14170,,CHEMBL874441,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12686,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,U,14171,,CHEMBL627685,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,14172,,CHEMBL627686,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8057,Apparent rate constant Koff for inactivation of dTMP synthase.,U,14173,,CHEMBL627687,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15778,The irreversible inhibitor activity by second order rate equation.,U,14174,,CHEMBL627688,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,N,14175,,CHEMBL628038,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,N,14176,,CHEMBL628039,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,N,14177,,CHEMBL628040,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,13588,Dissociation rate calculated from the first-order equation using t1/2 value,U,14178,,CHEMBL628041,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15039,The compound was tested for Binding constant against DNA,U,14179,,CHEMBL630226,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9500,First order rate constant for cyclization of the compound,U,14180,,CHEMBL628042,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10014,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,14181,,CHEMBL625232,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10014,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,14182,,CHEMBL625233,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,568,Hydrolysis rate constant was determined,U,14183,,CHEMBL625979,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10026,Observed first order rate constant,U,14184,,CHEMBL625980,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,14185,,CHEMBL625981,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,14186,,CHEMBL625982,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9680,Second-order rate constant for attack on PNPA at 25 degree Centigrade,U,14187,,CHEMBL625983,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14188,,CHEMBL625984,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14189,,CHEMBL625985,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14190,,CHEMBL625986,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14191,,CHEMBL625987,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14192,,CHEMBL625988,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14193,,CHEMBL625989,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14194,,CHEMBL625990,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14195,,CHEMBL625991,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14196,,CHEMBL625992,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14197,,CHEMBL625993,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14198,,CHEMBL631973,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14199,,CHEMBL632143,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14200,,CHEMBL632144,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14201,,CHEMBL632145,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14202,,CHEMBL632146,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14203,,CHEMBL632147,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14204,,CHEMBL632148,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14205,,CHEMBL632149,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14206,,CHEMBL632150,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14207,,CHEMBL632151,,Autocuration,22224,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,3008,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,N,14208,,CHEMBL632152,9606.0,Intermediate,50587,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,4509,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,14209,,CHEMBL632153,9606.0,Intermediate,50587,1
,,,,,A,Homo sapiens,1,,,,,BAO_0000218,4509,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,14210,,CHEMBL632154,9606.0,Intermediate,50587,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,N,14211,,CHEMBL632155,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,N,14212,,CHEMBL632156,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,N,14213,,CHEMBL632157,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,N,14214,,CHEMBL632158,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,N,14215,,CHEMBL632159,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,N,14216,,CHEMBL626305,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,N,14217,,CHEMBL626306,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,N,14218,,CHEMBL626307,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,N,14219,,CHEMBL626308,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,N,14220,,CHEMBL626479,10298.0,Intermediate,50602,1
,,,,,A,Human herpesvirus 1,1,,,,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,N,14221,,CHEMBL626480,10298.0,Intermediate,50602,1
,,,,,P,,0,,,,,BAO_0000100,6021,Calculated partition coefficient (clogP) (MlogP),U,14222,,CHEMBL626481,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,9348,Equipotent potent ratio relative to carbachol (nicotinic activity),U,14223,,CHEMBL626482,,Autocuration,22224,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",N,14224,,CHEMBL626483,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",N,14225,,CHEMBL626484,9615.0,Intermediate,50588,1
,,,,,P,,0,,,,,BAO_0000100,15592,Solubility at pH 7.4 in micro g/mL;NA denotes available,U,14226,,CHEMBL626485,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,15592,Solubility at pH 7.4 in micro g/mL;NA denotes not available,U,14227,,CHEMBL626486,,Autocuration,22229,1
,,,,,P,,0,,,,,BAO_0000100,15592,Solubility at pH 7.4 in ug/mL;NA denotes not available,U,14228,,CHEMBL626487,,Autocuration,22229,1
Plasma,,In vivo,,,A,Canis lupus familiaris,1,,1969.0,,,BAO_0000218,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,14229,,CHEMBL626488,9615.0,Intermediate,50588,1
Serum,,,,,A,Rattus norvegicus,1,,1977.0,,,BAO_0000218,7095,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,N,14230,,CHEMBL626489,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,16618,Area under the MAP curve measured over 5 min; ND means Not determined,U,14231,,CHEMBL626490,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,16835,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,U,14232,,CHEMBL626491,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,15284,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,U,14233,,CHEMBL626492,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,15750,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,U,14234,,CHEMBL626493,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16618,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,N,14235,,CHEMBL626494,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,16618,Half life after oral tested,U,14236,,CHEMBL626495,,Autocuration,22224,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15812,Half life was determined in plasma of rat; NT indicates not tested,N,14237,,CHEMBL626496,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,16618,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,N,14238,,CHEMBL626497,10116.0,Intermediate,50597,1
,,In vivo,,,A,,0,,,,,BAO_0000218,16618,Oral bioavailability after oral tested,U,14239,,CHEMBL626498,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13098,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),N,14240,,CHEMBL626499,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13098,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),N,14241,,CHEMBL626500,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15812,half life was determined in plasma of rat; NT indicates not tested,N,14242,,CHEMBL626501,10116.0,Intermediate,50597,1
Plasma,,,,,A,Rattus norvegicus,1,,1969.0,,,BAO_0000218,15812,half life was determined in plasma of rat; NT means not tested,N,14243,,CHEMBL626502,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,N,14244,,CHEMBL626503,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); inactive,N,14245,,CHEMBL626504,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,N,14246,,CHEMBL626505,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,N,14247,,CHEMBL626506,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,N,14248,,CHEMBL626507,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,N,14249,,CHEMBL626508,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,N,14250,,CHEMBL626509,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,N,14251,,CHEMBL875480,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,N,14252,,CHEMBL626510,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,N,14253,,CHEMBL626511,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,N,14254,,CHEMBL626512,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,N,14255,,CHEMBL628208,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,N,14256,,CHEMBL628209,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,N,14257,,CHEMBL628210,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,N,14258,,CHEMBL628211,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,N,14259,,CHEMBL628212,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,N,14260,,CHEMBL628213,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,14261,,CHEMBL628214,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,14262,,CHEMBL628215,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,14263,,CHEMBL628216,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,14264,,CHEMBL626595,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,14265,,CHEMBL626596,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,14266,,CHEMBL626597,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,14267,,CHEMBL626598,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,14268,,CHEMBL622242,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,14269,,CHEMBL622243,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,14270,,CHEMBL622244,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,14271,,CHEMBL622245,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,14272,,CHEMBL622246,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,14273,,CHEMBL622247,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,14274,,CHEMBL622248,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,14275,,CHEMBL877483,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,14276,,CHEMBL622249,10116.0,Intermediate,50597,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,14277,,CHEMBL622250,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,14278,,CHEMBL622251,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,14279,,CHEMBL622252,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,14280,,CHEMBL622253,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,14281,,CHEMBL622254,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,14282,,CHEMBL622255,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,14283,,CHEMBL622256,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,14284,,CHEMBL622257,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,14285,,CHEMBL622258,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,14286,,CHEMBL622259,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,14287,,CHEMBL622927,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,14288,,CHEMBL622928,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,14289,,CHEMBL622929,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,14290,,CHEMBL623182,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,14291,,CHEMBL623183,9615.0,Intermediate,50588,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,N,14292,,CHEMBL623184,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,14293,,CHEMBL623185,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,14294,,CHEMBL877484,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,14295,,CHEMBL627274,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,N,14296,,CHEMBL623186,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,N,14297,,CHEMBL623187,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,14298,,CHEMBL623188,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,N,14299,,CHEMBL628055,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,14300,,CHEMBL628056,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,N,14301,,CHEMBL628200,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,14302,,CHEMBL628201,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,N,14303,,CHEMBL628202,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,14304,,CHEMBL628203,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,N,14305,,CHEMBL628204,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,14306,,CHEMBL628205,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,N,14307,,CHEMBL628206,10116.0,Intermediate,50597,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),U,14308,,CHEMBL628207,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,U,14309,,CHEMBL627220,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,U,14310,,CHEMBL627221,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),U,14311,,CHEMBL627222,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,U,14312,,CHEMBL627223,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,U,14313,,CHEMBL632062,,Autocuration,22224,1
Spleen,,In vivo,,,A,,0,,2106.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,U,14314,,CHEMBL632063,,Autocuration,22224,1
Urinary bladder,,In vivo,,,A,,0,,1255.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,U,14315,,CHEMBL632064,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,U,14316,,CHEMBL632065,,Autocuration,22224,1
Bone element,,In vivo,,,A,,0,,1474.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,U,14317,,CHEMBL632066,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,U,14318,,CHEMBL632067,,Autocuration,22224,1
Kidney,,In vivo,,,A,,0,,2113.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,U,14319,,CHEMBL629188,,Autocuration,22224,1
Liver,,In vivo,,,A,,0,,2107.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,U,14320,,CHEMBL629189,,Autocuration,22224,1
Lung,,In vivo,,,A,,0,,2048.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,U,14321,,CHEMBL629190,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,U,14322,,CHEMBL629191,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),U,14323,,CHEMBL629192,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,U,14324,,CHEMBL629193,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),U,14325,,CHEMBL629194,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,U,14326,,CHEMBL629195,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,U,14327,,CHEMBL629373,,Autocuration,22224,1
Spleen,,In vivo,,,A,,0,,2106.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,U,14328,,CHEMBL629374,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,U,14329,,CHEMBL629375,,Autocuration,22224,1
Urinary bladder,,In vivo,,,A,,0,,1255.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,U,14330,,CHEMBL629376,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,U,14331,,CHEMBL629377,,Autocuration,22224,1
Bone element,,In vivo,,,A,,0,,1474.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,U,14332,,CHEMBL629378,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,U,14333,,CHEMBL629379,,Autocuration,22224,1
Kidney,,In vivo,,,A,,0,,2113.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,U,14334,,CHEMBL629151,,Autocuration,22224,1
Liver,,In vivo,,,A,,0,,2107.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,U,14335,,CHEMBL629152,,Autocuration,22224,1
Lung,,In vivo,,,A,,0,,2048.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,U,14336,,CHEMBL629153,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,U,14337,,CHEMBL629154,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),U,14338,,CHEMBL629155,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,U,14339,,CHEMBL629156,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,U,14340,,CHEMBL629157,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),U,14341,,CHEMBL629158,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,U,14342,,CHEMBL629159,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,U,14343,,CHEMBL629160,,Autocuration,22224,1
Spleen,,In vivo,,,A,,0,,2106.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,U,14344,,CHEMBL629161,,Autocuration,22224,1
Urinary bladder,,In vivo,,,A,,0,,1255.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,U,14345,,CHEMBL629162,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,U,14346,,CHEMBL629163,,Autocuration,22224,1
Bone element,,In vivo,,,A,,0,,1474.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,U,14347,,CHEMBL629164,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,U,14348,,CHEMBL629165,,Autocuration,22224,1
Liver,,In vivo,,,A,,0,,2107.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,U,14349,,CHEMBL629166,,Autocuration,22224,1
Lung,,In vivo,,,A,,0,,2048.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,U,14350,,CHEMBL629167,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,U,14351,,CHEMBL629168,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,U,14352,,CHEMBL629169,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,U,14353,,CHEMBL629170,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,U,14354,,CHEMBL631153,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,U,14355,,CHEMBL875121,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,U,14356,,CHEMBL631154,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,U,14357,,CHEMBL631155,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,568,Hydrolysis rate constant was determined,U,14358,,CHEMBL631156,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9680,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",U,14359,,CHEMBL631157,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9680,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,14360,,CHEMBL631158,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9680,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,14361,,CHEMBL631159,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10026,Observed second order rate constant,U,14362,,CHEMBL631160,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,14363,,CHEMBL631161,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10014,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,14364,,CHEMBL631162,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10014,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,14365,,CHEMBL630313,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9680,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,14366,,CHEMBL630314,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9680,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,14367,,CHEMBL630315,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14368,,CHEMBL630316,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14369,,CHEMBL630986,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14370,,CHEMBL630987,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,U,14371,,CHEMBL630988,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14372,,CHEMBL630989,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14373,,CHEMBL630990,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14374,,CHEMBL630991,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14375,,CHEMBL630992,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14376,,CHEMBL630993,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,14377,,CHEMBL630994,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,10014,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,N,14378,,CHEMBL630995,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,9962,Association constant for compound at 31 degree C was determined,U,14379,,CHEMBL629252,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12029,Calculated antagonist equilibrium dissociation constant of the compound,U,14380,,CHEMBL629253,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12029,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,U,14381,,CHEMBL629944,,Autocuration,22224,1
Trachea,,,,,A,Cavia porcellus,1,,3126.0,,,BAO_0000218,10583,Dissociation constants vs LTE4 on guinea pig trachea,N,14382,,CHEMBL629945,10141.0,Intermediate,50512,1
,,,,,A,,0,,,,,BAO_0000019,568,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",U,14383,,CHEMBL629946,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,568,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",U,14384,,CHEMBL629947,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,568,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",U,14385,,CHEMBL629948,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,568,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",U,14386,,CHEMBL856024,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7493,Affinity constant KD value was derived from TMP,U,14387,,CHEMBL629949,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8371,Apparent dissociation (binding) rate constant was evaluated,U,14388,,CHEMBL629950,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,13114,Dissociation constant (KD) of the compound,U,14389,,CHEMBL630127,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,15515,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,U,14390,,CHEMBL630128,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,522,Dissociation constant from ESR titration experiments,U,14391,,CHEMBL630129,,Autocuration,22224,1
,,,,,,,0,,,,,BAO_0000019,13888,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),U,14392,,CHEMBL630130,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,2616,Dissociation constant was evaluated.,U,14393,,CHEMBL875234,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,3798,Dissociation constant was reported,U,14394,,CHEMBL630131,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,8731,Dissociation constant was determined in rat pituitary cells.,N,14395,,CHEMBL630132,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,11892,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,U,14396,,CHEMBL630133,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11892,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,U,14397,,CHEMBL630134,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2582,Equilibrium dissociation constant of the compound,U,14398,,CHEMBL630135,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11892,Equilibrium dissociation constant was determined,U,14399,,CHEMBL630136,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13396,Kinetic constant KD was evaluated,U,14400,,CHEMBL630137,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,603,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,U,14401,,CHEMBL630138,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15673,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,U,14402,,CHEMBL630139,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10368,Rate constant for hydrolysis in aqueous acetone.,U,14403,,CHEMBL630140,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14228,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,U,14404,,CHEMBL875235,,Autocuration,22224,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,N,14405,,CHEMBL876439,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,N,14406,,CHEMBL630605,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,N,14407,,CHEMBL630606,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,N,14408,,CHEMBL630607,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,N,14409,,CHEMBL630608,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,N,14410,,CHEMBL630609,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,N,14411,,CHEMBL630610,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,N,14412,,CHEMBL630611,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,N,14413,,CHEMBL629552,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,14414,,CHEMBL629733,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,14415,,CHEMBL629734,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,14416,,CHEMBL629735,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,14417,,CHEMBL629736,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,14418,,CHEMBL629737,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,14419,,CHEMBL629738,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,14420,,CHEMBL629739,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,14421,,CHEMBL629740,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,14422,,CHEMBL629741,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,14423,,CHEMBL629742,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,14424,,CHEMBL629743,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,14425,,CHEMBL629744,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,14426,,CHEMBL629745,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,14427,,CHEMBL629746,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,14428,,CHEMBL629747,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,14429,,CHEMBL629748,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,14430,,CHEMBL629749,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,14431,,CHEMBL629750,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,14432,,CHEMBL629751,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,14433,,CHEMBL629752,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,14434,,CHEMBL629753,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,14435,,CHEMBL629754,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,14436,,CHEMBL629755,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,14437,,CHEMBL629756,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,14438,,CHEMBL629757,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,14439,,CHEMBL629758,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,14440,,CHEMBL629759,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,14441,,CHEMBL629760,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,14442,,CHEMBL876443,10116.0,Intermediate,50597,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8310,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,N,14443,,CHEMBL629761,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8310,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,N,14444,,CHEMBL629762,9615.0,Intermediate,50588,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,14445,,CHEMBL629763,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,14446,,CHEMBL629764,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,14447,,CHEMBL629765,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,N,14448,,CHEMBL629766,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,14449,,CHEMBL629767,10090.0,Intermediate,50594,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8310,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,N,14450,,CHEMBL629768,9615.0,Intermediate,50588,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,N,14451,,CHEMBL629769,10090.0,Intermediate,50594,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8310,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,N,14452,,CHEMBL629770,9615.0,Intermediate,50588,1
,,,,,A,Canis lupus familiaris,1,,,,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,N,14453,,CHEMBL629771,9615.0,Intermediate,50588,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,14454,,CHEMBL629772,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,14455,,CHEMBL629773,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,14456,,CHEMBL625455,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,N,14457,,CHEMBL625456,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,N,14458,,CHEMBL625457,10090.0,Intermediate,50594,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,14459,,CHEMBL625458,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,N,14460,,CHEMBL625459,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,14461,,CHEMBL875483,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,N,14462,,CHEMBL634779,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,N,14463,,CHEMBL625460,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,14464,,CHEMBL626117,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,N,14465,,CHEMBL626118,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,N,14466,,CHEMBL628342,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,14467,,CHEMBL628343,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,14468,,CHEMBL628344,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,14469,,CHEMBL628345,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,N,14470,,CHEMBL628346,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,N,14471,,CHEMBL628347,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,14472,,CHEMBL628348,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,14473,,CHEMBL628349,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,14474,,CHEMBL875611,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,N,14475,,CHEMBL628350,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,14476,,CHEMBL628351,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,N,14477,,CHEMBL628352,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,14478,,CHEMBL628353,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,N,14479,,CHEMBL628354,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,14480,,CHEMBL626667,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,14481,,CHEMBL626668,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,14482,,CHEMBL626669,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,N,14483,,CHEMBL626670,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,N,14484,,CHEMBL626671,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,14485,,CHEMBL626672,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,N,14486,,CHEMBL626673,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,14487,,CHEMBL626674,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,14488,,CHEMBL626675,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,N,14489,,CHEMBL626676,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,N,14490,,CHEMBL626677,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,14491,,CHEMBL626678,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,14492,,CHEMBL626679,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,14493,,CHEMBL875612,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,14494,,CHEMBL626680,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,14495,,CHEMBL626681,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,14496,,CHEMBL626682,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,14497,,CHEMBL626683,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,14498,,CHEMBL626684,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,14499,,CHEMBL626685,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,14500,,CHEMBL626686,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,14501,,CHEMBL626687,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,14502,,CHEMBL624978,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,14503,,CHEMBL624979,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,14504,,CHEMBL624980,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,14505,,CHEMBL624981,10116.0,Intermediate,50597,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,14506,,CHEMBL624982,9615.0,Intermediate,50588,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),U,14507,,CHEMBL627564,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),U,14508,,CHEMBL627565,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,U,14509,,CHEMBL627566,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,U,14510,,CHEMBL627567,,Autocuration,22224,1
Spleen,,In vivo,,,A,,0,,2106.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,U,14511,,CHEMBL627568,,Autocuration,22224,1
Kidney,,In vivo,,,A,,0,,2113.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,U,14512,,CHEMBL627569,,Autocuration,22224,1
Urinary bladder,,In vivo,,,A,,0,,1255.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,U,14513,,CHEMBL627570,,Autocuration,22224,1
Blood,,In vivo,,,A,,0,,178.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,U,14514,,CHEMBL627571,,Autocuration,22224,1
Bone element,,In vivo,,,A,,0,,1474.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,U,14515,,CHEMBL627572,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,U,14516,,CHEMBL627573,,Autocuration,22224,1
Kidney,,In vivo,,,A,,0,,2113.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,U,14517,,CHEMBL627574,,Autocuration,22224,1
Liver,,In vivo,,,A,,0,,2107.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,U,14518,,CHEMBL627575,,Autocuration,22224,1
Lung,,In vivo,,,A,,0,,2048.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,U,14519,,CHEMBL627576,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,U,14520,,CHEMBL627577,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),U,14521,,CHEMBL627578,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,U,14522,,CHEMBL627579,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,U,14523,,CHEMBL627580,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),U,14524,,CHEMBL627581,,Autocuration,22224,1
,,In vivo,,,A,,0,,,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,U,14525,,CHEMBL627582,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,U,14526,,CHEMBL627583,,Autocuration,22224,1
Spleen,,In vivo,,,A,,0,,2106.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,U,14527,,CHEMBL627584,,Autocuration,22224,1
Prostate gland,,In vivo,,,A,,0,,2367.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,U,14528,,CHEMBL627585,,Autocuration,22224,1
Muscle tissue,,In vivo,,,A,,0,,2385.0,,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,U,14529,,CHEMBL627586,,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,N,14530,,CHEMBL627587,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,14531,,CHEMBL627588,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,N,14532,,CHEMBL628250,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,14533,,CHEMBL628251,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,N,14534,,CHEMBL628252,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,14535,,CHEMBL628253,10116.0,Intermediate,50597,1
Hypothalamus,,In vivo,,,A,Rattus norvegicus,1,,1898.0,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,N,14536,,CHEMBL628254,10116.0,Intermediate,50597,1
Hypothalamus,,In vivo,,,A,Rattus norvegicus,1,,1898.0,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,14537,,CHEMBL877493,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,14538,,CHEMBL628255,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,14539,,CHEMBL628256,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,14540,,CHEMBL628257,10116.0,Intermediate,50597,1
Hypothalamus,,In vivo,,,A,Rattus norvegicus,1,,1898.0,,,BAO_0000218,15413,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,14541,,CHEMBL628258,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,14542,,CHEMBL628259,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,14543,,CHEMBL628429,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,14544,,CHEMBL626862,10116.0,Intermediate,50597,1
Hypothalamus,,In vivo,,,A,Rattus norvegicus,1,,1898.0,,,BAO_0000218,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,N,14545,,CHEMBL626863,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,N,14546,,CHEMBL625886,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,N,14547,,CHEMBL625887,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat cortex,N,14548,,CHEMBL625888,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,N,14549,,CHEMBL625889,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,N,14550,,CHEMBL625890,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,N,14551,,CHEMBL625891,10116.0,Intermediate,50597,1
Hypothalamus,,In vivo,,,A,Rattus norvegicus,1,,1898.0,,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,N,14552,,CHEMBL625892,10116.0,Intermediate,50597,1
Hypothalamus,,In vivo,,,A,Rattus norvegicus,1,,1898.0,,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,N,14553,,CHEMBL625893,10116.0,Intermediate,50597,1
Cerebellum,,In vivo,,,A,Rattus norvegicus,1,,2037.0,,,BAO_0000218,15413,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,N,14554,,CHEMBL625894,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15413,Biodistribution of the [18F]-radiolabeled compound in rat cortex,N,14555,,CHEMBL625895,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,14556,,CHEMBL625896,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,568,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",U,14557,,CHEMBL625897,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,568,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,14558,,CHEMBL625898,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,568,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,14559,,CHEMBL625899,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,14560,,CHEMBL626124,,Autocuration,22224,1
,,,,,A,Escherichia coli,1,,,,,BAO_0000218,7624,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,N,14561,,CHEMBL628500,562.0,Intermediate,50212,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7624,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",N,14562,,CHEMBL857856,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7624,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",N,14563,,CHEMBL628501,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,4643,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",U,14564,,CHEMBL628502,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11532,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,U,14565,,CHEMBL628503,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11018,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,U,14566,,CHEMBL628504,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,14567,,CHEMBL628505,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",U,14568,,CHEMBL874452,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",U,14569,,CHEMBL628506,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,14570,,CHEMBL628507,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",U,14571,,CHEMBL628508,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8949,Michaelis constant (KM) was evaluated,U,14572,,CHEMBL628509,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,14573,,CHEMBL628510,,Autocuration,22224,1
,,,,,B,,0,,,,,BAO_0000019,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase I,U,14574,,CHEMBL628511,,Autocuration,22224,1
,,,,,B,,0,,,,,BAO_0000019,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase II,U,14575,,CHEMBL628512,,Autocuration,22224,1
,,,,,B,,0,,,,,BAO_0000019,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase III,U,14576,,CHEMBL628513,,Autocuration,22224,1
,,,,,B,,0,,,,,BAO_0000019,7625,Substrate concentration for half maximal velocity was reported for yeast hexokinase,U,14577,,CHEMBL628514,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,12908,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,U,14578,,CHEMBL628515,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10368,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,U,14579,,CHEMBL628516,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13108,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,14580,,CHEMBL628517,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13108,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,14581,,CHEMBL628518,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15217,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,U,14582,,CHEMBL628519,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15217,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,U,14583,,CHEMBL628520,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10933,Binding constant was determined,U,14584,,CHEMBL628521,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2363,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,U,14585,,CHEMBL630443,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2363,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,U,14586,,CHEMBL630444,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,U,14587,,CHEMBL857732,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,14915,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,U,14588,,CHEMBL630445,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8847,Catalytic rate constant of the compound,U,14589,,CHEMBL630446,,Autocuration,22224,1
,,,,,B,,0,,,,,BAO_0000019,15357,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,U,14590,,CHEMBL630447,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2869,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),U,14591,,CHEMBL630448,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3484,Catalytic rate constant against phospholipase A2 was determined,U,14592,,CHEMBL630449,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,1373,"Compound was evaluated for catalytic constant, Kcat",U,14593,,CHEMBL630450,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8142,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,U,14594,,CHEMBL630451,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14131,Kcat calculated from 0.693/T1/2,U,14595,,CHEMBL630452,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,17269,Kcat was determined,U,14596,,CHEMBL630453,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3485,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,U,14597,,CHEMBL630454,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3485,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,U,14598,,CHEMBL630455,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3485,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,U,14599,,CHEMBL631487,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,5962,Kcat value was determined,U,14600,,CHEMBL631488,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3133,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,U,14601,,CHEMBL876440,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3133,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,U,14602,,CHEMBL631489,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,14603,,CHEMBL857742,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,14604,,CHEMBL631490,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",U,14605,,CHEMBL631491,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,14606,,CHEMBL631492,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,14607,,CHEMBL631493,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,4892,Kinetic parameter for rate of conversion to PABA was determined,U,14608,,CHEMBL631494,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3133,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,14609,,CHEMBL631495,,Autocuration,22224,1
Feces,,,,,A,Rattus norvegicus,1,,1988.0,,,BAO_0000218,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,14610,,CHEMBL631496,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,14611,,CHEMBL631497,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,14612,,CHEMBL631498,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,14613,,CHEMBL629776,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,14614,,CHEMBL629777,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,14615,,CHEMBL629778,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,N,14616,,CHEMBL630456,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,N,14617,,CHEMBL630457,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,N,14618,,CHEMBL630458,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,N,14619,,CHEMBL630459,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,N,14620,,CHEMBL630460,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,N,14621,,CHEMBL876550,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,N,14622,,CHEMBL630461,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,N,14623,,CHEMBL630462,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,N,14624,,CHEMBL630463,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,N,14625,,CHEMBL630464,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,N,14626,,CHEMBL630465,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,N,14627,,CHEMBL630466,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,N,14628,,CHEMBL630467,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,N,14629,,CHEMBL630633,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,N,14630,,CHEMBL630634,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,N,14631,,CHEMBL630635,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,N,14632,,CHEMBL630636,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,N,14633,,CHEMBL630637,10116.0,Intermediate,50597,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,14634,,CHEMBL630638,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,14635,,CHEMBL630639,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,14636,,CHEMBL630640,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,14637,,CHEMBL876551,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",N,14638,,CHEMBL630641,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,14639,,CHEMBL630642,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,14640,,CHEMBL630643,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,14641,,CHEMBL630644,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,14642,,CHEMBL630645,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,14643,,CHEMBL625599,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,14644,,CHEMBL625600,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,14645,,CHEMBL625601,9986.0,Intermediate,50592,1
Feces,,,,,A,Oryctolagus cuniculus,1,,1988.0,,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,14646,,CHEMBL625602,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",N,14647,,CHEMBL627470,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,14648,,CHEMBL627471,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,14649,,CHEMBL627472,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,14650,,CHEMBL627473,9986.0,Intermediate,50592,1
Urine,,,,,A,Oryctolagus cuniculus,1,,1088.0,,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,14651,,CHEMBL627474,9986.0,Intermediate,50592,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13925,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14652,,CHEMBL627475,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,13925,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14653,,CHEMBL627476,10116.0,Intermediate,50597,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,14654,,CHEMBL627477,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,14655,,CHEMBL627478,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,14656,,CHEMBL627479,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,14657,,CHEMBL627480,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,14658,,CHEMBL627481,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,14659,,CHEMBL627482,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,14660,,CHEMBL627483,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,14661,,CHEMBL875636,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,14662,,CHEMBL625764,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,14663,,CHEMBL625765,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,N,14664,,CHEMBL625766,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,14665,,CHEMBL625767,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,14666,,CHEMBL625768,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,14667,,CHEMBL625769,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,14668,,CHEMBL625770,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,14669,,CHEMBL625771,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,N,14670,,CHEMBL625772,9615.0,Intermediate,50588,1
Urine,,,,,A,Canis lupus familiaris,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,14671,,CHEMBL625773,9615.0,Intermediate,50588,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,14672,,CHEMBL625774,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,N,14673,,CHEMBL625775,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,14674,,CHEMBL625776,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,14675,,CHEMBL625777,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,14676,,CHEMBL625778,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,N,14677,,CHEMBL625779,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,N,14678,,CHEMBL625780,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,14679,,CHEMBL625781,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,N,14680,,CHEMBL875637,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,14681,,CHEMBL626473,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,N,14682,,CHEMBL626474,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,14683,,CHEMBL626475,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,N,14684,,CHEMBL626476,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,14685,,CHEMBL634397,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,N,14686,,CHEMBL626477,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,14687,,CHEMBL631069,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,N,14688,,CHEMBL631070,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,14689,,CHEMBL631071,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,N,14690,,CHEMBL631072,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,14691,,CHEMBL631073,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,N,14692,,CHEMBL631074,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,N,14693,,CHEMBL631075,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,14694,,CHEMBL631725,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,N,14695,,CHEMBL631726,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,N,14696,,CHEMBL631727,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,14697,,CHEMBL631728,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,14698,,CHEMBL631729,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,N,14699,,CHEMBL631730,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,N,14700,,CHEMBL631731,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,14701,,CHEMBL631910,10116.0,Intermediate,50597,1
Hippocampus,,In vivo,,,A,Rattus norvegicus,1,,10000000.0,,,BAO_0000218,15413,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,N,14702,,CHEMBL631911,10116.0,Intermediate,50597,1
Hypothalamus,,In vivo,,,A,Rattus norvegicus,1,,1898.0,,,BAO_0000218,15413,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,N,14703,,CHEMBL631912,10116.0,Intermediate,50597,1
Hypothalamus,,In vivo,,,A,Rattus norvegicus,1,,1898.0,,,BAO_0000218,15413,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,N,14704,,CHEMBL631913,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14705,,CHEMBL631914,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14706,,CHEMBL631915,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14707,,CHEMBL875778,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14708,,CHEMBL631916,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14709,,CHEMBL631917,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14710,,CHEMBL631918,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14711,,CHEMBL631919,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14712,,CHEMBL631920,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14713,,CHEMBL631921,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14714,,CHEMBL631922,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,12017,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14715,,CHEMBL631923,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14716,,CHEMBL631924,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14717,,CHEMBL630234,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14718,,CHEMBL630235,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14719,,CHEMBL630236,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14720,,CHEMBL630237,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14721,,CHEMBL630238,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14722,,CHEMBL630239,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14723,,CHEMBL630303,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14724,,CHEMBL630304,10116.0,Intermediate,50597,1
,,In vivo,,,A,Rattus norvegicus,1,,,,,BAO_0000218,12017,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14725,,CHEMBL630305,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14726,,CHEMBL630306,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14727,,CHEMBL630307,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14728,,CHEMBL630308,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14729,,CHEMBL630309,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14730,,CHEMBL629309,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14731,,CHEMBL629993,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14732,,CHEMBL629994,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14733,,CHEMBL629995,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14734,,CHEMBL631993,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14735,,CHEMBL631994,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14736,,CHEMBL631995,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14737,,CHEMBL631996,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14738,,CHEMBL631997,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14739,,CHEMBL631998,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14740,,CHEMBL631999,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14741,,CHEMBL632000,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14742,,CHEMBL632001,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14743,,CHEMBL874424,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14744,,CHEMBL632002,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14745,,CHEMBL632003,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,3133,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,14746,,CHEMBL632004,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2742,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,U,14747,,CHEMBL632005,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2742,Compound was tested for amidase rate in the presence of N62C screen enzyme,U,14748,,CHEMBL632006,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2742,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,U,14749,,CHEMBL632007,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2742,Compound was tested for amidase rate in the presence of S166C screen enzyme,U,14750,,CHEMBL632008,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2742,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,U,14751,,CHEMBL632009,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2742,Compound was tested for esterase rate in the presence of N62C screen enzyme,U,14752,,CHEMBL632010,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2742,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,U,14753,,CHEMBL857750,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2742,Compound was tested for esterase rate in the presence of S166C screen enzyme,U,14754,,CHEMBL632011,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,14755,,CHEMBL632012,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,14756,,CHEMBL632013,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",U,14757,,CHEMBL632014,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,14758,,CHEMBL629622,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,14759,,CHEMBL629623,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",U,14760,,CHEMBL629624,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,17269,Ratio of Kcat to that of Km was determined,U,14761,,CHEMBL629625,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,14762,,CHEMBL629626,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,14763,,CHEMBL629627,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,15917,"Compound was evaluated for constant, Kd",U,14764,,CHEMBL629628,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10933,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,U,14765,,CHEMBL629629,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10933,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,U,14766,,CHEMBL629630,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14293,Dissociation Constant of compound determined,U,14767,,CHEMBL856030,,Autocuration,22224,1
,,,,,B,,0,,,,,BAO_0000019,6698,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,U,14768,,CHEMBL629631,,Autocuration,22224,1
,,,,,B,,0,,,,,BAO_0000019,6698,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,U,14769,,CHEMBL629632,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,4318,Dissociation constant of compound with Fructose was determined,U,14770,,CHEMBL629633,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,4318,Dissociation constant of compound with Fructose was determined; Not determined,U,14771,,CHEMBL629634,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,4318,Dissociation constant of compound with Lactulose was determined,U,14772,,CHEMBL629635,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,4318,Dissociation constant of compound with Lactulose was determined; Not determined,U,14773,,CHEMBL629636,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,14959,Dissociation constant of the Compound,U,14774,,CHEMBL629637,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,5913,Dissociation constant by non-linear regression analysis,U,14775,,CHEMBL629638,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,14218,Dissociation constant was determined,U,14776,,CHEMBL629639,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,10689,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,U,14777,,CHEMBL629640,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,13925,Dissociation constant was determined,U,14778,,CHEMBL629641,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,16359,Dissociation constant was determined,U,14779,,CHEMBL631344,,Autocuration,22224,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10944,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,N,14780,,CHEMBL631345,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,11080,The dissociation constant determined by fluorescence displacement assay,U,14781,,CHEMBL631346,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,17805,kd value surface plasmon resonance (SPR) method,U,14782,,CHEMBL631524,,Autocuration,22224,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,10944,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,N,14783,,CHEMBL631525,10116.0,Intermediate,50597,1
,,,,,F,,0,,,,,BAO_0000019,16645,First dissociation constant of the binding of compound to V30M TTR,U,14784,,CHEMBL631526,,Autocuration,22224,1
,,,,,F,,0,,,,,BAO_0000019,16645,Second dissociation constant of the binding of compound to V30M TTR,U,14785,,CHEMBL631527,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7793,"Compound was evaluated for equilibrium constant, Ke",U,14786,,CHEMBL631528,,Autocuration,22224,1
Hypothalamus,,,,,A,,0,,1898.0,,,BAO_0000019,12199,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,U,14787,,CHEMBL631529,,Autocuration,22224,1
Hypothalamus,,,,,A,,0,,1898.0,,,BAO_0000019,12199,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,U,14788,,CHEMBL631530,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9680,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,U,14789,,CHEMBL631531,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9680,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,U,14790,,CHEMBL631532,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,9680,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,U,14791,,CHEMBL631533,,Autocuration,22224,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13758,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,14792,,CHEMBL876552,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13758,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,14793,,CHEMBL631534,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13758,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,14794,,CHEMBL631535,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,14795,,CHEMBL631536,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,N,14796,,CHEMBL631537,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,14797,,CHEMBL631538,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,N,14798,,CHEMBL631539,10090.0,Intermediate,50594,1
,,,,,A,Mus musculus,1,,,,,BAO_0000218,13758,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,14799,,CHEMBL631540,10090.0,Intermediate,50594,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,14800,,CHEMBL625637,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14393,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,14801,,CHEMBL625638,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,15078,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,14802,,CHEMBL625639,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13925,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14803,,CHEMBL625640,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,13925,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14804,,CHEMBL625641,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13925,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14805,,CHEMBL625642,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,13925,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14806,,CHEMBL625643,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13925,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14807,,CHEMBL625644,10116.0,Intermediate,50597,1
Kidney,,In vivo,,,A,Rattus norvegicus,1,,2113.0,,,BAO_0000218,13925,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14808,,CHEMBL625645,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13925,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14809,,CHEMBL625646,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,13925,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14810,,CHEMBL625647,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13925,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14811,,CHEMBL625648,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,13925,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,N,14812,,CHEMBL625649,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13925,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14813,,CHEMBL625650,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,13925,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14814,,CHEMBL625651,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,13925,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14815,,CHEMBL625652,10116.0,Intermediate,50597,1
Zone of skin,,In vivo,,,A,Rattus norvegicus,1,,14.0,,,BAO_0000218,13925,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14816,,CHEMBL625653,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,13925,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14817,,CHEMBL625654,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,13925,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,14818,,CHEMBL625655,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9712,Biodistribution of Compound in rat blood after 15 minutes of administration,N,14819,,CHEMBL625656,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Rattus norvegicus,1,,178.0,,,BAO_0000218,9712,Biodistribution of Compound in rat blood after 2 minutes of administration,N,14820,,CHEMBL625657,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,9712,Biodistribution of Compound in rat brain after 15 minutes of administration,N,14821,,CHEMBL625658,10116.0,Intermediate,50597,1
Brain,,In vivo,,,A,Rattus norvegicus,1,,955.0,,,BAO_0000218,9712,Biodistribution of Compound in rat brain after 2 minutes of administration,N,14822,,CHEMBL625659,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9712,Biodistribution of Compound in rat heart after 15 minutes of administration,N,14823,,CHEMBL625660,10116.0,Intermediate,50597,1
Heart,,In vivo,,,A,Rattus norvegicus,1,,948.0,,,BAO_0000218,9712,Biodistribution of Compound in rat heart after 2 minutes of administration,N,14824,,CHEMBL625661,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9712,Biodistribution of Compound in rat liver after 15 minutes of administration,N,14825,,CHEMBL625662,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,9712,Biodistribution of Compound in rat liver after 2 minutes of administration,N,14826,,CHEMBL625663,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,9712,Biodistribution of Compound in rat lung after 15 minutes of administration,N,14827,,CHEMBL875621,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,9712,Biodistribution of Compound in rat lung after 2 minutes of administration,N,14828,,CHEMBL628382,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9712,Biodistribution of Compound in rat muscle after 15 minutes of administration,N,14829,,CHEMBL628383,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,9712,Biodistribution of Compound in rat muscle after 2 minutes of administration,N,14830,,CHEMBL628384,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,N,14831,,CHEMBL628385,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,N,14832,,CHEMBL875753,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,N,14833,,CHEMBL628386,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat blood 2 minutes after intravenous injection,N,14834,,CHEMBL628387,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat blood 2 hr after intravenous injection,N,14835,,CHEMBL628388,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat blood 30 minutes after intravenous injection,N,14836,,CHEMBL628389,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat blood 30 min after intravenous injection,N,14837,,CHEMBL632756,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat brain 2 minutes after intravenous injection,N,14838,,CHEMBL628390,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat brain 2 hr after intravenous injection,N,14839,,CHEMBL631811,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat brain 30 minutes after intravenous injection,N,14840,,CHEMBL631812,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat heart 2 minutes after intravenous injection,N,14841,,CHEMBL631813,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat heart 2 hr after intravenous injection,N,14842,,CHEMBL631814,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat heart 30 minutes after intravenous injection,N,14843,,CHEMBL631815,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat kidney 2 minutes after intravenous injection,N,14844,,CHEMBL631816,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat kidney 2 hr after intravenous injection,N,14845,,CHEMBL875758,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat kidney 30 minutes after intravenous injection,N,14846,,CHEMBL631817,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,6941,Organ distribution in rat liver 2 minutes after intravenous injection,N,14847,,CHEMBL631818,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,6941,Organ distribution in rat liver 2 hr after intravenous injection,N,14848,,CHEMBL631819,10116.0,Intermediate,50597,1
Liver,,,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,6941,Organ distribution in rat liver 30 minutes after intravenous injection,N,14849,,CHEMBL631820,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat lung 2 minutes after intravenous injection,N,14850,,CHEMBL631821,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat lung 2 hr after intravenous injection,N,14851,,CHEMBL631822,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,6941,Organ distribution in rat lung 30 minutes after intravenous injection,N,14852,,CHEMBL631823,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,6941,Organ distribution in rat muscle 2 minutes after intravenous injection,N,14853,,CHEMBL631824,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,6941,Organ distribution in rat muscle 2 hr after intravenous injection,N,14854,,CHEMBL631825,10116.0,Intermediate,50597,1
Muscle tissue,,,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,6941,Organ distribution in rat muscle 30 minutes after intravenous injection,N,14855,,CHEMBL631826,10116.0,Intermediate,50597,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),N,14856,,CHEMBL631827,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),N,14857,,CHEMBL631828,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),N,14858,,CHEMBL631829,10090.0,Intermediate,50594,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,14859,,CHEMBL875759,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,N,14860,,CHEMBL631830,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,N,14861,,CHEMBL631831,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,14862,,CHEMBL631832,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,N,14863,,CHEMBL631833,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,14864,,CHEMBL631834,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,N,14865,,CHEMBL631835,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,14866,,CHEMBL631836,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,14867,,CHEMBL631837,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,14868,,CHEMBL631838,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,N,14869,,CHEMBL631839,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,N,14870,,CHEMBL631840,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,14871,,CHEMBL631841,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,14872,,CHEMBL631842,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,14873,,CHEMBL631843,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,14874,,CHEMBL631844,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,14875,,CHEMBL631845,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,14876,,CHEMBL631846,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,14877,,CHEMBL875760,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,14878,,CHEMBL632199,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,14879,,CHEMBL631847,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,14880,,CHEMBL631848,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,14881,,CHEMBL628707,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,14882,,CHEMBL628708,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,14883,,CHEMBL628709,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,14884,,CHEMBL628710,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,14885,,CHEMBL628711,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,14886,,CHEMBL628712,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,14887,,CHEMBL628713,10116.0,Intermediate,50597,1
Urine,,,,,A,Rattus norvegicus,1,,1088.0,,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,14888,,CHEMBL628714,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,7415,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",N,14889,,CHEMBL628715,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,U,14890,,CHEMBL629179,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,U,14891,,CHEMBL629180,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,U,14892,,CHEMBL875108,,Autocuration,22224,1
Adrenal cortex,,,,,A,,0,,1235.0,,,BAO_0000019,7570,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,14893,,CHEMBL629181,,Autocuration,22224,1
Adrenal cortex,,,,,A,,0,,1235.0,,,BAO_0000019,7570,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,14894,,CHEMBL629182,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7570,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,U,14895,,CHEMBL629183,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7570,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,14896,,CHEMBL629184,,Autocuration,22224,1
Adrenal cortex,,,,,A,,0,,1235.0,,,BAO_0000019,7570,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,14897,,CHEMBL629185,,Autocuration,22224,1
Adrenal cortex,,,,,A,,0,,1235.0,,,BAO_0000019,7570,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,U,14898,,CHEMBL629186,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7570,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,U,14899,,CHEMBL629187,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7570,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,U,14900,,CHEMBL629887,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7570,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,U,14901,,CHEMBL629888,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7570,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,U,14902,,CHEMBL629889,,Autocuration,22224,1
Adrenal cortex,,,,,A,,0,,1235.0,,,BAO_0000019,7570,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,U,14903,,CHEMBL629890,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7570,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,14904,,CHEMBL629891,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7570,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,U,14905,,CHEMBL629892,,Autocuration,22224,1
Adrenal cortex,,,,,A,,0,,1235.0,,,BAO_0000019,7570,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,14906,,CHEMBL629893,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7570,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,U,14907,,CHEMBL629894,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,7570,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,U,14908,,CHEMBL629895,,Autocuration,22224,1
,,In vivo,,,A,Canis lupus familiaris,0,,,,,BAO_0000218,14122,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",U,14909,,CHEMBL875109,9615.0,Autocuration,22224,1
,,In vivo,,,A,Macaca fascicularis,0,,,,,BAO_0000218,16449,Absolute bioavailability in male cynomolgus monkeys,U,14910,,CHEMBL629896,9541.0,Autocuration,22224,1
,,In vivo,,,A,Rattus norvegicus,0,,,,,BAO_0000218,16449,Absolute bioavailability in maleSprague-Dawley rats,U,14911,,CHEMBL629897,10116.0,Autocuration,22224,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14912,,CHEMBL629898,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14913,,CHEMBL630057,10116.0,Intermediate,50597,1
Liver,,In vivo,,,A,Rattus norvegicus,1,,2107.0,,,BAO_0000218,12017,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14914,,CHEMBL630058,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14915,,CHEMBL630059,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14916,,CHEMBL630060,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14917,,CHEMBL630061,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14918,,CHEMBL630062,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14919,,CHEMBL630063,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14920,,CHEMBL630064,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14921,,CHEMBL630065,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14922,,CHEMBL630066,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14923,,CHEMBL630067,10116.0,Intermediate,50597,1
Lung,,In vivo,,,A,Rattus norvegicus,1,,2048.0,,,BAO_0000218,12017,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14924,,CHEMBL630068,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14925,,CHEMBL631113,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14926,,CHEMBL631114,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14927,,CHEMBL631115,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14928,,CHEMBL631116,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14929,,CHEMBL630528,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14930,,CHEMBL630529,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14931,,CHEMBL630530,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14932,,CHEMBL630531,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14933,,CHEMBL630532,10116.0,Intermediate,50597,1
Muscle tissue,,In vivo,,,A,Rattus norvegicus,1,,2385.0,,,BAO_0000218,12017,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14934,,CHEMBL630533,10116.0,Intermediate,50597,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,15045,Biodistribution in normal mice blood after 120 hr,N,14935,,CHEMBL630534,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,15045,Biodistribution in normal mice blood after 24 hr,N,14936,,CHEMBL630535,10090.0,Intermediate,50594,1
Blood,,In vivo,,,A,Mus musculus,1,,178.0,,,BAO_0000218,15045,Biodistribution in normal mice blood after 4 hr,N,14937,,CHEMBL630536,10090.0,Intermediate,50594,1
Bone,,In vivo,,,A,Mus musculus,1,,10000001.0,,,BAO_0000218,15045,Biodistribution in normal mice bone after 120 hr,N,14938,,CHEMBL630537,10090.0,Intermediate,50594,1
Bone,,In vivo,,,A,Mus musculus,1,,10000001.0,,,BAO_0000218,15045,Biodistribution in normal mice bone after 24 hr,N,14939,,CHEMBL630538,10090.0,Intermediate,50594,1
Bone,,In vivo,,,A,Mus musculus,1,,10000001.0,,,BAO_0000218,15045,Biodistribution in normal mice bone after 4 hr,N,14940,,CHEMBL630539,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,15045,Biodistribution in normal mice heart after 120 hr,N,14941,,CHEMBL630540,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,15045,Biodistribution in normal mice heart after 24 hr,N,14942,,CHEMBL630541,10090.0,Intermediate,50594,1
Heart,,In vivo,,,A,Mus musculus,1,,948.0,,,BAO_0000218,15045,Biodistribution in normal mice heart after 4 hr,N,14943,,CHEMBL630542,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,15045,Biodistribution in normal mice kidney after 120 hr,N,14944,,CHEMBL630543,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,15045,Biodistribution in normal mice kidney after 24 hr,N,14945,,CHEMBL630544,10090.0,Intermediate,50594,1
Kidney,,In vivo,,,A,Mus musculus,1,,2113.0,,,BAO_0000218,15045,Biodistribution in normal mice kidney after 4 hr,N,14946,,CHEMBL630545,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,15045,Biodistribution in normal mice liver after 120 hr,N,14947,,CHEMBL630546,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,15045,Biodistribution in normal mice liver after 24 hr,N,14948,,CHEMBL630547,10090.0,Intermediate,50594,1
Liver,,In vivo,,,A,Mus musculus,1,,2107.0,,,BAO_0000218,15045,Biodistribution in normal mice liver after 4 hr,N,14949,,CHEMBL630548,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,15045,Biodistribution in normal mice spleen after 120 hr,N,14950,,CHEMBL630549,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,15045,Biodistribution in normal mice spleen after 24 hr,N,14951,,CHEMBL630550,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Mus musculus,1,,2106.0,,,BAO_0000218,15045,Biodistribution in normal mice spleen after 4 hr,N,14952,,CHEMBL876426,10090.0,Intermediate,50594,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14953,,CHEMBL630551,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14954,,CHEMBL630552,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14955,,CHEMBL630553,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14956,,CHEMBL630554,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14957,,CHEMBL630555,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14958,,CHEMBL630556,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14959,,CHEMBL630557,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,14960,,CHEMBL630558,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14961,,CHEMBL630559,10116.0,Intermediate,50597,1
Spleen,,In vivo,,,A,Rattus norvegicus,1,,2106.0,,,BAO_0000218,12017,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14962,,CHEMBL630560,10116.0,Intermediate,50597,1
Thyroid gland,,In vivo,,,A,Rattus norvegicus,1,,2046.0,,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,14963,,CHEMBL876427,10116.0,Intermediate,50597,1
,,,,,A,Rattus norvegicus,1,,,,,BAO_0000218,14941,The Kel values in female wistar rats.,N,14964,,CHEMBL630561,10116.0,Intermediate,50597,1
,,,,,A,,0,,,,,BAO_0000019,4646,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,U,14965,,CHEMBL630562,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8847,Hydrolysis rate constant of the compound,U,14966,,CHEMBL630563,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,11778,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,U,14967,,CHEMBL629673,,Autocuration,22229,1
,,,,,A,,0,,,,,BAO_0000019,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",U,14968,,CHEMBL629674,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",U,14969,,CHEMBL629675,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",U,14970,,CHEMBL629676,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",U,14971,,CHEMBL629677,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8371,Apparent inactivation rate constant was evaluated,U,14972,,CHEMBL629678,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14883,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,U,14973,,CHEMBL629679,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,14883,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,U,14974,,CHEMBL629680,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,4643,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,U,14975,,CHEMBL629681,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,3519,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,U,14976,,CHEMBL629682,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,10600,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,U,14977,,CHEMBL629683,,Autocuration,22224,1
,,,,,F,,0,,,,,BAO_0000019,8501,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,U,14978,,CHEMBL629684,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,8505,Dissociation constant was determined,U,14979,,CHEMBL629685,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,9778,Dissociation constant was determined,U,14980,,CHEMBL629686,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,9778,Dissociation constant at pH 7.4,U,14981,,CHEMBL872932,,Autocuration,22224,1
,,,,,P,,0,,,,,BAO_0000100,9778,Dissociation constant in presence of 1 mM dithiothreitol,U,14982,,CHEMBL629687,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13007,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,14983,,CHEMBL872931,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13007,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,14984,,CHEMBL628151,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13007,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,14985,,CHEMBL628152,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,13007,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,14986,,CHEMBL628153,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11482,Kinetic constant for aromatization of androstenedione,U,14987,,CHEMBL628154,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11482,Kinetic constant for aromatization of testosterone,U,14988,,CHEMBL628155,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,2303,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,U,14989,,CHEMBL628156,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,11964,Local inhibition constant was determined,U,14990,,CHEMBL628157,,Autocuration,22224,1
,,,,,A,Saccharomyces cerevisiae,1,,,,,BAO_0000218,3140,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,N,14991,,CHEMBL857533,4932.0,Intermediate,50347,1
,,,,,P,,0,,,,,BAO_0000100,10650,Dissociation constant value of the compound,U,14992,,CHEMBL628158,,Autocuration,22224,1
Cornea,,,,,A,,0,,964.0,,,BAO_0000019,4667,In vitro permeability through cornea without epithelium,U,14993,,CHEMBL628159,,Autocuration,22224,1
Cornea,,,,,A,,0,,964.0,,,BAO_0000019,4667,In vitro permeability through intact cornea,U,14994,,CHEMBL875616,,Autocuration,22224,1
Cornea,,,,,A,Oryctolagus cuniculus,1,,964.0,,,BAO_0000218,9199,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,N,14995,,CHEMBL628160,9986.0,Intermediate,50592,1
,,,,,A,,0,,,,,BAO_0000019,11966,Rate of enzyme inactivation for the compound was determined,U,14996,,CHEMBL628161,,Autocuration,22224,1
Cornea,,,,,A,,0,,964.0,,,BAO_0000019,4667,In vitro permeability through cornea without epithelium,U,14997,,CHEMBL628162,,Autocuration,22224,1
Cornea,,,,,A,,0,,964.0,,,BAO_0000019,4667,In vitro permeability through intact cornea,U,14998,,CHEMBL628163,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,14999,,CHEMBL628164,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15000,,CHEMBL628165,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15001,,CHEMBL628166,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15002,,CHEMBL628167,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15003,,CHEMBL628168,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15004,,CHEMBL628169,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15005,,CHEMBL628170,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15006,,CHEMBL628171,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15007,,CHEMBL627434,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15008,,CHEMBL627435,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15009,,CHEMBL628110,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15010,,CHEMBL628111,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15011,,CHEMBL628112,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15012,,CHEMBL628260,,Autocuration,22224,1
,,,,,A,,0,,,,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,15013,,CHEMBL628261,,Autocuration,22224,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),N,15014,,CHEMBL628262,10090.0,Intermediate,50594,1
,,In vivo,,,A,Homo sapiens,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,N,15015,,CHEMBL628263,9606.0,Intermediate,50587,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),N,15016,,CHEMBL628264,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),N,15017,,CHEMBL628265,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),N,15018,,CHEMBL628266,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),N,15019,,CHEMBL628267,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,N,15020,,CHEMBL628268,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),N,15021,,CHEMBL628269,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),N,15022,,CHEMBL628270,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),N,15023,,CHEMBL628271,10090.0,Intermediate,50594,1
,,In vivo,,,A,Mus musculus,1,,,,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),N,15024,,CHEMBL628272,10090.0,Intermediate,50594,1
